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Abstract 
 
This thesis aimed to establish the impact of pressure ulcers (PUs) on health-related 
quality of life (HRQL) and determine the need for a PU-specific patient-reported 
outcome (PRO) instrument.  The thesis comprises literature reviews, development of a 
conceptual framework and development and evaluation of a PU-specific PRO (PU-
QOLI) for future research and clinical practice.  Methodological developments were 
woven into the research. 
 
This thesis demonstrates that PUs impact HRQL and there is need for standardised 
methods for assessing health outcomes important in PUs.  The PU-QOLI was 
developed using qualitative and quantitative psychometric methods and meets 
international standards for rigorous measurement.  Individual scales can be selected 
from 10 outcomes of PU-symptoms, physical functioning, psychological well-being, and 
social participation, intended for interview-administration.  It is appropriate for use in 
adults with any type of PU and suitable for all UK healthcare settings.   
 
This research makes important contributions to the PU and wider health measurement 
fields.  The findings demonstrate that mixed methods, including Rasch measurement, 
were suitable for developing a PRO instrument, the PU-QOLI provides a means for the 
comprehensive assessment of PU impact and for quantifying the benefits of PU 
interventions from the patient‟s perspective, thus far lacking in the area, and the use of 
PROs will provide evidence-based information to allow health authorities to select the 
most effective healthcare for patients and to audit and monitor the quality of care given 
in the PU field.   
 
This work was the first step towards establishing measurement precision.  Further 
research is needed to improve some of the measurement properties of PU-QOLI 
scales, assess responsiveness, confirm study findings in an independent sample, 
investigate feasibility of use in specific subgroups and economic evaluation, and 
develop proxy measures and language translations.  Long-term goals include 
developing the PU-QOLI as a clinical tool intended for individual-patient decision 
making.   
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Chapter 1  
BACKGROUND 
 
1.1 Introduction 
Chronic wounds are a major health problem and challenge to patients, healthcare 
professionals and the healthcare system, particularly as the age of the population 
increases.  Pressure ulcers (PUs) are common chronic wounds that occur as localised 
injury to the skin and/or underlying tissue usually over a bony prominence, as a result 
of pressure, or pressure in combination with shear (1).  PUs range in size and severity 
of tissue layer affected, with the majority occurring below the waist; particularly 
vulnerable areas are the sacrum, buttocks and heels (2).  With widespread prevalence 
and incidence in all health settings (3), PUs, often a complication of serious acute or 
chronic illness, are a significant health problem associated with increased morbidity (4), 
mortality (5), healthcare costs and hospitalisation, and identified as a UK National 
Health Service (NHS) quality indicator and priority through Department of Health (DoH) 
policy (6, 7, 8).   
 
PUs impact quality of life (QoL) and can severely compromise all areas of patient 
functioning (Chapter 2).  Intensive interventions for preventing and treating PUs pose 
additional patient burden and further affect QoL (9).  Therefore, evaluating outcomes 
such as QoL is particularly important and relevant in PUs where the condition and 
associated interventions pose patient burden.  
 
This chapter provides a brief summary of key areas of the literature including the 
definition and classification of PUs, the theoretical basis for the value of patient-
reported outcomes (PRO), measurement of PROs and methodological developments. 
 
1.2 Pressure Ulcer Definition and Classification  
PUs, also known as pressure or bed sores, decubitus ulcers or dermal ulcers, are a 
common type of impaired skin integrity that results in erythema and destruction of skin 
layers due to pressure alone or pressure in combination with shearing forces (1).  
Areas of necrosis and ulceration occur where skin or deeper soft tissues compress 
between bony prominences and hard surface.  PUs usually develop from laying or 
sitting in one position for prolonged periods (10).  For those immobile, PUs will most 
likely form on or around the heels, hip-bone and/or lower back/sacrum.  However, 
unlike other chronic wounds where ulceration is constrained to the limbs (e.g. leg or 
diabetic foot ulcers), PUs can develop anywhere on the body (11). 
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PUs range in severity and various PU classifications have been used over the years 
(i.e. PU grade or stage; often used interchangably in the literature).  To provide a 
standardised method of record-keeping and a common description of PU severity for 
the purposes of clinical practice, audit and research, a recent international collaboration 
agreed a PU classification system using the term category (1) (Table 1.1).  This 
classification posits that PU severity ranges from non-blanchable skin erythema of 
intact skin (category 1) and superficial skin loss (category 2) to, in serious cases, tissue 
destruction involving skin, subcutaneous fat, muscle and bone damage (category 3/4) 
(1).  For the purpose of this research, the classification has been adapted to enable 
classification of normal skin and unstageable PUs, and the term grade and stage will 
be used when referring to earlier studies, depending on classifications used. 
 
Table 1.1 Pressure Ulcer Classification System  
Category Description 
Category 1 
Non-blanchable erythema 
of intact skin 
Intact skin with non-blanchable erythema of a localised area 
usually over a bony prominence. Discolouration of the skin, 
warmth, oedema, hardness or pain may also be present. 
Darkly pigmented skin may not have visible blanching. 
Category 2 
Partial thickness skin loss 
or blister 
Partial thickness loss of dermis presenting as a shallow 
open ulcer with a red pink wound bed, without slough. May 
also present as an intact or open/ruptured serum or sero-
sanginous-filled blister. 
Category 3 
Full thickness skin loss 
Full thickness tissue loss. Subcutaneous fat may be visible 
but bone, tendon or muscle not exposed. Some slough may 
be present. May include undermining and tunnelling. 
Category 4 
Full thickness tissue loss 
Full thickness tissue loss with exposed bone, tendon or 
muscle. Slough or eschar may be present. Often includes 
undermining or tunnelling. 
Category U 
Unstageable 
Full thickness skin loss where actual depth of the ulcer is 
completely obscured by slough (yellow, tan, grey, green or 
brown) and/or eschar (tan, brown, black) in the wound bed. 
 
The intial sign of pressure is skin redness (non-blanchable erythema); skin does not 
blanch (whiten) under light finger pressure.  Whilst commonly classed as category or 
grade 1 PU, it is regarded in Europe as a precursor to PU development, as the 
erythema may resolve without skin destruction.  However, grade 1 ulcers are also an 
early warning sign for healthcare providers and patients to apply adequate 
interventions to avoid further deterioration (12).  Grade 1 PUs have been identified as a 
risk factor for PU development, with approximately one third of grade 1 PUs 
deteriorating to a grade 2 ulcer (13, 14).  Grade 2 PUs are reportable as clinical 
incidents across the UK NHS and Grade 3/4 PUs represent serious clinical events, 
increasingly subjected to investigation for abuse, neglect and litigation (15).  
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To date, PU research has been encumbered by methodological issues (e.g. differences 
in data collection and study methodology) and variability in describing and reporting 
PUs (16).  This may be due to the variability in classification systems.  PUs have been 
previously classified using terms grade or stage, which implies a natural progression 
from 1 to 4, however not all PUs progress in this way.  Further, identifying and 
assessing grade 1 or equivalent PUs is difficult, resulting in inflated prevalence rates in 
some health settings and lower/under-reported rates in others.  Reports of inter-rater 
reliability have been high in detecting grade 2 PUs, but there is also high disagreement 
between detection and accurate PU severity classification when skin is assessed by 
multiple clinical staff (17, 18). 
 
1.2.1 What are the risk factors and who is at risk? 
The primary PU risk factor is immobility (19).  The likelihood of PU development in 
immobile patients is increased by interactions between the intensity and duration of 
mechanical load and factors affecting skin tolerance, namely increased age, impaired 
circulation, nutritional deficiencies, skin perfusion (e.g. diabetes, vascular disease), 
incontinence, altered consciousness, and exposure to pressure and shear (5, 20, 21, 
22, 23, 24, 25, 26, 27).  These factors are common in patients with serious acute and 
chronic illness and high risk groups include elderly1, medical, cardio/vascular surgical 
(13), orthopaedic (28), intensive care (29), end-stage terminally ill (30), long-term care 
and community care populations (e.g. spinal cord injured (SCI), brain injured, 
neuromuscular disease – multiple sclerosis, neurologically compromised – demented, 
who may be both insensate and immobile, spending extended time lying supine) (23).   
 
Despite a number of contributing or confounding factors associated with PUs, available 
risk assessment scales yield conflicting results regarding their usefulness as predictors 
of PU development.  Various scales exist for identification of people at increased risk of 
PUs (31, 32, 33, 34, 35, 36, 37) but there is currently no uniform characterisation of PU 
risk factors.  Risk assessment scales were developed ad hoc based on opinions about 
the relative importance of risk factors rather than rigorous evidence (38).  The most 
valid way of determining risk factors is through use of statistical regression models that 
weigh factors which best predict PU development (39) (i.e. accurately detect PU 
occurrence and link it to risk variables).  Currently, no risk assessment scales have 
been developed in this way (40) and many patients are falsely identified as at risk or 
                                               
1 Age alone is not a risk factor for PUs but rather problems common to elderly people 
such as altered molecular and cellular characteristics of aged skin and various  
associated comorbidities. 
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not at risk (41), suggesting the scales lack sensitivity and specificity.  Further, attempts 
to synthesise meaningful risk factor data were performed in sample sizes not permitting 
multivariate analyses (PU risk factor systematic review – unpublished).  There is need 
for improved methods for accurately identifying those at risk and targeting appropriate 
interventions that prevent PU development and improve outcomes important to patients 
(i.e. QoL). 
 
1.3 Epidemiology 
PUs are widespread and often an underestimated health problem.  They are common 
in hospital, nursing home facilities and homecare patients (42).  Prevalence is defined 
as the number of patients with a PU in a specific population at a specific time, usually 
evaluated on a one-time, cross-sectional basis while incidence is the number of 
patients that develop a new PU after, for example, hospital admission (43).  Prevalence 
rates for PUs in several countries report rates between 5.3% and 69% in acute care 
settings (28, 44, 45, 46, 47, 48); 2.6% and 25.9% among nursing home residents (46, 
49, 50); and 0.31% and 6.3% in home care patients (42, 51).  Approximately one in 10 
hospital and one in 20 community patients are affected by PUs (3).  In the UK it has 
been estimated that between four and 10% of all patients admitted to hospital will 
develop at least one PU during their hospital stay (52).   
 
1.4 Economic impact 
Due to high prevalence, the overall prevention and management of PUs is both a 
national and international healthcare issue.  Despite advances in medicine, surgery, 
nursing care and self-care education, some PUs are considered unavoidable and 
remain a major cause of morbidity and mortaility.  In addition to the cost of human 
suffering, substantial costs to the healthcare system demonstrate the importance of 
preventing PUs and providing cost-effective PU management.  The cost of PUs is 
estimated at £1.4-2.1 billion annually; equivalent to 4% of total NHS expenditure (6).  
Costs arise from increased length of hospital stay/community nursing care; treatments; 
complications such as serious infection (53); risk assessment of all acute and 
community nursing patients on admission; and litigation, which is predicted to increase 
due to both general societal trends (aging population) and proposed changes in the law 
leading to investigation of severe PUs by government agencies to detect institutional 
and professional neglect of vulnerable adults (15). 
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1.5 Prevention and treatment 
Due to the complexity of PUs, healthcare providers face the challenge of providing 
effective preventative and treatment interventions for PUs.  The choice of intervention 
depends on the purpose, for example, pressure damage prevention, skin protection 
from moisture or removing necrotic tissue to promote healing.  NHS practice guidance 
is focused upon identifying patients at risk through risk assessment of all patients on 
admission to acute hospitals and community nursing services, implementing 
preventative care (e.g. specialist mattresses, turning, skin care) and using interventions 
to halt damage and promote healing (e.g. mattresses, dressings, nutritional 
supplements) (1, 19, 54, 55, 56).   
 
Preventative interventions include: positioning and support surfaces (e.g. mattresses, 
cushions, heel elevation, turning) and nutritional supplements (56, 57).  PU treatment 
can be divided into non-operative, including: positioning and support surfaces; 
nutritional supplements; topical treatments (e.g. dressings, Maggot Debridement 
Therapy (MDT), negative pressure wound therapy – Vacuum Assisted Closure (VAC)); 
adjuvant therapies; and hospitalisation, and operative treatments (e.g. plastic surgery 
involving flap repair) (1, 19, 55, 58, 59, 60, 61): 
 
 Positioning and support surfaces  
Repositioning and support surfaces are a widely used modality in the prevention and 
treatment of PUs.  They are intended for patient positioning to avoid compression of 
soft tissues against bony prominences or hard surfaces and to reduce pressure (e.g. 
pressure-relieving mattress/cushion to manage tissue load or distribute weight) (1, 56).   
 
 Nutrition  
Adequate protein, carbohydrates, vitamins and minerals are considered important for 
wound healing (1), specifically the growth of granulation tissue, although the 
effectiveness of nutrition has not been demonstrated in  randomised controlled trials 
(RCTs) (62).  Being under or over–weight have been associated with PU development 
(63). 
 
 Topical treatments  
Topical treatments, mainly dressings, are intended to manage odour, exudate and 
pain, promote wound healing, protect the skin from further damage due to incontinence 
(e.g. ointments, creams), and for bacterial and infection management.  MDT, also 
known as maggot therapy, is a topical treatment for hard to heal wounds where  
sterile fly larvae are applied to the wound for two or three days within special dressings 
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to keep them from migrating.  Other topical treatments involve wound management to 
accelerate endogenous healing or facilitate the effectiveness of other therapeutic 
methods, such as debridement to remove necrotic tissue, excessive bacteria and/or 
dead cells (e.g. VAC therapy); wound cleansing to remove loose impediments to 
wound healing; and moisture balance to facilitate granulation and reepithelialisation (1, 
60, 61).   
 
 Surgery  
Surgical treatment of PUs can be for preparing the wound for healing (e.g. removal of 
prominences without excessive incision to alleviate pressure due to compression of 
soft tissue between the skeleton/support surfaces) or definitive wound closure (e.g. 
direct closure, skin grafts, skin and musculocutaneous flaps) (1). 
 
 Adjuvant therapies 
Electrical stimulation (e.g. electrotherapy), hyperbaric oxygen therapy, and negative 
pressure intended for exudate and debris removal, increasing wound perfusion, and 
formation of granulation tissue, are examples of adjuvant therapies for PUs.  Few 
studies have assessed the efficacy of these methods and therefore they tend to be 
used when healing with conventional methods fails (1).  
 
In the PU field there is limited evidence of treatment effectiveness because of the poor 
quality of RCTs conducted (56, 60, 61), a lack of standard outcome measures and the 
use of clinician- rather than patient-reported outcome measures (see section 1.13).  
However, interventions are still required and used for PU prevention and treatment but 
they can cause patients considerable pain and discomfort, affect health, functioning 
and QoL, and cause significant treatment burden (9, 64).  As PUs are painful (65), 
malodorous (66), and can exudate profusely (67), especially during the early 
inflammation phase, frequent dressing changes may be required.  The intensity of PU-
symptoms and the severity and duration of PUs and of receiving PU interventions 
contribute to treatment burden.  One study found that for hospice patients, comfort 
superseded PU prevention and wound care, particularly if patients were dying or had 
conditions causing them to lie in a single position (64).  Therefore not only PU 
prevention and effective PU management, but assessment of PU interventions against 
outcomes important to patients (i.e. treatment burden, QoL) is needed.  For example, 
even though we can measure the level of PU exudate or odour, the experience of 
these symptoms and the impact they may or may not have is subjective and individual.  
Furthermore, due to differences in healing patterns between acute and chronic 
wounds, complete wound closure may not be a realistic outcome in many chronic PUs.  
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Therefore, alternative endpoints such as reduction of exudate, improved pain 
management or an overall improvement in health outcomes may be more appropriate 
in the assessment of PUs. 
 
1.6 The history of health outcome measurement 
Health outcome measurement is a relatively new concept that has grown steadily over 
the past 40 years.  Traditionally health was thought of as a physical or mental state 
with assessments focusing on the presence or absence of disease.  With an increase 
in chronic diseases where cure may not be possible but the disease may cause severe 
disability, treatment focus has shifted from cure and prolonging life - „life quantity‟ - to 
alleviating symptoms and returning patients to pre-disease levels of functioning; 
essentially „life quality‟ (68).  Methodological advances in measuring patient-reported 
health outcomes have led to a departure from the traditionally perceived biomedical 
model to a broader perspective of health and disease that perceives health as not 
merely the absence of disease but complete physical, mental and social well-being 
(69).  Stemming from this emerged a biopsychosocial model (70) that integrates the 
psychological and environmental (the „social‟) into the biomedical model of health.  This 
fundamental shift in health-related thinking led to an increasing interest in health 
measurement, outcomes such as health status, functioning, well-being and patient 
satisfaction, and in the use of such outcomes in healthcare research, practice and 
policy (71).  The field of health is reliant on health outcome measurement to provide a 
strong evidence-base incorporating both patient perspectives and cost analyses. 
 
Models that define and measure health outcomes are principally based on the World 
Health Organisation‟s (WHO) definition of health where the patient perspective is 
central to the concept of health, not simply the presence or absence of disease (72, 
73).  The WHO distinguished between the aetiology and processes (pathology) of non-
fatal chronic diseases on human life (International Classification of Impairments, 
Disabilities, and Handicaps [ICIDH]) at three levels: impairment (any loss or 
abnormality of psychological, physiological or anatomical structure or function at organ 
level); disability (physical and psychological functional limitation caused by 
impairment); and handicap (the effects of disability, and of adaptations to it, on an 
individual‟s ability to perform social roles and thus the degree of social disadvantage 
conferred by the disability) (74, 75).  To address shortcomings of the ICIDH (i.e. 
overlap between dimensions of impairment, disability and handicap; lack of clarity 
about causal and temporal relationships between these three dimensions; and 
insufficient attention to the role of the environment) (76), a new classification model of 
functioning and activity was developed, the ICIDH-2 (77), and organised into three 
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dimensions: body level (loss of body functions and structure considered as 
impairments), individual level (relates to performance of person-level tasks and 
limitations that cause an individual difficulty performing the activity) and societal level 
(relates to an individual's participation and involvement in life situations in relation to 
body functions and structure, health conditions, activities and contextual factors (77);  
involvement, inclusion of the individual in life activities in the context of where they live, 
is key (76)).   
 
Wilson and Cleary (1995) proposed a conceptual model of measures of health 
outcome, integrating both biological and psychological aspects into five levels (Figure 
1.1) (78).  They proposed a theoretical link between clinical variables and measures of 
QoL (see Section 1.8), linking the biomedical (i.e. biological, physiological, and clinical 
outcomes) with the social sciences (i.e. functioning and well-being).  In doing so they 
proposed a wider linear progression than that suggested by WHO.  Biological factors 
directly relate to symptoms; symptoms influence functioning; and functional status 
directly influences patient perceptions of health outcomes.  The concepts proposed are 
integrated but in addition there are a number of individual and environmental factors 
that contribute to relationships; factors that cannot be controlled by clinicians or 
healthcare systems.  The model has been widely applied to different populations, 
including patients with chronic heart failure, HIV infection, and cancer (79, 80, 81). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Conceptual model of Health Outcomes (78) 
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Conceptual models are useful for proposing a theoretical link between health problems 
(e.g. chronic disease, trauma and injury) and the extent these health problems and 
associated treatments effect patient functioning and well-being (82).  In the process of 
developing a conceptual model, important PROs for measurement, associated to a 
particular health problem, are identified.   
 
1.7 Patient-reported outcomes  
Assessment of PROs has become increasingly important in many conditions (83, 84), 
and there is now an international consensus that PROs play an important role in clinical 
practice and research (83, 85, 86, 87).  A PRO is a measurement of any aspect of a 
patient‟s health status that comes directly from the patient without any interpretation of 
the patient‟s response by physicians or others, about how they function or feel in 
relation to a health condition or its therapy (86).  Some variables can be measured 
directly such as physiologic measurements (i.e. blood pressure) that may assist 
clinicians in diagnosing or treating an illness.  Other variables, such as information 
about how a patient feels or some treatment effects, are measured indirectly and 
therefore can only come directly from the patient.  Variables that cannot be measured 
directly (as opposed to observable variables) are called latent variables.   
 
PRO is an umbrella term that has been adopted to describe a set of tools (usually 
questionnaires) that attempt to measure one or more latent variables related to health.  
The term does not tell us what is being measured, only that the patient is providing the 
data.  These tools can enhance healthcare provider-patient communication and 
decision-making and assist in evaluating how well a new drug or medical intervention is 
working to improve patient care by providing information to physicians and patients 
needed for selection of the best treatment (see section 1.12).  Relying solely on direct 
measures of health status such as a clinician‟s assessment of exudate level does not 
account for an individual‟s threshold for tolerance of or the amount of bother attributed 
to the exudate experienced.   
 
1.8 Quality of Life versus Health-Related Quality of Life 
A patient‟s health status can be measured through various concepts including 
symptomatic outcomes (i.e. pain), effect on ability to carry out daily tasks, and to more 
complex concepts such as QoL.  QoL is a broad concept used (and abused) widely 
with the assumption that everyone knows what it means.  There is no universal 
definition but it is accepted that QoL is a multi-dimensional concept referring to all 
aspects of a person‟s well-being influenced by the persons‟ perceived level of 
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satisfaction in a variety of circumstances (i.e. perceived happiness relative to their life 
in general).  It encompasses four primary domains: psychological, physical, social and 
role functioning (88, 89).  Psychological factors include depression, anxiety, and 
adjustment to illness and treatments; physical factors include pain, discomfort, mobility, 
sleep, appetite, and nausea; social factors include personal and sexual relationships, 
and engagement in social and leisure activities; role functioning includes daily activities 
such as the ability to cope with household duties and fulfilling roles within the family 
(73, 88, 90, 91).  Other domains in QoL models include: occupational (88), health 
perceptions (92), housing, recreation, environment, independence and spirituality (88, 
90, 91, 93, 94, 95) as it is considered that QoL is influenced by factors beyond health 
status.   
 
QoL is a concept that means different things to different people and takes different 
forms depending on the specific circumstances and conditions under which the term is 
measured and applied.  When assessed in two people with similar circumstances (i.e. 
same medical condition), both people may have entirely different evaluations of their 
QoL, therefore QoL is subjective in nature and best measured by directly asking the 
person themselves.  In healthcare, QoL refers to the impact of a given disease or 
medical condition on a patients overall normal functioning in addition to the effects of 
the intervention being evaluated (90), a concept referred to as health-related quality of 
life (HRQL).   
 
QoL and HRQL are often used interchangeably in the literature but they are distinct 
concepts.  Like QoL, HRQL is a multi-dimensional construct that represents an 
individual‟s perceptions of how a given disease or medical condition and its treatment 
affect, at a minimum, their psychological, physical and social functioning.  Several 
general models of HRQL also include separate domains for adjustment to illness and 
treatment, psychological symptomology, pain and other physical symptoms (96, 97), 
general health and health perceptions (73, 91), immobility, sleep disturbance and 
energy (73, 88, 90, 91, 93, 95).  Essentially, HRQL measurements assess physical 
consequences of disease (symptoms and decreased function), effect of disease on a 
person‟s emotional state, feelings, coping behaviours, and self-identify (psychological 
functioning), and a person‟s ability to interact with others and participate socially (work, 
social interaction and relationships, role functioning).  The term HRQL will be used 
throughout this work. 
 
HRQL is viewed as an important outcome in the overall healthcare of patients.  If the 
goal of healthcare is to protect, promote and preserve people‟s health then we need 
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standardised methods for assessment of health outcomes.  A simple way of assessing 
HRQL would be to ask a patient how they are feeling but this would produce vastly 
subjective data.  Therefore we need ways to quantify how people are feeling, for 
example, how a particular disease and/or treatments are affecting the patient.  We can 
do this with rating scales (now known as PRO instruments).  PRO instruments 
measure complex variables broken down into their component parts; manifestations of 
latent variables are transformed into numbers that can be taken as measurements (87).  
As HRQL is a multidimensional construct, in practice, HRQL is broken down into core 
components (domains) that are measured by PRO instruments as separate constructs 
or variables.  
 
1.9 Types of PRO instruments 
There is increasing international consensus advocating the use of scientifically 
meaningful PRO instruments in clinical trials and healthcare evaluation (83, 84, 86).  
The best PROs are designed to probe patients in a structured, formal way to give 
reproducible, meaningful, quantitative assessments of how patients feel and how they 
function from their perspective (86).  PROs may be generic, disease/condition specific 
and preference based.  Questions range from simple dichotomous responses (Yes/No) 
to those with several possible responses (e.g. Likert scales).  The intention is to 
produce a summed score of responses for a particular variable (e.g. pain).   
 
Generic instruments are designed to measure a range of concepts that can be applied 
across multiple diseases, outcomes, treatments/healthcare programmes and 
populations, as well as used with healthy populations (84, 98, 99).  Being applicable to 
various populations makes them useful for broad comparisons of the relative impact of 
healthcare programs across diseases.  A commonly used generic instrument is the 
medical outcomes study (MOS) short-form (SF-36) health survey (100).  
 
In contrast, disease-specific instruments cover measures that are directly related to a 
particular disease and used to assess the impact of that disease on patients‟ health 
and functioning, with the goal of detecting minimally important effects in individuals 
(99).  Disease-specific instruments often have a better sensitivity to minor changes in 
HRQL than generic instruments.  The two approaches are not mutually exclusive; each 
has its strengths and weaknesses and are suitable under different circumstances (99).   
 
Although also used to evaluate HRQL outcomes, preference-based measures of health 
are a means of estimating health state values or preferences for calculating quality 
adjusted life years (101).  These tools are used in economic evaluation alongside 
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clinical trials to value the benefits of treatment or other healthcare (i.e. cost-based 
evaluations considering the cost of treatment against time to healing).   
 
1.10 What to consider when selecting a PRO instrument 
In practice and research, only structured and psychometrically rigorous instruments 
should be used.  PRO instruments should be designed to minimise measurement error 
and ensure consistency, ultimately providing a more reliable measurement than one 
that would be obtained by informal interviews.  The Scientific Advisory Committee of 
the Medical Outcomes Trust identified eight key attributes that a PRO instrument 
should meet (102); an instrument should be appropriate, acceptable, feasible, 
interpretable, have precision, reliability, validity and be responsive to change.   More 
recently, the US Department of Health & Human Services Food & Drug Association 
(FDA) produced guidance to help ensure that PRO instruments are developed to 
measure what they are intended to measure and that they are supported by solid, 
scientific rationale (reliable, interpretable, and valid) (86).  When selecting an 
instrument, in the first instance, determining whether an instruments‟ content is 
appropriate for addressing a particular research question should be made.  For 
example, what is the area of investigation?  If it is HRQL, then what domains are 
relevant and does the intended instrument represent these domains?  Then we might 
look at the instruments‟ psychometric properties and make judgements about these 
properties in respect to specific contexts (103).  In healthcare, where we might require 
scales that are sensitive to changes over time, we would look for evidence of the 
instruments responsiveness.  Key instrument attributes and measurement properties 
will be discussed in detail in subsequent chapters. 
 
1.11 Measurement of HRQL in patients with PUs 
The development of PUs is widely perceived to impact on HRQL although few studies 
contain empirical data to substantiate this assumption (see Chapter 2 for a review of 
the literature).  Work to date has been mainly qualitative; identifying that PUs cause 
substantial pain and discomfort and affect sleep, rehabilitation and mobility, and 
psychological, physical and social aspects of patient‟s lives (104, 105, 106, 107).  PUs 
require intensive treatment that consequently affects patient health and functioning and 
causes significant treatment burden (9), particularly the frequency and regularity of 
dressing changes which in turn affects daily routine, fatigue, restrict mobility, and cause 
pain or discomfort.  Broader changes to health and well-being include loss of 
independence associated with functional decline, altered eating habits, emotional well-
being (from feeling annoyed and frustrated to angry and depressed), social isolation 
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and reduced activity.  The presence of these factors can influence the development of 
new PUs or exacerbate the severity of or ability to heal existing ulcers. 
 
A lack of quantitative data may be due to no appropriate instruments being available.  
There has been a growth of HRQL instrument development in chronic wounds, 
however, there are no PU-specific instruments available (108).  Attempts to measure 
changes in HRQL in people with PUs using quantitative data collection methods (i.e. 
use of generic PROMs to evaluate HRQL in PUs) have had inconsistent results; some 
findings indicate reductions in HRQL for patients with PUs compared to those without 
(109, 110, 111) while others found no differences in HRQL between people with PUs 
and controls (112).   
 
1.12 HRQL assessment: Why measure it? 
Assessment of HRQL outcomes can serve a number of important purposes, many 
which are not yet being realised in the PU field.   
 
1.12.1 Clinical 
Healthcare is increasingly patient-centred with focus moving towards holistic care.  An 
increase in chronic conditions, where cure may be unrealistic, improving HRQL has 
been an important outcome.  In cancer, individual patient level HRQL data has led to 
improved outcomes for patients as it has been an important way of supplementing 
informed decisions regarding treatment, acknowledging patient preference for 
treatments, and improving service provision (113).  In PUs, there is some evidence that 
both short and long term interventions can have a dramatic impact upon key aspects of 
patient‟s lives, such as comfort, stability (due to bed/chair height), sleep, and pain.  
Noteworthy is that in many instances, a patient may not immediately return to their 
previous levels of functioning once their PU has healed.  Therefore important patient 
outcomes such as HRQL may provide information about the effectiveness of a PU 
intervention (e.g. an intervention may be perceived as effective in reducing pain, an 
outcome important to the patient, irrespective of whether the PU has healed); patient-
priorities and preferences; acceptable symptom states; and treatment burden (or 
important improvements with treatment) (83, 114).  These patient outcomes are crucial 
for monitoring treatment success/failure (changes in HRQL) over time and quantifying 
symptom severity and functional ability that can be used in adjunct to routine clinical 
assessment to improve quality of care (e.g. a physical function score provides a 
common reference base for multidisciplinary teams) (113, 115).  Further, HRQL 
outcomes are important when two people with the same clinical criteria have 
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dramatically different HRQL responses.  For this reason, we need instruments that can 
differentiate between people who have better HRQL from those with worse HRQL. 
 
A study of functional disability in ambulatory patients found that 66% of patient-reported 
functional limitations were underestimated or not detected by clinicians (116).  
Importantly, a patient advocate wrote (117) that symptoms are consequences of illness 
that affect HRQL as does anticipation (hypothetical) of symptoms; but HRQL affects 
tolerance for symptoms, supporting claims that reduced HRQL may be reported without 
presence of disease or symptoms.  Measuring how a patient feels is as important as 
objective clinical measures and certainly more important than healthcare provider 
perceptions of how a patient “ought” to be feeling based on clinical measurements 
alone. 
 
In addition to informing decisions about treatment selection and healthcare 
management, assessment of HRQL helps patients make informed decisions based on 
what others have experienced (i.e. likely effects of treatments); the efficacy and 
mortality associated with a particular treatment/intervention; and the expected impact 
on HRQL outcomes (118).  Patients can feel empowered from being involved in 
informing decisions about their care and the role of nurses as patient advocates is 
enhanced (119). 
 
1.12.2 Research 
In the current healthcare environment, rapidly evolving technologies and treatments 
must be evaluated in light of the impact (and benefits) on patients and cost 
effectiveness.  This is particularly important as patients want information to make 
informed decisions about their healthcare; healthcare providers are being made 
accountable for what happens to their patients; and there is  growing emphasis on EBP 
and rising pressure on healthcare providers to provide credible evidence regarding the 
effectiveness and efficiency of both new and existing treatments and technologies; 
making it pertinent to appropriately monitor and measure health outcomes and 
healthcare costs (86, 120).  As such, HRQL outcomes can be used in clinical trials as 
primary endpoints to assess the benefits of one treatment/medical device/management 
programme over another or when developing new technologies to incorporate the 
patient perspective; wasted time could be spent on developing new technologies that 
are later found to be unacceptable to patients.  HRQL outcomes are useful when two 
treatments reveal similar clinical benefits but exhibit differences in HRQL outcomes.  
When the efficacy of two treatments evaluated in a clinical trial are found to be 
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equivalent, the treatment associated with better HRQL is more likely to be adopted 
(121).  
 
1.12.3 Economic 
Technology and health practices are continually developing and measures of HRQL 
are increasing used in studies of cost-effectiveness which produces evidence for those 
making decisions about resource allocation (24); resource allocation is justified by 
determining the benefits of treatments against financial costs with consideration of 
„human cost‟.  To inform the development of the most effective PU-interventions and to 
provide the most effective management of PUs, assessment of the benefits of an 
intervention needs to be determined (86, 119, 120).  In PUs, many practice 
recommendations are not based on good research evidence and the evidence-base 
associated with PU intervention effectiveness has not been demonstrated using 
appropriate methods (122).  Effective wound management should not only be about 
dressing a wound or applying pressure-relieving equipment but also consideration of 
the effect of the ulcer and its treatment on the patient and whether alternative 
treatments that better suit patient needs are available. 
 
1.13 Measuring HRQL in PUs: measurement and practical issues 
In clinical trials of PU intervention effectiveness, assessment of outcomes other than 
conventional clinical outcomes has often been neglected.  Where HRQL was 
measured, PRO instruments without established psychometric evidence, single-item 
questioning methods or non-validated questionnaires were used (123).  To have true 
measurement, instruments need to be reliable and valid.  Related, some illnesses may 
not have appropriate PRO measures available; and instrument development can be a 
long and arduous process, or validated language translations (PROs are usually 
developed in dominant languages that might not transcend cross-culturally).   
 
A growing number of studies indicate discordance between patient and healthcare 
provider reports of HRQL outcomes, with discrepancy between what is important to 
patients compared to what healthcare providers think are important outcomes (124, 
125, 126).  Therefore PROs should ideally be patient- not clinician-reported.  Training 
in the application, administration, scoring and interpretation of PRO scores requires 
time and therefore has administrative burdens and cost implications.  Use of some 
instruments requires permissions and additional cost to use.  Another practical issue is 
that PRO instruments often contain a multitude of items on numerous domains.  
Completion requires time and effort on the part of the patient, introducing respondent 
burden and potentially raising sensitive issues that could be distressing to patients.   
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Many patients who develop a PU often have a range of additional comorbidities adding 
to the burden.  This can affect attrition and response-rates as patients with a poorer 
outcome prognosis are less likely to report HRQL data (127).  Further, the 
pathophysiology and aetiology of developing a PU, living with a PU, and the burden of 
various concomitant diseases, contributes to the formation of a complex interaction of 
factors that need to be accounted for when assessing HRQL in patients with PUs; the 
HRQL data obtained may not solely reflect PU impact but a combination of factors. 
 
Reviews of the effectiveness of using health outcomes in routine practice report 
conflicting results; there is limited evidence that their use substantially changes patient 
management or improves patient outcomes, and a general lack of clarity about the 
intended applications of PROs in clinical practice (128, 129, 130).  An important factor 
is the selection of appropriate PROs to ensure that the information provided is 
sufficiently specific and relevant to clinicians and patients to prompt changes to patient 
management.  Clinicians indicate positive attitudes to the feasibility, acceptability and 
utility of PROs, and their ability to detect psychological, and to a lesser extent, 
functional problems (128), but mixed reports of the benefits of PRO data limit their use 
in routine practice.  Clinicians seem willing to use PROs but particularly in the PU field, 
appropriate PROs may not be available.   
 
 1.13.1 Methodological developments 
Recently there has been an expansion of sophisticated quantitative methods for 
assessing HRQL.  Guidance for the development and evaluation of instruments to 
obtain HRQL data (86) highlight the importance of conceptually sound, reliable and 
valid measures that explicitly define the constructs measured (what is measured), the 
intended population (range and characteristics of people for whom the instrument is 
suitable for application/use); and the measurement model (scale scores and what 
values mean in terms of individual measurements).  This has resulted in improved 
measurement properties and aids in the selection of instruments that are fit for purpose 
and satisfy established scientific criteria.  Thus, PRO data are an integral aspect of 
patient care, policy decision making and healthcare delivery (87).   
 
1.14 Research aims and structure of thesis 
The principal aim of this project was to develop a patient-centred measure of HRQL 
specific for people with PUs (the PU QoL instrument - PU-QOLI).  The aim was to 
produce an acceptable, reliable and valid PRO, suitable for use in clinical trials, 
epidemiological studies and in routine clinical practice.  The perspective of persons 
17        Background   
 
with PUs was central in all stages of development and evaluation.  Collaboration was 
sought from members of the European Pressure Ulcer Advisory Panel (EPUAP) and 
from various acute and primary care NHS Trusts around the UK.   
 
1.14.1 PUQOL project in the context of Pressure Ulcer Programme 
The Pressure Ulcer Programme of Research (PURPOSE) funded by the National 
Institute of Health Research aims to reduce the impact of PUs on patients through two 
streams: 1) early identification of patients at risk of PU development and patients at risk 
of progression to severe PUs; and 2) development of methods to capture outcomes 
important to patients including HRQL and health utilities for routine clinical use and in 
clinical trials.  The pressure ulcer quality of life (PUQOL) project falls under research 
stream two of the Programme.  
 
1.14.2 Research Design Overview 
This multi-centre study is designed to develop and evaluate the psychometric 
properties of a PU-specific HRQL instrument for patients with PUs.  Guidelines for 
developing and evaluating health outcome measures were consulted to ensure high 
quality and standardisation for PU-QOLI development (86, 131, 132).  These guidelines 
recommend that patients and collaboration with experts is utilised through all stages of 
instrument development and it proposes distinct phases for the development of a PRO 
measure: 1) conceptual framework; 2) generation of items for the PU-QOLI and 
pretesting; and 3) item reduction followed by a full test of psychometric properties. 
Figure 1.2 details these three phases. 
 
 Chapter 2 describes the development of a working conceptual framework of 
PU-specific HRQL based on a comprehensive and systematic review of the 
international literature on PUs and HRQL including both quantitative and qualitative 
primary research. 
 Chapter 3 describes a qualitative study of 30 patients, conducted to explore 
determinants of HRQL in people with PUs and to refine and further develop the working 
conceptual framework to produce a final framework, providing a structured and formal 
method for assessing content of available PRO instruments. 
Chapter 4 describes a review undertaken to identify and evaluate currently 
available PRO instruments used in PU research and other chronic wounds to 
determine the suitability of available instruments for use in PUs. 
 Chapter 5 describe the development (phase 2) of the PU-QOLI, specifically the 
construction (item generation, design and format) and pretesting of the preliminary PU-
QOLI using mixed methods (qualitative and Rasch measuremment methods).   
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Chapter 6 describes the psychometric evaluation (phase 3) of the PU-QOLI in 
the first field test, intended for establishing feasibility and acceptability; producing a 
shorter version by selecting items that perform best against established psychometric 
criteria; and identifying sub-scales and testing scaling assumptions. 
Chapter 7 describes the psychometric evaluation of the PU-QOLI in a second 
field test, intended for carrying out a full psychometric evaluation of the reliability and 
validity of the final PU-QOLI version in a large independent sample of patients with 
PUs. 
The final chapter summarises the conclusions from the research included in this 
thesis and discussed some methodological considerations.  The implications of the 
research for clinical practice and future research directions are also discussed. 
 
In addition, methodological developments have been woven into the research, 
including:  an evaluation of optimal search strategy for retrieving HRQL data 
electronically (Chapter 2); mixed methods for pretesting and the added value of Rasch 
measurement methods (Chapter 5); and mixed methods for optimal PRO instrument 
mode of administration  (sub-study, Chapter 6). 
 
1.15 Summary of Chapter 1 
PUs are a major health problem and challenge to patients, healthcare professionals 
and the healthcare system.  They are prevalent in all health settings, considered a 
significant health problem associated with morbidity and mortality, and have cost and 
quality implications for health services.  PUs can severely compromise all areas of 
patient functioning, and the intensive interventions for preventing and treating PUs 
pose additional patient burden, and subsequently impact HRQL.  Therefore, evaluating 
HRQL outcomes is particularly important and relevant in PUs.  The extent and nature 
of the impact of PUs on HRQL needs to be determined. 
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Figure 1.2 Flow diagram of the research design including 3 phases of the development 
and evaluation of the PU-QOLI 
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Chapter 2  
SYSTEMATIC REVIEW OF THE LITERATURE 
A working conceptual framework of health-related quality of life 
in pressure ulcers 
 
2.1 Overview 
Chapter 2 reports the methods and results of a systematic review of the PU and HRQL 
literature.  This chapter includes both qualitative and quantitative research used to 
identify PU-specific PROs and to develop a working conceptual framework of only PU-
specific HRQL outcomes. 
 
2.2 Background 
Decisions about the delivery of healthcare and about healthcare policy development 
need to be informed by „best‟ EBP.  One key element of EBP is reviewing, appraising 
and synthesising research in the form of robust systematic reviews.  Whilst it is widely 
established that randomised controlled trials (RCTs) are the „best‟ approach to 
generating evidence of effectiveness, RCTs have provided limited information about 
HRQL in the PU field.  RCTs in this area have relied on objective clinical assessments 
such as PU healing time, and rarely included HRQL assessment in their methodology, 
particularly outcomes directly reported by patients, to gain information about patients‟ 
perspective of the impact of PU interventions on HRQL (55, 62, 123).  
 
PU development places the individual at risk for a multitude of negative psychological 
consequences that can affect health, well-being, and HRQL.  Understanding the basic 
mechanisms underlying the psychological consequences of having a PU and the 
outcomes that matter most to patients can help provide the basis for interventions 
aimed at preventing or treating PUs that will benefit patient HRQL.  A way to assess 
these benefits would be with psychometrically robust measures.  The existing literature 
is the best starting point to determine if appropriate measures are available, before 
adapting or commencing development of new ones.  It is also a good source for 
developing a disease-specific conceptual framework that available measures could be 
assessed against or used to inform the development of new measures if required. 
 
There are established scientific methods for systematic reviewing to produce a collation 
of the best available evidence, and these methods seek to minimise bias and error.  
These methods have predominantly focused on synthesis of RCTs with use of meta-
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analysis, although qualitative research is increasingly contributing to EBP, with more 
recent qualitative synthesis methods established (i.e. meta-synthesis) (133, 134).  A 
wide range of research approaches, from both qualitative and quantitative disciplines 
have been utilised to generate information about HRQL for further knowledge and 
enhancing healthcare practice.  Specifically, assessment of HRQL has been useful in 
research, clinical practice, health services evaluation and public health, as well as 
enormously influential in improving service provision and health care management in 
many disease areas.  One such area is oncology, where the assessment of HRQL in 
patients with breast cancer (135) found that HRQL assessment was important for 
supplementing informed decisions regarding treatment and patient preference for 
treatments.  
 
A problem with researching HRQL in PUs is determining which methodology is most 
effective for obtaining information about the impact of PUs from the patients‟ 
perspective.  There is ongoing debate between the proponents of qualitative and 
quantitative research.  On the one hand, advocates of qualitative methods discount 
quantitative methods on the basis that they produce distorted or inconclusive results; 
results produced by biased samples (136).  While, qualitative methods are argued to 
be more about creativity and less about scientific knowledge, validity and rigour; data 
obtained are dependent on individual perceptions and on the interactions between the 
researcher and participant which may introduce bias (137, 138).  Both approaches 
have their own strengths and weakness and are increasingly advocated and used in 
combination in research (139).  Including studies that have used either approach for 
data collection may provide a broader, deeper interpretation of PRO data in this field.  
 
In this thesis, of primary importance is the conceptualisation of HRQL specific to PU 
impact. As such there is a need to investigate the impact of PUs on patients‟ and of the 
HRQL achieved with different interventions.   
 
2.3 Aim 
The aim was to undertake a comprehensive and systematic review of the international 
literature on PUs and HRQL including both quantitative and qualitative primary 
research, based on the methods suggested by the United Kingdom National Health 
Service Centre for Research and Dissemination (140).  
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2.3.1 Objectives 
The objectives were to develop a working conceptual framework of PU-specific HRQL 
by identifying the impact of PUs and PU interventions on HRQL (e.g. PROs important 
to patients who have a PU or are receiving PU treatment interventions) and the relative 
PU impact and burden from the patients‟ perspective. 
 
2.4 Methods 
2.4.1 Search strategy  
An iterative process was used to develop an optimal search strategy to ensure 
sensitivity without yielding too many results.  The search strategy (Appendix 2.1) 
sought to identify all research investigating patient reports about the impact of PUs and 
PU interventions on HRQL.  It incorporated search terms used by other reviews, 
extensive consultation among the collaborative group and input from a methodological 
research advisory group.  To heighten sensitivity, the search was designed to identify 
qualitative research that explored patients‟ subjective experience and quantitative 
studies that measured HRQL using standardised or study-specific HRQL measures.    
 
In addition, an evaluation of the effectiveness of research-methodology (qualitative) 
based search strategies with subject-specific (HRQL) search strategies for electronic 
retrieval of qualitative patient-reported HRQL research data was undertaken (141).  
This was in order to determine the best combination of search terms to ensure 
comprehensive and precise retrieval of all qualitative patient-reported HRQL data, 
regardless of research methodology, without missing key studies or retrieving 
excessive numbers of irrelevant studies. 
 
Search terms of key words for: PUs (60), PU-symptoms, patient views (142), HRQL 
(140), RCT (143), qualitative methodology (144), were combined by Boolean operators: 
(PUs) and (PU symptoms) and (patient views) or (QoL) and (RCT) or (qualitative). 
 
2.4.2 Data sources 
Thirteen electronic databases were searched from inception until 4th July 2008: AMED, 
British Nursing Index (BMI), MEDLINE, EMbase, PsycINFO, Cumulative Index to 
Nursing and Allied Health Literature (CINAHL), The Cochrane Library, Proquest, 
Networked Digital Library of Theses and Dissertations, International Theses in 
Progress, Theses Canada Portal, Australian Digital Theses Program, and Index to 
Theses.  An auto alert function was set up within the electronic databases until 
September 2008 to identify additional studies meeting the search criteria.  
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Systematic reviews of beds, mattresses, dressings and other PU interventions were 
identified through the Cochrane Library database (62) and a citation search performed 
(60, 145, 146, 147).  RCTs published after the census date of each systematic review 
were also searched and included in the review if they met eligibility criteria (140).  This 
process was undertaken to ensure that any RCT that had addressed a HRQL outcome 
as a secondary outcome but not reported this outcome in the abstract, was not missed. 
 
To identify unpublished and on-going research, the electronic searches were 
supplemented by a hand search of specialist journals, relevant conference proceedings 
and dissertations.  Twelve experts were contacted, the PRO and QoL Database and 
the UK National Research Register searched, a citation search of all included studies 
performed, and an internet search of web content relating to PU self-help and focus 
group websites undertaken (see Appendix 2.2 for detailed list).  
 
2.4.3 Criteria for study selection 
Primary research was included if it: addressed the impact of PUs and interventions on 
HRQL including symptoms and evaluation of interventions (e.g. pain, ease of use, 
comfort)2 by direct patient-reports; in adult populations; with existing PU ≥ Grade 1 
(148); from any setting; and reporting qualitative and/or quantitative data.  Thus, 
studies were excluded if PU-related outcomes were not reported (i.e. methods for 
obtaining data were not described/no HRQL results reported); samples of patients with 
mixed chronic wounds studied and no separate analysis of findings for PU patients 
undertaken3; only adverse effects reported (e.g. pain may be an adverse effect of 
treatment but not measured as a PRO)4; outcomes reported by clinicians, nurses or 
carers; or the paper was unobtainable or missing data could not be obtained from the 
authors.  No language, date or methodology restrictions were applied.  Members of the 
EPUAP were contacted, requesting their support to review abstracts and studies not 
published in English or readily accessible (see Intellectual Property Section, page ii). 
                                               
2 Studies that only asked patients if an intervention was acceptable or satisfactory 
(yes/no) were excluded. Acceptability, satisfaction and compliance with interventions 
raise important issues for healthcare but do not necessarily provide information about 
the impact on HRQL. A yes/no measure of acceptability/satisfaction is not a sensitive 
measure and not the focus of this review.  
 
3 Studies with mixed chronic wound patients were obtained to determine if independent 
PU analysis had been performed and PU results presented. If not presented, authors 
were contacted for their PU data. 
 
4 AEs and SAEs were not deemed as PROs (i.e. they are not an outcome that is 
collected systematically for all patients) 
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2.4.4 Selection of studies 
Abstracts from studies retrieved were screened for relevance by one researcher 
(Claudia Gorecki; CG).  Studies that did not meet the inclusion criteria were excluded 
at this stage. Studies assessed as potentially relevant or where relevance was 
ambiguous, were obtained in full for further scrutiny.  Two researchers (CG, JN) 
independently assessed potentially relevant studies and studies not meeting the 
eligibility criteria were excluded from further analysis.  Where there was lack of 
consensus, disagreements were resolved through discussion with a third reviewer (JB).  
Where study details were lacking, attempts were made to contact the authors for 
additional information.   
 
2.4.5 Quality appraisal 
The methodological quality and issues associated with assessment and measurement 
of HRQL in PUs were considered.  There is on-going debate about whether all patient-
reported testimony should be included irrespective of quality vs. inclusion of only high 
quality research.  A pragmatic choice was made to include studies meeting a minimum 
criteria to ensure comprehensiveness of patient voices but not at the complete expense 
of quality.  Therefore, the following quality components for study methodologies 
including qualitative studies, RCTs, cohort studies and cross-sectional studies were 
developed and applied to studies identified as eligible: 
 
Qualitative studies 
Qualitative studies were appraised using a standard quality appraisal form included in 
the Joanna Briggs Institute Qualitative Assessment and Review Instrument (JBI-QARI) 
(149).  Studies assessed as yes to at least 6 of the 10 quality statements, including yes 
to two critical methodological questions: there is congruity between i) the research 
methodology and the methods used to collect data (Q3) and ii) the research 
methodology and the representation and analysis of data (Q4), were included.  These 
two questions were considered important to ensure that appropriate data collection and 
analysis methods were used that reflected the study‟s methodological approach; 
without this information reported and congruency in the methodology it would be 
difficult to conclude accuracy of results (i.e. can we conclude the results are valid 
based on the methods used to collect and analyse the data?).  
 
Randomised Controlled Trials (RCTs) 
RCTs were included if there was: clearly stated primary outcome; a priori sample size 
calculation; randomised allocation to treatment; intention to treat analysis; and no more 
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than 5% patients excluded from analysis of primary outcomes for reasons including 
loss to follow-up, withdrawal, death and protocol violations (150). 
 
Cohort Studies 
Prospective cohort and cross-sectional studies were included if they had no more than 
20% of the study sample excluded from analysis for reasons including withdrawal, 
death, lost to follow-up and missing records (39, 151).  Quality was assessed by two 
independent reviewers (CG and JN); studies failing to meet the quality criteria were 
excluded from further consideration.  
 
2.4.6 Data extraction  
All findings from included studies were extracted by one reviewer (CG).  Qualitative 
findings were extracted into a QARI database as QARI was developed to manage, 
appraise, analyse and synthesise study findings that utilise any qualitative approach as 
part of a systematic review of evidence.  QARI incorporates data extraction and quality 
appraisal forms; a data synthesis function; and a reporting function.  This software has 
been internationally peer reviewed and was successfully used in a recent review with a 
similar research question (152). 
 
For qualitative studies, findings in the form of textual data, emerged themes and author 
interpretations (149) were extracted.  Data extraction involved the reviewer (CG) 
reading carefully and thoroughly through each study and identifying the findings in the 
form of either a direct quote from patients or a statement by the author that was 
supported by patient reported data; to establish the credibility of the authors‟ statement 
and interpretation.  This process involved identifying and transferring actual patient-
reported text from the original paper to produce a data set of findings that could be later 
categorised and synthesised. Information pertaining to methodology (i.e. 
phenomenology; textual narrative; grounded theory), methods to obtain data (i.e. semi-
structured interview; face-to-face or telephone), participant characteristics, setting and 
geographical location, cultural description (i.e. elderly stroke patients; SCI), and 
analytical methods were also summarised.  Data from the quantitative studies were 
extracted into pre-prepared data-extraction tables based on study design (i.e. RCT 
prevention or treatment, prospective cohort, cross-section/survey, case series).  Data 
extraction involved the reviewer reading each study and identifying findings in the form 
of individual questionnaire items or domain results.  Participant characteristics, setting, 
geographical location, study design, HRQL outcomes and assessment methods, and 
both significant and non-significant results specific to PUs were summarised.  For 
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studies employing both research methods, qualitative and quantitative results were 
extracted into their corresponding methodology databases.  
 
The data extraction process was undertaken three times on separate occasions (i.e. on 
each occasion the reviewer thoroughly read each paper and extracted findings) to 
establish a systematic approach for data extraction, minimise error and ensure that 
relevant findings were not missed.  Data extraction ceased when saturation was 
reached, with no new themes emerging (152).  Where duplicate publications of patient 
datasets were identified, the most detailed report was used for data extraction.  A 
second independent reviewer (JN) extracted data for 20% of the studies, selected at 
random.  Consistency in extraction and agreement on the main themes was compared.  
 
2.4.7 Analytical procedures 
A combined synthesis of qualitative and quantitative research was performed, which 
involved generation of a list of likely factors and their relative importance, and using 
content analysis to generate common categories and themes from study findings.  The 
principles of the triangulation method for integrating mixed method data (153), which 
involves determining consistency or inconsistency in findings from each method, were 
utilised.  In the first instance, meta-synthesis (149, 154) was carried out on the 
qualitative data set of findings, pooling all findings from qualitative research.  Each 
finding was allocated to one defined category.  A category was determined by grouping 
findings that reflected relationships between similar phenomena and variables.  
Categorising findings was a way of aggregating findings and focusing on findings as a 
whole rather than individual studies.  Categories sufficiently similar in meaning were 
generated into synthesised themes.  Synthesising categories was a way of aggregating 
grouped findings into specific HRQL themes, providing a summary of the evidence for 
that particular domain.  All findings from the quantitative data set were encoded to the 
categories and themes generated by meta-synthesis, with new categories added if 
necessary.  This process allowed for comparing findings from both methods for 
agreement or identifying where findings appear to contradict.  The combined emerging 
categories and themes were reviewed by a collaborative group (see Intellectual 
Property Section, page ii) and revised until consensus, producing a working conceptual 
framework of HRQL specific to PUs.  
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2.5 Results 
2.5.1 Studies included in the review 
A total of 6086 citations were retrieved, of which 5416 were excluded. 649 (11.29%) 
were assessed as potentially relevant and obtained in full for further scrutiny.  Of these, 
53 met the eligibility criteria however, 22 were excluded after quality appraisal (Figure 
2.1).  A total of 31 studies were included in the review.  Sample sizes ranged from 5-
468 participants with PUs from acute, community and long-term care settings, across 
Europe, USA, Asia and Australia (n=2463), between the ages of 17 and 96 years, with 
approximately 35% aged 65 years or more. 
 
 
 
Figure 2.1 Flowchart of studies for inclusion and exclusion 
 
 Not satisfying eligibility criteria (n=618) 
 Not primary research (n=63) 
 No HRQL outcomes assessed (n=375) 
 Not adult PU population (n=76) 
 Outcomes or methods not described or 
HRQL data not presented (16) 
 No independent PU analysis 
performed; only mixed sample results 
presented (26) 
 Study reported only adverse effects (6) 
 Publication unobtainable (3) 
 Only at-risk patients without PUs (31) 
 Quality criteria not met (22) 
 
Retrieved 
(n=6086) 
Assessed as not relevant- 
excluded (n=5437) 
Assessed as potentially 
relevant, obtained in full for 
further scrutiny (n=649) 
Included (31) 
Qualitative studies (10) 
 Interview studies (2) 
 Phenomenological 
studies (7) 
 Focus group (1) 
Quantitative studies (21) 
 Cross-section (19) 
 Cohort(2) 
 
 ( ) Number of studies 
Excluded at quality assessment 
stage 
RCTs (12) 
 No primary endpoint stated (1) 
 No sample size calculation (4) 
 RCT: 5% or more lost to 
follow-up (6) 
 Not intention to treat analysis 
(1) 
Cohort/cross-section (7) 
 20% or more excluded from 
analysis (7) 
Qualitative (3) 
 Incongruence between 
research objectives, methods 
& analysis (3) 
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Analysis of the qualitative studies extracted 222 findings which were allocated to one of 
46 categories and synthesised into 11 themes (Table 2.1).  A total of 71 findings were 
extracted from the quantitative studies and allocated to one of 20 categories and 7 
themes; no additional categories or themes were identified (Table 2.1).   
 
A total of 293 findings, 46 categories and 11 themes emerged from the included 
studies combined.  Table 2.2 classifies the qualitative and quantitative studies by 
corresponding theme.  A narrative summary of HRQL themes generated from the 
combined synthesis is provided in detail below. 
 
2.5.2 Synthesised HRQL themes 
Physical impact and limitations  
Eleven studies reported PUs having a significant impact on physical aspects including 
imposing physical restrictions, lifestyle changes, and the need for environmental 
adaptations.  PUs restricted most day-to-day activities such as performing self-care, 
shopping, mobility, and ability to move and assume comfortable positions.  Patients 
reported reduced physical activity due to prescribed bed rest and less participation in 
outdoor activities than before the PU developed.  In order to reduce the number of days 
lost from activity or days spent hospitalised for PU treatment, patients introduced 
skincare as part of their lifestyle.  Skincare caused problems for some patients, 
although many thought that it was important to comply with recommended skin care.  
 
Patients perceived PU treatment including hospitalisation as an intrusion in their daily 
lives, describing their PU as inconvenient, troublesome, and interfering their usual 
schedule.  They attributed their PU with loss of appetite and interest in physical 
activities, insomnia, and the reason for them being less actively engaged in life in 
general.  Physical dependence and need for assisted care resulted in patients being 
hospitalised, moving to more suitable accommodation, or needing to make their home 
wheelchair friendly (i.e. some patients with heel ulcers became wheelchair dependent). 
 
Social impact  
Social impact was represented in 10 studies in terms of restricted social activity, social 
isolation, and impact on personal lives.  Patients reported that their social life was 
restricted due to the physical restrictions imposed by the PU and PU treatments.  
Patients expressed an inability to participate in social activities, explaining that need for 
wound care restricted social activity and social connectedness, and resulted in them 
feeling socially isolated, confined and missing family and friends.  PUs, as well as 
hospitalisation for PU treatment, impacted on personal relationships because of 
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limitations regarding intimacy and sexual relations.  The inability to participate in social 
activities contributed towards reduced social interaction, poorer social integration and 
adjustment issues, loss of interest in social activities, less positive engagement, and 
poorer interpersonal relationships.  Loss of interest in social activities was also related 
to various PU symptoms such as pain and odorous exudate and contributed towards 
self-imposed isolation (i.e. distancing behaviours, detaching from others). 
 
Psychological impact  
Psychological impact was reported in 12 studies as coping and acceptance; body 
image and self-concept changes; desire for regained control and independence; and a 
variety of emotional problems.  Patients found it difficult to deal with their PU and 
reported avoiding thinking about it which contributed to poor adjustment outcomes.  
Some coped by comparison with others, to the self in the past, and knowledge that it 
could be worse, resulting in resignation.  Others found hope and support from their 
spirituality and expressed that the support and help given from family and friends was 
important and appreciated, especially help with daily activities and wound care.  
 
Physical changes such as scarring and seeing the PU (e.g. “ugly”, “dirty”, “black hole”) 
impacted self-concept and body image.  Patients stated feeling useless and 
inadequate, and a key issue identified from the studies was patients‟ desire and 
struggle for control and independence.  Patients expressed wanting to be involved in 
decisions about their wound care and wanted help from healthcare providers to 
become more independent (i.e. self-care).  Many patients expressed loss of 
independence and some experienced self-inflicted tension between what one wanted 
to do with what one should do to promote PU healing. 
 
Patients commonly reported negative emotions such as low mood, anger, frustration, 
anxiety and depression.  Feeling hopeless was associated with depression and 
powerlessness, with some patients requiring treatment for their PU-related depression.  
Feeling shocked described the initial reaction to the PU, and as the PU worsened, 
dislike and hate were experienced.  Preoccupation with healing and anticipation of pain 
also contributed towards emotional problems.  Patients worried about the time it took 
for the PU to heal, fearing that it would never heal (“I‟ve spent a year on that mattress”).  
In some instances, patients came to accept their situation and the impact the PU had 
on their HRQL, reducing negative emotions and improving psychological well-being. 
 
Impact of PU symptoms  
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Fifteen studies reported the impact of PU-related symptoms. Pain was the most 
significant consequence of PUs.  It impacted on every aspect of patients‟ lives, and 
was described using evaluative, sensory and affective pain descriptors (107).  
Evaluative descriptors described constant pain experienced (“never ending”, “intense 
pain”), which varied in location, severity and duration.  For some, pain was perceived 
as a punishment for having a PU.  Sensory descriptors included feels like “stabbing”, 
“burning”, “throbbing” and “needles”.  Affective descriptors described emotional feelings 
about the pain experience such as frustrating, annoying, unbearable, angry and 
inconvenience.  Pain caused discomfort and inability to move, stand, walk and assume 
comfortable positions.  Experience of early symptoms such as pain or discomfort was 
indicative of pressure or skin damage.  Patients felt that they were responsible for 
communicating any first signs or symptoms and that their healthcare provider was 
responsible for attending to reports made.  Some patients practiced skin protection and 
pain prevention behaviours such as staying still, adding to immobility problems, or 
repositioning, which at times was “uncomfortable”, “difficult” or “caused pain”. 
 
Patients reported that PU symptoms interfered with activities of daily living, contributed 
to sleep disturbances and impaired appetite.  In turn, physical restrictions contributed to 
decreased social interaction.  Patients attributed exudate with more frequent dressing 
changes and impaired ability to walk because “the exudate would ooze out”, 
contributing to further problems with immobility.  Self-imposed isolation was a result of 
the embarrassment and distress experienced by patients due to foul-smelling PUs. 
 
Impact on general health and consequences  
Health and healthcare problems were identified in 12 studies.  PU-related health 
complications and health deterioration, such as infection, delayed wound healing and 
led to additional problems with fitness and health status.  The PU and PU symptoms 
had implications for the healthcare that patients received.  Patients reported extended 
hospital stays, additional hospital admissions, and restrictions on rehabilitation places.  
For some, PU pain prevented rehabilitation and receiving treatment for PUs or other 
medical conditions, as well as making patient handling difficult for healthcare providers 
and carers.  For other patients, the PU was perceived as an acute problem compared 
to other existing conditions.  Many patients have other health conditions and 
comorbidities and a PU may develop as a consequence of this.  Therefore, the PU is 
not perceived as a significant health problem.  For example, palliative care and SCI 
patients did not report pain as a significant experience of having a PU.  This may be 
because SCI patients have reduced sensitivity or palliative care patients received 
better pain control.  
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2.5.3 Synthesised themes: Other impact 
Impact on others  
Patients from four studies reported their PU impacting on family/friends. These patients 
believed that their PU-related suffering and poor mood was projected onto those 
closest to them.  In addition, restrictions imposed on patients caused others additional 
work and worry.  Those closest are crucial in providing assistance with skin inspection, 
PU management and treatment, and assistance with daily activities (i.e. personal 
hygiene, shopping, cleaning, repositioning).  Requiring assistance made patients feel 
dependent on others and they feared they were being a burden. 
 
Financial impact  
Three studies reported PUs contributing towards socioeconomic and financial 
consequences such as poor living circumstances and work opportunities (inability to 
work), and financial costs (medical/treatment costs, loss of income). 
 
Need vs. impact of interventions and wound care  
Eleven studies reported findings in the theme need for vs. impact of interventions, 
making it the most commonly occurring theme in both qualitative and quantitative 
studies.  These studies assessed a plethora of treatments for wound management 
including dressings and pressure-relieving interventions, predominantly patient comfort.  
Patients also reported concerns about whether their pressure-relief allowed 
independence, ability to move, ability to get in/out of their bed or chair, whether it was 
noisy or loud therefore disrupting sleep, and whether they felt safe in bed or sitting on 
their cushion.  Topical treatments were also evaluated (i.e. dressings, creams/lotions, 
maggot therapy) and some patients reported benefit in reduced pain and exudate, and 
wound healing.  Conversely, for some, benefit was not experienced as analgesia did 
not reduce or eliminate pain even though it was intended for PU-related pain reduction. 
 
Interventions that assisted wound healing and symptom relief had positive outcomes 
for patients and improved well-being and HRQL.  This was evident from patient reports 
that wound healing and symptom relief increased physical and social activity, allowing 
participation in daily activities and social interaction.  Alternatively, some patients 
reported that surgical interventions restricted activity and mobility and contributed to 
reducing HRQL.  These patients reported frustration and emotional problems 
associated with physical body changes.  For example, one patient reported that after 
surgical intervention their “bottom looked like a meat cleaver was taken to it” (106). 
 
 Table 2.1 Synthesised categories and themes identified by both qualitative and quantitative research 
Theme Category Qualitative  Quantitative  
Health-related quality of life    
   Physical impact & limitations Physical restrictions caused by pressure ulcers   
 PUs contribute towards lifestyle changes   
 Adapt living arrangements to incorporate pressure ulcer impact 
 
 
 
  
 
 
   Social impact Social life restricted due to physical restrictions including treatment   
 Social isolation & loss of interest   
 Pressure ulcer impact on personal lives   
   Psychological impact Develop & use of coping mechanisms   
 Support & help from family and friends is important & appreciated   
 Changes to body image & self-concept   
 Desire & struggle for control & independence   
 Emotional problems (impact on mental health & psychological well-being)   
 Preoccupation with pressure ulcer healing & anticipation of pain   
 Acceptance of pressure ulcer & their situation   
   Impact of pressure ulcer Evaluative pain descriptors   
   symptoms Sensory pain descriptors   
 Affective pain descriptors   
 Pain contributed to sleep disturbances   
 Symptoms interfere with activities of daily living & contribute to social isolation   
 Wound smell caused embarrassment & distress    
 Wound exudate resulted in increased need for dressing changes   
 Experience of early symptoms indicate skin damage   
 Skin protection & pain prevention behaviours were practiced   
   Impact on general health & 
consequences 
Health complications & health deterioration caused by pressure ulcer   
   consequences Pressure ulcer & symptoms had consequences and implications to healthcare received   
 Comorbid influence & impact on pressure ulcer patients   
 
 Table 2.1 Cont. 
Theme Category Qualitative Quantitative 
Other impacts    
   Impact on others Dependence on others   
 Perceived impact imposed by pressure ulcer on others   
 Fear of being a burden to others   
   Financial impact Perceived financial impact & consequences    
Experiences of care    
   Need for vs. impact of  Patient evaluations of mattresses & cushions (product evaluations)   
   Interventions & wound care Satisfaction & benefit experienced from topical treatment   
 Quality of life & satisfaction with life improved with wound healing & symptom relief   
 Lack of resources result in inability to deliver effective wound care   
 Hospitalisation for pressure ulcer had consequences on the individual   
 Incongruence between patient need & clinical/nursing needs   
 Pain caused by interventions and ineffective analgesia   
 Reliance on healthcare provider to assist with wound care & daily activities   
 Patients complained about time spent on treatment for pressure ulcer healing   
   Healthcare provider-patient  Therapeutic nurse/carer-client interaction & communication   
   relationships Skills & expertise of nurses instilled hope   
 Professional competence of healthcare provider had benefits to patients   
Knowledge about pressure ulcer    
   Perceived aetiology Self-responsibility attributed to pressure ulcer development   
 Intrinsic factors caused pressure ulcer to develop   
 Extrinsic factors caused pressure ulcer to develop   
   Need for knowledge Need for knowledge about pressure ulcer development & prevention   
 Need for knowledge of pressure ulcer physiologic processes & wound care/treatment   
√ Represents the category and theme identified by particular research method 
 Table 2.2 Classification of included studies according to theme  
Theme Reference to 
relevant 
Quantitative 
paper  
No. (% of 10 
qualitative  
studies) 
Reference to relevant 
Qualitative paper  
No. (% of 21 
quantitative  
studies) 
Health-related quality of life      
    Physical impact & limitations (9, 104, 105, 106, 
107, 155, 156) 
  7 (70) (112, 157, 158, 159)   4 (19) 
    Impact of pressure ulcer symptoms (9, 104, 105, 106, 
107, 155, 160) 
  7 (70) (112, 158, 161, 162, 163, 
164, 165, 166) 
  8 (38.1) 
    Psychological impact (9, 104, 105, 106, 
155, 156) 
  6 (60) (158, 162, 167, 168, 169, 
170) 
  6 (28.6) 
    Social impact (9, 104, 105, 106, 
155, 156) 
  6 (60) (157, 158, 159, 169)   4 (19) 
    Impact on general health & consequences (9, 105, 106)   3 (30) (157, 158, 162, 169, 171, 
172, 173, 174, 175) 
  9 (42.9) 
Other impacts     
    Impact on others (9, 104, 105, 106)   4 (40) 0  
    Financial impact (106)   1 (10) (157, 169)   2 (9.5) 
Experiences of care      
    Healthcare provider-patient relationships (9, 107, 155, 156)   4 (40) 0   0 
    Need versus impact of interventions  (9, 105, 106, 155, 
156, 176) 
  6 (60) (161, 163, 166, 177, 178)   5 (23.8) 
Knowledge about pressure ulcers     
    Perceived aetiology (9, 106, 107)   3 (30) 0   0 
    Need for knowledge (105, 106, 160)   3 (30) 0   0 
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Both community and hospitalised patients reported being dependent on healthcare 
providers to assist with wound care and daily activities.  For some patients, the time 
spent obtaining information about various treatments, treatment regimens such as 
wound dressings, and waiting time for treatment or nurse home visit caused additional 
burden.  The main issue for patients requiring home care for their PU was that their 
whole morning was disrupted because nurses were unable to provide an estimated 
time when they would be arriving and patients felt that they missed out on social 
activities because they were required to wait at home for the nurse.  Hospitalisation for 
PU treatment had a different set of consequences.  The hospital environment 
undermined patients‟ psychological well-being as patients felt captive, disconnected 
from the outside world, and confined and alienated.  
 
A major issue identified from studies was evident as incongruence between patients‟ 
needs and clinical/nursing needs.  What was important to patients (i.e. to sleep through 
the night) was not always the same as the clinical or nursing priority (i.e. turning 
throughout the night to relief the pressure).  Some patients felt that their complaints and 
symptom reporting were ignored or not attended to by staff.  These patients reported 
that when they complained of pain, their skin may have been inspected but because no 
damage was observed, nothing was done and consequently a PU developed.  Others 
said that additional pain was experienced with treatments and use of some equipment 
(dressing changes, friction from being pulled over mattress, use of hoists and pulleys), 
and this was associated with poor care.  Hospitalised patients also mentioned that 
neglect to draw the curtain during skin inspection or treatment regimen, allowing others 
to see the wound, left them feeling exposed and humiliated. 
 
Nurse-client relationships  
The therapeutic relationship between patient and healthcare provider and the patients‟ 
perception of their healthcare providers‟ competence had important implications for 
patients.  The skills and expertise of healthcare providers instilled hope in patients and 
contributed to compliance with PU treatment.  A healthcare provider‟s ability to interact 
with the patient in a holistic way, communicate by explaining the wound care treatment, 
and teaching patients‟ how to undertake their own wound care where appropriate, was 
indicative of a positive therapeutic environment.  Agreement about symptoms and 
treatment regimen through mutual dialogue and decision making was important to 
patients as it allowed them to regain some control and independence over their lives.   
Also important was the attitude of the healthcare provider; a positive, friendly attitude 
contributed to forming a positive therapeutic relationship, and was equated with 
adequate care.  Some patients felt that their healthcare provider had a poor attitude 
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towards them, making them feel blamed for the PU developing, a nuisance when they 
asked for assistance or that providing their healthcare was an effort and problem.  
 
Perceived aetiology  
Three studies presented patients‟ beliefs about causative factors.  Some attributed self-
responsibility, believing that their own actions (i.e. failure to inspect skin, reduced 
mobility, not reducing risk factors) contributed to the PU developing.  Others believed 
that intrinsic factors (i.e. existing risk factors: incontinence/moisture, inability to move or 
walk) caused the PU, but for the majority, extrinsic factors were attributed as being the 
primary cause of PU development.  Factors such as incompetent healthcare, 
inadequate use of equipment, and delays in noticing and treating reports of pain, were 
the main factors believed to have caused the PU.  These patients were angry that their 
PU developed because of inadequate healthcare and felt that the PU may have been 
prevented if adequate care was provided.  
 
Need for knowledge  
Although some patients were aware of the various risks for PU development and 
attributed them as being the cause for their PU, some demonstrated a lack of 
knowledge and understanding about PU development and prevention, suggesting a 
need for greater patient knowledge.  Specifically, patients need more information about 
PU causes, risks, prevention, the physiological processes, and the various wound care 
strategies and treatment interventions available.  Of the patients who demonstrated 
knowledge about these factors, many were either SCI patients who had been educated 
about PU risk or people with a history of having previous PUs. 
 
2.5.4 Existing measures to assess HRQL in PUs 
No disease-specific measure of HRQL was identified to assess HRQL outcomes in 
PUs.  The measures used were either generic measures (e.g. Short Form-36 health 
survey (95)) or measures not developed or validated for use with PUs but intended for 
other chronic wounds (e.g. Cardiff Wound Impact Schedule (CWIS) (179)).  Various 
non-validated questionnaires (i.e. ad hoc) were developed to assess outcomes such as 
pain, comfort and exudate, although they were study-specific and had not undergone 
the same rigorous psychometric evaluation as other established PRO measures. 
 
2.6 Discussion 
This is the first comprehensive and systematic review of the PU and HRQL literature 
that has identified HRQL factors that are important to people with PUs.  The studies 
37   Systematic review of the literature 
 
identified reported the range of HRQL domains that are impacted by PUs and PU 
interventions.  The review shows that PUs impact on a range of HRQL domains, 
however the size of the impact is not covered by this review.  In addition, a range of 
treatment side effects and quality of care problems were identified.  
 
Not only do PUs impact HRQL, some patients believe that they have become a burden 
to others, perceiving assistance with wound care and daily activities as an imposition, 
causing them additional anxiety and worry.  The most common belief about the cause 
of Pus was that they were a direct result of poor quality healthcare.  Further, it was 
evident that unless patients had a history of PUs or belonged to a group at high-risk of 
PU development, there was lack of knowledge about PUs, suggesting a need for more 
patient information and education about PU risks and treatments. 
 
This synthesis concurs with reviews undertaken to investigate the impact of leg ulcers 
on HRQL (152, 180).  The most commonly occurring findings for people with leg ulcers 
and PUs included: restrictions on physical and social aspects of patients‟ lives (152, 
180); experience of emotional problems such as low mood, anxiety, frustration, anger, 
depression (180) and disparaging self views of physical appearance (152, 180); 
perceptions of the therapeutic relationship (152); and severe and constant pain.  
Patients with PUs commonly reported pain from the wound site, during dressing 
changes, and with use of pressure-relieving interventions and other medical 
equipment.  Not only was pain a central and ever-present feature of having a PU, 
mirroring findings by Briggs and Flemming (152), pain was debilitating and contributed 
to restricting physical and social activities, sleep disturbances, difficulties with 
ambulation and inability to assume comfortable positions.  A key issue for patients with 
PUs was that many complaints of pain made were largely unrecognised and ignored by 
healthcare providers (9, 107, 181); a surprising finding considering that sensory pain 
could be an indicator of possible skin damage and a pre-empting of a PU developing in 
the future.  Thus, while it would appear that PUs cause patient‟s substantial pain, it is 
underestimated by nurses and other healthcare providers or potentially overlooked 
because of existing comorbidities. 
 
In contrast to the wider leg ulcer literature, PUs contributed towards lifestyle changes, 
adapting living environments to incorporate wound care (i.e. nurse visits, hospital 
admissions) into their life and schedule (9, 156), and an inability to perform normal day-
to-day activities.  Patients with PUs were concerned about the time taken for wound 
healing and experienced conflict between what one wanted to do with what one should 
do to promote healing.  Many patients had difficulty accepting their PU while others 
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developed coping strategies and learnt to accept their PU and situation.  For patients 
able to accept their PU, this had positive implications on their psychological health.  
 
Leg ulcer patients‟ treatment issues were mainly associated with difficulties with 
compression (152, 180).  For patients with PUs, regardless of type, PU interventions 
caused patients substantial burden and consequences including physical and social 
restrictions, continued discomfort/pain, sleep disturbances, loss of appetite, feeling 
powerless, and additional emotional problems (e.g. low mood, hopelessness, anger).  
In addition, the impact of hospitalisation was not a feature for leg ulcer patients (152, 
180).  However, both wound groups expressed the importance of a positive therapeutic 
relationship with their healthcare providers  (152).  A positive relationship was 
perceived as a means of providing healthcare required for PU healing, a way of 
improving psychological well-being by providing a sense of support and hope, and an 
opportunity to engage patients in communication about their PU treatment, improving 
both their self-concept and independence.  On the other hand, a poor relationship was 
detrimental to patients and an additional consequence of the PU experience. 
 
The strength of this review is the robust methods used. Information derived from this 
review stems from a combination of both qualitative and quantitative research. It has 
been argued that both methodologies have their own strengths and weakness but they 
are increasingly advocated and used in combination in research (139).  Including 
studies that have used either method for data collection has provided a complimentary, 
deeper interpretation of PRO data on this complex phenomena.  For example, pain has 
two elements; physical and emotional.  Quantitative measurement provided information 
about physical aspects of pain such as pain intensity and severity, but provided little 
about the emotional and psychological impact of pain.  Qualitative measurement, on 
the other hand, provided information about the emotional and psychological 
consequences of severe pain in a descriptive way.  It also provided a greater overall 
account of the impact PUs have on HRQL.  Quantitative measurement was mostly 
focused around intervention evaluation, specifically in terms of comfort, sleep and pain, 
failing to identify many of the HRQL issues that are important to patients.  These 
observations highlight the need for quantitative measures that can accurately depict 
impact of PU and PU interventions on patients‟ HRQL. 
 
Only studies that presented independent PU results and obtained HRQL issues by 
direct patient reports were included.  Many studies did not differentiate participants by 
wound aetiology, recruiting mixed wound samples, or obtained outcomes by a 
healthcare provider or carer.  In dementia, a discrepancy between patient-proxy reports 
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of QoL has been observed (182).  Further, bias is introduced when, for example, pain 
measurement is obtained by the same person who administered a dressing change, 
then questioned the patient about any pain experienced; the method used in some 
studies identified.  Including only studies with independent PU analyses and outcomes 
obtained directly by patients ensured the HRQL issues identified from this review were 
in fact reported by patients with PUs and about the impact of PUs and not other 
wounds.  Further, this review had international collaboration which allowed for 
translation of non-English papers from settings outside the UK/US; a limitation of other 
reviews has been the under-representation of non-English speaking cultures and 
languages.  The emergent themes might be transferable across other cultures and 
languages, although this assumption would need to be validated.  
 
To reduce selection bias, all research designs and studies yielding both statistically 
significant and insignificant results were included in data analysis.  Methodological and 
clinical heterogeneity were not criteria for exclusion.  Although differences in study 
design and between study interventions and outcome measures were present, it was 
deemed appropriate to pool data, regardless of known heterogeneity, in order to 
identify all HRQL outcomes important to patients.  Attempts were made to reduce bias, 
but a limitation of this review was that only one reviewer extracted findings.  Data 
extraction was repeated until saturation and categories and themes were reviewed by 
the collaborative group to reduce reviewer bias.  In addition, the review findings were 
not qualified in terms of weight given to the majority view (i.e. greater emphasis on 
findings featured in more studies) as has been done in other qualitative synthesis 
(152).  This was to ensure that all issues important to patients were represented. 
 
A number of general observations about study quality were made.  The qualitative 
studies demonstrated good quality as appraised by QARI (149); seven of 10 studies 
scored ≥7, indicating congruity between research methodology and research 
objectives, and between research methodology and analysis, interpretation of results 
and final conclusions.  However, there were limitations associated with the conduct and 
reporting of quantitative studies.  Seven (25%) cohort and cross-sectional studies were 
excluded as more than 20% of the study sample was excluded from analysis.  Some 
studies had used generic or measures not developed or validated for PUs.  The quality 
of the 12 RCTs was poor, limiting the value RCTs provided in furthering our 
understanding of the impact of PUs on HRQL: formal sample size calculations were not 
reported, analysis was not intention to treat, primary end points not stated; or more 
than 5% of the recruited sample was excluded from analysis, therefore all RCTs were 
excluded.  In addition, methods of administration were poorly described, HRQL was 
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usually of secondary interest, and all RCTs used visual analogue scales (VAS) or ad-
hoc questioning methods rather than utilising existing PRO measures.  Consequently, 
due to poor quality, formal statistical analysis of HRQL outcomes was not performed.  
Further, the impact of individual PU interventions was not determined as RCTs of PU 
intervention effectiveness were not designed to assess HRQL outcomes appropriately 
so comparison between individual interventions was not possible.  
 
There is need for comprehensive, valid and reliable outcome measures to assess 
HRQL in the PU field.  Measuring HRQL would provide information to support 
decisions for resource allocation, know treatment benefits from the patient perspective, 
and increase patient compliance with treatment, as the focus would be shifted from 
wound management to individual holistic healthcare.  Further, measuring HRQL would 
promote patient-centred communication, identify issues that are important to patients 
on an individual level, and reduce patient suffering, in turn increasing HRQL.  
Assessing HRQL would provide healthcare providers with greater understanding of 
specific patient needs and better understanding of the PU experience in order to 
provide the best possible care to patients.  In light of the findings from this review, 
national guidelines need to be reviewed with consideration of the impact of PUs on 
HRQL to improve PU healthcare in the future. 
 
2.7 Summary of Chapter 2 
A systematic review of the PU and HRQL literature was undertaken to identify and 
synthesise common issues reported directly by patients about living with a PU.  PUs 
cause patients significant impairment and burden.  Major issues identified relate to 
severe pain, patients‟ views and concerns ignored by healthcare professionals, early 
warning signs (e.g. pain) do not prompt action, treatments increase discomfort and 
pain, and the physical, social and psychological aspects of patient need are not met.  
This review identified HRQL domains specific to PUs and highlights the potential need 
for outcome measures that can accurately depict the impact of PUs on HRQL.  
However, the review findings were not qualified in terms of weight given to the majority 
view, therefore the next stage of this research is to confirm the relative importance of 
the findings (working conceptual framework domains) with patients with PUs.   
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Chapter 3 
DEVELOPMENT OF A PU-SPECIFIC CONCEPTUAL 
FRAMEWORK OF HRQL 
 
3.1 Overview 
Chapter 3 reports the methods and results of a qualitative study including interviews 
with patients with PUs and expert opinion to formulate a final conceptual framework of 
PU-specific HRQL. 
 
3.2 Background and aims 
Evaluating outcomes such as HRQL is particularly important and relevant in PUs where 
the condition and associated interventions pose substantial burden to patients. 
Although the management of PUs has received considerable attention in the literature, 
far less has been given to the impact PUs have on HRQL.  A systematic review of the 
HRQL and PU literature (Chapter 1) identified relatively few studies that have 
considered HRQL outcomes important to patients with PUs.  The review highlighted 
HRQL outcomes that are unique to the impact of PUs although these outcomes are 
currently not systematically included as outcomes in clinical trials.  Therefore the PU 
literature is unconvincing in terms of robust evaluation of the impact of PUs on HRQL.  
 
The most appropriate way to assess HRQL is with the use of PRO instruments but 
PRO instrument development is time consuming and demanding as several stages 
must be undertaken to ensure that they are carefully designed and fit for purpose.  This 
is particularly important since PRO data is now an integral facet impacting patient care, 
policy decision making and healthcare delivery, and the adequacy of these decisions 
depends directly on the scientific quality of the PRO instruments used (87).  As such, of 
primary importance is consideration of conceptualisation (clearly defining constructs or 
variables measured) and operationalisation (content or items) of the instruments‟ 
scales; a minimum prerequisite for acceptance of a PRO instrument (86).  A conceptual 
model should guide what a PRO instrument measures, how it should be measured, 
and provides a context for interpreting findings (82).  Therefore scale construction 
should be underpinned with a strong conceptual base from the outset utilising three 
sources: existing literature, patients and clinical experts (86, 131, 132).  Grouping items 
statistically or thematically through expert opinion alone does not ensure that items in a 
group (scale) measure the same construct or map out a variable in a clinically 
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meaningful way (82, 87).  No amount of statistical manipulation can compensate for 
poorly conceptualised and operationalised variables. 
 
Developers of PRO instruments have often utilised „top-down‟ approaches (i.e. 
literature review, content from existing measures) for conceptualisation and content 
development.  A risk of this methodology for developing disease-specific measures is 
that they may not reflect those aspects of HRQL that are most important to patients 
with the underlying condition.  Not utilising patients‟ perspective in the development of 
new instruments may pose a threat to the validity and responsiveness of scales to 
estimate accurately the effect of a disease or to detect clinical change as outcomes 
relevant to patients may not be included (183, 184).  
 
Various methods have been used to perform qualitative data analysis.  Qualitative 
methods are useful for obtaining direct patient accounts of the illness experience, its 
impact on human suffering, and the impact of related treatments received (185).  
Qualitative research produces large amounts of textual data which is explored 
inductively (i.e. content analysis) to generate categories and likely explanations of the 
relationships between categories and their properties.  Data analysis often takes place 
alongside data collection to allow the refinement of interview questions based on 
emerging information, new avenues of inquiry to develop, and confirmation of 
categories identified in the literature.   
 
There is growing application of qualitative research methods, both in psychology and 
health sciences research, including the use of numerous qualitative methods to 
analyse textual data.  An analytic method common across many qualitative approaches 
is thematic analysis; an approach dealing with data that involves the creation and 
application of „codes‟ to data (186).  Since FDA guidance (86), qualitative methods 
have been more scrutinised but unlike quantitative analysis, there are no clearly 
defined methods of analysis for qualitative data.  Approaches to analysis should be 
determined based on the main focus and aims of the analytical process.   
 
3.2.1 Aims and objectives 
This study was conducted to: 
 examine what determines HRQL for people with Pus 
 identify HRQL domains and their components specific to and important to 
patients with any grade PU  
 identify whether the impact on HRQL is the same in relation to PU severity (i.e. 
superficial vs. severe), location (i.e. torso vs. limb skin sites) and interventions 
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 refine and further develop the working conceptual framework to produce a final 
PU-specific HRQL framework (i.e. conceptualise and operationalise variables) 
 
3.3 Methods 
3.3.1 Development of a conceptual framework 
A PU-specific conceptual framework of HRQL was developed by combining top-down 
(existing literature) and bottom-up (qualitative data) approaches.   
 
Top-down approach 
In the previous chapter, a top-down approach was used to develop a working 
conceptual framework based on a systematic review of the PU and HRQL literature.  
The review identified common HRQL components specific to PUs and PU 
interventions, and general issues associated with having a PU that were grouped into 
relevant HRQL domains.  This produced a list (working conceptual framework) 
including nine broad provisional domains associated with PU occurrence (physical, 
social and personal relationships, psychological, general health, symptoms, perceived 
impact on others, financial) and wound management (need for vs. impact of PU 
interventions, nurse-client relationships).   
 
Bottom-up approach 
The provisional domains formed a topic guide for interviews (Appendix 3.1).  The 
working framework was subsequently revised and extended on in light of the bottom-up 
data obtained from qualitative interviews, followed by expert opinion and review to 
finalise the framework.  The bottom-up approach involved qualitative work to elicit 
information pertaining to the impact of PUs on HRQL, define specific domain 
components (content), and confirm the importance of identified outcomes with a group 
of patients with PUs.  Individual face-to-face, semi-structured interviews, guided by the 
topic guide, with the addition of a series of open-ended questions to elicit any new 
relevant information (e.g. is there anything else that you want to add about how your 
PUs may have impacted you?), were undertaken.  Specifically, information sought from 
interviews related to: how having a PU impacted on life from the perspective of the 
sufferer; which HRQL components are important to patients with PUs and whether 
some are more important than others; how PU interventions impact HRQL; and 
information about the relative importance of having HRQL outcomes assessed as part 
of healthcare.  In addition, patients with PUs commonly have severe comorbidities.  To 
ensure reported issues were PU-specific, clarifying questions were asked (e.g. Do you 
think [that] is only because of your PU or resulting from a combination of things?). 
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The individual face-to-face method was chosen to encourage participants to reflect and 
speak openly in personal terms about their PU experience and the impact it may have 
had on HRQL.  The individual method was chosen rather than focus groups to maintain 
confidentiality, prevent collaboration in responses, and to allow an environment where 
the participant could freely and openly talk about their experience.  It was also 
considered that focus groups, although perhaps more cost effective and less time 
consuming, would have been difficult for participants to attend as many are elderly, 
chronically ill or have mobility problems.  Details regarding participant characteristics, 
the PU (i.e. PU grade, location, duration) and any treatment received were requested 
verbally either from the patient of from the treating nurse.   
 
3.3.2 Participants 
Thirty two patients with PUs from seven acute and primary care settings in England 
and Northern Ireland during December 2007 to October 2008 consented to participate.  
It was considered important to include patients from both acute and primary care due to 
the high prevalence of PUs in both settings.  Sites active in tissue viability research 
with a track record of multi-centre research were invited to participate.  A purposive 
sampling method was devised, with sampling of patients targeted to key factors to 
reflect the range and diversity of the target population, including age (under and over 
70 years), PU severity (superficial and severe PUs) (Table 1.1) and location (torso and 
limb sites), healthcare setting, and experience of different PU treatments.  A minimum 
of five patients per key factor were consecutively sought and found. 
 
Adult patients with a PU of any grade or location were included if they were aged ≥18 
years, from hospital, rehabilitation or community settings and under the care of a 
specialist tissue viability nurse (TVN) or care-of-the-elderly team, able to reflect on and 
share their experience and provide informed consent to participate.  Patients were 
excluded if they did not currently have a PU or one that had healed within the previous 
three months, or who were unconscious, confused, cognitively impaired or unable to 
speak English.  Including patients from acute, community and rehabilitation settings 
allowed collection of data on a wide range of patient experiences.  The 3-month recall 
period was used to reduce recall bias as longer periods could obscure individual recall.  
 
3.3.3 Recruitment and consent procedure 
Specialist nurses at participating hospitals and community services identified and 
approached eligible patients and provided them with study information that included 
details about the rationale, design and personal implications of the study, and an „agree 
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to be contacted by the researcher‟ form.  Following information provision, patients had 
as much time as they needed to consider participation.  The TVN, researcher (CG), 
and the research supervisor were available to answer any questions that patients had 
about the study.  After receiving a signed agreement to be contacted, CG telephoned 
the patient to arrange a time for the interview. CG provided further information about 
the study and interview process, and answered any questions raised before gaining 
verbal consent and arranging an interview at a mutually convenient time.  For in-
patients who could not be contacted by phone and were expected to be in the hospital 
during the interview, with the patient‟s permission, the TVN liaised with CG and the 
patient and arranged a mutually convenient time for CG to visit the patient on the ward.  
 
CG interviewed patients at their home or on the hospital ward, as determined by the 
patient‟s circumstances and preferences at the time of the interview.  Before the 
interview, each patient was given a further verbal explanation of the study, informed 
that the interview would be audio-recorded but that all identifiable information would 
remain anonymous, reminded that they could withdraw from the study at anytime 
without it affecting their care, and then invited formally to participate.  Patients were 
given an opportunity to ask any questions and then if they agreed to take part, they 
were asked to sign a consent form.  For any patients with difficulty writing but who fully 
comprehended, an audio-recording was taken of the verbal agreement.  The right of 
the patient to refuse consent without giving reasons was respected.  Patients remained 
free to withdraw from the study at any time, again, without giving reasons and without 
prejudicing any further treatment.  
 
Ethical approval was obtained by the North West Research Ethics Committee prior to 
study commencement.  This study recruited elderly and highly dependent patients 
considered as vulnerable.  Ethical issues surrounding these potentially vulnerable 
patients were addressed through the study design including a thought out consent 
process and the use of one-to-one interviews to provide a flexible and supportive 
interview environment. 
 
3.3.4 Data Collection 
Semi-structured interviews were useful for suggesting a topic to patients to discuss 
freely, and then using specific probes to elicit more focused information.  This method 
allowed for detailed investigation of patient‟s personal perspective in order to gain 
understanding and clarity of complex phenomena; the impact of PUs on HRQL.  
Interviews followed a topic guide that was revised as new information emerged 
deductively.  Issues that gave insights into the impact of PUs and PU interventions on 
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HRQL were incorporated into discussion of subsequent interviews in response to 
emerging data, allowing confirmation of new issues with successive patients.  The 
working framework was revised and extended based on qualitative data.  This process 
ensured that the research remained participative.  Interviews were undertaken until 
saturation; the stage where no new information appears to emerge during data coding, 
that is when no new properties, dimensions, conditions, actions, interpretations or 
consequences are seen in the data (187, 188).  Interviews lasted a mean of 42 
minutes, and were audio recorded, transcribed verbatim and content analysed by the 
researcher (CG).  No new information was obtained after interview 25. 
 
3.3.5 Quality Assurance 
To ensure quality of data collection and that CG was not leading patients, a researcher 
with experience of undertaking and supervising qualitative research (see 
acknowledgements) listened to the first three recorded interviews, read the transcripts 
and fed-back on performance (e.g. discussed instances in the transcript where CG 
could have probed or clarified further).  Throughout interviews, CG took notes, and 
where required, fed back issues to patients to ensure comprehension of responses. 
 
3.3.6 Analysis 
In the literature, qualitative interviews with patients are promoted as a valid way of 
generating items for new PRO instruments.  However, the method of analysing data 
generated for this purpose is confusing, with various qualitative approaches used but 
without consensus about which method is most appropriate.  Considering that the 
study aim was to build on an emerging theory, validate, and possibly extend a 
framework developed from the literature, qualitative approaches that develop theory 
from data, such as Grounded theory, were not deemed appropriate; the theory would 
not be truly grounded as at least some issues related to the impact of PUs on HRQL 
were known.  Instead, qualitative approaches involving inductive reasoning where initial 
coding starts with a theory were considered.  The analysis approach needed to allow 
the development of a coding schema to be derived from theoretical concepts of HRQL 
generated from the literature as well as additional HRQL components identified from 
patient-reported textual data.  These two sources would provide the basis for 
generating new codes or modifying codes developed by induction.  
 
A criticism of inductive methods is that the coding and sorting of emerging categories 
(codes) may be constrained by existing knowledge of the relationships between some 
categories and their properties.  However, the intention here was to provide support for 
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work that has been done before and to formulate a final PU-specific conceptual 
framework of HRQL that incorporated previous research and new patient-reported 
data.  As such, the directed content analysis approach (189) was used as it is intended 
for extending a conceptual framework.  This method uses structured data collection 
and an explicit analytical procedure informed by a priori reasoning based on existing 
theory (relevant research), thus making it a suitable methodology for the objectives of 
this study.  
 
In content analysis, a large amount of textual data can be analysed.  The process 
involves interpreting data on a higher logical level by creating codes, categories and 
themes (i.e. condensing text by aggregating common data) in relation to the context.  A 
category is a group of content that shares a commonality (190).  Categories should be 
exhaustive and mutually exclusive with all relevant data fitting into a category and not 
excluded due to lack of a suitable category.  A category is a thread throughout the 
codes; a descriptive level of the aggregated content. Linking the underlying meanings 
in categories creates themes.  A theme is a thread of meaning through condensed 
meaning units, codes or categories, on an interpretative level (191). 
 
Generating a series of main themes and subdividing them into a succession of related 
components (categories and codes) was the systematic approach of this study.  
Ongoing analysis of interviews during data collection was undertaken to allow 
provisional HRQL themes to be refined and to inform the focus and prompts for 
subsequent interviews.  First, transcripts were read while listening to the recording to 
confirm accuracy of transcription and to get an overview of the data collected.  Any first 
impressions and interpretations were noted including any thoughts about main HRQL 
components, general feelings about the interview, and audio cues from the patient that 
would be lost in transcription.  This process allowed CG to become immersed in the 
data and note key ideas and recurrent components.   
 
Following this, two researchers (CG and JF) conducted thematic content analysis 
manually for textual data from the first four interviews.  This involved identifying and 
examining evidence (text) from the transcripts for any HRQL issues and coding to a 
provisional coding schema developed using a combined inductive (codes arising from 
transcripts) and deductive (codes developed from the interview topic guide) approach.  
The provisional coding schema consisted of six broad themes (first level codes): 
physical functioning and limitations; social activities and relationships; psychological 
well-being; self-concept; pain; and exudate and odour.  The provisional coding schema 
was refined to reflect the emerging data during subsequent stages of the analysis; data 
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collection and coding were conducted iteratively in multiple rounds of interviews so that 
subsequent data collection was informed by earlier coding and confirmed in later 
interviews.  Note-taking, constant comparison and identifying emerging categories until 
saturation, allowed the data analysis to be responsive to the data.  Specifically, the 
categories suggested in the transcript of the first interview were identified.  Coding 
categories in the second interview were done with the first interview in mind.  
Subsequent coding was done with the emerging theory in mind and so on.  The 
emerging theory was developed as new categories emerged from the data.  This 
process of constant comparison ensured that the theory emerged from the data rather 
than from any preconceived ideas.  Further, continuous analysis ensured that the 
emerging coding schema was complete or saturated, and captured the specific 
components within the first level codes and emerging HRQL themes.  
 
In the second round of coding, the researchers independently assigned codes to 30% 
of transcripts.  An inclusive approach was taken, adding HRQL components (codes) to 
reflect the emerging nuances in the data rather than reducing data to a few numerical 
codes (i.e. first level codes).  This type of textual analysis and consensus coding 
allowed the researchers to identify themes and their specific components inductively as 
they emerged from the data.  Further, any new aspects could be tested with 
subsequent patients to confirm their relevance and importance (i.e. confirm new issues 
are important to more than just one patient).  Issues mentioned infrequently were 
discussed by an expert group (see Expert Review section below) and components 
considered not clinically relevant were either excluded or consolidated with related 
components (e.g. emotions such as irritated and distressed were consolidated with 
„negative mood‟) rather than retained as separate themes in the conceptual framework.   
 
The extraction process involved coding any patient phrase or statement to the 
appropriate code.  If the same text was describing two independent issues, they would 
be coded to both codes.  The two researchers reviewed the independent sets of 
coding, including any gaps in information or discrepancies, agreed the final framework 
by consensus and discussed any discrepancies in coding with a third researcher (JN).  
The intention was to establish a common conceptual understanding of the codes 
between the researchers and generate a consolidated coding schema.  The final 
schema consisted of main domains divided into sub-domains.  Sub-domains comprised 
a number of components describing slightly different characteristics of the domain.  For 
example, „irritated‟ and „distressed‟ were components of sub-domain (variable) „mood‟.  
By analysis of the twenty fifth transcript, no new themes or categories emerged in the 
data and therefore the conceptual framework was considered saturated. 
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Reliability 
Consistent with methods used by others (192), a Kappa statistic (193) was performed 
to determine the extent of agreement between the two researchers in applying the final 
coding schema; a Kappa >.70 is considered acceptable for inter-rater reliability (193, 
194).  Kappa‟s (SPSS 13.0) were 0.924 and 0.908 for coding main and sub-domains, 
respectively, showing almost perfect agreement between the researchers (195).  
 
Cross-case analysis 
Following manual coding, transcripts were entered into QSR NVivo 7 (2007) and the 
final coding schema applied to all text data.  This was undertaken to enable complex 
organisation and manipulation of textual data for the purpose of performing cross-case 
analysis.  Such analysis was important to establish the extent to which HRQL domains 
were consistent across the patient sample as well as to explore any differences.  An 
exploratory cross-case analysis was performed by mapping and interpreting the data 
from case charts (by patient across all HRQL domains); a method adapted from 
Framework Analysis (196, 197).  The charts were used to search for any patterns and 
associations in the data; components that occur repeatedly in the data, unique to each 
patient factor (i.e. age, gender, PU location and severity, and comorbidity) as well as 
similarities or variations in individual experiences (197, 198).  
 
Expert review 
Following data analysis, a multidisciplinary expert group consisting of seven tissue 
viability specialists, one chronic pain specialist and five outcome methodologists (see 
acknowledgments section for membership) reviewed the final conceptual framework.  
As the intension was to develop a HRQL PRO measure, a distinction between HRQL 
outcomes versus other contributory factors which may affect HRQL (i.e. behaviours, 
satisfaction with healthcare) was made.  The relative importance of outcomes in terms 
of how commonly they were reported (i.e. the number of times a verbatim was coded 
as the same code, for example “I feel pain when I move” x12) as well as clinical 
relevance was determined.  A final PU-specific HRQL conceptual framework that 
adequately defined, conceptualised and operationalised constructs (specific 
components) was produced. 
 
3.4 Results 
3.4.1 Participants 
Participants were selected to ensure representation of the PU population, including 
targeting to factors such as age, gender, setting and comorbidity.  Thirty patients 
consented to participate.  They ranged in age from 22 to 94 years (mean age 62.2 yrs), 
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of which 18 (56%) were male and 19 had other chronic conditions (e.g. 8 with spinal 
cord injury (SCI) and 3 with multiple sclerosis (MS)).  Patients represented 
hospital/rehabilitation (n=17) and community (n=13) settings, PU severity (12 
superficial, 15 severe, 3 mixed severity), duration (from a few days up to 4 years) and 
skin site. Sacrum (n=15) and heel (n=14) PUs were the most frequently occurring with 
other sites including the lower back, buttocks, ankles, hips, back of head, and elbows 
(Table 3.1). 
 
3.4.2. Conceptual Framework  
The final PU-specific HRQL conceptual framework includes four domains and 13 sub-
domains (Figure 3.1).  All domains and descriptive components are described below.  
 
3.4.2.1. Symptoms 
Pain and discomfort 
Patients with PUs commonly reported some form of pain or discomfort.  Pain interfered 
with sleep, general movement, walking/sitting, daily activities and socialising: “I can‟t 
face [activity] because of the pain” (62mG4C)5.  The pain could be “unbelievable” and 
they would “do anything to be rid of it”, and some even perceived it as a “punishment” 
for the PU.  Patients reported anticipatory pain (e.g. during dressing changes) which 
caused anxiety, while others coped by comparison with worst pain ever experienced.  
 
Commonly, PU pain was described as “sore”, “stabbing”, “burning”, “throbbing” or 
“stinging” - words often associated with both nociceptive and neuropathic pain.  A large 
proportion of patients experienced severe and persistent pain that varied in duration 
(i.e. constant, never ending, intermittent).  Most commonly, patients felt pain in and 
around the PU, shooting up through various parts of the body (e.g. up the leg or back), 
upon contact, pressure (e.g. when sitting), upon movement, or with various PU 
treatments (e.g. dressing changes, debridement) or medical equipment (e.g. hoists). 
 
Pain caused discomfort and interfered with one‟s ability to participate in daily life, 
move/walk or assume comfortable positions, or engage in sexual activity.  Some 
patients felt that pain made their manual handling and treatment difficult for healthcare 
providers and carers.  The few patients who did not report their PU pain to a healthcare 
provider claimed it was difficult to describe, feared being a burden or nuisance, thought 
nothing could be done about it, or perceived it to be the norm. 
                                               
5 Annotations refer to participant‟s age, gender (m or f), PU severity: superficial (G1/2) 
or severe (G3/4) and healthcare setting: community (C) or hospital (H). 
 Table 3.1 Participant Characteristics 
Age Gender PU (Grade) & location PU 
duration 
PU 
recurrence 
Other 
condition 
Setting PU on 
admission 
Interventions 
received 
38 Male (3)left elbow; (3)left hip 3mths Yes SCI Acute rehab, PU treatment Yes VT,M,D 
41 Male (4)sacrum 3-4yrs Yes SCI, SB Acute rehab, PU treatment  Yes M,C,D,VT,LT,NT 
45 Male (3)heel; (4)repaired hip 8wks Yes,24 yrs SCI Acute rehab, PU treatment Yes D,M,C,SR 
49 Male (4)left buttock 2yrs Yes SCI Acute rehab, PU treatment yes M,C,SR,VT,LT,D 
52 Male (4)right hip 9mths No SCI Acute rehab, PU treatment Yes M,C,D,VT 
55 Male (4)left buttock 1.5yrs No MS Community NA M,C,D 
59 Male (1)lower back; (3)sacrum; 
(3)both heels 
3mths Yes SCI Acute Vascular, PU treatment Yes M,D,WC 
60 Male (4)sacrum 6mths No SCI SCI Rehab  No M,C,D,VT 
61 Male (2)sacrum 8wks No unk Acute rehab  No M,D,WC 
62 Male (1)both hips; (2)sacrum 9 yrs Yes unk Acute general surgery Yes D,M,C,VT 
62 Male (4)sacrum 3mths No Renal  Community NA M,D,VT 
64 Male (1)right heel; (1)right hip;  
(2)buttocks/sacrum 
1mth No Neurofibrom
atosis 
Acute neurosurgery 
neurofibromatosis 
No M,D 
71 Male (2)heels 5wks No Elderly Acute neurosurgery  No D, creams 
71 Male (2)sacrum; (2)buttocks 2 yrs Yes Lymp Acute lymphodeoma Yes M,C,D 
82 Male (4)left buttock 18mths Severe PU Tumour  Community NA M,C,D 
88 Male (3)left heel; (3)right heel 10mths No Pneumonia Community NA C,D 
88 Male (2/3)right heel 6mths No Elderly Acute general surgery Yes M hospital 
89 Male (2)left heel 7mths No Elderly Long-term care No M,D 
 Age Gender PU (Grade) & location PU 
duration 
PU 
recurrence 
Other 
condition 
Setting PU on 
admission 
Interventions 
received 
22 Female (3)sacrum; (4 left thigh 2.5mths Yes SCI, lymp Acute rehab, PU treatment Yes M,D,VT,NT 
43 Female (3)sacrum 5wks No Vascular  Acute Vascular No M,D 
52 Female (1)lower back; (4)sacrum 1yr Superficial  MS Community NA M,D 
52 Female (1)both heels; (1)sacrum 
(3)back of head 
16wks No unk Acute ICU  No M,C,D,VT 
55 Female (4)right heel 3yrs No SB Community NA D 
56 Female (3)right heel 3mths Superficial  Blood clots  Community NA M,WC,D,LE 
59 Female (2)sacrum 3mths No COPD Community NA M,C,D 
59 Female (2)sacrum; (4)both ankles 
(4)both thighs 
13mths PUs over 12 
yrs 
MS Community NA M,C,D,LT,NT 
64 Female (3)right heel 4mths No Stroke Acute stroke unit No M,C,D 
67 Female (1)heel; (3)heel 4wks 
3.5mths 
No Rheumatoid 
arthritis 
Community NA M,D,LE 
71 Female (2)left buttock 6mths No Incontinent  Community NA Cream/lotion 
79 Female (1)right heel; (2)left heel 4wks No Elderly Rehab, fall  No M,D,LE 
82 Female (2)sacrum 3wks Yes Elderly Acute, fall No M,D,lotions 
94 Female (1)left heel Few days No Hip surgery Community NA None 
M Mattress; D Dressing; WC Wheelchair Cushion; C Cushion; VT VAC Therapy; NT Nutrition Therapy; LT Larval Therapy; SR Surgical Repair, LE 
Leg Elevation; wks Weeks; mths Months; yrs Years; SCI Spinal Cord Injury; MS Multiple Sclerosis; Chronic Obstructive Pulmonary Disease COPD; 
Lymp lymphodeoma; SB Spina Bifida; rehab Rehabilitation ward/facility; ICU Intensive Care Unit; unk Unknown; NA not applicable
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 Exudate and odour 
Exudate and odour were problems, particularly for patients with severe PUs.  Both 
symptoms interfered with daily life, intimacy and being close with others, contributed 
towards social problems such as self-imposed isolation or choosing not to take part in 
social activities, and caused emotional distress such as feeling self-conscious or 
embarrassed.  Exudate increased the need for frequent dressing changes and/or 
caused the dressing to come off, leaving the wound exposed or staining clothes.  Some 
patients reported that frequent dressing changes helped to contain leaking and odour 
thus reducing symptom bother.  
 
3.4.2.2. Physical Functioning 
Mobility and daily activities  
Patients reported that PUs restricted movement and mobility and limited activity.   
These restrictions contributed to the inability to participate in daily activities such as 
preparing meals, shopping, getting dressed, doing house chores, undertaking self-care 
and hygiene, and enjoying hobbies and interests.  Activity and going out were difficult 
for patients, restricting their daily life: “I can‟t do things like before” (67fG1/3C), 
“stopped me doing what I want to do” (55fG4C), and “life put on hold” (52mG4H), 
because of limitations in movement and mobility.  Enforced bed rest for PU treatment 
made travelling and planning trips at the weekend difficult, further restricting 
participation. 
 
Patients described PUs as inconvenient and troublesome, with PU symptoms 
interfering with mobility and daily activities.  Repositioning or movements were at times 
uncomfortable, difficult or caused severe pain.  Some patients were unable to walk 
because of oozing exudate.  While the majority of responses were negative, some 
patients found ways around their physical limitations and occasionally perceived them 
as an opportunity to pursue new hobbies or learn new skills (e.g. using a computer). 
 
General malaise and sleep  
PUs and treatments caused problems with quality of sleep, with some patients having 
to learn to sleep in new positions.  For some, appetite was reduced due to the 
appearance, smell or pain of the PU.  Others complained of feeling unwell, tired, 
fatigued or lacking energy: “I haven‟t got the same go in me” (67fG1/3C), making it 
difficult to carry out normal daily tasks or accomplishing less than normal.  
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Figure 3.1 PU-Specific HRQL conceptual framework 
 
 
3.4.2.3. Psychological Well-Being 
Mood 
PUs and PU treatments have a substantial affect on psychological well-being.  All but 
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taking to heal...it‟s never ending” (56fG3C).  Others reported feeling angry, irritated or 
annoyed that “I can‟t do what I want to do” (55mG4C and 59mG1/3H) or that “I have a 
PU and it needs to be treated” (82mG4C).  Feelings of hopelessness and helplessness 
were usually a result of perceiving that “they‟ve [nurses] tried everything and it‟s just 
not getting any better” (59fG2C).  Some felt despondent about PU-associated 
limitations, perceiving this to be out of their hands: “Why the hell has this 
happened…it‟s not fair…on top of everything else” (41mG4H).  Extreme frustration was 
also common, particularly when PUs prevented patients from doing things for 
themselves, moving as normal or doing things they enjoyed (e.g. participating in 
hobbies or leisure activities).  Ineffective treatment or pain relief, the length of time 
spent undergoing treatment, and feeling there was nothing that could be done further 
contributed to frustration. 
 
Emotional distress was lower when there was evidence that the PU was improving 
since this meant regaining independence and being able to do more (i.e. walk again), 
making patients feel happier and more hopeful and optimistic.  Negative affect was also 
reduced when the patient had realistic expectations about prognosis, such as 
accepting that the PU would take a long time to heal and require extensive treatment: 
“you know the dressing has to be changed every day and so on, so it‟s just a bit of a 
hassle really but that‟s the way it is” (62mG4C).  For some patients, negative emotions 
resulted from the perceived failures of healthcare providers.  
 
Anxiety and worry 
Anxiety concerning the PU and wound care were both general and specific.  Patients 
worried about infection, medical complications, the PU getting worse or not healing, 
prognosis, and recurrence.  Other worries concerned the dressing coming off (i.e. 
exposing the PU or causing exudate to leak), time taken to heal, and about being a 
burden on others.  Additional worries related to healthcare and competence of 
healthcare providers, how the PU was being managed, and anxieties specific to being 
hospitalised for PU treatment (i.e. length of hospitalisation, possible neglect of the PU, 
potential for hospital equipment causing pain or PU deterioration). 
 
Self-efficacy and dependence 
Loss of independence was associated with loss of control over one‟s life.  Patients felt 
as if their life had been “robbed”, since it now revolved around the PU and PU care.   
Patients who had different nurses attending to their PU felt that, although it was their 
body, they could do nothing about who saw it, touched it, attended to it, or when any of 
this occurred.  Patients reported tension between what one should do to promote PU 
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healing (i.e. medical advice) versus what one would prefer to be doing, which involved 
weighing up pros and cons for doing something that could be detrimental to the PU: 
“You know you shouldn‟t but you do it [going out instead of bed rest] anyway” 
(41mG4H).  Fear of being a burden was a major component of loss of independence 
and many felt guilty about the additional work imposed on significant others.  
 
Appearance and self-consciousness  
The physical appearance and severity of the PU was frightening, disgusting, gruesome, 
and shocking to patients: “To think I have that on my body…that big black gaping 
hole…I wasn‟t expecting that” (52fG1/4C).  Others were concerned about the size and 
depth of the PU, particularly if bone was exposed.  Seeing the PU allowed insight into 
its severity and the monitoring of progress: “It‟s encouraging to hear that my PU is 
improving but it‟s better yet to see the improvement for yourself…seeing improvement 
makes it all worth it” (22fG3/4H).  Observing the PU improve helped reclaim a positive 
body image. However, a practical issue for many was that their PU was in a place that 
was not easy for them to view (i.e. sacrum, back of heels).  These patients found it 
troubling listening to others talk about something that was on their body but that they 
could not see or reach.  Hence, using a mirror or taking a photograph were helpful 
strategies.  Others had a disinterest in seeing the PU as it was “ugly and dirty”, and 
“unattractive”, and they preferred to remain detached from it or not thinking about the 
PU as a part of them.  
 
Physical attractiveness and physical changes such as scarring had negative 
consequences on body image and self-concept.  Being treated by others as a PU-
patient or as someone with a disability was associated with self-identity problems.  The 
physical appearance and exudate and odour of the PU had a negative impact on body 
image, leaving patients embarrassed and self-conscious that their “body stinks and is 
leaking gunge” (22fG3/4H).  Others reported feeling ashamed “that [PU/smell] is part of 
me and others can [see/smell it]” (43fG3H).  Becoming totally dependent on others was 
also embarrassing and affected self-concept, as patients felt useless and inadequate, 
impacting self-respect, self-esteem, and their confidence.  Others felt that their PU had 
taken on its own identity: “see me and not the PU” (41mG4H), eliciting anxiety about 
having their identity reduced to being a PU-patient. 
 
3.4.2.4. Social Functioning 
Social isolation 
Feeling left out or isolated, commonly expressed as feeling “captive”, “confined” and 
“alienated”, was an important consequence of having a PU.  Many patients were 
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confined to bed or hospitalised for PU treatment, leaving them feeling disconnected, 
alone, missing family, friends and pets, and restricting social connectedness and 
interaction. 
 
Participation 
Patients reported a variety of social problems including restrictions in social 
participation (e.g. where one can go, how long they can stay out).  Social lives were 
disrupted mainly because of physical restrictions including treatment (i.e. time spent on 
wound treatment regimens, hospitalised or in bed), which kept patients away from 
friends and loved ones.  Related to this was the wait for PU treatment, which further 
restricted social activities and interfered with going out, making social plans, and loss of 
control over planned activities.  Others mentioned disinterest in socialising: “I don‟t 
want to go out because of [pain or the smell]…don‟t enjoy it” (41mG4H and 62mG4C) 
or described how they were unable to enjoy socialising because they were aware of 
time restrictions and the need to return home for bed-rest or treatment. 
 
The ability to function in several common roles (e.g. self-care, social/familial, and 
vocational/educational) was severely impaired because of PUs.  Patients reported 
problems in relationships (marriage, parenting, friendship), with their self-esteem/self-
concept and psychological well-being.  Many worried about the impact of the PU on 
relationships with partners, who often had to take on roles that the patient could no 
longer manage.  Patients were also concerned that their relationship would change if 
they became dependent on their partners for PU care, leaving their partners feeling like 
a nurse/carer.  Difficulties with closeness and interpersonal communication were also 
reported.  For younger adults, having sexual relations, being able to see each other 
and interference with work or school were additional concerns.  
 
3.4.2.5. Patterns of association  
Associations in the data were considered for the following patient factors: age, gender, 
PU severity and location, and comorbidity (e.g. patients considered elderly, acutely ill 
or with neurological impairment such as SCI or MS).  No gender or PU location 
differences emerged.  For other factors, the reported HRQL issues were largely the 
same for all patient types, with some minor differences emerging.  Specifically, 
irrespective of age, PU severity, and comorbidity, patients reported physical impairment 
(e.g. difficulties with movement, daily activities and sleeping) and restricted social 
participation.  About a third who reported social impairment also reported role 
functioning difficulties.  Patients who reported social isolation all had severe PUs of 
duration greater than 3 months.  All patients who reported a problem with pain also 
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reported that pain contributed to emotional distress and restricted physical and social 
functioning, whereas smell and exudate were problems mainly for patients with severe 
PU (i.e. skin breakdown).  Older patients were less likely to report pain, fearing being a 
burden or nuisance.  Those with SCI reported pain or discomfort however the 
sensations experienced differed from those of others depending on the level of injury. 
 
Apart from three, all patients reported impaired psychological functioning, and physical 
and social limitations irrespective of individual patient factors.  Patients who were 
frustrated reported limitations in physical and social functioning, loss of independence 
and treatment burden.  Loss of independence led to self-concept and identity problems 
(i.e. questioning self-worth, confidence and importance).  Patients who worried about 
their PU or who were bothered by their physical appearance reported negative 
emotional problems.  Most patients reported some form of coping however not all 
patients who used coping mechanisms reported less negative psychological impact.  
 
One third of patients had neurological impairment (i.e. SCI or MS) as well as severe 
PUs of duration greater than 3 months.  These patients reported learning to live and 
function with their existing condition until medical “set-backs” such as PUs caused 
them substantial impairment and difficulty.  On the other hand, patients with acute 
medical problems (i.e. broken hip, accident/trauma) found that their primary medical 
condition caused them greater impairment and burden, with the PU perceived to not 
impact greatly on their lives.  
 
3.5. Discussion 
This study produced a PU-specific conceptual framework of HRQL that includes four 
domains or constructs: PU-symptoms, physical functioning, psychological well-being 
and social functioning.  These constructs are similar to those in generic HRQL models 
(78, 89, 96), however, this framework also incorporates components specific to PUs.  
For example, “social isolation” is often excluded from the social domain in generic 
models, but was found to be important to people with PUs.  “Appearance and Self-
consciousness” also appear specific to PUs, especially embarrassment and concerns 
about changes to self-concept.  In addition, several components emerged that were not 
identified by previous research (9, 104, 105, 106, 112, 155, 171, 199).  Components 
added to the psychological well-being domain included extreme frustration, feeling 
hopeless, helpless and anxious, appearance/self-consciousness and self-efficacy.  
Malaise and sleep were added to the physical functioning domain.   
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This is the first study to conceptually map the range and nature of the impact of PUs on 
HRQL and investigate patterns of association unique to specific patient factors.  For 
people with PUs, irrespective of age, gender, PU severity and location, and 
comorbidity, the main impact on HRQL is in terms of restrictions in physical and social 
functioning, particularly mobility and movement, looking after oneself, malaise and 
sleep disturbance, emotional problems, and pain.  Impaired physical and social 
functioning contributes to emotional and mood problems and is associated with low 
self-efficacy and independence and negative self-concept.  Physical appearance is 
also associated with self-consciousness and identity problems, reducing psychological 
well-being.  Emotional distress and mood can affect all other components in the HRQL 
model. For example, self-consciousness about PU appearance, smell or exudate, or 
anticipation of pain may reduce physical and social activity.  Reduced physical or social 
functioning may, in turn, lead to depression, anxiety and frustration.  PU symptoms and 
anticipation of pain were associated with emotional distress and anxiety and 
contributed towards limitations in physical and social functioning.  
 
Despite relatively few studies relating to HRQL in individuals with PUs (199), previous 
research has identified common concerns reported by patients about the experience of 
living with a PU and the burden of PU interventions on their lives (9, 104, 105, 106, 
107, 112, 161, 164, 165, 166).  Consistent with previous findings, PUs have negative 
effects on HRQL (9, 104, 105, 106), restrict activities and mobility (9, 105, 106), 
contribute towards social isolation (104, 106), emotional problems (9, 104), and cause 
severe and persistent pain (9, 104, 105, 106).  In addition, early warning signs for skin 
damage (i.e. pain) do not prompt action, treatments increase pain and discomfort, and 
patients‟ views and concerns relating to physical, social and psychological aspects are 
not being met.  Evidence from existing qualitative research relates to patients‟ 
experience of living with a PU (9, 104, 105, 106) and not specifically about how PUs 
impact HRQL. Lived experience studies give meaning to what it is like to experience 
having a PU, but patient reports are broader than HRQL issues, including experience 
of care reports and factors that might be consequences of having PUs but that are not 
specifically HRQL outcomes; the distinction between concepts is not made.  Further, 
operationalisation of HRQL constructs has not previously been made 
 
Building on previous research, the conceptual framework was developed with 
qualitative work that incorporates views from a representative sample of patients with 
PUs.  This ensures that the conceptual framework content is characterised by 
outcomes that are important and relevant to patients.  Importantly, poor interview 
techniques can introduce bias.  An interview guide was developed to ensure that 
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interviews were guided and leading questions avoided.  The transcriptions of the first 
few interviews were checked for context and content before subsequent interviews 
were undertaken and data analysis begun.  Independent coding by two researchers, 
inter-rater reliability and consensus meetings were undertaken.  These precautions, the 
fact that data was analysed in a systematic and rigorous manner, and that data 
interpretations were grounded in actual patient data helped minimise the risk of bias. 
 
Patients across all adult age-groups and gender, PU severity and skin site, clinical 
specialities and healthcare settings were included however the sample was limited to 
English-speaking British nationals without cognitive impairment.   Differences were 
explored by age, gender, PU severity and location, but no major differences among 
these subgroups was observed.  Inclusion of patients with varying comorbidities 
assisted in separating out the effect of existing conditions from the effect of PUs to 
ensure that the conceptual framework was representative of PU-specific impact on 
HRQL and relevant to all types of patients with PUs.  PU symptoms were problematic 
for all patients, however older patients were less likely to report pain and for those with 
impaired sensitivity it was assumed pain was not a problem.   
 
3.6. Summary of Chapter 3 
This study provides insight into PU-specific components of HRQL and provides 
qualitative evidence for HRQL outcomes that are important from the perspective of 
patients with PUs.  This work assisted in operationalising PU-specific HRQL constructs; 
an essential step towards ensuring valid measurement.  The final PU-specific HRQL 
conceptual framework will be used to assess any PROMs identified from a review of 
existing measures (Chapter 4).  The earlier review (Chapter 2) failed to identify PROs 
specific for PUs.  However, the review was not intended to determine whether 
measures for other similar chronic wounds were available and suitable for PUs.  As 
such, this conceptual framework will provide a structured and formal method to assess 
the content of available measures against.  It will also provide the basis for the 
development of a new PU-specific PRO measure of HRQL if required.  
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Chapter 4  
SYSTEMATIC REVIEW OF THE LITERATURE 
Existing PROs used in PU and other chronic wound research 
 
4.1 Overview 
Chapter 4 reports the methods and results of a systematic review of the literature 
intended to identify and evaluate currently available PRO instruments used in PUs and 
other chronic wounds.  The conceptual framework developed in the previous chapter 
provides a structured and formal method to assess the content of available instruments 
to determine suitability for use in PUs or the need for a PU-specific PRO instrument.   
 
4.2 Background 
There has been a growth of PRO instruments to evaluate HRQL in many disease areas 
including chronic skin conditions, with a number of condition-specific measures 
developed for different chronic wounds.  The application of PRO instruments in the 
evaluation of healthcare has become increasingly important in other disease areas (83, 
84) as PROs have commonly been the main dependent variable on which decisions 
are made that influence patient care.  However, in PUs, assessment of outcomes in 
clinical trials of PU intervention effectiveness have been limited to conventional clinical 
outcomes and HRQL outcomes rarely assessed (Chapter 2).  What is not clear is 
whether failure to incorporate patients‟ assessment of outcomes arises because 
appropriate methods do not exist or whether methods exist but have not been widely 
adopted or „fit for purpose‟ has not been determined (i.e. inadequately validated).   
 
Despite the impact on HRQL, little research has been done to determine the availability 
of PRO instruments, either generic or disease-specific, and their suitability for use in 
PU research.  A review of the PU and HRQL literature (Chapter 2) failed to identify 
PROs specific for PUs but the review aims were not to systematically search for PRO 
instruments.  Therefore it was deemed necessary to determine whether PROs for PUs 
or for other similar chronic wounds were available and suitable for use in PUs.   
 
4.3 Aim 
In the absence of any known scientifically robust PU-specific HRQL measure, this 
pragmatic review is based on the need to identify and evaluate currently available PRO 
instruments used in research with PU populations and other similar chronic wounds to 
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determine how useful or appropriate these measures are for use with people with PUs.  
Specific objectives were to comprehensively and systematically search the 
international literature on PUs and other chronic wounds to identify generic, PU-specific 
and chronic wound-specific PRO instruments used to assess HRQL in patients with 
PUs or other chronic wounds and to assess PRO instruments‟ content against the PU-
specific HRQL conceptual framework (Chapter 3), in addition to evaluating feasibility 
for use with patients with PUs (i.e. item specificity, response burden). 
 
In the previous chapter, a PU-specific HRQL conceptual framework was derived from a 
systematic review of the literature and the views of patients with PUs.  The conceptual 
framework includes four HRQL domains divided into 13 sub-domains.  Not only will the 
conceptual framework be important for informing future HRQL research in this field, but 
the intention was to have a structured and formal method to assess any available 
measures against for their feasibility and relevance to PUs. 
 
4.4 Methods 
4.4.1 Search strategy  
Consistent with the methods undertaken in the first systematic review (Chapter 2), an 
iterative process was used to develop an optimal search strategy to ensure sensitivity 
without yielding too many results.  The search strategy was developed (Appendix 4.1) 
to retrieve all research related to HRQL instruments used in studies of patients with 
PUs or other chronic wounds (e.g. leg ulcers, diabetic foot ulcers, fungating ulcers, 
dehisced surgical wounds).  Search terms consisted of key words for the clinical 
disease area and HRQL and related concepts (QoL, health status, function and well-
being), which were combined using Boolean operators as follows: (PU or chronic 
wounds) and ((HRQL concepts) or (patient-reported) or (questionnaire)).  To increase 
specificity, the searches were refined by publication (not commentary, letter, guidelines 
or audit), wound type (not buruli, digital ulcers, burns or spider bites), and limited to 
humans and adults (aged 18 years or above).  
 
4.4.2 Data sources 
The following databases were searched from inception until June 2009: MEDLINE, 
Embase, PsycINFO, CINAHL, BMI, AMED, The Cochrane Library and Web of 
Knowledge (WOK).  The Cochrane and WOK databases were searched using „PU‟ or 
„pressure sore‟ and „QoL‟ topic words.  Auto alerts via OVID database library were set 
up until data extraction was completed (November 2009) to notify of any additional 
papers that had been added to the databases since the original search was performed. 
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To identify unpublished and on-going studies, the electronic searches were 
supplemented by a hand search of specialist journals, relevant conference proceedings 
and theses and dissertations.  Twelve experts were contacted, the Patient-Reported 
Outcome and Quality of Life Database (PROQOLID, http://www.qolid.org/) and the UK 
National Research Register searched, a citation search on all included studies and 
systematic reviews identified in the searches (147, 200, 201, 202, 203, 204, 205, 206, 
207, 208, 209, 210) performed, and an internet search of web content relating to PU 
self-help and focus group websites undertaken (see Appendix 4.2 for detailed list).  
 
4.4.3 Criteria for study selection 
Studies of any design were included if PRO instruments were used to assess HRQL in 
adult patient populations presenting with any category PU or chronic wound, from 
hospital, rehabilitation or community health settings within Europe, North America or 
Australia.  Thus, studies were excluded if: HRQL was assessed by a healthcare 
provider or proxy (i.e. not patient-reported); the PRO was intended primarily for other 
medical conditions where PUs are secondary outcomes (e.g. Life Situation 
Questionnaire), assessed mediating or contributory outcomes only (e.g. social support, 
personality, locus of control, coping or mini-mental for screening cognition), or used 
single-item rating scales (i.e. VAS); the sample was limited to paediatric populations or 
wounds caused by trauma (e.g. burns); or the development/use of the PRO was 
outside Europe, North America or Australia as it would not be culturally appropriate for 
use in a UK setting.  PRO instruments which had not undergone psychometric 
evaluation for reliability or validity (i.e. ad hoc instruments) were also excluded.  
 
4.4.4 Selection of studies 
Abstracts from studies retrieved were screened for relevance by one reviewer (CG).  
Studies that did not meet the inclusion criteria were excluded at this stage.  Studies 
assessed as potentially relevant or where relevance was ambiguous, were obtained in 
full for further scrutiny.  Two researchers (CG, JN) independently assessed potentially 
relevant studies and those that did not meet the eligibility criteria were excluded from 
further analysis.  Where there was lack of consensus, disagreements were resolved 
through discussion with a third reviewer (DL).  Where study details were lacking, 
attempts were made to contact the authors for additional information.  
 
4.4.5 Quality appraisal 
Individual quality components of PRO instrument methodology were not used as a 
threshold for inclusion of instruments in this review as the intention was to assess the 
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content of available instruments.  However, one piece of empirical evidence for 
reliability and validity was a minimum requirement for instrument inclusion.  It was 
proposed that the strength of the psychometric evidence would be appraised by two 
researchers (CG and YA) if studies met thresholds as described in section 4.4.7.  The  
appraisal was based on a 3-point rating scale where  + = some limited evidence in 
favour (weak evidence); ++ = some good evidence in favour, but some aspects do not 
meet criteria or not reported (adequate evidence); +++ = good evidence in favour, all 
major forms of evaluation reported (211).  
 
4.4.6 Data extraction  
Two researchers (CG, YA) independently extracted data using structured data 
collection forms developed to investigate theoretical underpinnings for PRO 
instruments (83, 212, 213).  Data extracted included: descriptive characteristics (name 
of instrument, mode of administration, modified versions), PRO-specific issues 
(purpose, intended population, actual population validation performed in, theoretical 
orientation), content (evidence for an underlying conceptual model, list of all domains 
and items) and measurement properties (development method, item reduction, 
psychometric analysis).  Extractions were cross-checked for errors, omissions and 
consistency in extractions.  Disagreements or discrepancies were discussed between 
the two researchers and confirmed with a psychometrics expert (DL).  Data pertaining 
to the development and validation of measures were extracted from the original 
development paper.  Information about the use and application of the measure and 
further descriptive and psychometric data were extracted from additional papers.  
 
4.4.7 Analytical procedures 
The analytical procedure was designed to systematically determine the extent to which 
PROMs covered the PU-specific framework (see Chapter 3), were relevant to PUs 
(item specificity), and posed minimal response burden.  
 
Two level content validity: i) Domain level content analysis – determined the 
percentage of PROM domains that mapped onto the PU-specific conceptual domains 
and sub-domains; the higher the percentage the better coverage of PU-specific 
domains (e.g. How many domains map onto PU-specific domains?).  To ensure 
relevant domains were not excluded, where domain names differed from those in the 
PU-specific framework, item content, as described by the authors, was compared 
against the PU-specific domain content to determine domain consistency irrespective 
of different labelling (e.g. activity domain content was consistent with physical 
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functioning content).  For PRO instruments with domains that mapped 75% or more 
onto PU-specific domains, the percentage of items representing mapped domains was 
considered (e.g. how many items represent mapped domains?).  For instruments with 
75% or more items representing mapped domains, item-specificity was determined 
(level two analysis). 
 
ii) Item level content analysis – item-specificity was determined by the percentage of 
PRO instrument items that are PU-specific (e.g. to what degree are items relevant to 
PUs?).  Two researchers (CG, JN) independently undertook a critical appraisal of items 
by making a judgement about whether they represented HRQL outcomes relevant to 
the impact of PUs.  Items were considered PU-specific if they mapped onto the 
descriptive components of the PU-specific framework (see Chapter 3, section 3.3.2 for 
specific components).  The two sets of assessments were cross-checked for 
consistency. 
 
Response burden: In addition to content validity and item-specificity, PRO instruments 
may contain domains and/or items that are not relevant or appropriate for use with 
patients with PUs.  The balance between relevant and non-relevant content (referred to 
here as response burden) was expressed as the percentage of items representing non-
mapped domains (i.e. the inverse of the percentage of items representing mapped 
domains (above)).   
 
Psychometric properties: For PRO instruments that had at least 75% of PU-specific 
content (at both domain and item level) and no more than 25% of non-relevant content, 
it was proposed that psychometric properties, including reliability, validity and 
responsiveness would be appraised.  As none of the identified instruments met these 
criteria, the psychometric properties were not assessed.  
 
4.5 Results 
4.5.1 Studies included in the review 
A total of 2616 papers were retrieved, of which 248 were assessed as potentially 
relevant and 50 met inclusion criteria.  From these, 19 potential instruments were 
identified; however, two were excluded, one at development stage (214) and one 
provided no evidence for reliability or validity (215).  A total of 17 PRO instruments 
fulfilled the inclusion criteria, including three generic and 14 chronic wound-specific (9 
for leg ulcers, 4 for diabetic foot ulcers and 1 for mixed; leg and diabetic foot wounds).  
No instruments were identified that had been developed and validated in PUs.  The 
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results of the two-level content (domain and item level) and response burden analysis 
of existing PRO instruments are presented in table 4.1.  
 
Generic measures 
There is a plethora of generic instruments with evidence of validity and reliability; 
however, only five studies investigated HRQL in patients with PUs using three generic 
measures: Ferrans and Powers Quality of Life Index (QLI) (216), the Medical 
Outcomes 36-item Short-Form Health Survey (SF36) (112, 172, 217) and the Medical 
Outcomes 12-item Short-Form Health Survey (SF12) (218).  The three generic 
measures covered six of the 13 (46%) PU-specific HRQL domains, with response 
burden ranging from 17-68%. None of the generic measures met the 75% criterion of 
content validity.  Four of the 13 PU-specific domains – social isolation, sleep 
impairment, exudate and odour – were not covered by any generic measures. In 
addition, the QLI did not include items about mobility or activities of daily living.  
 
 Chronic wound-specific measures 
The 14 chronic wound-specific instruments were developed for measuring HRQL in leg 
ulcers (Hyland Questionnaire (219), Venous Leg Ulcer QoL Questionnaire (VLU-QoL) 
(220), Charing Cross Venous Leg Ulcer Questionnaire (221), Chronic Lower Limb 
Venous Insufficiency (222), Freiburger Questionnaire of QoL in venous diseases (223), 
modified version (FLQA-M) (224), Skindex-61 (225), Skindex-29 (226), Venous 
Insufficiency Epidemiology and Economic Study (227) or diabetic foot ulcers (Diabetic 
Foot Ulcer Scale (DFS) (228), DFS-Short Form (229), American Academy of 
Orthopaedic Surgeons Foot and Ankle Outcomes Questionnaire (230), Neuropathy and 
Foot Ulcer-Specific QoL Instrument (231)).  One instrument, the Cardiff Wound Impact 
Schedule (CWIS) (179), was developed for mixed wounds but only evaluated in leg 
and diabetic foot ulcer patients.  The CWIS is the only chronic wound-specific 
instrument used in patients with mixed chronic wounds that included six patients with 
PUs (23% of the total sample) (232). 
 
The percentage of the 13 PU-specific HRQL sub-domains covered by the 14 chronic 
wound instruments was higher than for generic instruments, ranging from 31-77%.  
However, as seen with generic instruments, social isolation, sleep, exudate and odour 
sub-domains were not well covered.  Only two instruments, the VLU-QoL and DFS, 
represented more than 75% of PU-specific HRQL domains with coverage of 10 of the 
13 (77%) PU-specific conceptual domains: VLU-QOL with 29/34 items (85%) and the 
DFS with 38/58 items (66%).  As the VLU-QOL met the 75% criterion of items 
representing mapped domains, item-specificity was determined.  
 Table 4.1 Chronic Wound-Specific and Generic Quality of Life Instruments: Content analysis 
 Patient Population Venous Leg Ulcer (number of items) Diabetic Foot Ulcer  Mixed Generic 
Pressure ulcer-specific 
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Pain & discomfort from ulcer                  
Odour                  
Exudate/blood                  
Mobility                  
Daily activities                  
General malaise                  
Sleep                  
Mood                   
Anxiety & worry                  
Self-efficacy & dependence                  
Appearance & self-
consciousness  
                 
Participation                  
Isolation                  
Indicator of 
content validity  
Number (%) of 13 PU-specific 
domains covered 
7 
(54%) 
10  
(77%) 
8 
(62%) 
8 
(62%) 
4 
(31%) 
4 
(31%) 
9 
(69%) 
9 
(69%) 
6 
(46%) 
10 
(77%) 
9 
(69%) 
4 
(31%) 
7 
(54%) 
8 
(62%) 
6 
(46%) 
6 
(46%) 
6 
(46%) 
Number (%) of items - 29  - - - - - - - 38 - - - - - - - 
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representing mapped domains (85%)  (66%)  
Indicator of item 
specificity 
Number (%) range of PU-
specific items  
- *19-21 
(56-62%) 
- - - - - - - - - - - - - - - 
Indicator of 
response burden 
Number (%) of items that do not 
map onto PU-specific domains 
9 
(26%) 
5  
(15%)  
4 
(20%)  
5 
(25%)  
32 
(39%)  
45 
(47%)  
17 
(28%)  
2  
(7%)  
7 
(27%)  
20 
(44%)  
2 
(7%)  
8 
(32%)  
9 
(32%)  
13 
(39%)  
25 
(68%) 
8 
(22%) 
2 
(17%) 
-Did not meet criteria for evaluation 
^Questionnaire published in German and translated into English 
*Range based on 2 independent item assessments 
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Independent item-specificity assessment by two researchers revealed that 19 and 21 of 
the 34 items (only 56-62%) were PU-specific (e.g., „can not wear what I like‟ is relevant 
to leg ulcers as they are visible on the legs whereas PUs are usually in areas hidden 
from view such as the sacrum).   
 
Response burden for all measures ranged between 7-68%.  Items representing non-
HRQL domains: treatment/healthcare satisfaction; analgesic side-effects; financial-
occupation; cognition; time spent on ulcer; change over past year; impact on others; 
avoidance behaviours; footwear/clothing; non-wound related symptom distress; 
attitude; support; achievement goals; and happiness and/or spiritual.  
 
4.6 Discussion 
This systematic review identified PRO instruments used in studies to measure HRQL 
outcomes related to PU and PU treatment impact.  Where HRQL outcomes have been 
assessed, generic or chronic-wound specific PRO instruments were used.  HRQL is a 
complex construct in terms of conceptualisation and measurement.  Conceptualisation 
of HRQL specific to PUs has been mapped including four core domains (Chapter 3).  
This review identified that these domains are common in other generic and chronic 
wound-specific HRQL models however the content differs at sub-domain and item 
level.  There is inadequate PU-specific sub-domain coverage by generic instruments 
(between 0-46% coverage).  Chronic wound-specific instruments have better coverage 
(31-77%), although important components such as issues stemming from PU 
treatments and symptoms, movement, sleep, isolation, body image/self concept, 
embarrassment and physical appearance were not well represented.  Therefore, 
despite common conceptual domains in chronic wound HRQL models, the available 
instruments do not adequately represent PU-specific HRQL, questioning their 
appropriateness for use in PU research.  
 
The most frequently applied PRO instrument used in PU research (3 out of 5 studies), 
the SF36, is not conceptually comprehensive in its assessment of HRQL outcomes 
important in PUs.  The SF36 has been validated and applied in many disease areas 
including dermatology, so perhaps it would be the obvious choice by researchers.  
However, based on conceptual content, some items appear too crude to pick up 
differences in PUs.  At domain level, the SF36 contains 75% of domains (variables) 
relevant to PUs.  However, upon closer inspection of individual items, many were not 
PU-specific.  It is therefore not surprising that attempts to measure changes in HRQL in 
patients with PUs using the SF36 and other generic instruments have had mixed 
results.  Some findings indicate lower HRQL outcomes for patients with PUs compared 
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to those without (109) while others found no difference (112).  In other clinical areas, 
generic-instruments were found less powerful in detecting treatment effects compared 
to disease-specific instruments as they generally reflected a limited perspective (233, 
234, 235, 236).  
 
The optimal use of generic instruments would be for population comparisons on broad 
domain level (i.e. compare PU population with the larger general or chronic wound 
population).  Generic measures are intended to be suitable for a wide range of health 
conditions and therefore may not be sensitive enough to detect important changes due 
to a particular disease.  Item analysis revealed that generic instruments contained 
fewer PU-specific content which might make it difficult to detect the true impact of PUs 
on HRQL and failing to provide information about the real changes within patients with 
PUs or differences among them.  One instrument, the VLU-QoL, emerged as 
conceptually comprehensive (77%), but only 56-62% of items were judged PU-specific.   
This finding may not be surprising as the VLU-QoL measure‟s content was developed 
based on the SKINDEX model (which is intended to assess dermatological conditions) 
(226)and focus groups with patients with leg ulcers between the knee and ankle; the 
most common location of PUs is the sacrum. 
 
As a whole, the PRO instruments presented some degree of response burden for this 
population either from items representing non-HRQL content or from those not specific 
to PUs.  This poses questions about item relevance and redundancy.  Irrelevant items 
introduce unnecessary response burden.  Other general considerations observed 
during item analysis related to item wording.  Ambiguous or not easily understood 
items leave too much room for individual interpretation.  Items can also be problematic 
in capturing PU-impact if they are too specific (e.g. „frustrated because you were 
unable to do things that you wanted‟ is too specific because frustration is a problem for 
patients with PUs but not only because of inability to do things they want) or double-
barrelled (i.e. „frustrated by others doing things for you when you would rather do things 
yourself‟).  
 
Based on the above observations, it seems that failure to incorporate patients‟ 
assessment of outcomes in PU research may be due to the fact that appropriate 
instruments do not exist for evaluating the impact of PUs on HRQL.  In the first 
instance, when selecting the most appropriate instrument, one needs to determine 
whether it is fit for purpose (i.e. is the content appropriate to the research question) (83, 
87).  Regardless of their psychometric properties, PRO instruments can only be 
considered fit for purpose for the assessment of patient outcomes if they are valid with 
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minimal response burden (i.e. are constructs and content [items] relevant to the 
particular disease/outcome of interest?).  Other considerations may include 
determining whether the intended instrument was developed from the patient 
perspective using patients‟ words or whether the psychometric properties have been 
evaluated in the target population.  The findings from this review provide further 
support for the importance of clearly defining and conceptualising the constructs 
measured when developing new condition/disease-specific instruments. 
 
Reviews of PRO instruments for other disease areas have predominantly evaluated 
content at broad domain level (constructs) and psychometric properties, without 
reporting extensive evaluation of content relevance (item specificity) to the particular 
disease of interest based on conceptualisation and response burden (237, 238, 239).  
This research is the first to undertake a comprehensive evaluation of the conceptual 
content of available PRO instruments used in PUs and other chronic wounds based on 
domain and item content validity, item specificity and response burden to determine 
appropriateness for use in PU populations.  The main strength was consideration and 
inclusion of available measures, both generic and condition-specific (chronic wound), in 
an attempt to comprehensively represent HRQL models and map them conceptually to 
a PU-specific HRQL conceptual framework.  
 
This review had collaboration which allowed for the inclusion of relevant PRO 
instruments developed in languages other than English (e.g. FLQA developed in 
German), and inclusion of studies undertaken with PU populations across multiple 
continents.  Thus, the conceptual mapping of instruments included in this review may 
be transferable to European, North American and Australian cultures and languages, 
although cross-cultural validity of the PU-specific framework needs to be determined.  
However, only instruments validated for use within these populations were included.  
Measures developed in countries outside these regions had been identified but it was 
considered that those measures would not be culturally appropriate for Western 
populations.  Another limitation of this review is that it is not comprehensive of all 
available generic instruments; only inclusive of those used previously in PU research.  
It is possible that other available generic measures may be appropriate for use in PU 
research but their content and psychometric properties would need to be examined.  
 
No condition-specific PRO instrument for assessing HRQL outcomes in patients with 
PUs was identified.  Some generic and chronic wound-specific instruments were 
identified but these do not cover content relevant to PUs.  Various non-validated 
questionnaires had been developed to assess outcomes such as pain, comfort and 
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exudate, although these instruments were study-specific and had not undergone the 
same rigorous psychometric evaluation as other established generic and disease-
specific instruments. 
 
4.7 Summary of Chapter 4 
A comprehensive and systematic search of the international literature on PUs and 
other similar chronic wounds was undertaken to identify and evaluate available PRO 
instruments based on content validity, item specificity and response burden against an 
empirically derived PU-specific conceptual framework.  This review provides the 
necessary information for the appropriate selection of PRO instruments when 
measuring impact of PUs on HRQL.  Currently, HRQL outcomes important in PUs are 
inadequately covered by available instruments despite similarities between conceptual 
models, and they contain irrelevant content introducing response burden.  The findings 
highlight the need for clear conceptualisation of PRO instruments‟ content as well as 
determining fitness-for-purpose when selecting instruments in the future.  As no PU-
specific PRO instruments exist, and to address some of the limitations of using 
available instruments in PU research, a new patient-assessed HRQL measure specific 
for patients with PUs is needed for use in clinical practice and future research. 
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Chapter 5 
PU-QOLI DEVELOPMENT AND PRETESTING 
 
5.1 Overview 
Chapter 5 reports the methods and results of the development and pretesting of the 
PU-QOLI.  This chapter includes the methods used to generate content (selection of 
items) and construct scales, based on a conceptual model.  This is followed by a 
pretest, using mixed methods including qualitative work to ensure that the PU-QOLI 
was clear, understood and relevant to people with PUs, followed by a Rasch analysis 
to identify and resolve problems with layout, time frame, response options, framing of 
items and administration, and confirm content prior to formal psychometric evaluation.   
 
5.2 Background and aims 
Scientifically robust PRO instrument development is a timely, costly and demanding 
process.  PROs should possess various attributes that are critical for judging its‟ 
strength for measuring health outcomes, including: its conceptual and measurement 
model; reliability; validity; responsiveness; interpretability; burden; translations; and 
cultural adaptability (86, 102, 240, 241).  To ensure that new instruments meet such 
standards and are designed and developed for the purpose intended, various stages 
are undertaken including: 1) item generation (Sections 5.3-5.5); 2) operationalisation 
(Section 5.6.2) and pretesting (Section 5.7); and 3) field testing (Chapter 6 and 7).  A 
multidisciplinary team consisting of clinical experts and methodologists and input from 
patients representing the target population is also advised (86). 
 
The first phase of development, item generation, is the stage in which a comprehensive 
list of items is generated relevant to important issues specific to the topic under 
investigation.  A systematic approach was used to ensure generation of an exhaustive 
and unbiased item list, utilising three sources: i) patients (Chapter 3), ii) relevant 
literature (Chapter 2) including generic and disease-specific instruments (Chapter 4), 
and iii) clinical experts. 
 
5.3 Item generation from patients: semi-structured interviews 
An important consideration when developing PRO instruments is conceptualisation and 
content (120).  Developers of new instruments often utilise „top-down‟ approaches (i.e. 
review of literature and content from existing PROs) for conceptualisation and content 
development.  A risk of solely using this methodology for developing disease-specific 
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instruments is that it may not reflect HRQL aspects most important to patients with the 
underlying condition and threaten content validity and responsiveness to change as 
outcomes relevant to patients may not be included (183).  
 
5.3.1 Methods 
As previously described (Chapter 3), content (patient words verbatim) from 35 patient 
interviews were used to generate items.  All content was grouped into HRQL domains, 
with each domain (variable) comprising a number of items describing slightly different 
components.  Grouped items were listed and frequency of reports indicated (i.e. I get 
frustrated x5).  The intention was to be inclusive therefore all verbatims were included if 
reported more than once.  Verbatims were an excellent source for generating items, as 
items using patients‟ words and representing variable components across the broad 
spectrum of PU-specific HRQL outcomes were identified.  Items generated from 
patients are indicated in Appendix 5.1. 
 
5.4 Item generation from existing instruments 
Critical appraisal and building on the work of others is recommended by Streiner and 
Norman (132).  Modifying relevant, important or discriminating items rather than 
constructing new ones could save unnecessary work as items from existing validated 
instruments have generally undergone repeated testing and proven useful and 
psychometrically sound.  Further, there is no need to be creative; there are a limited 
number of ways to ask about a specific problem.  For example, the impact of a given 
disease on physical function is likely so instruments in similar disease areas may have 
developed items for this variable.   
 
5.4.1 Methods 
Available generic and chronic wound-specific PRO instruments were identified and 
reviewed for content and psychometric properties in chapter 4.  Items from identified 
instruments were mapped to the PU-specific conceptual framework (Chapter 3) to 
determine relevance to PUs.  Those considered relevant could be included in the item 
pool.  In addition to literature identified electronically or from hand searching, the 
internet was searched for patient information and self-help forums relevant to PUs; 
however, no such information was retrieved.  Although a potentially valuable source of 
generating items, few items were assessed as PU-specific (i.e. worded to assess 
impact of other conditions and not specifically PU-impact) and those assessed as PU-
specific were items already generated from patient reports. 
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5.5 Source 3: Item generation from experts 
Patients with PUs receive specialist care from nurses, tissue viability specialists and 
other healthcare professionals who have a vast range of experience treating patients 
with PUs and probable insight into patients‟ experiences.  A group of nursing and TVN 
specialists were selected to review items generated from patient interviews. 
 
5.5.1 Method 
Clinical Group 
The clinical expert group consisted of three community and acute TVN specialists (LW, 
NS, EM), three nurses with extensive experience undertaking chronic wound research 
predominantly in PUs (JN, EAN, CD), one chronic wound pain specialist (MB) and one 
nurse with experience of healthcare policy development (SC).  The group reviewed the 
item pool, with instructions to focus on item relevance, content and wording, and 
clinical importance, until consensus.  Items with similar content were highlighted and 
accuracy of domain categorisation (item grouping) discussed.  Additional items were 
added if necessary.  The researcher (CG) made notes. 
 
Items were retained if they were considered: clinically relevant; frequently reported; not 
too similar (redundant items combined or removed); or pertaining to HRQL (not 
measuring other constructs, i.e. personality, satisfaction).  Final item elimination 
decisions were based on consideration of item problems in combination.  At this stage 
an important conceptual decision was made to include PU-symptoms: pain, exudate 
and odour into the PU-specific model.  These symptoms are important consequences 
of having a PU but they were initially not considered HRQL outcomes and therefore 
excluded from the original item pool.  Counting frequency or assessing intensity of 
symptoms may not be an adequate measure of HRQL (242), but the impact of 
symptoms and the meaning they have for individuals is an important aspect of HRQL.  
Therefore, symptoms were considered important for inclusion in a PU-specific PRO 
instrument.  Patient comments pertaining to these outcomes were detected from the 
qualitative work (Chapter 3) and patient verbatims were used to add items representing 
these symptoms.  Following expert review, the item list was amended.   
 
Outcome Methodology Group 
The amended item pool and content mapping was reviewed by a group of seven health 
outcome methodologists (DL, SSc, SS, SCa, KH, YA, JP) (see Intellectual Property 
Section, page ii for group membership).  The group focused on the construct being 
measured (e.g. are items for each domain representative of the construct being 
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measured?) and item wording (i.e. are any items confusing, ambiguous, double-
barrelled?).  Appendix 5.1 represents domains, final items retained for the first PU-
QOLI version and any modifications made to the item pool (e.g. consolidation of similar 
items or elimination).   
 
5.5.2 Content validity 
Using three sources, a pooled item list was produced.  Items came from patients but 
were also consistently identified from the literature and supported by experts.  Utilising 
multiple sources for item generation reduced bias and allowed for an exhaustive item 
pool.  Although some items were not included in the final instrument, it was important 
for retained items to adequately represent all important domain components to support 
content validity; item pooling was initially over-inclusive but poor items could be 
detected and withdrawn during pretesting and psychometric evaluation (Chapter 6).  
Some theorists have argued that „content relevance‟ and „content coverage‟ are more 
accurate descriptors (243).  Each domain component should be represented by at least 
one item (content coverage); depending on the variable, more items might be needed 
to tap into all relevant aspects of a variable to ensure that important aspects are 
captured and reflected in the final score.  Each item in a group (scale) should represent 
the content area (content relevant to each domain).  Items not related introduce error in 
the measurement; the item is measuring some other variable and therefore 
discriminating between respondents on a different variable (87).  Items, representing 
individual domain components, combined, provide content validity for that specific 
HRQL domain (i.e. physical function).   
 
5.6 Construction of the PU-QOLI 
In order to encourage optimal instrument completion (the best responses and 
completion with no missing data), it is of paramount importance that the way the PU-
QOLI is presented is tailored to the characteristics of patients with PUs (i.e. understood 
by and relevant to the intended population). This section describes the careful stepwise 
construction of the preliminary PU-QOLI version (Appendix 5.1), based on current 
detailed guidelines (86, 132, 211, 244).  The processes of scale construction, known as 
operationalisation (logically related item clusters), questionnaire design and pretesting 
are described.  
 
The pooled item list was transformed into scales to construct the preliminary PU-QOLI 
(Section 5.6.2, selecting the questions).  Although this process is seemingly 
straightforward, careful consideration of the design, layout and instructions, framing of 
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questions, response format and recall period is needed to reduce cognitive and 
respondent burden and to ensure that respondents understand each question the way 
it is intended so that they can accurately formulate responses.  Factors influencing 
scale construction and instrument design are discussed below.   
 
5.6.1 Mode of administration 
Mode of administration can be interviewer administered (i.e. face-to-face, telephone) or 
patient self-completed (e.g. postal survey, during clinic visit).  Decisions regarding 
administration mode selection are assessed against the advantages and 
disadvantages of both methods.  In research, self-completed versions are preferred as 
they are associated with lower costs; can cover largely dispersed populations (if 
postal); require less time to collect data but time spent on late returns and follow-up 
attempts may extend the data collection period; and avoid potential interviewer bias as 
no interviewer is required (e.g. respondents make less socially desirable responses or 
more truthful responses with self-completion) (132, 244).  Self-completed methods, on 
the other hand, typically produce lower response rates due to literacy visual or motor 
impairment, or questionnaires misplaced or forgotten to be returned) (244). 
 
There are also disadvantages to interviewer administration.  This method can be time-
consuming and costly (i.e. training interviewers, travel to interview) but no waiting time 
for data returns (ensures returns); produce random variance due to interviewer 
inaccuracy (e.g. altering item wording by mistake) or systematic bias (e.g. one 
interviewer consistently records respondents‟ answers inaccurately); and produce bias 
due to the social interaction between the respondent and interviewer (e.g. social 
acquiescence or characteristics of the interviewer may affect both response rates and 
the nature of responses given) (244).  However, the advantages of administration make 
this method preferable for elderly or chronically ill populations.  Specifically, the burden 
of completion lies with the interviewer, thus, response rates are typically higher, 
reducing non-response bias; interpersonal interaction (interviewer can provide 
clarification or explanation); it enables those with reading or writing difficulties to be 
included in research; it enhances data quality (i.e. less missing data, facilitation with 
visual aids such as prompt cards for response options and checking data for 
completeness); and reduces sample bias (ensures that information is actually collected 
from the target sample) as self-completion often relies on self-selected samples (e.g. 
those who actually complete and return instruments), with findings not necessarily 
generalisable to the target population (244). 
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The current evidence is inconsistent in differentiating the superiority of any one 
administration method in terms of quantity and quality of response (238, 244).  
Therefore, the selection of administration mode should be made on a case-by-case 
basis, taking into account the research population, topic and setting, anticipated 
response rates, acceptability, time available, and financial budget.  Patients with PUs 
may have difficulty with self-completion (i.e. acutely ill, elderly), but as the PU-QOLI is 
intended for PU intervention effectiveness research (there is cost-benefit associated 
with self-completion methods in clinical trials that require large samples (245)), the 
decision was made to develop a self-completed version in the first instance.  The 
suitability of this method was determined during pretesting.   
 
5.6.2 Design and layout 
The design and layout of PRO instruments can effect completion; therefore, careful 
consideration of item selection, framing and sequencing, time frame, response 
categories and instructions is needed.  Few studies have explored design and layout in 
the context of health-related topics (244).  In the absence of empirical evidence, advice 
regarding questionnaire design (i.e. length, pagination, colour), supported by theories 
of cognition, perception and pattern recognition (246), was considered.  Based on 
recommendations, the PU-QOLI was designed as a double-sided A4 size booklet on 
white paper.  Font size 12 was chosen as respondents are largely elderly people with 
some visual impairment.  Questions were grouped into item sets and numbered, not 
crowded or split between two pages with horizontal response formats attached; and 
ended with a thank you (247).  
 
Selecting the questions: question blocking and item sequence 
Three important issues were considered when selecting items: operationalisation, 
measurement continuum, and the number of items.  Scales are constructed through a 
process known as operationalisation, where logically related items are grouped or 
blocked.  Blocked items may be prone to order effects but this method allows for the 
sequencing of items within a scale and focuses the mind to recall events about one 
topic at a time (248).  Following item grouping, the items within each group/scale were 
ordered in a logical sequence to map out a discernable line of increasing intensity.  
What is implied is that as people, for example, experience progressively more pain 
because of their PU, they move along the pain continuum from left to right and if their 
pain reduces they move from right to left.   
 
Multiple item scales improve validity, responsiveness and precision in measurement as 
complex variables are broken down to their component parts (items) but there needs to 
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be a balance between asking many items to allow a detailed assessment of each 
variable but not too many to risk respondents getting bored, fatigued, and increasing 
respondent burden (244).  This is particularly important if PROs are to be used in 
longitudinal research or on-going clinical assessment as completing lengthy 
instruments over and over may threaten compliance (i.e. follow-up data is not returned 
or loss to follow-up bias is introduced into the analysis).  The intention was to keep the 
overall length of the PU-QOLI as short as possible but ensure that each construct was 
adequately operationalised with enough items to mark out constructs on a continuum.  
An inclusive approach was taken to ensure all aspects relevant to the construct and 
important to patients were included.  The choice of items was subsequently pretested 
(section 5.7).  The ordering of items was tested in later stages (Chapter 6) to determine 
whether a discernable line of increasing intensity had been mapped out by the items.  
 
Framing of questions 
Guiding principles for framing questions for new instruments (132, 247, 248) were 
consulted.  Questions that were too specific, hypothetical, employ technical words or 
jargon, double-barrelled, misleading, vague or ambiguous, contained acronyms, 
abbreviations or pertained to changes were avoided.  The FDA guidance for 
developing PRO instruments (86) recommends that items should adequately cover the 
domains under investigation, relate to the instruments objectives, use words familiar to 
patients, and not be confrontational, upsetting or ambiguous.  These recommendations 
were considered when constructing the PU-QOLI to ensure clearly formulated and 
precise items. 
 
Question Sequencing 
- Question order 
The ordering of questions has an effect on the responses given (244).  Roberson and 
Sundstrom (249) posit that one of the most important aspects of questionnaire design 
relates to early items.  Opening questions should be easy, non-threatening and salient 
to respondents.  Opening with items relevant to the respondents‟ circumstances 
highlights to them the apparent relevance of the questionnaire, encouraging 
completion.  Two descriptive questions pertaining to PUs (i.e. how many PUs do you 
have and on what part of your body?) were placed on the front page following the 
instructions to focus patients‟ thinking about the medical condition of interest.  This is 
particularly important as people who develop PUs usually have a multitude of medical 
problems.  Based on qualitative work with patients with PUs (Chapter 3), PU symptoms 
were salient for all patients and therefore the decision was made to place symptom 
questions at the beginning of the PU-QOLI.  Beginning with symptom questions set the 
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context for later questions and ensured a logical sequence of questioning (250).  
Demographic questions were placed at the end as they were not considered part of the 
measurement. 
 
- Sensitive items 
Sensitive or threatening questions may result in misled, understated or exaggerated 
responses (249).  Questions concerning intimacy and body image may be viewed by 
patients as sensitive.  A method of reducing sensitivity is to embed sensitive items 
within the body of a questionnaire (247).  Hence, items pertaining to intimacy and body 
image were placed toward the middle of the PU-QOLI. 
 
Time-frame 
The accuracy with which participants respond to questions is influenced by response or 
memory error (failure to recall an event within the specified time-frame).  Respondents 
recall and count relevant events when formulating answers to survey questions (251).  
Setting a too long time-frame may result in under-reporting of events occurring in the 
past.  For HRQL instruments, a short time-frame may not be appropriate as changes in 
disease impact or treatment burden may not have occurred to warrant assessment.  As 
such, important disease changes/progression and memory error (recall bias) need to 
be considered when choosing a time-frame.  A recall period of the past week was 
chosen on clinical grounds, as changes in PU severity and symptomology often occur 
over days and thus a longer recall period would risk not capturing relevant changes to 
HRQL.  Events that occurred over a month ago may no longer be relevant or have 
been resolved/treated. 
  
Response category format 
Having devised a set of questions (scales with multiple items), a response method had 
to be chosen.  There are various response methods and deciding on which method is 
most appropriate depends largely on the nature of the questions asked.  In healthcare 
research, responses to outcomes are generally continuous rather than categorical.  
Approaches that attempt to quantify continuous information include Direct Estimation 
techniques (132).  These methods are designed to elicit from participants a direct 
quantitative estimate of the magnitude of a latent variable, where responses are 
indicated by a mark on a line such as in visual analogue scale (VAS) or box checking 
as with Likert scales.  A VAS is a line of fixed length, usually 100mm, which is often 
used to measure pain severity or intensity levels.  Using VASs to measure HRQL may 
not be an optimal method as they assess a variable with a single item, potentially 
yielding less precise measurement than other methods (132).  Likert scales quantify 
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data on a continuum but rather than marking on a line, a number of discrete response 
options are offered along a multiple item continuum and respondents are required to 
select a response most closely representing their experience (85, 132).  The Likert 
scale rating method is commonly used in PRO measurement and was the chosen 
method for the PU-QOLI.   
 
When constructing Likert scales, the number of response categories to use and how 
they should be labelled needs to be considered.  Deciding on the number of response 
options to include is a balance between maximising precision and minimising bias and 
respondent burden (85, 132).  Category labels are intended to elicit judgements about 
the frequency of occurrence of an event or intensity of a feeling.  FDA guidance (86) 
suggests that wording used in response options should: be clear and appropriate to the 
question stem and intended population; offer a clear distinction between choices; be 
appropriately ordered and appear to represent equal intervals; avoid potential ceiling or 
floor effects; and not bias the direction of responses.  Based on these 
recommendations, the response descriptors chosen for PU-QOLI related to the amount 
of bother of a particular variable rather than frequency (e.g. a symptom might be 
frequent but might not necessarily cause bother). Patients were required to respond to 
items in terms of the amount of bother attributed (e.g. “How much have you been 
bothered by…?”) and each item used a discrete response option category scored with 
successive integer scores (e.g. 0 = no bother at all to 3 = a lot of bother) that implied a 
continuum of increasing impact (bother), from less (no bother) to more (a lot of bother).  
This assumption was tested by examination of threshold ordering in subsequent testing 
(see Chapter 6).  Item response descriptors were kept on the same differentiating scale 
and in the same order to reduce respondent burden and confusion caused by reversed 
responses.  Numbers were placed beside boxes to reduce ambiguity and reinforce that 
responses were on a continuum, and a „tick box‟ instruction was chosen for all items to 
ensure consistency in the method of responding (252). 
 
Introduction and instructions 
Instructions for completing questionnaires need to be clear and unambiguous, using 
simple, jargon free language that will be easily understood by respondents or 
interviewers.  Consistent with recommendations (247), general information pertaining 
to what the PU-QOLI is about and instructions about how questions should be 
answered were placed at the beginning of the PU-QOLI, while instructions specific to 
individual questions were placed close to the relevant question.  Instructions were 
made brief and clear, and bold font used to highlight important components (e.g. during 
82                     Development and pretesting 
 
 
the past week and tick all that apply).  A statement to ensure confidentiality was 
included to encourage accurate reports.   
 
Expert appraisal of preliminary PU-QOLI 
Prior to pretesting the draft PU-QOLI was reviewed by an expert group of health 
outcome methodologists (Section 5.4.1.2) with consideration of question wording, 
meaning, relevance and format.  It was hoped that this would lead to the detection of 
problems with design or items that could pose potential problems for respondents and 
threaten response rates or data quality. 
 
Amendments made to the draft PU-QOLI included: reordering of questions (i.e. 
question order included symptoms then physical limitations, psychological impact and 
finally social participation as this was considered conceptually logical); inclusion of 
introducing sentences for each question; single items were separated out as previously 
they were combined into one grouping; and an overall QoL question, with responses 
based on other commonly used measures (SF36), added.  Amendments produced a 
preliminary version ready for pretesting (Appendix 5.1). 
 
The preliminary PU-QOLI consisted of 118 items grouped into 10 scales (covering 4 
domains and 13 sub-domains): pain (17 items), exudate (12 items), odour (10 items), 
sleep (7 items), malaise (3 items), mobility (11 items), activities of daily living (ADL; 11 
items), mood (9 items), anxiety (8 items), self-consciousness and appearance (9 
items), autonomy (5 items), isolation (5 items) and participation (11 items).  Three 
single item questions were included (items that did not fit into scales or were 
descriptive items).  Items considered similar in content were grouped together so that 
respondents could consider the amount of similarity/difference in wordings.  The PU-
QOLI was intended as a self-completed instrument and patients rated the amount of 
bother attributed (e.g. “During the past week, how much have you been bothered 
by…?”) on a 4-point response scale (e.g. 0=not at all – 3=a lot). 
 
5.7 Pretesting preliminary PU-QOLI 
The first part of this chapter described methods used to construct a preliminary PU-
QOLI version.  This part describes pretesting the PU-QOLI, which is key in PRO 
instrument development.  It is a process for evaluating patients‟ understanding of the 
items, instructions, response options and recall period, determining whether readability 
is appropriate for the target population, and confirming completeness of concepts 
covered by items (86).  These steps ensure items are appropriately worded, 
unambiguous and relevant. 
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The mainstay of pretesting has traditionally been qualitative methods based on 
cognitive theory (i.e. cognitive interviewing or debriefing).  Cognitive theory techniques 
such as principles of Cognitive Aspects of Survey Methodology (CASM) (253) are 
applied to investigate and understand response problems in surveys to improve the 
quality of data collected (254) and the design of questionnaires by evaluating sources 
of response error (255).  Techniques are used to understand how respondents process 
and respond to questionnaire items (i.e. the underlying cognitive processes employed 
in reading, comprehending and interpreting questions and formulating answers), with 
the intention to improve the design of PRO instruments and improve data quality (86, 
254, 256).   
 
There are a number of models which are comparable in processes that explain the 
underlying cognitive processes involved in completing questionnaires. The most 
general, Tourangeau‟s (251) four-stage model, posits that respondents follow a 
sequence when completing questionnaire items, involving comprehension, retrieval, 
estimation/judgement and response.  This four-stage processing model is appropriate 
for application to HRQL as the model aims to explain the cognitive processes 
employed by respondents when trying to understand and respond to questions dealing 
with complex concepts such as QoL.  
 
More recently, guidance for developing PRO instruments (86, 102, 120, 240) has 
emphasised the importance of pretesting using cognitive methods to ensure that PRO 
instruments are understood and relevant to the target population.  Cognitive testing is 
important for identifying problems with PRO instrument items (e.g. lack of clarity), 
layout and administration.  Better formatting and phrasing improves comprehension, 
ensures less time and effort to complete, and increases respondent participation and 
compliance, thus reducing item non-response and missing data (257) and establishing 
content validity (86). 
 
Cognitive methods offer a well-established method of improving the precision and 
content validity of newly developed PRO instruments.  However, one avenue which has 
had less investigation is the use of quantitative methods in the pretesting process.  
Resultant scales are eventually examined against quantitative criteria, but not usually 
employed in pretesting due to the traditional psychometric sample size requirements 
(258, 259) for confident inferences to be made.  However, new psychometric methods, 
such as Rasch measurement methods (260), afford the possibility of being used in 
pretesting as relatively stable estimates are possible even in small samples (n≥30) 
(261) (see section 5.7.10 for details). 
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Pretesting using Rasch methods provides a useful early view for checking whether 
items can be combined using the test of fit between the data and Rasch model.  Misfit 
indicates that combining a set of items may not be justified (e.g. an item is not 
measuring the same variable), but rather than remove the items, the cause of misfit 
should be explored and explained in the first instance (85, 262).  Application of the 
model early in the development stage of new PRO instruments may provide a useful 
method for exploring the choice of items in specific scales, item scoring, suitability of 
response options, and appropriateness of combining items into scales.  It may also be 
useful in demonstrating the extent to which scale scores are free from random error 
(reliability) and measure the variables they purport to measure (validity).  In such 
contexts, application of the Rasch model can be used as a diagnostic tool for 
determining how well items, scales and response options work to measure what they 
are intended to measure (see Chapter 6, Section 6.5.3 for details).   
 
5.7.1 Aims 
The aims of this study were two-fold: 
1. Pretest preliminary PU-QOLI version, using cognitive interviewing methods, to 
reduce respondent burden, decrease data errors and non-response due to poor 
questionnaire design, layout and unclear, misunderstood or irrelevant items, and 
to ensure that the PU-QOLI was relevant to and understood by people with PUs   
2. Rasch analysis to identify and resolve problems with layout, time frame, response 
options, framing of items and administration, and confirm content (i.e. need for 
additional items or elimination/rewording of other items) prior to formal 
psychometric evaluation 
 
Part of the second aim was to test the added value of Rasch measurement methods in 
detecting problems with items, scales and response options by comparing Rasch 
findings with the findings from the cognitive interviews for consistency.  The 
perspective of people with PUs was central in all aspects of pretesting.   
 
5.7.2 Study design 
Cognitive processes involved in completing the PU-QOLI were investigated through 
structured face-to-face cognitive interviews.  Face-to-face interviews are preferable as 
they allow observation of non-verbal cues and provide a natural interchange between 
patient and interviewer.  Cognitive interviews were undertaken to elicit feedback from 
respondent‟s on their understanding of individual questions, associated response 
options, and instructions, and to verbalise how they had gone about producing their 
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answers (263).  Emphasis was on comprehension (i.e. clarity, language), retrieval from 
memory and response judgements (i.e. frequency judgments, logic decisions).  
Interviews were conducted in patients‟ homes, clinics or wards, as determined by the 
patient‟s circumstances at the time of interview.   
 
5.7.3 Study population 
The participant sample was intended to represent the PU population.  Therefore 
patients from 11 acute and community services across England were recruited from 
April 2009 to September 2009 if they: had a PU of any grade (148), duration or 
location; were aged ≥18 years; from hospital, rehabilitation or community settings; and 
able to read and write in English.  Patients who: did not have a PU; were unconscious, 
confused or cognitively impaired; unable to speak English; or deemed ethically 
inappropriate to approach (e.g. death was imminent) were not eligible.   
 
5.7.4 Recruitment and consent procedure 
Participants were purposively sampled according to key factors: age (under 70 years 
and over 70 years); PU severity (superficial, grade 1–2 and severe, grade 3-4) and 
location (torso and limb sites); healthcare setting; and experience of different PU 
treatments, with a minimum of five patients per factor consecutively sought.  All 
patients with PUs were screened for eligibility.  Age, gender and PU grades and 
locations were recorded on screening logs.  Refusals were recorded and reasons for 
refusal were noted if known.  The purpose of collecting data on non-participants was to 
check for sample bias and to assess the generalisability of the participating sample 
against the general PU population. Recruitment continued on a rolling basis until no 
new problems with the preliminary PU-QOLI emerged (i.e. saturation).  
 
Members of tissue viability teams (TVT), including the local Principal Investigators, 
tissue viability nurse specialists, nurse consultants and other members of local clinical 
teams (i.e. tissue viability and clinical research nurses) at participating sites identified 
participants.  Those meeting eligibility were approached, informed about the study and 
provided with a project information leaflet detailing the rationale, design, and personal 
implications of the study, and an „agree to be contacted by researcher (CG)‟ form to be 
either contacted by telephone or visited at the ward.  
 
Following information provision, participants had as much time as they needed to 
consider participation and return researcher contact forms.  Upon receipt, the 
researcher telephoned the participant and provided further study information, answered 
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questions, and following verbal consent, arranged an interview for a mutually 
convenient time.  For in-patients who could not be contacted by telephone, the TVT 
member, with the patient‟s permission, liaised with the researcher and patient to 
arrange a time for a ward visit.  
 
Prior to commencing the interview, the researcher gave each participant a verbal 
explanation of the study, informed them that the interview would be recorded but any 
identifiable information would remain anonymous, reminded them that participation was 
completely voluntary and that they could withdraw at anytime without it affecting their 
care, and asked them to sign a consent form.  The study received ethical approval by a 
UK National Health Service Research Committee.  All patients gave written informed 
consent to participate. 
 
5.7.5 Cognitive interviewing methods: Think-aloud and verbal probing 
The mostly commonly applied cognitive interviewing methods are think-aloud and 
verbal probing techniques.  The think-aloud method, derived from psychological 
procedures described by Ericsson and Simon (264), explicitly instructs participants to 
"think aloud" or vocalise the thoughts that occur concurrently as they read and provide 
answers to questions.  This method provides information about the cognitive processes 
respondents employ when completing questionnaires, including comprehension and 
language (whether the question is worded and understood in the way it is intended), 
memory (how information is recalled), and problem-solving (whether respondents recall 
information or simply guess).  An alternative to think-aloud is use of verbal probing, 
where the interviewer asks questions about the processes going on while respondents 
complete questions, either concurrently or retrospectively.  This method elicits 
respondents‟ understanding of questionnaire items by asking respondents to say aloud 
questions in their own words, explain: i) what specific words mean to them and ii) their 
responses, and identify where difficulty in understanding, interpretation and completion 
occur (265).  Specifically, misunderstandings, incomplete content coverage, and 
inconsistent interpretations are explored.  
 
Concurrent probing minimises recall bias as the information requested is fresh in the 
respondent's mind at the time of probing.  However, think-aloud speech and concurrent 
probing may serve to burden or contaminate the cognitive processes used in 
answering questionnaire items.  Switching between tasks can be distracting and may 
affect responses to subsequent questions.  The alternative is debriefing the participant 
by probing following questionnaire completion.  This allows the natural flow of an 
interview, but risks participants failing to recall what they were thinking when answering 
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a question, introducing recall bias and hindsight effects (266).  To overcome limitations, 
both methods were combined for the cognitive interviews (see below).   
 
The key differences between the two techniques are (267, 268): 
 
    Think-aloud            Probing 
 Respondent-driven; open-ended 
format; free from interviewer-
imposed bias, but tendency for 
respondent to wander off-track, 
spend significant time on one 
question, delve into irrelevant areas 
 Interviewer–driven; avoids discussion 
that may be irrelevant and non-
productive; interviewer can focus on 
particular areas that appear to be 
relevant as potential sources of 
response error 
 Lower burden on interviewer as 
respondent does most of the talking; 
minimal interviewer training required 
 Lower burden on respondent as 
interviewer does the questionning; 
minimal respondent training required 
 Thinking-aloud places the main 
burden on respondent, making the 
interview more difficult for them; 
need for subject training as many are 
not proficient in thinking-aloud  
 Interview is easier for respondents, 
however risks artificial dialogue where 
interviewer simply administers 
questions and respondent answers,  
leaving little room for spontaneous 
dialogue 
 Bias in subject information 
processing: a considerable amount 
of mental effort is invested into 
processing questions when thinking-
aloud, relative to when simply 
answering questions.  
 Use of probes are a potential for bias, 
need for careful selection of "non-
leading" probing techniques that 
minimise bias 
 
5.7.6 Conducting cognitive interviews: Procedure and Data collection 
Cognitive interviewing techniques were employed to gain understanding of how 
respondents interpret questions and whether questions are understood as intended.  
All participants completed the preliminary PU-QOLI without researcher assistance.  
 
Two interviewing techniques were employed; however, the first three participants 
asked to think-aloud (spontaneous conversation) while completing the PU-QOLI 
reported that the method made completion difficult.  Therefore, the remaining 
participants were instructed to flag/mark items they found confusing/difficult to 
understand, upsetting/intrusive or annoying while completing the PU-QOLI.  Following 
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completion, going item-by-item and guided by an interview schedule consisting of 
open-ended questions and scripted probes to ensure standardisation across 
administration, the researcher used de-briefing questioning to elicit the cognitive 
processes used by respondents while completing the PU-QOLI.  Probes based on the 
Tourangeau (1984) cognitive model included: comprehension (i.e. patient interprets 
questions by determining what s/he believe the question to be asking based on what 
specific words/phrases mean to them); retrieval (i.e. relevant information searched from 
long-term memory to enable a response and the strategies used to retrieve the 
information); estimation/judgement (i.e. information retrieved from memory is evaluated 
for its relevance to the question and judged for completeness); and response (i.e. the 
initial response is considered for consistency/acceptability, and the internally generated 
answer [judgement] mapped onto a response category) (see Table 5.1 for examples).   
 
Probes were carefully developed to ensure unbiased phrasing (i.e. ensure probes were 
not leading respondents) and sought comments about questionnaire design (i.e. item 
stem, response options, instructions, format/layout, time frame) and specific items 
anticipated to be problematic (i.e. "What does feeling emotionally close mean to you?").  
Spontaneous probes were used when responses led to the interviewer wanting 
additional information or clarification (i.e. follow-up on issues that emerged or probing 
for additional information: “Can you tell me more about that”).   
 
Tabel 5.1 Example probes with cognitive components 
Cognitive component Interview probe 
Comprehension Can you repeat the question in your own words? 
 What does the word X mean to you? 
Retrieval How did you come to think of that? 
 Did you have a particular time period in mind? 
Judgement How did you arrive at your response? 
 How well do you remember this? 
Response How did you feel about answering this question? 
 Were you able to find your first answer to the question from 
the response options? 
 
During cognitive interviews the researcher took notes, fed-back to patients to ensure 
comprehension of responses and reviewed recorded interviews, making notes on 
structured data extraction forms.  Interviews lasted for a mean of 46 minutes (range 28 
to 112 minutes). 
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5.7.7 Data analysis schema 
An analysis schema was developed based on the Question Appraisal System (QAS-
99).  The QAS-99 (269) is a coding tool that has been used for pretesting instruments 
(270, 271) that focuses on the cognitive demands required for answering a question 
and potentially problematic item characteristics that may lead to response error 
including: content, instructions, layout, length, time frame and response options (Table 
5.2).  The intention was to develop a systematic way of categorising the processes 
underlying responses to PU-QOLI items.  Specifically, dominant trends across 
interviews (i.e. problems that occurred repeatedly) and key findings (i.e. problems 
identified in a single interview, but considered problematic) were considered.   
 
Table 5.2 QAS-99 categories (269) 
Step 1: READING: Determine any difficulties for interviewers in reading questions 
uniformly to all respondents 
Step 2: INSTRUCTIONS: Determine any problems with introductions, instructions or 
explanations from the respondent’s point of view 
Step 3: CLARITY: Identify problems related to communicating the intent or meaning 
of the question to the respondent 
Step 4: ASSUMPTIONS: Determine any problems with assumptions made to the 
underlying logic 
Step 5: KNOWLEDGE/MEMORY: Check whether respondents are likely to not know 
or have trouble remembering relevant information 
Step 6: SENSITIVITY/BIAS: Assess questions for sensitivity, wording and bias 
Step 7: RESPONSE CATEGORIES: Assess the adequacy of the range of responses 
to be recorded 
Step 8: OTHER: Detect any problems not identified in Steps 1-7 
 
5.7.8 Subsequent rounds cognitive testing  
To maximise benefit from cognitive interview, multiple interviewing rounds were 
proposed.  Once major conceptual problems were identified and addressed from early 
interviews, later rounds of interviewing focused more exclusively on the 
appropriateness of individual questions, testing items in the context of the 
questionnaire, for example, in terms of clarity, appropriateness of item series, or biases 
due to question ordering (268).  An iterative process was adopted during data 
collection and analysis, to saturation, using patients‟ qualitative reports from three 
rounds of interviews to modify the PU-QOLI.  Following the first round (n=10), major 
problems emerged that required substantial revision (i.e. modifications made to PU-
QOLI) prior to subsequent interviews.  A second round of interviews were undertaken 
(n=10) to test the changes made and to provide additional testing of questionnaire 
aspects not previously explored.  A final round (n=15) was undertaken to ensure that 
90                     Development and pretesting 
 
 
no additional problems were reported or introduced with changes made, and previously 
identified problems had indeed been rectified.  Misunderstanding of item stem, 
response options or instructions (i.e. vague wording, complicated syntax); unclear 
wording (i.e. used expressions like should, needs to, must); and negative comments 
about an item were considered a problem.   
 
5.7.9 Expert appraisal and revisions to PU-QOLI 
As there is no standard method for using cognitive interview data to modify PRO 
instruments (270), the outcome methodologists (Section 5.4.1.2) discussed and 
resolved aggregated findings (both within and across interviews) after each interview 
round in an iterative process.  This was done on a consensus, item-by-item basis, to 
decide whether to retain, revise, eliminate or add items or make changes to design and 
layout, with particular weight given to the same comments by several respondents.  
Occasionally, a single negative remark led to an item revision (e.g. a remark signalling 
a serious misunderstanding of an item).  A group of clinical experts (Section 5.5.1) also 
reviewed PU-QOLI revisions to ensure clinical relevance.  Expert appraisal assisted in 
avoiding bias that would be introduced when relying solely on the judgement of one 
researcher in determining the implications of the cognitive interview findings. 
 
5.7.10 Rasch measurement methods– a ‘quantitative de-briefing’ 
Unlike traditional psychometric methods that are based upon correlational or 
descriptive analyses, Rasch analysis provides a formal method of testing PRO 
instruments or rating scales (e.g. health scales considered unidimensional) against a 
mathematical measurement model developed by Danish mathematician Georg Rasch 
(260).  The Rasch model defines how a set of items should perform to generate reliable 
and valid measurements (272) and evaluates the legitimacy of summing items to 
generate measurements (260, 273).  In a Rasch analysis, the extent to which observed 
data (patients‟ actual responses to scale items) are concurrent with („fit‟) predictions of 
those responses from the Rasch model are examined; whereby the difference between 
expected and observed scores indicates the degree to which rigorous measurement is 
achieved (274).  The expected response structure for the Rasch model is a 
probabilistic Guttman pattern, which assumes that for the same person ability, the 
probability of endorsing an easy item is higher than the probability of endorsing a more 
difficult item, and vice versa (275).  When a rating scale is used to discriminate 
between persons with different abilities, someone with higher ability is expected to 
affirm all items endorsed by a person with lower ability in addition to items 
representative of higher ability. 
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Rasch measurement methods (260) were used to undertake a preliminary analysis of 
the PU-QOLI investigating items within the context of the instrument, response options, 
appropriateness of item series and question ordering (item-fit).  The Rasch model for 
ordered response categories (276) was used and analyses were performed using 
RUMM2030 (277), including: targeting of sample to items (i.e. is the scale-to-sample 
targeting adequate for making judgements about the performance of the scales and the 
measurement of people?), ordering of response options (i.e. are respondents using the 
response options provided in a manner consistent with the level of the construct being 
measured?–demonstrated by ordered thresholds (278), item-fit statistical indicators 
(i.e. fit residuals within +/-2.5 and non-significant chi square values provide evidence 
that scale items contribute to defining the construct measured (279)), and the spread of 
item locations (279, 280)).  Items should ideally spread out evenly over a reasonable 
measurement range and be appropriately targeted to the people they are measuring.  
Items with similar locations on the continuum indicate redundancy.  Details of the 
psychometric criteria are described in Chapter 6, Section 6.5.3.   
 
For the purpose of pretesting, Rasch measurement methods were used as a diagnostic 
tool at an early stage in instrument development, whereby problems with items, scales 
and response options could be evaluated against psychometric criteria and findings 
compared with cognitive interviews for consistency to determine the value of Rasch 
methods in pretesting.   
 
5.8 RESULTS 
Patients (n=134) were screened for eligibility from 6 hospitals, 4 community Trusts and 
1 hospice.  Patients ranged in age from 32 to 98 years, with 66% aged 70 years or 
older (7 did not have age recorded); 94 were male (57%); and all were of white 
ethnicity.  PUs varied in severity (representation of all grades including mixed) and 
location (both torso and limb sites).  The screening process is detailed in figure 5.1. 
 
Recruited patients (n=35) ranged in age from 36 to 85 years (mean age 65 yrs) with 
half (49%) aged 70 years or more.  Of these, 16 (46%) were male and 18 (51%) had 
additional chronic conditions (e.g. SCI, multiple sclerosis).  Patients represented 
different settings (23 hospital/rehabilitation, 12 community), PU severity (13 superficial, 
18 severe, 4 mixed severity), duration (2 weeks up to 5 years) and skin site (33 
sacrum/buttocks, 13 heel, others on lower back, groin, hips, back of thighs, ankles).  
 
Tables 5.4 and 5.5 present a summary of findings from interviews and Rasch analysis, 
respectively, and instrument modifications.  Flow diagram 5.2 illustrates the integration 
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of the two methods in an example with one scale to help clarify the iterative nature of 
the approach and how both methods informed modifications to the PU-QOLI. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.8.1 Cognitive Interviews 
Cognitive interviews identified five problem areas: content, mode of administration, 
instruction/layout/length, recall period and response options. 
 
Content 
Based on patients‟ comments, 18 items reported to be difficult to understand, confusing 
or unclear were revised, six items considered redundant were merged and 25 irrelevant 
items removed (i.e. items that >40% of respondents indicated not relevant; a crude 
estimate consistent with standard psychometric criteria for acceptability (281, 282)).   
 
For example, patients reported that there were too many items about odour: “How 
many different words do you need for smell, you could remove a lot of these…”  Other 
words used were too sensitive (dirty smell) or not commonly understood (foisty).  
Revisions focused on using words „that patients‟ use (e.g. pressure sore instead of 
pressure ulcer).  As patients reported that all important aspects of the impact of PUs on 
HRQL were covered, no new items were added.  Review of content resulted in a 
revised 87-item PU-QOLI (Table 5.3) grouped into 10 scales: pain (11 items), exudate 
(8 items), odour (6 items), sleep (6 items), vitality (3 items), mobility/movement (11 
items), ADL) (9 items), mood (7 items), anxiety (3 items), self-consciousness and 
appearance (7 items), autonomy (3 items), isolation (4 items), participation (9 items).   
Not consented: 32 
10 Refused without reason 
  7 Not wanting involvement in research 
11 Feels poorly/unwell 
  4 Other 
   
   
 
 
 
 
 
 
 
 
Unable to disturb 
Communication difficulties 
Other 
 
Screened 
n= 165 
Eligible 
n=67 
Not eligible: 98 
    7 Patient transferred 
    2 Patient does not speak English 
  14 Patient unable to self-complete 
  12 Unable to self-complete 
  50 Patient cognitively impaired 
  13 Patient on care pathway for the dying 
Consented 
n=35 
 
Figure 5.1 Detailed Assessment Process for pretest 
93                     Development and pretesting 
 
 
Flow diagram 1 Example using the Daily Activities Scale to demonstrate the mixed 
methods approach, including findings and modifications  
 
 
 
 
  
Original Item set 
1. Washing yourself in the bath or shower 
2. Getting dressed or undressed 
3. Doing housework (e.g. cooking or cleaning) 
4. Doing gardening 
5. Doing shopping 
6. Going to the toilet 
7.  Being able to travel in or drive a car 
8.  Doing things that you enjoy (e.g. reading a book, 
watching a movie) 
9.  Getting up and about to do things that you enjoy 
10. Being intimate with loved ones 
11. Doing usual work (e.g. employment, 
volunteering, university, clubs) 
Round 1 interviews 
(n=10) 
Item 3-housework 
not relevant to all pts 
Item 10-considered 
too sensitive and 
confusing 
Expert review 
Item 3 and 10 
revised, no 
other changes 
made 
Revised Item set 
1. Washing yourself in the bath or shower 
2. Getting dressed or undressed 
3. Doing jobs around the house (e.g. 
cooking,housework,DIY) 
4. Doing gardening 
5. Doing shopping 
6. Going to the toilet 
7. Being able to travel in or drive a car 
8. Doing things that you enjoy (e.g. reading a 
book, watching a movie) 
9. Getting up and about to do things that you 
enjoy 
10. Being emotionally close or affectionate with 
loved ones  
11. Doing usual work (e.g. employment, 
volunteering, university, clubs) 
Round 2 interviews  
(n=10) 
Items 1 and 6-not clear to 
pts, issue is around ability 
Item 7-considered not 
relevant/too specific, issue 
is around ability to sit, 
covered by previous 
scales 
Item 8-needed more 
examples to make clearer 
and relevant to all pts 
Item 9-similar to item 8 
and also covered 
previously in mobility scale 
Item 11-not only about 
work but usual activities, 
including work 
Expert review 
Items 1, 6, 8 
and 11 revised 
Items 7 and 9 
removed 
Revised Item set - final items retained 
1. Being able to wash yourself in your usual way 
(e.g. hand wash, bath, shower) 
2. Getting dressed or undressed 
3. Doing jobs around the house (e.g. cooking, 
housework, DIY) 
4. Doing gardening 
5. Doing shopping 
6. Being able to go to the toilet 
7. Doing things that you enjoy (e.g. reading a 
book, watching a movie, using a computer) 
8. Being emotionally close or affectionate with 
loved ones  
9. Doing your regular daily activities (e.g. work, 
volunteering, church attendance, university, 
clubs) 
Round 3 
interviews 
(n=15) 
No problems 
reported 
Expert review 
Item 9 – 
examples 
revised (e.g. 
work, 
volunteering, 
religious service, 
university, clubs) 
Rasch analysis (n=35) 
No problems with item fit; all items 
disordered threshold; PSI=0.48 
indicating moderate reliability in 
detecting true misfit 
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Table 5.3 Summary of item changes at each cognitive interview round based on 
patient reports and consensus discussion 
Item at pretest Round 1  Round 2  Round 3  
Pain Index items    
1) Feeling uncomfortable No change No change Retained 
2) Annoying pain or discomfort No change No change Retained 
3) Itchiness No change No change Retained 
4) Tenderness No change No change Retained 
5) Niggling No change Removed  
6) Soreness Removed   
7) Aching No change Revised - Dull 
ache 
retained 
8) Pins and needles Removed   
9) Tingling No change No change Retained 
10) Throbbing No change No change Retained 
11) Nagging Removed   
12) Shooting Removed   
13) Stinging No change No change Retained 
14) Stabbing Revised – 
Stabbing pains 
No change Retained 
15) Electric shocks Removed   
16) Red raw No change No change Retained 
17) Burning No change No change Retained 
Exudate Index items    
1) Weeping No change No change Retained 
2) Oozing Removed   
3) Running No change No change Retained 
4) Sticky No change No change Retained 
5) Slimy Removed   
6) Wet Removed   
7) Messy No change No change Retained 
8) Staining No change No change Retained 
9) Causing dressing to come off No change No change Retained 
10) Gungy Removed   
11) Pus No change No change Retained 
12) Bleeding No change No change Retained 
Odour Index items    
1) An unpleasant smell No change No change Retained 
2) A lingering smell No change No change Retained 
3) A dirty smell Removed   
4) A foisty smell Removed   
5) A stench Merged –  
A stench or stink 
No change Retained 
6) A stink 
7) A stale smell Removed   
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Item at pretest Round 1  Round 2  Round 3  
8) A pungent smell No change No change Retained 
9) A sickening smell No change No change Retained 
10) A putrid smell No change No change Retained 
Sleep scale    
1) Trouble falling asleep No change No change Retained 
2) A restless sleep Revised –  
Interrupted sleep 
(e.g. restless 
sleep, woken up 
during your sleep) 
No change Retained 
3) Being kept awake No change No change Retained 
4) Being woken up during your 
sleep 
Merged with b)   
5) Not getting the amount of 
sleep that you needed 
No change No change Retained 
6) Having to sleep in one position 
(e.g. your back or side) 
No change No change Retained 
7) Trouble finding a comfortable 
position 
No change No change Retained 
Mobility/movement scale    
1) Difficulty sitting up in bed No change No change Retained 
2) Difficulty adjusting yourself in 
bed 
No change No change Retained 
3) Difficulty turning in bed No change Revised – 
difficulty turning 
or moving around 
in bed 
Retained 
4) Difficulty pushing up to a 
sitting position 
No change No change Retained 
5) Difficulty sitting up in one 
position for long periods 
No change No change Retained 
6) Difficulty standing for long 
periods 
No change No change Retained 
7) Difficulty transferring from a 
bed to a chair 
No change No change Revised – 
difficulty 
transferring (e.g. 
from a bed to a 
chair or to a car) 
8) Feeling limited in your ability to 
walk 
No change No change Retained 
9) Feeling limited in your ability to 
go up and down stairs 
No change No change Retained 
10) Feeling limited in how far you 
were able to walk 
No change No change Retained 
11) Feeling that your walking was 
slowed down 
No change No change Retained 
Vitality/Fatigue scale    
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Item at pretest Round 1  Round 2  Round 3  
1) Feeling that your appetite has 
reduced 
No change No change Retained 
2) Feeling unwell or poorly No change No change Retained 
3) Feeling that your energy levels 
have been reduced (i.e. 
feeling tired or fatigued) 
Revised - Feeling 
that your energy 
levels have been 
reduced (i.e. 
tired, fatigued) 
No change Retained 
ADL scale    
1) Washing yourself in the bath 
or shower 
No change Revised – being 
able to wash 
yourself in your 
usual way (e.g. 
hand wash, bath, 
shower) 
Retained 
2) Getting dressed or undressed No change No change Retained 
3) Doing housework (e.g. 
cooking or cleaning) 
Revised – Doing 
jobs around the 
house (e.g. 
cooking, 
housework, DIY) 
No change Retained 
4) Doing gardening No change No change Retained 
5) Doing shopping No change No change Retained 
6) Going to the toilet No change Revised – being 
able to go to the 
toilet 
Retained 
7) Being able to travel in or drive 
a car 
No change Removed  
8) Doing things that you enjoy 
(e.g. reading a book, 
watching a movie) 
No change Revised -  Doing 
things that you 
enjoy (e.g. 
reading a book, 
watching a movie, 
using a computer) 
Retained 
9) Getting up and about to do 
things that you enjoy 
No change Removed  
10) Being intimate with loved 
ones 
Revised – Being 
emotionally close 
or affectionate 
with loved ones 
No change Retained 
11) Doing usual work (e.g. 
employment, volunteering, 
university, clubs) 
No change Revised – doing 
your regular daily 
activities (e.g. 
work, 
volunteering, 
church 
attendance, 
university, clubs) 
Revised – doing 
your regular 
daily activities 
(e.g. work, 
volunteering, 
religious 
service, 
university, 
clubs) 
Mood and Anxiety scale    
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Item at pretest Round 1  Round 2  Round 3  
1) Feeling frustrated No change No change Retained 
2) Feeling fed-up No change No change Retained 
3) Feeling annoyed Merged -  feeling 
annoyed or 
irritated 
No change Retained 
4) Feeling irritated 
5) Feeling bad tempered Removed   
6) Feeling angry No change No change Retained 
7) Feeling miserable No change No change Retained 
8) Feeling down No change No change Retained 
9) Feeling depressed No change No change Retained 
10) Feeling fearful Removed   
11) Feeling afraid Removed   
12) Feeling upset No change No change Retained 
13) Feeling concerned Merged -  feeling 
concerned or 
worried 
No change 
 
Retained 
14) Feeling worried 
15) Feeling anxious No change No change Retained 
16) Feeling surprised Removed   
17) Feeling shocked Removed   
Self-conscious & Appearance Scale   
1) Feeling helpless No change No change Retained 
2) Feeling a lack of self-
confidence 
Revised – feeling 
lack of confidence 
No change Retained 
3) Feeling a lack of self-esteem Removed   
4) Feeling self-conscious No change No change Retained 
5) Feeling embarrassed No change No change Retained 
6) Feeling physically unattractive No change No change Retained 
7) Feeling disinterested in 
socialising 
No change Removed  
8) Feeling uneasy being close to 
people 
No change Revised -  
Feeling uneasy 
being close to  or 
around other 
people 
Retained 
9) Feeling worried about how 
others will react to your ulcer 
No change Removed  
Isolation scale    
1) Feeling physically dependent 
on others 
No change No change Retained 
2) Feeling left out Removed   
3) Feeling isolated Merged – feeling 
cut of or isolated 
from others 
No change Retained 
4) Feeling cut off 
5) Feeling lonely No change No change Retained 
6) Feeling like you were missing No change No change Retained 
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Item at pretest Round 1  Round 2  Round 3  
out 
Autonomy & independence Scale   
1) Feeling that people avoided 
you or treated you differently 
now 
No change No change Retained 
2) Feeling a lack of 
understanding from those 
close to you 
No change No change Retained 
3) Feeling like a burden or 
nuisance on others 
No change No change Retained 
4) Feeling like you have no 
control over your life? 
Revised – feeling 
like you have no 
control over your 
life or your ulcer 
Revised – feeling 
like you have no 
control over your 
life or your sore 
Retained 
Participation scale    
1) Difficulty going out No change No change Retained 
2) Being unable to meet up with 
others 
Merged – 
difficulty meeting 
up or seeing 
family and/or 
friends 
No change Retained 
3) Difficulty seeing family and/or 
friends 
4) Being unable to participate in 
family gatherings or activities 
No change No change Retained 
5) Having to plan going out 
around ulcer care 
No change Revised -  Having 
to plan going out 
around pressure 
sore care 
Retained 
6) Being able to do things 
spontaneously 
Removed   
7) Giving up on hobbies or 
leisure activities 
No change Revised -  having 
to give up on 
hobbies or leisure 
activities 
Retained 
8) Being restricted to where you 
could go out 
No change No change Retained 
9) Being restricted to how long 
you could stay out 
No change No change Retained 
10) Being unable to get away for 
a holiday or make a trip at the 
weekend 
No change No change Retained 
11) The amount of time involved 
in caring for your ulcer 
No change Revised -  The 
amount of time 
involved in caring 
for your sore 
Retained 
 
Mode of administration 
Despite the inclusion criteria of patients being able to self-complete a questionnaire, 
almost half the sample (n=15; 43%) needed some assistance with completion; of 
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these, eight were 70 years or older.  Older patients were also more likely to not 
respond to one or more items.  Reasons for needing assistance included: too ill/weak 
to sit up and/or hold a pen (n=5); visually impaired/no glasses (n=2); too tired to finish 
completion (n=2); and comorbidities (e.g. multiple sclerosis, arthritis) prevented self-
completion (n=6).  As patients who needed assistance with PU-QOLI completion were 
generally elderly people or wheelchair users – those at highest-risk of PU development 
–the mode of administration was changed to interview-administered to ensure 
suitability across the wide spectrum of PU patients.  The equivalence of self-completed 
and interview-administered versions was therefore explored in a mode of 
administration sub-study (see Chapter 6, Section 6.6.2). 
 
Instruction, layout and length  
Changes were made to the instructions, including: rewording to reflect interviewer 
administration; reducing content to only contain essential information; and the 
statement „We understand that you may have a combination of medical problems, but 
please try to think about only your pressure sore(s) when answering the questions‟ 
added.  Statements „Please tick one box on each line‟ and „…because of your pressure 
sore‟ added to all questions.  Changes to the design/layout included: less on each 
page; larger font; length reduced by eliminating redundant items or merging similar 
ones; and scales reordered where responses to one question (e.g. feeling isolated) 
were reported to influence responses to another (e.g. mood)).   
 
Recall period 
Interviews confirmed the appropriateness of the „past week‟ recall period.  In light of 
comments from patients who had spent time both at home and in hospital, the wording 
was changed to „overall impact during the past week‟. 
  
Response options 
Patients reported difficulty selecting a response option if they: i) did not feel or 
experience what an item referred to, ii) experienced it but not because of PUs, or iii) felt 
it applied in the past.  Response options were revised to „no bother‟, „a little bother‟ and 
so on, to anchor patients to think about bother (impact) rather than frequency.  
Because some items (e.g. shopping) were not applicable to hospitalised patients and 
those with mobility problems, a not applicable response option (0=I did not experience 
the problem/symptom because of my PU) was added.  The numeric values beside 
response categories were removed as patients reported these to be a confusing visual 
distraction.  Important aspects were made bold (i.e. „past week‟, „bothered‟, „PU‟). 
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5.8.2 Preliminary Rasch Analysis 
The Rasch analyses did not uncover significant problems with targeting or item-fit 
(Table 5.4).  No items had fit residuals outside the recommended range +/-2.5 and only 
one scale, „isolation‟, had an item with significant chi-square probability.  However, 
consistent with qualitative findings, Rasch analyses did not support the 4-point item 
response options.  Disordered thresholds were found in 74 of 90 items, indicating that 
the proposed scoring function was not working as intended.  A post hoc analysis of 
category probability curves (CPC), which plots scale scores on the x-axis against the 
probability of endorsing each item response category on the y-axis, suggested that 
patients were unable to reliably discriminate between options a little bother and quite a 
bit of bother.  Item locations for all scales were generally spread over a reasonable 
continuum (e.g. 2-logit spread, Table 5.4).  However, examination of item locations 
indicated that some items clustered at similar locations, suggesting redundancy (Table 
5.5).  As the Rasch analysis was preliminary, it was considered premature at this stage 
to make changes to the scales until further empirical evidence confirmed these issues.  
 
Table 5.4 Summary of Rasch analysis on all pretest PU-QOLI scales  
  Item 
Locations 
Logits range 
Fit Statistics 
Fit residuals 
outside +/-2.5 
Items with Chi-
Square probability 
significance 0.001 
Person 
Separation 
Index 
Disordered 
Thresholds 
Scale (items) 
Pain (11) -1.564 – 2.460 0 0 0.960 Items 5,6,7, 
9,11,12 
Exudate (8) -1.198 – 2.605 0 0 0.473 All 8 items 
Odour (6) - - - - All 6 items 
Sleep (6) -0.614 – 0.543 0 0 0.611 All 6 items 
Mobility (11) -0.713 – 0.736 0 0 0.636 Items 1,2,3,5 
6,8,9,10,11 
Vitality (3) -0.150 – 0.165 0 0 0.191 Items 2,3 
ADL (9) -0.367 – 0.378 0 0 0.479 All 9 items 
Mood (7) -0.778 – 0.595 0 0 0.833 Items 2,4.6,7 
Anxiety (3) -1.164 – 1.903 0 0 0.842 All 3 items 
Self-conscious 
(7) 
-0.895 – 0.496 0 0 0.363 Items 1,2,4,5 
6,7,8,9 
Autonomy (3) -1.358 – 2.002 0 0 -0.037 All 3 items 
Isolation (4) -5.836 – 4.238 0 1 0.972 Items 1,3 
Participation 
(9) 
-0.788 – 0.736 0 0 0.734 Items 1,2,3,4 
5,6,7,8 
- Not powered to perform analysis 
  
  
Table 5.5 Identified problems with PU-QOLI: Comparison of qualitative reports (patients) with quantitative findings (Rasch)  
Scale Rasch findings Qualitative patient-reports 
Pain  Item 3 significant p for item-fit (Item may be a different 
symptom from pain; measuring different construct) 
Item 5 removed (patients consistently said redundant) and 
item 6 wording revised 
Exudate  No concerns  No problems reported by patients 
Odour Unable to perform Rasch No problems reported by patients 
Sleep No concerns  No problems reported by patients 
Mobility Item 3 significant p for item-fit Item 3 revised based on patient comments (item „difficulty 
turning in bed‟ revised to „difficulty turning or moving around in 
bed‟). No other problems 
Vitality/Fatigue Power of item-fit too low No problems reported by patients 
ADL Power of item-fit too low Item 1 and 6 revised as patients indicated items were too 
specific and not capturing what the problem actually was 
Mood Item 4 significant p for item-fit No problems reported by patients 
Anxiety Power of item-fit too low No problems reported by patients 
Self-
consciousness 
Item 9 approaching criterion Item 6 removed (patients said redundant and too ambiguous); 
item 7 revised (ambiguous and sensitive); item 8 removed 
Autonomy Power of item-fit too low Item 2 revised (ambiguous, needed clarifying) 
Isolation Items 2,3,4 item-fit p=0.000 No problems reported by patients 
Participation Item 9 item-fit p =0.009 approaching significance – (possibly 
item not measuring participation but another construct) 
Item 4 and 5 revised (ambiguous, needed clarifying) 
Other findings 
   Response 
options 
Main problem for all scales is disordered thresholds (6/13 
scales all items thresholds disordered; 7/13 some items 
within scale with disordered thresholds) 
11/35 items not relevant and thought a „did not experience 
symptom/problem b/c of PU‟ was required otherwise difficult 
to answer with the current response options 
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5.9 Discussion 
To provide evidence that PRO data collected by PRO instruments is credible, two 
general criteria should be considered: Does the data stem from an instrument that has 
a theoretically sound conceptual framework? Do the data meet necessary and 
sufficient psychometric standards? (283).  An item-pool should be developed and 
tested against a well-founded theoretical model (87) and after thorough familiarity with 
relevant work in the area (283).  To ensure the first criteria was met, the development 
of PU-QOLI scales was theoretically driven (proceeded from a conceptual framework, 
Chapter 3) with items derived from patients, using patient words.  Items for each 
construct (or scale) needed to be captured and quantified into rigorous measurements.  
Items are considered the measurement parts of each variable (construct); items are 
component parts of complex variables broken down into measurements (87).   
 
Development of PU-QOLI scales was based on first identifying main conceptual 
domains and then mapping the patient experience.  For example, the theory postulates 
that the development of PUs is associated with PU-specific symptoms (pain, exudate, 
odour).  Symptoms impact on patients‟ mobility and movement which affects their sleep 
quality, ability to perform daily activities and reduces vitality (physical functioning 
domains).  These restrictions consequently affect patient‟s mood and cause anxiety 
and self-consciousness (i.e. embarrassment; psychological well-being domains), which 
lead to social isolation and restricted social participation (social functioning domains).  
In order to devise items into scales representing these domains, key components, as 
described by patients and clinical experts, were mapped onto sub-domains.  Patient 
transcripts were revisited and other instruments‟ scales viewed.  This process allowed 
the devising of a preliminary PU-QOLI version consisting of items that captured 
components representing PU-specific domains representative of the PU patients‟ 
perspective (e.g. what is it specifically about PUs that affects mobility – it is inability to: 
i) stand for long periods, ii) walk long distance, iii) sit for long periods, and so on).   
 
Cognitive interviewing with immediate retrospective probing proved valuable for 
identifying problems with PU-QOLI content and design including: i) items requiring 
rewording, clarification or additional examples; ii) problems with instructions and self-
completion; iii) inappropriate reference period for patients both hospitalised and at 
home; and iv) response options.  Most importantly, as almost half the sample had 
difficulty with self-completion, the mode of administration was changed to interview-
administered.  If mode was not changed then a large proportion of eligible patients 
would be excluded in future research due to being unable to self-complete the PU-
QOLI.  The modified PU-QOLI was tested to ensure that no subsequent problems were 
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introduced after modifications had been made and to confirm acceptability of the final 
version (Appendix 5.2), which took around 30 minutes to complete.   
 
The Rasch analyses complemented the qualitative results.  It revealed no problems 
with sample-to-scale targeting or item-fit, thus supporting the summing of items to 
produce scale scores, but the analysis uncovered problems with the scoring function 
and redundant items.  A large proportion of items showed disordered thresholds, the 
result of too many response options for patients to discriminate between.  Both 
methods independently confirmed the problems with response options, with Rasch 
analyses detecting the specific point of difficulty discriminating between two response 
options.  The Rasch analysis detected redundant items; patients reported too many 
items but were unable to consistently decide on which items they considered 
redundant.  It also provided useful information for scale development, specifically 
support for item-fit, ordering and validity, supporting patients' views that items made 
contextual sense and were relevant.  This important contribution ensures that PU-QOLI 
scale construction is underpinned with a strong conceptual base, a process central to 
valid measurement (87, 284).  Item estimates (locations) were cross referenced and 
checked for stability during the full psychometric evaluation (Chapter 6, Section 6.5.3).   
 
This was the first study to use Rasch measurement methods during early PRO 
development.  Rasch methods provided detailed item-level diagnostic information, both 
corroborating the qualitative work and expanding on the information provided by 
pinpointing specific psychometric issues, thus demonstrating its value as an additional 
method to standard pretesting methods for improving PRO instruments.  Had the 
Rasch analyses been undertaken prior to item revisions rather than retrospectively, it 
may have provided additional information needed for improving the scales at this stage; 
however it did confirm that the modifications made were appropriate and provided 
quantitative support for them.  Items that present with misfit from the Rasch model 
should be explored qualitatively in subsequent rounds of interviews with the intention of 
providing explanations for the misfit (i.e. clinical relevance, importance to patients).   
 
This work adopted an experimental approach that suits the Rasch paradigm, providing 
cross validation, for example, where patients reported problems with the PU-QOLI, the 
quantitative preliminary analysis verified qualitative comments made.  The ultimate goal 
for including Rasch analysis at this stage was to provide an early quantitative view of 
the extent of potential problems/issues with the PU-QOLI.  However, despite the issue 
of disordered thresholds and redundant items being flagged, all findings need to be 
verified and empirically strengthened in a larger sample (e.g. full psychometric 
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evaluation in subsequent PU-QOLI testing, Chapters 6 and 7) before any actions to 
make changes (i.e. reducing responses to three categories) are made.   
 
Other limitations to the methodology need to be mentioned.  In the early stages of item 
generation, one researcher performed the literature search and undertook patient 
interviews.  Despite efforts made to remain open to the HRQL issues emerging during 
interviews, having been immersed in the literature, some bias may have been 
introduced.  Involving both clinical and PRO outcome methodologists at the conceptual 
framework development, item generation and pretesting stages assisted in finalising 
the content map - final item pool was mapped onto conceptual domains - and produced 
a clear and succinct item list on which to base the preliminary PU-QOLI version.  A 
high proportion of patients unable to take part in the study due to cognitive impairment 
and despite all ethnicities being eligible, only white British Nationals consented to take 
part.  Therefore item generation from patient transcripts does not include the views of 
those with cognitive impairment and may not be representative of outcomes important 
to non-white ethnicities.  However, the conceptual framework development, which 
formed the basis of PU-QOLI scales, was based on mixed ethnic views.   
 
5.10 Summary of Chapter 5 
The development of PU-QOLI scales proceeded from a conceptual framework.  Items 
were derived from patients that captured all elements of the impact of PUs on HRQL, 
quantifying them into measurements.  Careful consideration of item selection, framing 
and sequencing, time frame, response categories and instructions was made, 
producing a preliminary PU-QOLI version that was pretested with patients with PUs.  
The use of mixed-methods in PRO development and pretesting was effective for 
identifying problems with items and questionnaire design early in the development 
process, and for guiding changes to layout, content and mode of administration.  Using 
both methods together provided useful information about item selection and deletion, 
particularly for ensuring clinical meaningfulness, importance to patients and good 
measurement properties.  Rasch measurement methods thus provide a 
complementary method alongside standard qualitative pretesting, for evaluating the 
strengths and weaknesses of PRO instruments during the early stage of testing.   
 
As scales are the building blocks for the conceptual framework and items within scales 
are the component parts of complex variables, evidence is required that they are the 
optimal combination of items that measure the variable they purport to measure.  
Therefore, the next stage required is quantitative confirmation and psychometric 
support for the combining of items into scales. 
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Chapter 6  
PRELIMINARY FIELD TEST 1 – 
PSYCHOMETRIC EVALUATION OF THE PU-QOLI  
 
6.1 Overview 
Chapter 6 presents the methods and results of the first of two quantitative field tests 
undertaken to evaluate the measurement properties of the PU-QOLI scales developed 
in Chapter 5.  A Rasch analysis was performed first on all PU-QOLI scales, followed by 
traditional psychometrics. 
 
6.2 Background  
Conventionally PRO instruments or rating scales have been developed and evaluated 
according to traditional psychometric standards derived from Classical Test Theory 
(CTT) (285, 286).  CTT comprises a set of principals and related statistical techniques 
for developing and testing measures (e.g. PRO instruments) against to determine how 
successful they are at estimating unobservable (e.g. HRQL) variables of interest (287).  
However, some concerns have been raised about existing PRO instruments developed 
according to CTT; they may be cumbersome for respondents, burdensome for clinical 
use, not applicable over the continuum of care or across research settings, suffer from 
floor and ceiling effects, and/or lack a standardised scoring metric to allow comparisons 
across health conditions (87, 288, 289, 290).  
 
More recent advances in psychometrics have seen the development and application of 
two independent psychometric methods: Item Response Theory (IRT) and Rasch 
measurement theory (see Section 5.7.10 for additional information), to supplement 
traditional approaches in rating scale development (290).  There are some similarities 
between IRT and Rasch measurement theory; both postulate theories of how scores 
generated by rating scales relate to measurements of the variables they seek to 
measure and they both provide mathematical models for which measurement 
expectations can be formally and rigorously tested against (85).  This may be the 
reason for confusion within the literature that the Rasch model is the IRT one-
parameter model, but they both come from different origins and represent different 
research perspectives.  The fundamental difference between the two is that proponents 
of IRT give primacy to the data, therefore attempting to best explain observed data by 
fitting it to mathematical models (essentially finding a model that fits the data).  On the 
other hand, Rasch measurement theorists give primacy to the mathematical model, 
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offering a criterion for fundamental measurement (291).  From the Rasch measurement 
theory perspective, when data does not fit the Rasch model it is further examined to 
understand why (e.g. response options not working as intended) and, if required, items 
are removed, data recollected or the construct reconceptualised.  The inherent 
properties of the Rasch model enable it to be used as a diagnostic tool for investigating 
rating scales, and it is therefore the scientific perspective favoured for use in this work. 
 
In comparison with traditional psychometric methods, the Rasch model (260) provides 
a powerful framework to address some of the limitations of classical methods through 
the assessment of a range of additional measurement properties intended to provide 
information about a scale‟s performance, and consequently developing instruments 
with greater precision, reduced response burden and floor/ceiling effects, and reduced 
cultural biases (292, 293).  Ensuring key measurement requirements are met (e.g. 
unidimensionality, a requirement for construct validity (132)) should be established 
prior to the more commonly evaluated standards of measurement (i.e. reliability) (290).  
 
Rasch measurement and traditional psychometric methods were used in the 
development of the PU-QOLI.  Use of both methods would allow the selection of scale 
items that reduce patient burden and eliminate redundant items and include items that 
are free of bias, fit measurement model expectations and demonstrate 
unidimensionality (Rasch).  It is important to note that some assumptions that underlie 
scale properties differ between CTT and Rasch measurement theory, however the 
objective is the same; scale items are the building blocks for the conceptual framework 
(283) (developed in Chapter 3). 
 
The psychometric properties of the PU-QOLI were evaluated through two-stage field 
testing including a preliminary field test (evaluation of the preliminary PU-QOLI scales) 
and a final field test (psychometric evaluation of final PU-QOLI scales) (Chapter 7).  
The overall strategy and methods for the psychometric evaluation are based on 
methods used to develop PROs in several areas of medicine and surgery (85, 97, 182, 
274, 281, 294, 295, 296).  Table 6.1 presents full details of the tests and criteria used in 
the psychometric evaluation.  
 
6.3 Preliminary Field Test: Analysis of preliminary (87-item) PU-QOLI 
To enable the PU-QOLI to be used with confidence in clinical practice and future 
research it must be shown to meet psychometric standards for reliable and valid 
measurement.  As such, a preliminary field test study was undertaken to perform a 
psychometric evaluation of the preliminary PU-QOLIs‟ scales and items, produce a 
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shorter version if appropriate (i.e. reduce instrument length without losing 
measurement precision), evaluate the measurement properties of the short PU-QOLI, 
and empirically investigate optimal mode of administration in a sub-study. 
 
6.3.1 Objectives 
The objectives of the psychometric evaluation of the preliminary PU-QOLI were to: 
i) confirm the feasibility and acceptability of the instrument; 
ii) produce a scientifically robust shorter version PU-QOLI by selecting items 
that perform best against robust psychometric criteria; 
iii) examine the legitimacy of summing items into scales and test scaling 
assumptions;  
iv) carry out a preliminary evaluation of the psychometric properties of the 
shorter item-reduced PU-QOLI; and 
v) determine optimal mode of administration for the PU-QOLI (i.e. can PU-
QOLI be developed for use with both self-completed and interview-
administered modes or are two mode-specific instruments required?)  
 
6.4 Methods 
6.4.1 Design for Preliminary Field Test 1 
The evaluation strategy (Table 2) for field test 1 was developed to assess PU-QOLIs: i) 
response format, item content, response bias, dimensionality and appropriate scale 
targeting to develop scales and identify items with poor psychometric properties for 
possible elimination; ii) conduct a preliminary evaluation of PU-QOLIs‟ scales; and iii) 
undertake a preliminary evaluation of the acceptability, reliability and validity of the item 
reduced PU-QOLI. 
 
In addition, to address methodological issues identified during pretesting (Chapter 5), a 
mode of administration sub-study was undertaken to determine optimal mode of 
administration for the PU-QOLI.  Initially the intention was that the PU-QOLI would be 
self-completed, however pretesting identified problems with completion rates, 
questioning the appropriateness of a self-completed instrument for patients with PUs, 
particularly those aged over 70 years.   
 
The sub-study included response rate, data quality and differential item functioning 
(DIF) analyses (297) to establish measurement equivalence across two mode of 
administration groups (self-completed and interview-administered).  Two outcomes 
were possible from the sub-study: 1) one instrument could be developed for both self-
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completion or interview-administration or; 2) two mode-specific versions were required.  
Only an interview-administered version would be developed if the analysis uncovered 
that two mode-specific versions were required.  
 
6.4.2 Participants 
Field test 1 sample 
For the PU-QOLI to be relevant to all patients with PUs, a sample of 200-250 patients 
with PUs were purposively sampled ensuring representation of patients across PU 
categories (superficial and severe) and location (torso and limb skin sites), settings 
(acute and community), age (under 70 years and 70 or older) and gender.  The 
intention was to evaluate the PU-QOLI in patients with various experiences including 
patients treated for PUs in different healthcare settings, receiving different treatments 
(i.e. pressure-relief, topical), and with various acute and chronic conditions. Accrual 
was reviewed to ensure balanced representation of patients.  
 
Sub-study sample 
A sub-sample (60-100 patients) of field test study participants were recruited to the 
sub-study.  
 
6.4.3 Sample size 
No formal sample size estimation methods for evaluation of PRO instruments were 
found. The „rule of thumb‟ sample size recommendation for psychometric analyses of 
new summated scales are best done with five to 10 subjects per item, to reduce the 
effect of chance (131, 286).  Following this recommendation, if we take the longest 
potential summated scale, assessing pain which contains 11 items, a 110 patient 
sample would be required.  For the Rasch analysis, a sample of 200-250 patients was 
sought.  This estimate was based on a need for sample selection across the range of 
measurement.  Class interval membership to five class interval groups (see Section 
6.5.3 for description) of around 50 patients in each group is suggested (273, 298).   
 
For the sub-study, it was anticipated that up to 100 patients would be required to meet 
the data requirement for the DIF analysis and to account for the likelihood of missing 
data from the self-complete group.  Rasch measurement methods (260) are able to 
provide useful exploratory data in small samples (n>30) (261).  Small sample has an 
effect on significance testing and further implications for the interpretation of results, 
however one of the unique features of the Rasch model includes parameter 
separatability; relatively robust estimates are possible with small sample sizes and the 
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stability of fit statistics in different sample sizes has previously been empirically proven 
(261, 299, 300, 301).   
 
6.4.4 Eligibility  
Patients from acute and community NHS Trusts around England and Scotland, with 
existing PUs were included in the field test and sub-study if they were hospital, 
intermediate care, nursing home or community patients, and: aged ≥18 years; with an 
existing PU of any category, location or duration; and able to provide informed consent 
to participate.  
 
Patients were excluded if they had only moisture lesions, were unconscious, confused, 
cognitively impaired or deemed ethically inappropriate to approach (e.g. death was 
imminent), did not speak or understand English or unable to provide informed consent. 
 
Sub-study 
To ensure an equivalent or representative sample in both administration groups 
(groups need to have the same clinical presentation to perform a DIF analysis; Section 
6.6.2), the eligibility criteria was adapted from the main study to include only patients 
able to read and write in English (e.g. patients able to self-complete a questionnaire).  
 
6.4.5 Recruitment and consent procedures  
Consecutive patients were identified and approached to participate by members of 
TVTs at participating trusts.  A record of those identified as eligible, approached to 
participate, refusals, consents and questionnaire returns was made.   
 
Informed consent was obtained prior to baseline data collection and questionnaire 
completion.  Informed consent and data collection was undertaken by the TVT member 
or researcher (CG).  
 
A verbal explanation of the study and Patient Information Leaflet was provided by the 
TVT member or researcher6 (CG) for the patient to consider.  These included detailed 
information about the rationale, design and personal implications of the study.  
Following information provision, patients had as much time as they needed to consider 
participation and were given the opportunity to discuss the study with their family and 
                                               
6 Where the researcher was involved in the recruitment and consent process, the 
patient was asked to give verbal permission to be approached by the researcher. 
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healthcare professional before being asked to take part.  The right of the patient to 
refuse consent without giving reasons was respected. 
 
Assenting patients were invited to provide informed, written consent to collect baseline 
assessment data and to complete PU-QOLIs.  Formal eligibility assessment and 
informed consent was undertaken by TVT members.  All patients were free to withdraw 
from the study at any time without giving reasons and without prejudicing any further 
treatment.   
 
6.4.6 Registration and Randomisation 
Screened patients eligible for sub-study participation were registered and randomised 
on a 2:1 basis to receive either self-complete or interview-administered mode of 
administration.  The 2:1 ratio was used to account for the likelihood of increased 
missing data from self-completed questionnaires (see Section 6.4.3).  Randomisation 
was stratified by: age (  70, 70 years) and PU severity (superficial vs. severe PU).  
 
Those assessed „not eligible‟ for sub-study participation but who met criteria for field 
test 1, were enrolled, and registered to the main study.  Following registration, baseline 
data were collected and PU-QOLIs completed. 
 
6.4.7 Data collection/assessment  
Study data (registration, baseline clinical data and PU-QOLI) were recorded on case 
record forms (CRFs) by members of TVTs, the researcher or by patients who were 
included in the sub-study and randomised to the self-complete group. 
 
Preliminary PU-QOLI 
The preliminary PU-QOLI version (Appendix 5.1) consisted of 13 scales (87 items): 
pain (11 items); exudate (8 items); odour (6 items); sleep (6 items); malaise (3 items); 
mobility (11 items); activities of daily living (ADL) (9 items); mood (7 items); anxiety (3 
items); self-consciousness and appearance (7 items); autonomy (3 items); isolation (4 
items); and participation (9 items).  Scales represent unique outcomes of the impact of 
PUs (key domains important to patients with PUs are presented in the conceptual 
framework, Chapter 3) and responses are in terms of amount of bother attributed (e.g. 
“During the past week, how much have you been bothered by…?”) on a 4-point 
response scale (e.g. 0=not at all – 3=a lot).  A recall period of the past-week was 
chosen on clinical grounds, as changes in PU severity and symptomology often occur 
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over days and thus a longer recall period would risk not capturing relevant impact on 
HRQL (see Chapter 5 for PU-QOLI development). 
 
Self-completed mode 
Patients enrolled to the sub-study and randomised to the self-completed group were 
provided with the PU-QOLI and instructed to complete the instrument on their own.  A 
TVT member returned to collect completed PU-QOLIs 
 
Interview-administered mode 
A questionnaire pack was administered to all participants by TVT members or the 
researcher, following an interview manual.  Training in administering the PU-QOLI was 
provided by CG. 
 
6.4.8 Data monitoring 
Data was monitored for quality and completeness by CG upon receipt to the CTRU. 
Attempts were made to chase any missing clinical data (e.g. baseline data).  However, 
it was not possible to implement a thorough data chasing process as it was not 
possible to locate some patients after data had been collected and returned due to data 
being linked anonymised data.  Principal investigators at each participating site were 
responsible for site monitoring of consent forms for all patients enrolled into the study.   
 
6.4.9 Data entry, transfer and cleaning  
Data was entered onto a MACRO database with 100% of data cross-checked.  In 
addition, a random sample of records for five patients from each CRF was checked 
against the data as seen on the database to ensure that the database was set up 
correctly and that the data entry had been successful.  Data were downloaded from 
MACRO and read into excel spreadsheets for validation by CG.  Data was checked for 
errors to ensure data transfer had been accurate and set-up to be entered into SPSS.  
Identified errors were corrected in the data file (e.g. entering 45 when 4 was intended).  
In SPSS, data were checked for outliers and variables defined (302).  No unusual or 
outlying data were observed.  Data were transferred from SPSS to RUMM20/30 
software to enable Rasch analyses. 
 
6.5 Analysis Plan for Field Test 1 
6.5.1 Baseline characteristics of sample  
Baseline analysis took the form of data summaries (no formal statistical testing was 
conducted).  Assessment of patients through the study, including those screened, 
112    Preliminary psychometric evaluation 
 
 
assessed as eligible, recruited and data returned was summarised.  Population 
screening data and main study baseline characteristics were performed using SPSS 
and tabulated using frequencies and summary statistics (see Table 6.5).  Percentages 
were calculated using the total number of patients from the relevant population as the 
denominator (i.e. including all patients with missing data for that variable) and rounded 
to 1 decimal place.  Means, medians, standard deviations and ranges were also 
summarised to one decimal place.  
 
6.5.2 Sub-study analyses 
Response rate and data quality 
The proportion of completed and returned PU-QOLIs (response rate) and percentage 
of missing data (data quality) per PU-QOLI and per item by administration mode group 
was calculated.   
 
Differential item functioning (DIF) 
A Rasch analysis was performed to examine for item bias or DIF within items (260, 
273).  DIF provides a method of exploring conditional relationships between item 
response and group membership by examining the significance of differences 
observed between different levels (class intervals) of a Person Factor (e.g. 
administration mode group) (303).  Groups to be studied are selected based on 
theoretical considerations about whether or not the construct studied is hypothesised to 
have the same conceptual meaning across groups.  DIF occurs when people from 
different groups (e.g. self-completed and interview-administered groups) with the same 
latent trait (e.g. pain) have a different probability of giving a certain response to an item.  
A DIF analysis can provide an indication of unexpected behaviour by an item(s) on a 
test (297); respondents with similar ability/disability should respond in similar ways to 
individual items regardless of their sex, ethnicity or administration mode.  Here, the 
construct studied was HRQL specific to PUs, measured by disease-specific scales and 
by subgroup mode of administration.  PU-QOLs‟ HRQL subscales should measure the 
same unidimensional constructs across specified mode groups.   
 
To ensure that any detected bias was a valid interpretation of group differences 
dependent on administration mode and not an artefact of differences within groups; 
differences that could present if for example younger, healthier patients were assigned 
to the self-complete group and older, more frail patients were assigned to the interview-
administered group, only patients who met the inclusion criteria (Section 6.4.4) were 
included in the sub-study.  This ensured that group participants were matched on 
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clinical presentation and relevant underlying ability before determining whether the two 
administration mode groups differ in their probability for success (297). 
 
A DIF analysis was undertaken to establish measurement equivalence across the two 
administration mode groups by investigating the equivalence of responses to PU-QOLI 
items (i.e. whether responses to items are directly comparable between both groups).  
A between groups analysis (an analysis of variance for each item, comparing across 
levels of participant characteristics and levels of latent trait (304)) was performed to 
indicate any patterns of responses (i.e. differences dependent on administration mode) 
to determine whether it matters how the PU-QOLI is administered; similar responses 
between groups would support the development of one version suitable for both 
administration modes, divergent responses would require two mode-specific versions.   
 
DIF occurs when different groups within a sample (e.g. males and females), despite 
equal levels of the underlying trait being measured, respond in a different manner to an 
individual item.  For example, given the same level of pain, the expected score on any 
item within the pain scale should be the same irrespective of gender.  There are two 
types of DIF: uniform DIF is where a consistent systematic difference occurs in a 
subgroup‟s responses to an item across the whole range of the trait being measured 
(same amount of item DIF regardless of person ability/disability level) and non-uniform 
DIF is where the magnitude of DIF varies according to ability/disability (non-uniformity 
amongst differences between subgroup, for example, responses vary across levels of 
the trait).  
 
When uniform DIF is detected, the problem can be remedied by splitting the item(s) by 
subgroup (e.g. administration mode) and separately calibrating the item for each 
subgroup (298).  This effectively allows the item to be specific to the subgroup in 
question (e.g. in the case of administration mode, Item # for self-completed version and 
Item # for administered version).  Alternately, items with DIF can be grouped into a 
subtest to determine whether the DIF identified cancels out at scale level (e.g. an item 
within a scale may be biased towards self-completed mode but another item biased 
towards administered mode, then if all persons respond to all items, the apparent DIF 
would cancel out at scale level and the person ability estimates would not be adversely 
affected) (298).  However, little can be done to correct the problem of non-uniform DIF, 
and it is often necessary to remove the item from the scale (305).   
 
In RUMM the presence of DIF can be detected both statistically and graphically. 
Analysis of variance is conducted for each item comparing scores across each level of 
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the selected person factor (e.g. gender) and across different levels of the underlying 
trait (the class intervals).  Uniform DIF is indicated by a significant main effect for the 
person factor, while the presence of non-uniform DIF is indicated by a significant 
interaction effect between the person factor and the class intervals (298).  
 
6.5.3 Item and scale analysis using Rasch  
Rasch analysis is increasingly used in the development of rating scales for the health 
and medical sciences (87, 290).  Rasch measurement methods add value in the 
development of new PRO instruments by allowing the evaluation of scale functioning 
(i.e. response format, item content, response bias, dimensionality, precision) and the 
transformation of ordinal level scale scores7 into linear, interval scale measurement8 
(Rasch analysis allows the estimation of the intervals between ordinal numbers), an 
attribute important when measuring change over time (85, 87, 290, 292, 308).  
Traditional methods of item reduction that rely on item-total correlations and/or indices 
of internal consistency can affect the sensitivity of measures and their ability to produce 
valid scores at the extremes of the construct range as items at the extreme of the 
measurement range are generally discarded because too many/few respondents affirm 
them (290).  In reality, „extreme‟ items are important in a scale for extending the 
constructs‟ range of coverage (85). 
 
A Rasch analysis, using the Andrich Rating Scale Model (276), was performed in 
RUMM2030 (309) to construct PU-QOLI scales that contained the best possible set of 
items for measurement of each conceptual domain (scale).  PU-QOLI data was tested 
against model expectations.  Any deviations from model expectations were examined 
to determine whether scale attributes could be improved.  Final decisions on item 
inclusion/exclusion were made according to appraisals of the analyses of the observed 
data against measurement criteria as described below, and clinical relevance (the 
extent to which items within proposed scales are clinically cohesive), as opposed to 
examinations carried out singularly or sequentially.   
 
                                               
7 Ordinal measurements describe order (numbers are assigned to objects/events in 
rank order, for example, from strongly agree to strongly disagree) but not the relative 
size or degree of difference between measurements (306).  Numerical values are 
assigned to item responses but the difference between, say „strongly agree‟ and „agree‟ 
is not necessarily the same as the difference between „agree‟ and „disagree‟ (the 
interval between values is not interpretable in ordinal measurement). 
 
8 In interval measurement, the traits measured have more or less equal intervals, or the 
distance between traits has meaning (307).  For example, when temperature is 
measured, the distance from 10-20 is the same as the distance from 30-40. 
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Targeting of persons and items 
To assess the ability of the PU-QOLI scales to appropriately target the population being 
measured, person-item threshold distribution maps were inspected.  A well targeted 
scale should include a set of items that span the full range of person estimates (person 
locations should be covered by items and item locations covered by persons).  A well 
targeted sample is one in which the person distribution closely matches the item 
distribution when they are both calibrated on the same metric scale (85).  Comparison 
of the mean location score obtained for the persons with that of the value of zero set for 
the items (e.g. zero logits representing the item average difficulty for a scale, range -5 
to +5), provides an indication of how well-targeted the items are for people in the 
sample (85).  For a well-targeted measure (not too easy, not too hard) the mean 
location for the persons would also be around the value of zero.  A positive mean value 
for persons would indicate that the sample as a whole was located at a higher level of 
the trait (e.g. pain) than the average of the scale, while a negative value would suggest 
the opposite.  Arguably, if many patients are at the margins, then the scale is not 
properly targeted (262).   
 
Threshold ordering - are response categories appropriate?  
A common source of item misfit occurs due to respondents' inconsistent use of 
response options; known as disordered thresholds - the failure of respondents to use 
the response options in a manner consistent with the level of the trait being measured 
(278).  Disordered thresholds occur when respondents have difficulty consistently 
discriminating between response options either because there are too many options or 
the labelling is potentially confusing or open to misinterpretation (e.g. sometimes, often, 
frequently terms used) (305).  The expectation is that respondents with high levels of 
the trait (e.g. pain) being measured would endorse high scoring responses (e.g. a lot of 
bother), while individuals with low levels of the trait would consistently endorse low 
scoring responses.  This would be indicated by an ordered set of response thresholds 
for each scale item.  The term threshold refers to the point between two response 
options where either response is equally probable.  For example, for each PU-QOLI 
item, the use of response options scored with successive integer scores (e.g. 0 = „no 
bother‟ to 3 = „a lot of bother‟) implies a continuum of increasing impact (bother), from 
less (no bother) to more (a lot of bother).  This assumption was tested by examining 
the ordering of thresholds (or points of crossover between two adjacent response 
options; the point where the probability of scoring a 0 or a 1 on an item is 50/50).  
Category probability curves were inspected to determine appropriate response 
category ordering (i.e. whether the ordering of polytomous response options was 
working as expected).  
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Overall model fit (summary statistics) 
The objective of a Rasch analysis was to test how well the observed data fit the 
expectations of the measurement model.  The Summary Statistics screen in RUMM 
provides a general view of how the data is behaving.  Three summary fit statistics are 
reported: two are item-person interaction statistics, transformed to approximate a z 
score representing a standardized normal distribution (if the items and persons fit the 
model then a fit residual mean of approximately zero and a standard deviation of 1 is 
expected) and the third is an item-trait interaction statistic reported as a chi square; a 
formal test of invariance to the scale (indicates whether or not data fit the model for 
discrete groups (class intervals) along the scale or across the trait – in HRQL 
terminology, traits are often called dimensions, subscales or constructs.  A significant 
chi square (p = <0.05) indicates that there is no significant deviation between the 
observed data and what is expected from the model (298).  The „power‟ of the tests of 
fit are presented, indicating the power in detecting the extent to which the data do not 
fit the model, not that data-fit to the model is good or poor (fit statistics are interpreted 
in light of the power) (298).  The power of tests-of-fit is intimately related to the person 
separation index (PSI), which is also presented (see Reliability below).   
 
Individual model fit analyses  
In addition to summary fit statistics, individual item-fit statistics were determined.  Item 
fit tests provide information about how well each item in a scale contributes to defining 
the construct measured by the scale.  Misfit implies that an item is not working as 
intended in a scale and may be regarded as not measuring the scale‟s intended 
construct.  As there are no absolute criteria for interpreting fit statistics, to ensure 
meaningful interpretation, findings were considered together and in the context of their 
clinical usefulness as an item set. 
 
 Item fit statistics 
The following indicators were examined to determine the extent to which observed data 
(patient‟s responses to items) accord with (fit) the responses expected for groups of 
responders across the trait (class intervals):  
o Fit residuals (item-person interaction) - summation of individual person and item 
deviations. 
o Chi-square statistics (item-trait interaction) – for each item, several chi-squares 
are computed (dependant on sample size) and summed to give an overall chi-
square value for items with degrees of freedom being the number of groups 
minus 1.  If chi-square values are less than 0.05, then the item is deemed to 
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misfit model expectations.  To take account of multiple testing, Bonferroni 
corrections9 are applied to adjust the chi squared p value (312). 
o Item characteristic curves (ICC) (graphical indicator of model fit or misfit) (279) - 
data are plotted against the expected model curve (ICC).  Items with good fit 
show group plots lying on the curve; those with plots steeper than the curve are 
considered to be over-discriminating; those flatter than the curve, under-
discriminating. 
 
 Item locations 
The aim of scale items is to mark out the trait or construct as a continuum on which 
people can be located or measured.  Measurement continuum implies that individual 
scale items are located across a continuum in the same way that the location of 
individual people are spread out across the continuum (ability/disability) (87).  Items 
with similar locations on the continuum may indicate that one of them may be 
redundant.  The spread of item locations was examined for evidence that items spread 
out to define a measurement continuum (279, 280).  
 
Tests of local dependence and dimensionality 
A problem in local dependence of items can be found by response dependency and 
multidimensionality.  The assumption of local independence implies that once the 
Rasch factors have been extracted (final scales) no leftover patterns in the residuals 
should be present.  An absence of any meaningful pattern in the residuals is 
considered support for the assumption of local independence and consequently the 
unidimensionality of the scale (313).  Response dependency is where items are linked 
in some way, such that the response to one item will determine the response to 
another.  Response dependency was investigated by inspecting the residual 
correlations (279, 280) for pairs of items with correlations exceeding 0.3.  
 
Reliability 
In RUMM, the internal consistency reliability of a scale is measured by a person 
separation index (PSI).  A PSI reliability statistic quantifies how reliably the 
measurements of patients in the sample are separated (the estimates on the logit scale 
for each person are used to calculate reliability); it is comparable to Cronbach‟s alpha 
(314, 315).  Higher values indicate greater reliability; minimum values of 0.7 for group 
use and 0.85 for individual use are recommended (308). 
                                               
9 The Bonferroni adjustment is a method for adjusting the significance levels of 
individual tests when multiple tests are performed on the same data (the test-wise 
significance levels are divided by the number of tests) (310, 311).  An exact probability 
value using Bonferroni adjustment is calculated in RUMM20/30. 
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Like alpha, the PSI is sample dependent because it is computed from the person 
locations.  The PSI focuses on the separation of persons therefore it is a property of 
the scale in relation to the specific sample of persons measured, indicating the ability of 
scale items to separate the study sample (85).  Thus, the PSI is a function of the data, 
not an independent function of the scale.  In contrast, alpha has the same formulaic 
structure as the PSI but relates the variance among persons to the variance of the 
items.  Fundamental differences between the PSI and alpha is that the PSI: is 
expressed entirely in terms of person locations and so meets the true definition of 
reliability; is computed from linear measurements rather than raw scores; and can be 
computed when data has missing item responses because in Rasch analysis, missing 
responses affect the standard error of a person location not the ability to generate an 
estimate, whereas alpha requires complete data to enable computation (85, 316). 
 
6.5.3 Missing data from Rasch measurement perspective 
The RUMM software accounts for missing data through the „Use class intervals 
complied on individual item basis‟ function.  This function adjusts the calculation of 
interval class distributions to be estimated on an item-by-item basis rather than by 
persons to avoid any skew in distributions (e.g. underrepresentation in specific class 
intervals due to some persons not responding to every item).   
 
6.5.4 Traditional Psychometric Analyses 
The Rasch measurement paradigm views the Rasch model as a formulation that 
represents the structure which data should exhibit in order to obtain meaningful 
measurements from data (317).  To determine whether the Rasch model fulfilled 
fundamental prerequisites for rigorous measurement as defined by traditional 
psychometric criteria and FDA guidance (86), the Rasch developed PU-QOLI scales 
underwent a preliminary psychometric evaluation using standard psychometric tests 
(85, 86, 102, 132, 227, 281), examining for: acceptability and data quality, scaling 
assumptions, targeting, reliability and construct validity against pre-specified criteria 
(see Table 6.1).  Psychometric tests were performed using SPSS 15.0 software. 
 
 
 
  
Table 6.1 Psychometric Tests and Criteria (Adapted from (85, 86, 281, 318) 
Psychometric Property Definition/Test Criteria (Traditional methods) Criteria (Rasch methods) 
Data quality - 
Acceptability/Data 
completeness 
The extent to which scale items are scored and total scores can 
be computed; quality of data is assessed by data completeness 
and score distributions (computing the percentage of missing 
data for each item, and the percent of people for whom a scale 
score is computed (319)) 
 Item-level missing data <10% (320) 
 Computable scale scores >50% 
completed items (100) 
 A total score can only be computed if 
all items are scored as they have 
substantially different ranges. 
 Items in scales rated as „not relevant‟ 
<35% 
 Even distribution of endorsement 
frequencies across response 
categories (>80%) 
 Low number of persons at extreme 
(i.e. floor/ceiling)  ends of the 
measurement continuum 
Scaling assumptions The extent to which it is legitimate to sum a set of item scores, 
without weighting or standardisation, to produce a total score. 
Summing item scores is considered legitimate when items: 
  
 are approximately parallel (i.e. they measure at the same 
point on the scale (redundancy)) 
 contribute similarly to the variation of the total score (i.e. 
they have similar variances), otherwise these should be 
standardised 
 measure a common underlying construct 
 contain a similar proportion of information concerning the 
construct being measured, otherwise items should be 
given different weights (321) 
 Similar mean scores (321) and 
standard deviations (319) 
 Items have adequate corrected item-
total correlation (ITC ≥0.3) (259) 
 Items have similar ITCs (259) 
 
 Positive correlations above 0.3 
suggest local dependency 
 High negative correlations (>0.6) 
suggest redundancy 
 Items share common variance 
(unidimensionality) 
 Determine if items have similar 
locations on the measurement 
continuum; evenly spaced items 
spanning wide range of the 
continuum 
Item Response 
Categories 
The extent to which item response categories work in a logical 
hierarchy reflecting the measurement continuum within the 
frame of reference of the scale 
 
 NA  Ordered item response categories 
Targeting 
 
The extent to which the range of the variable measured by the 
scale matches the range of that variable in the study sample; 
examination of score distributions at both item and scale level in 
whole sample and defined disease severity subgroups 
(evidence of matched scale to sample targeting focussed 
 Scale scores should span the entire 
range 
 Floor (proportion of sample at 
maximum scale score) and ceiling 
(proportion of sample at minimum 
 Person-item threshold distribution: 
the extent to which the range of the 
variable (scale item locations) match 
the range of that variable in the study 
sample (person locations) – well 
  
Psychometric Property Definition/Test Criteria (Traditional methods) Criteria (Rasch methods) 
around the scale best point of measurement) 
 
scale score) effects should be low 
(<15%) (322) 
 Skewness statistics should range 
from -1 to +1 (323) 
 There is no published criteria for item 
level targeting, therefore scale level 
criteria will be used 
targeted is demonstrated by the 
mean location of items and persons 
around the value zero 
 Items span full range of person 
estimates 
Reliability    
Internal consistency  The extent to which items comprising a scale measure the same 
construct (e.g. homogeneity of the scale) 
 Cronbach's alphas for summary 
scores (adequate scale internal 
consistency is  0.7  (286)  
 Item-total correlations  0.4 
 High person separation index >0.7 
(324) 
 Power-of-tests indicate the power in 
detecting the extent to which the data 
do not fit the model (fit statistics are 
interpreted in light of the power) (298) 
 Items with ordered thresholds 
*Test-retest reliability The stability of a measuring instrument; assessed by 
administering the instrument to respondents on two different 
occasions and examining the correlation between test and 
retest scores 
 Scale –level Intra-class correlations 
(ICCs) coefficient >0.7 (102) between 
test and retest scores  
 Statistical stability across time points 
(no uniform or non-uniform item DIF 
(p=>0.05 or Bonferroni adjusted 
value)) 
Validity The extent to which a scale measures what it intends to 
measure (325) 
  
Content validity The extent to which the content of a scale is representative of 
the conceptual domain it is intended to cover 
 Qualitative evidence from patients, 
expert opinion and literature review 
that items in the scale are 
representative of the construct being 
measured 
 Clearly defined construct 
 Validity comes from careful item 
construction and consideration of 
what each item is meant to measure, 
and then testing against model 
expectations 
Construct validity    
i) Within-scale 
analyses  
 
Evidence that a single entity (construct) is being measured and 
that items can be combined to form a summary score; Factor 
analysis (using principal axis factoring, varimax rotation, with 
criteria for elimination applied to 2-factor model). 
 
 Cronbach alpha for scale scores >0.7 
 Item-total correlations >0.3 
 Scaling success 
 
 The extent items work together to 
represent  the construct (item fit 
statistics: fit residuals within given 
range +/-2.5; non-significant chi 
square values; no under– or over-
  
Psychometric Property Definition/Test Criteria (Traditional methods) Criteria (Rasch methods) 
discriminating item characteristic 
curves; mean fit residual close to 0.0 
and SD approaching 1.0 (usually 
<1.4) for summary statistics) (308) 
 Person fit residuals within given 
range +/-2.5 
ii) Between scale 
analysis – analyses 
against external 
criteria 
   
*Convergent validity 
 
Evidence that the scale is correlated with other measures of the 
same or similar constructs; assessed on the basis of 
correlations between the measure and other similar measures  
 Correlations are expected to vary 
according to the degree of similarity 
between the constructs being 
measured by each instrument.  
Specific hypotheses are formulated 
and predictions tested on the basis of 
correlations. 
 NA 
*Discriminant 
validity 
Evidence that the scale is not correlated with measures of 
different constructs; assessed on the basis of correlations with 
measures of different constructs (e.g. age, gender) 
 Low correlations between scale 
scores and measures of different 
constructs 
 NA 
*Known groups 
differences 
 
 
The ability of a scale to differentiate known groups; assessed by 
comparing scores for subgroups who are expected to differ on 
the construct being measured (significant differences between 
known groups or difference of expected magnitude) 
 Generate hypotheses and compare 
changes in mean scores (e.g. predict 
a stepwise change in PU-QOLI scale 
scores across PU severity groups, 
and mean scores would be 
significantly different) 
 Hypothesis testing (e.g. clinical 
questions are formulated as external 
and the empirical testing comes from 
data fit to the Rasch model) 
Responsiveness The ability of a scale to detect clinically significant change 
following treatment of know efficacy; assessed by examining 
within person change scores before and after treatment and 
calculating an effect size statistic (mean change score divided 
by standard deviation of pre-treatment scores). 
 Moderate to large effect sizes (small 
0.2, moderate 0.5 or large 0.8 or 
higher) (326) 
 Racking and stacking data for 
analysis (stablility of scale over time) 
and DIF (item stability over time) (85) 
*Additional tests performed for final field test (evaluation of short PU-QOLI) 
NA not assessed 
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Acceptability and Data quality 
Acceptability was determined by data quality; assessed by completeness of item- and 
scale-level data and score distributions (floor/ceiling effects and skew of scale scores).  
Data completeness concerns the extent to which scale items are completed in the 
target sample (percent of missing data for items) and the percent of people for whom it 
is possible to compute scale scores (319).  The criterion for acceptable item-level 
missing data was <10% (320) and for computable scale scores >50% (100).  The 
criterion for maximum endorsement frequencies is <80% (floor/ceiling effects <80%).  
 
Scaling Assumptions 
Tests of scaling assumptions examine whether it is appropriate to sum a group of items 
to generate a scale score.  Scaling assumptions are satisfied with similar item means 
and variances, and when items have adequate corrected item-total correlations (ITC; 
criterion for corrected ITC was ≥0.3) (259, 319, 321). 
 
Targeting 
Targeting assesses the match between the range of each variable (or trait) as 
measured by each PU-QOLI scale and the range of PU severity in the sample.  Scale-
to-sample targeting was determined by investigating whether: scale scores span the 
entire scale range; floor (proportion of the sample at the maximum scale range) and 
ceiling (proportion of the sample at the minimum scale range) effects are low (<15%) 
(322); and skewness statistics range from -1 to +1 (323). 
 
Reliability 
Reliability refers to the consistency of a measure yielding the same score at each 
administration, assuming all things being equal (i.e. true change has not occurred in 
the variable being measured), and the extent to which scale scores are free from 
random error.  A way of estimating reliability is to determine the consistency of results 
across items on the same measure (i.e. compare scale items that measure the same 
construct to determine a scales internal consistency). 
 
 Internal consistency reliability 
Internal consistency, reported as Cronbach‟s alpha coefficients (314), was determined 
for all PU-QOLI scales.  Alpha provides an indication of the degree of convergence 
between items hypothesised to represent the same variable.  Adequate scale internal 
consistency is indicated by Cronbach‟s alpha coefficients ≥0.8 (327), however, internal 
consistency estimates of 0.7 are considered acceptable for group comparisons (286).  
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 Item total correlation  
The relationship between an item and the total scale score was assessed using a 
Pearson correlation coefficient, expressed as a number between -1.0 to +1.0.  A 
negative correlation value indicates that an item is actually lowering an individual‟s 
score rather than raising it.  Item-total correlations (ITC) in the range of +0.4 to around 
+0.6 indicate items are moderately correlated with scale scores and higher values 
indicate well correlated items with scale scores (286). 
 
Validity 
Validity refers to the extent to which a scale measures what it intends to measure.  
Although a scale may be reliable, it may be consistently measuring the wrong thing.  
For example, demonstrating that a set of items intended to measure pain has good 
reliability merely indicates that the items are getting at the same true score, but not 
necessarily tapping into the pain true score (287).  Evaluating the validity of a measure 
involves accumulating evidence from different forms to indicate the degree to which the 
measure denotes what it is intended to represent.  
 
 Content  
Content validity is the extent to which a measure samples a representative range of 
content (items) for the construct measured.  Consideration of item sufficiency and the 
target population is essential and ideally should include systematic comparison with 
existing standards, well-accepted theoretical definitions, expert opinions and interviews 
with individuals for whom the measure is targeted (86).  These methods are described 
in detail in Chapters 3 (Development of a conceptual framework) and 5 (PU-QOLI 
development and pretesting). 
 
 Construct 
Construct validity evidence indicates the degree to which a measure represents what it 
is intended to represent.  A within-scale construct validity analysis was undertaken to 
determine the extent to which PU-QOLI scales measure a single entity (are PU-QOLI 
scales distinct constructs?) and therefore whether items can be combined to form scale 
scores; assessed on the basis of ITC >0.3.   
 
6.5.5 Missing data from the traditional psychometric perspective 
For the traditional psychometric evaluation, missing data was not imputed.  The 
frequency of missing data was determined and items with a response rate of <90% 
were investigated. 
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6.6 Results 
6.6.1 Sample 
A total of 989 patients were screened for study participation from 21 hospitals, 10 
community services and one hospice.  Of those screened, eligibility was assessed for 
787 (79.6%); 416 were considered eligible (52.9%); and of those eligible, 287 (69.0%) 
consented to participate (Figure 6.1).   
 
 
Figure 6.1 Assessment flow chart for field test 1 and sub-study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Main study 
analysis 
population (n=227) 
Screened (n=989) 
Assessed for 
eligibility (n=787) 
Consented (n=287) 
Can you self-complete 
a questionnaire? 
Y=sub-study; N=main 
study 
Enrolled to Sub-Study (n=75) 
 
Excluded from analysis (n=5, 6.7%): 
Questionnaire not returned (5) 
Enrolled to Main Study (n=233) 
 
Excluded from analysis (n=6, 
2.6%): 
Patient withdrew consent (3) 
Patient self-completed (2) 
Patient recruited twice (1) 
Self-complete 
(n=49) 
Administered 
(n=21) 
Not assessed: 202 
   24 Missed by TVS 
   26 Patient died 
   19 Patient transferred 
   90 Patient cognitively impaired 
42 Patient on care pathway for 
the dying 
     1 Reason missing 
 
 
 
Unable to disturb 
Communication difficulties 
Other 
 
Eligible (n=416) 
Not eligible: 371 
    0 Patient under 18 years of age 
  40 Patient does not have a PU 
    8 Patient does not speak English 
  37 Unable to self-complete 
142 Patient unable give informed   
consent 
144 Patient is cognitively impaired 
    0 Missing 
 
Sub-study analysis 
population (n=227) 
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Cognitive impairment was the main reason for ineligibility (38.8%).  Those able to self- 
complete were included in the sub-study (n=75) while those unable to self-complete 
were enrolled onto the main study.   
 
6.6.2 Sub-Study results: Response rates and data quality 
Respondents (n=75) in the sub-study sample represented a wide range of age groups, 
there was a higher proportion of men, just over half of the sample were hospitalized, 
and over half of PUs were superficial.  Table 6.2 presents the sub-study sample 
characteristics.  All 75 patients completed PU-QOLIs indicating a 100% response rate; 
no difference in response rate was observed by administration mode group.  Table 6.3 
indicates the percentage of missing data by sub-groups: mode (self-complete and 
administered), age (under 70 years and 70 years or over) and healthcare setting 
(hospital and community).  For the administered group (n=21), the possible range of 
missed items was 0-1827 (i.e. 87 items per PU-QOLI x 21 administrations = 1827 total 
items); a total of three PU-QOLIs were returned with 29 items missed (1.6%).  For the 
self-completed group (n=49), the possible range of missed items was 0-4263; 19 PU-
QOLIs were returned with 619 missed items (14.5%). 
 
Table 6.2 Patient characteristics (sub-study population) 
 Self-completed 
(n=49) 
Administered 
(n=21) 
Total (n=70) 
Patient age (years) 
     Mean (SD) 
     Median (range) 
     Under 70 years of age 
     70 years or older 
     Missing 
 
65 (15) 
68 (21-85) 
25 
24 
0 
 
62 (16) 
65 (27-93) 
14 
7 
0 
 
64 (15) 
66 (21-93) 
39 
31 
0 
Gender 
     Male 
     Female 
 
33 (67.3%) 
16 (32.7%) 
 
14 (66.7%) 
  7 (33.3%) 
 
47 (67.1% 
23 (32.9%) 
Type of healthcare setting 
     Acute 
     Community 
 
26 (53.0%) 
23 (47.0%) 
 
12 (57.1%) 
  9 (42.9%) 
 
38 (54.3%) 
32 (45.7%) 
Pressure ulcer severity 
     Superficial grades 1/2 
     Severe grades 3/4 
 
28 (57.1%) 
21 (42.9%) 
 
12 (57.1%) 
  9 (42.9%) 
 
40 (57.1%) 
30 (42.9%) 
 
Participants under 70 years of age who self-completed returned 12 PU-QOLIs with 336 
items missed (15.5%).  Those 70 years or older who self-completed returned seven 
PU-QOLIs with 283 items missed (13.6%).  Of the administered group, two PU-QOLIs 
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had three items missed from those under 70 years (0.3%) and one PU-QOLI with 26 
items missed from those 70 years or older (4.3%).  
 
Participants hospitalised who self-completed returned 16 PU-QOLIs with 604 items 
missed (26.7%).  Those living in the community who self-completed returned three PU-
QOLIs with 15 items missed (0.8%).  Of those hospitalised who were administered PU-
QOLIs, two were returned with 28 items missed (2.7%).  Only one PU-QOLI with one 
item missed was returned from those living in the community who had PU-QOLIs 
administered (0.1%) (Table 6.3).  Overall, a larger proportion of self-completed PU-
QOLIs were returned with missing data compared to those who had them 
administered.  No difference in missing data was observed by age.  A difference was 
observed by healthcare setting; hospitalised patients that self-completed returned PU-
QOLIs with the largest amount of missing data. 
 
Table 6.3 Data Quality – Missing data (sub-study population) 
 Self-completed  
(n=49) 
Administered  
(n=21) 
Total  
(n=70) 
PU-QOLIs with missing data   19 (38.8%)   3 (14.3%)   22 (31.4%) 
Total number of PU-QOLI items 
missed (range 1-87 items per 
PU-QOLI) 
 
619 (14.5%) 
 
29 (1.6%) 
 
648 (10.6% 
Age  
     Number Under 70 years  
          Number items missed 
     Number 70 years or older  
          Number items missed 
 
(n=12/25) 
336 (15.5%) 
(n=7/24) 
283 (13.6%) 
 
(n=2/14) 
  3 (0.3%) 
(n=1/7) 
26 (4.3%) 
 
(n=14/39) 
345 (10.2%) 
(n=8/31) 
309 (11.5%) 
Type of healthcare setting 
     Number Acute  
          Number items missed 
     Number Community 
          Number items missed 
 
(n=16/26) 
604 (26.7%) 
(n=3/23)   
  15 (0.8%) 
 
(n=2/12) 
28 (2.7%) 
(n=1/9) 
  1 (0.1%) 
 
(n=18/38) 
632 (19.1%) 
(n=4/32) 
  16 (0.6%) 
 
 
Qualitative observations 
PU-QOLIs returned with missed items were examined to investigate patterns in missing 
responses.  The following observations were noted.  Of the 19 self-completed PU-
QOLIs with missing data, four respondents wrote „n/a‟ next to items missed, suggesting 
that the response option „My pressure ulcer did not give me this problem‟ was not used 
as intended.  Six respondents completed only one item per scale; five respondents 
missed items at random; two missed a page; one missed items from only the daily 
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activities scale; and one mostly missed items at the beginning.  For the three 
administered PU-QOLIs with missing data, one had one item missed; one had two 
items missed; and one hospital patient requested to cease completion due to feeling ill, 
resulting in a large amount of items (n=26) missed towards the end.  No obvious 
patterns in responses emerged. 
 
6.6.3 Differential item functioning 
A summary of the DIF results are presented in Table 6.4.  In the context of the mode 
subgroups, DIF was demonstrated in 9/13 scales (seven scales with one item and two 
scales with 2 or 3 items); however, the DIF observed for most items was marginal.  
This finding provides preliminary evidence for stable item performance across mode 
subgroups; suggesting PU-QOLI subscales could be measured on a common metric 
(i.e. administration mode did not impact on the way patients responded to PU-QOLI 
items), as supported by equivalence of self-completed and interview-administered 
versions.  Statistically there were no items with significant DIF by mode for any PU-
QOLI scales at the 1% confidence level.  Due to the small sample size, it is unlikely 
that we would find significant DIF below 0.001 Bonferroni adjusted significance level, 
therefore the 95% confidence level was observed.   
 
As DIF is a product of the sample and not the scale (e.g. chi-squared values and 
probabilities are sample size dependent), additional exploration of DIF was undertaken 
with two hypothetical samples (n=200 and n=300) adjusted in RUMM from the original 
analysis sample (n=70).  Amending the sample size provides a better feel for the 
behaviour of the data and gives the DIF statistics a chance to reveal any DIF (the 
larger the sample size, the greater the values and the greater the apparent DIF (85)).  
This estimate was only a guide to give a feel for the behaviour of the data and did not 
affect other aspects of the analysis.  In both adjusted samples, 11/13 scales emerged 
with items with significant DIF.  The anxiety and autonomy scales remained without 
new items with significant DIF while all other scales had a significant proportion of 
items with both uniform and non-uniform DIF (Table 6.4).   
 
6.6.4 Main Study respondent characteristics 
Respondents in the main study sample represented a wide range of age groups.  
There was a slightly higher proportion of women, and a small percentage of 
respondents from minority ethnic groups.  Just over half of the sample was hospitalized 
patients and at on-going long-term risk of PUs.  Over two thirds of the sample was 
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married or cohabiting and just under half the sample had some educational 
qualification.  Table 6.5 presents patient characteristics for the main study. 
 
 
Table 6.4 Summary of DIF by administration mode for each PU-QOLI subscale  
Scale (sample size) 
Uniform  Non-uniform  
Item number 
(p < 0.001) 
Item number 
(p < 0.05) 
Item number 
(p < 0.001) 
Item number 
(p < 0.05) 
Pain     
   (n=70) x x x 10 (0.043) 
   (Adjusted n=200) 10 (0.001)   2 (0.008) 
  5 (0.002) 
  8 (0.005) 
  10 (0.001) 
10 (0.000) 10 (0.000) 
   (Adjusted n=300)   2 (0.000) 
  5 (0.000) 
  8 (0.001) 
10 (0.000) 
  1 (0.033) 
  2 (0.001) 
  5 (0.000) 
  8 (0.001) 
10 (0.000) 
11 (0.019) 
10 (0.000)   2 (0.026) 
  5 (0.031) 
  8 (0.019) 
10 (0.000) 
Exudate     
   (n=70) x x x x 
   (Adjusted n=200) 3 (0.000) 
5 (0.000) 
2 (0.048) 
3 (0.000) 
5 (0.000) 
  2 (0.001)   2 (0.001) 
  8 (0.037) 
   (Adjusted n=300) 3 (0.000) 
5 (0.000) 
1 (0.029) 
2 (0.015) 
3 (0.000) 
5 (0.000) 
  2 (0.000)   2 (0.000) 
  8 (0.010) 
Odour     
   (n=70) x 3 (0.006) x x 
   (Adjusted n=200) 2 (0.000) 
3 (0.000) 
6 (0.000) 
2 (0.000) 
3 (0.000) 
6 (0.000) 
1 (0.000) 
3 (0.000) 
6 (0.000) 
  1 (0.000) 
  3 (0.000) 
  6 (0.000) 
  (Adjusted n=300) 2 (0.000) 
3 (0.000) 
6 (0.000) 
2 (0.000) 
3 (0.000) 
4 (0.020) 
6 (0.000) 
1 (0.000) 
3 (0.000) 
6 (0.000) 
  1 (0.000) 
  3 (0.000) 
  5 (0.021) 
  6 (0.000) 
Sleep     
   (n=70) x x x 5 (0.026) 
   (Adjusted n=200) 5 (0.000) 
6 (0.001) 
4 (0.006) 
5 (0.000) 
6 (0.001) 
1 (0.002) 
5 (0.000) 
6 (0.000) 
1 (0.002) 
5 (0.000) 
6 (0.000) 
   (Adjusted n=300) 4 (0.001) 
5 (0.000) 
6 (0.000) 
1 (0.041) 
4 (0.001) 
5 (0.000) 
6 (0.000) 
1 (0.000) 
5 (0.000) 
6 (0.000) 
1 (0.000) 
5 (0.000) 
6 (0.000) 
Malaise      
   (n=70) x 2 (0.026) x x 
   (Adjusted n=200) 2 (0.000) 
3 (0.000) 
1 (0.031) 
2 (0.000) 
3 (0.000) 
3 (0.003) 3 (0.003) 
   (Adjusted n=300) 2 (0.000) 
3 (0.000) 
1 (0.008) 
2 (0.000) 
3 (0.000) 
3 (0.000) 1 (0.021) 
3 (0.000) 
Mobility     
   (n=70) x 7 (0.038) x   1 (0.024) 
  4 (0.023) 
  7 (0.042) 
   (Adjusted n=200) 5 (0.000) 5 (0.000)   1 (0.000)   1 (0.000) 
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Scale (sample size) 
Uniform  Non-uniform  
Item number 
(p < 0.001) 
Item number 
(p < 0.05) 
Item number 
(p < 0.001) 
Item number 
(p < 0.05) 
7 (0.000) 6 (0.048) 
7 (0.000) 
  2 (0.000) 
  3 (0.000) 
  4 (0.000) 
  6 (0.000) 
  7 (0.000) 
11 (0.000) 
  2 (0.000) 
  3 (0.000) 
  4 (0.000) 
  6 (0.000) 
  7 (0.000) 
11 (0.000) 
   (Adjusted n=300) 5 (0.000) 
7 (0.000) 
4 (0.050) 
5 (0.000) 
6 (0.015) 
7 (0.000) 
  1 (0.000) 
  2 (0.000) 
  3 (0.000) 
  4 (0.000) 
  6 (0.000) 
  7 (0.000) 
11 (0.000) 
  1 (0.000) 
  2 (0.000) 
  3 (0.000) 
  4 (0.000) 
  6 (0.000) 
  7 (0.000) 
  9 (0.031) 
10 (0.022) 
11 (0.000) 
Daily Activities     
   (n=70) x 2 (0.024) x 2 (0.018) 
  ( Adjusted n=200) 2 (0.000) 
4 (0.001) 
2 (0.000) 
4 (0.001) 
7 (0.008) 
1 (0.000) 
2 (0.000) 
1 (0.000) 
2 (0.000) 
7 (0.004) 
8 (0.026) 
9 (0.005) 
   (Adjusted n=300) 2 (0.000) 
4 (0.000) 
7 (0.001) 
2 (0.000) 
4 (0.000) 
6 (0.017) 
7 (0.001) 
1 (0.000) 
2 (0.000) 
7 (0.000) 
9 (0.001) 
1 (0.000) 
2 (0.000) 
3 (0.027) 
7 (0.000) 
8 (0.006) 
9 (0.000) 
Mood     
   (n=70) x x x 4 (0.026) 
   (Adjusted n=200) x 2 (0.047) 
4 (0.017) 
4 (0.000) 
6 (0.000) 
2 (0.48) 
4 (0.000) 
6 (0.000) 
7 (0.005) 
   (Adjusted n=300) x 2 (0.014) 
4 (0.003) 
5 (0.035) 
6 (0.049) 
4 (0.000) 
6 (0.000) 
7 (0.001) 
2 (0.015) 
4 (0.000) 
5 (0.028) 
6 (0.000) 
7 (0.001) 
Anxiety     
   (n=70) x x x x 
   (Adjusted n=200) x x x x 
   (Adjusted n=300) x x x x 
Self-
consciousness 
    
   (n=70) x x x x 
   (Adjusted n=200) 5 (0.000) 3 (0.012) 
4 (0.004) 
5 (0.000) 
6 (0.025) 
5 (0.000) 4 (0.037) 
5 (0.000) 
   (Adjusted n=300) 3 (0.002) 
4 (0.000) 
5 (0.000) 
3 (0.002) 
4 (0.001) 
5 (0.000) 
6 (0.006) 
5 (0.000) 3 (0.037) 
4 (0.010) 
5 (0.000) 
Autonomy     
   (n=70) x x x x 
   (Adjusted n=200) x  x 1 (0.001) 
2 (0.000) 
1 (0.001) 
2 (0.000) 
   (Adjusted n=300) x  x 1 (0.000) 1 (0.000) 
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Scale (sample size) 
Uniform  Non-uniform  
Item number 
(p < 0.001) 
Item number 
(p < 0.05) 
Item number 
(p < 0.001) 
Item number 
(p < 0.05) 
2 (0.000) 2 (0.000) 
Isolation     
   (n=70) x x x 4 (0.042) 
   (Adjusted n=200) 4 (0.000) 1 (0.012) 
4 (0.000) 
3 (0.000) 
4 (0.000) 
2 (0.015) 
3 (0.000) 
4 (0.000) 
   (Adjusted n=300) 1 (0.000) 
4 (0.002) 
1 (0.002) 
3 (0.036) 
4 (0.000) 
2 (0.003) 
3 (0.000) 
4 (0.000) 
2 (0.003) 
3 (0.000) 
4 (0.000) 
Participation     
  (n=70) x x x 3 (0.005) 
8 (0.014) 
   (Adjusted n=200) 1 (0.001) 
3 (0.001) 
4 (0.000) 
7 (0.001) 
1 (0.000) 
2 (0.001) 
3 (0.000) 
4 (0.000) 
5 (0.015) 
6 (0.003) 
7 (0.000) 
9 (0.000) 
1 (0.000) 
3 (0.000) 
5 (0.000) 
6 (0.000) 
7 (0.000) 
8 (0.000) 
9 (0.001) 
1 (0.000) 
3 (0.000) 
5 (0.000) 
6 (0.000) 
7 (0.000) 
8 (0.000) 
9 (0.001) 
   (Adjusted n=300) 1 (0.000) 
2 (0.001) 
3 (0.000) 
4 (0.000) 
7 (0.000) 
9 (0.000) 
1 (0.000) 
2 (0.001) 
3 (0.000) 
4 (0.000) 
5 (0.015) 
6 (0.003) 
7 (0.000) 
9 (0.000) 
1 (0.000) 
3 (0.000) 
5 (0.000) 
6 (0.000) 
7 (0.000) 
8 (0.000) 
9 (0.000) 
1 (0.000) 
3 (0.000) 
5 (0.000) 
6 (0.000) 
7 (0.000) 
8 (0.000) 
9 (0.000) 
x indicates no items detected with significant DIF within the scale 
 
 
6.6.5 Rasch analyses of Pain scale and any item reduction 
Rasch analyses of PU-QOLI scale data were undertaken for all scales independently.  
The results and interpretations for each psychometric property described in the 
methods Section 6.5.3 are reported in detail for the pain scale.  For the remaining 
scales, decisions made to any scale modifications and a summary of findings are 
presented in Tables 6.11 and 6.12, and results are interpreted and discussed 
interactively in Sections 6.6.9 to 6.6.26.   
 
It is important to mention that two Rasch analyses were performed.  The first analysis 
included a data set that combined response categories „not because of PUs‟ and „no 
bother‟, both scored as 0.  However, merging these two responses was considered an 
inappropriate method of analysis as „not because of PUs‟ category was essentially 
descriptive data about patient comorbidity and not part of the scale data.  Therefore, 
analysis two was performed using a data set where the „not because of PUs‟ response 
was treated as missing.   
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Table 6.5 Respondent Characteristics (n=227) 
Characteristics Range (Mean, SD) 
Age 24 to 98 years (72, 13.5) 
 Total n (%) 
Gender  
   Male 90 (39.6) 
   Female 137 (60.4) 
Ethnicity  
   White  223 (98.2) 
   Asian 1 (0.4) 
   Black/African 2 (0.4) 
   Chinese 0 
   Not stated 1 (0.4) 
Setting  
   Hospital (surgery) 99 (43.6) 
   Hospital (medicine) 21 (9.3) 
   Community 107 (47.1) 
PU severity  
   Category 1 38 (10.6%) 
   Category 2 144 (40.2%) 
   Category 3/4 175 (48.9%) 
   Missing 1 (0.3%) 
PU risk classification  
   Short-term 39 (17.2) 
   New medium to long-term 71 (31.3) 
   On-going long-term 116 (51.1) 
   Missing 1 (0.4) 
Marital status  
   Single (includes divorced, 
separated, widowed) 
59 (26.0) 
   Married 85 (37.5) 
   Cohabiting 81 (35.7) 
   Missing 2 (0.8) 
Living arrangements  
   Live alone 84 (37.0) 
   Cohabit with identified carer 63 (27.8) 
   Cohabit with other 61 (26.9) 
   Missing 19 (8.4) 
Education  
   No formal education 129 (56.8) 
   GCSE or equivalent 39 (17.2) 
   A-Level or equivalent 25 (11.0) 
  Degree or higher 15 (6.6) 
   Missing 19 (8.4) 
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Prior to formal Rasch analysis on PU-QOLI scales, both analyses were performed on a 
random selection of five scales and findings compared for consistency.  Treating „not 
because of PUs‟ as missing did not significantly change the Rasch or Classical test 
results; only marginal differences were observed, thus supporting the use of analysis 
two for the remaining scales.  For analysis purposes, „not because of PUs‟ was treated 
as missing for both Rasch and traditional analyses, except for computable scale scores 
(classical tests); treating „not because of PUs‟  as not missing enabled data 
completeness evaluation.   
 
This methodological evaluation resulted in a distinction being made between 
descriptive data and scale data.  Descriptive data equates to data collected for those 
patients that have the trait (construct property as measured by a particular item) but not 
because of PUs and helps formulate known groups hypotheses.  Scale data is 
essentially scale items scored as 0, 1 and 2.   
 
6.6.5.1 Scale-to-sample targeting  
Is the pain scale-to-sample targeting adequate for making judgements about the 
performance of the scale and the measurement of people?   
Figure 6.2 illustrates the targeting of the patient sample to the location‟s 11 items in the 
pain scale.  Scale range set from -4 to +4 units (logits) for symmetry (mean always set 
at 0).  The histogram bars represent the relative location of the item(s) and persons on 
the same variable (pain).  The curve represents where on the continuum the scale 
performs best.  Item locations range from -1.0 to +0.8 (bottom histogram) and person 
locations range from -4.0 to +3.2 (top histogram) (Figure 6.2).   
 
Item locations are covered by the people, but the person location are not covered by 
the items; reasonable sample to examine the scale but a suboptimal scale for 
measuring the sample.  There are no items representing people at the extremes of the 
sample distribution.  The scale performs best in the centre (range -1 to +1 logits) and 
worse at the extremes; about 72 (34.1%) of people in the sample are located outside 
the best functioning of the scale.  Figure 6.3 illustrates the targeting of the patient 
sample to the thresholds of the 11 items of the pain scale.  Item locations now spread 
from about -2.8 to +1.4 logits but still do not cover the range of person locations in the 
sample. 
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Figure 6.2 Pain scale – targeting of sample to item locations.  Person-item location 
distribution (grouping set to interval length of 0.2, making 45 groups). 
 
 
 
 
Figure 6.3 Pain scale – targeting of sample to item thresholds. Person-item threshold 
distribution (grouping set to interval length of 0.2, making 45 groups). 
 
 
The „power‟ of the tests of fit for the pain scale are good (Table 6.6); this indicates that 
there is good power in detecting the extent to which the data do not fit the model, not 
that data-fit to the model is good (fit statistics are interpreted in light of the power) 
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(298).  The power of tests-of-fit is intimately related to the person separation index 
(PSI) (see Section 6.5.3 Reliability).  If the PSI is low (i.e. persons have similar 
locations and not spread across the continuum), the power of the tests of fit is low.  
This is because a lack of variability in person locations makes it impossible to 
determine whether people with higher locations tend to get higher scores on items (e.g. 
unable to accurately estimate person ability).  The pain scale chi-square probability is 
0.000, indicating some items may misfit from model expectations.  
 
 
Table 6.6 Pain scale summary statistics 
 
 
 
6.6.5.2 Thresholds 
Do the item response categories work as intended?   
Each item instrument has four response categories, ordered to imply a continuum of 
increasing impact from less („no bother at all‟) to more („a lot of bother‟).  This 
continuum of increasing impact is further implied by assigning sequential integers to 
the response categories (0=no bother to 3= a lot of bother).  It is assumed that the 
response categories work as intended (ordered sequentially) but this needs to be 
checked empirically.  With four response categories, there are three thresholds (the 
Greek symbol „ ‟ (tau) is used to signify threshold): 
1 – where the probability of scoring either 0 („no bother‟) and 1 („a little bother‟) is 
the same 
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2 – where the probability of scoring either 1 („a little bother‟) and 2 („quite a bit of 
bother) is the same 
3 - where the probability of scoring either 2 („quite a bit of bother) and 3 („a lot of 
bother) is the same 
 
Disordered thresholds, the finding that threshold locations are not ordered sequentially, 
implies that the item scoring functions are not working as intended (276).  There are 
three main reasons for disordered thresholds: responders cannot use the response 
categories consistently (impacts item reliability); categories do not characterise the 
intended meaning of what it takes to reflect more of the property within an item 
(impacts item validity); and the item does not measure the same underlying trait as the 
other items in the scale (e.g. pain) (85). 
 
Table 6.7 indicates 3/11 pain scale items have disordered thresholds: items 4 
(„itchiness‟); 9 („stabbing‟); 11 („burning‟).  For example, for item 4, the estimate for 3 (-
0.074) is less than that for 2 (0.525), meaning that the estimated point on the 
continuum at which the probability is the same for scoring either 2 („quite a bit of 
bother‟) or 3 („a lot of bother‟) is lower than the point on the continuum at which the 
probability of scoring either 1 („a little bother‟) or 2 („quite a bit of bother‟) is the same; 
this does not make sense and indicates the response categories are not working as 
intended.   
 
 
Table 6.7 Pain scale: item thresholds and location estimates 
 Item Location 1 2 3 
1 Uncomfortable -0.828 -1.812 0.448 1.364 
2 Dull ache 0.183 -0.474 0.095 0.378 
3 Annoying  -0.562 -0.946 -0.041 0.987 
4 *Itchiness  0.764 -0.451 0.525 -0.074 
5 Tender -0.793 -1.532 0.528 1.004 
6 Tingling  0.625 -0.383 0.165 0.219 
7 Throbbing 0.210 -0.712 -0.019 0.732 
8 Stinging 0.058 -0.570 -0.089 0.659 
9 *Stabbing 0.349 0.117 -0.342 0.225 
10 Red raw -0.882 -0.388 -0.091 0.480 
11 *Burning 0.084 -0.283 0.199 0.084 
* Indicates disordered threshold 
 signifies threshold 
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Figure 6.4 illustrates the region of the continuum represented by each item response 
option for items with ordered thresholds.  This figure demonstrates that the area on the 
continuum represented by response options 1 (a little bother) and 2 (quite a bit of 
bother) is often very small. For the other items, the response categories are working as 
intended.   
 
 
 
Figure 6.4 Pain scale – threshold maps. xxReversed thresholds. Key: 0, response 
category labelled 0; 1, response category labelled 1; 2, response category labelled 2; 
3, response category labelled 3 
 
 
Inspecting category probability curves (CPC) indicates that items 1, 2, 3, 5, 6, 7, 8 and 
10 (Figure 6.5), despite ordered thresholds, thresholds ( 1 and 2) are very close to 
being disordered.  Possible explanations for this finding may be that there are too many 
response categories or the wording attached to response categories is difficult for 
people to relate to in practice.  CPC plot the probability of a response (y-axis) against 
the person‟s location on the pain bother continuum mapped out by 11 pain scale items.  
High scores indicate more bother.  Thus, as one moves from left to right on the x-axis, 
people have more pain bother.  The expectation is that as a person‟s pain bother 
increases, the probability of that person responding „no bother‟ falls and the probability 
of responding „a little bother‟ increases.  Figure 6.6 illustrates the CPC for items with 
reversed thresholds.  For example, the graph for item 4 illustrates that there is no point 
on the continuum at which categories 2 and 3 have the highest probability of being 
chosen.  Thus the intersection of response category 1 and 2 ( 2) is above the 
intersection of response category 2 and 3 ( 3).  Category 2 is problematic in that it 
appears that people are having difficulty distinguishing between category 1 and 2. 
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Item 1 Feeling uncomfortable  Item 2 dull ache 
  
Item 3 Annoying    Item 5 Tenderness 
  
Item 6 Tingling    Item 7 Throbbing 
  
Item 8 Stinging    Item 10 Red raw  
  
Figure 6.5 Items with ordered thresholds 
 
6.6.5.3 Measurement continuum 
Do the items map out a discernable line of increasing intensity?   
Item locations, their range, how they are spread, their proximity to each other and the 
precision of these estimates‟ standard error were examined. 
 
 
 
 
1 
2 3 
  0 Less pain (negative values) More pain (positive values) 
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Item 4 Itchiness     
 
 
Item 9 Stabbing    Item 11 Burning 
  
     
Figure 6.6 Items with disordered thresholds 
 
 
Table 6.8 illustrates the 11 pain items ordered by their location (also called calibration), 
in ascending order (from most negative to most positive), and presents the mean item 
locations.  Item locations range from about -1 to +1 logits (a 2 logit spread); the items 
define a line of increasing intensity, a continuum, rather than just a point but not a wide 
range.  A two logit spread is acceptable because this scale is attempting to tap into a 
very specific issue, pain.  Figure 6.7 illustrates that the scale is within the range where 
most of the people lie.  The mean of item locations is set at 0 and estimates of the 
locations of items and persons is relative to each other, not their absolute locations, 
therefore having values ranging from negative to positive. 
 
Figure 6.8 presents the measurement ruler mapped out by the 11 pain items, making 
its adequacy and limitations explicit and acting as an evidence base for improving the 
pain scale (e.g. adding items to capture measurement at the floor/ceiling range of the 
scale).  Figure 6.7 complements Table 6.8 by illustrating item locations graphically.  
The 11 pain items are not evenly spread but bunched in two ways: 1) multiple items 
1 
2 
3 
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have similar locations on the continuum (bunched around -0.8 to +1.0), indicated by 
thin arrow (Figure 6.7).   
 
 
 
Figure 6.7 Targeting of patient sample to the pain items  
 
 
Table 6.8 confirms items with similar locations (circled items): Items „feeling 
uncomfortable‟ (-0.828) and „tenderness‟ (-0.793); items „stinging‟ (0.058) and „burning‟ 
(0.084); and items „dull ache‟ (0.183) and „throbbing‟ (0.210).  Items with similar 
locations raise the possibility of one of the items being redundant; and 2) there are 
notable gaps in the continuum mapped out by items between -0.8 and -1.4, and -1.6 
and -2.2 units, indicated by thick arrow.  Gaps imply limited measurement at those 
areas on the continuum that they attempt to map out. 
 
6.6.5.4 Item locations 
Is the location of items along the line of increasing intensity reasonable?   
The ordering of items was examined to determine the extent to which it was consistent 
with clinical expectations and interpretability.  If ordering is consistent with clinical 
expectation, it provides evidence towards the construct validity of the variable.  
Departures from expectation require investigation and explanation, and can occur 
when items are ambiguous, misleading or poorly worded (85).   Item ordering for the 
pain scale is presented in Table 6.8.  „Feeling uncomfortable‟ (item 1) was predicted to 
be the least bothersome while „itchiness‟ (item 4) was predicted to be the most 
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bothersome.  The ordering of the 11 pain items were considered for clinical sensibility 
by a group of eight clinical specialists (i.e. TVN specialists).  The ordering of items 
along the variable was clinically sensible, except for the location of the „dull ache‟ item.  
This appeared to be more difficult than predicted.  The specialists indicated that 
„itchiness‟ may not be a property of pain but rather a separate symptom. 
 
 
Table 6.8 Pain item locations in ascending order (n=195; 227 (32 extremes excluded)) 
Sequence Item Location SE 
1 Uncomfortable -0.828 0.099 
5 Tenderness -0.793 0.096 
3 Annoying  -0.562 0.095 
10 Red raw -0.088 0.095 
8 Stinging 0.058 0.097 
11 Burning 0.084 0.094 
2 Dull ache 0.183 0.096 
7 Throbbing 0.210 0.102 
9 Stabbing 0.349 0.104 
6 Tingling 0.625 0.011 
4 Itchiness 0.764 0.116 
 Circled items indicate similar item locations 
 SE standard error 
 
6.6.5.5 Item fit 
Do the items work together to define a single variable?   
Three fit statistics were examined: the item-person fit residuals; item-trait chi-squared 
values and probabilities; and ICC.  There is no one indicator of fit of the observed data 
to the mathematical model, but rather multiple methods that each addresses different 
aspects of fit.  These three indicators were interpreted separately and then interactively 
to make decisions about item fit. 
 
 Fit residual 
The fit residual evaluates the fit of the observed data to the Rasch model from the 
perspective of the items (298).  It summarises the interaction between each scale item 
and all the persons for whom there is a response to that item, therefore the fit residual 
is a summary of the difference between observed and expected scores from every item 
response (item-person interaction).  The Rasch model derives an observed item score 
(0, 1, 2 or 3 for items on the pain scale) and an expected score for every item-person 
interaction (value between 0 and 1).  For each pain item, the residuals from the 
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interactions with each person in the sample (n=195; excluding 32 extremes) were 
squared, summed and transformed to give a summary value (the fit residual). 
 
Fit residuals are expected to be normally distributed with mean = 0 and SD = 1.  If data 
fit the model, the deviations (residuals) between observed responses and model-
derived expected values should be no more than random errors.  Therefore, if data fit 
the Rasch model, the mean fit residual across all items should be close to 0, the SD 
close to 1, and individual item values distributed in the approximate range +/-2.5 (more 
specifically, 99.5% of values in the range +/-2.5, and 99.9% in the range +/-3.0) (85).  
For individual items, observed fit residuals of 0 indicate no difference between 
observed and predicted scores (perfect fit); greater departure from 0 indicates greater 
discrepancy between observed and predicted responses, and thus greater misfit of the 
observed data to the model.  The +/- sign associated with fit residual values indicates 
the type of misfit; negative values indicate over discriminating items while positive 
values indicate under discriminating items.  Items with a fit residual of greater than +/- a 
certain level (generally set at 2.5) are cause for concern as they misfit to the model.  
Items with high negative residuals are normally interpreted to indicate item redundancy 
(i.e. information provided by the item is not adding any new information to the scale).   
 
Table 6.9 presents fit residuals for the 11 pain items.  Mean fit residual is 0.020, SD 
1.644 (a SD <1.4 would suggest no problems with misfitting items) (Table 6.6).  „A dull 
ache‟ (item 2) is outside the +/-2.5 fit residual level (Table 6.9).  No items have high 
negative residuals, suggesting no redundant items. 
 
 Chi-squared value and its probability 
The chi-squared value is a summary indicator of the interaction between individual 
items and the variable measured by the set of items (298).  It is computed by summing 
the chi-squared values for a series of class intervals.  Class intervals are achieved by 
dividing a given sample into a number of similarly sized groups based on their level of 
ability/disability (approximately 50 persons per class interval but it is more important to 
have equal distribution).  Here, the disability is pain, measured by 11 items.  For each 
class interval (in this case four), the mean location of people (n=195) and their mean 
score on each item (n=11) are computed; then, for each item, the mean observed 
scores for the class intervals are compared with the scores for those items predicted by 
the Rasch model at the mean location of the class interval (85).  Thus, the chi-squared 
value for each item is the sum of the chi-squared values computed for each of the four 
class intervals, indicating the probability that the discrepancy between the observed 
mean and the expected value is large relative to chance.  However, because chi-
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squared values increase with sample size; are affected by the number of class intervals 
chosen; and they only approximate a chi-squared statistic (the value is inflated when 
the estimated probabilities are close to 0 or 1), they should be best used as an order 
statistic (i.e. order of degree of misfit) to indicate items showing greater values than 
others (items with significant chi-squared values (p < 0.05 or 0.01) should be 
examined), and to examine the ICC (298).   
 
 
Table 6.9 Pain items in chi-squared probability order (n=195; 227 with 32 extremes 
excluded; 4 class intervals) 
Item Fit Residual Chi-square p 
Tingling 0.636 0.622 0.733 
Stinging 0.472 0.702 0.704 
Annoying -1.548 2.225 0.329 
Itchiness 1.848 3.089 0.213 
Burning -1.626 3.229 0.199 
Uncomfortable -1.065 4.079 0.130 
Throbbing -1.143 4.289 0.117 
Red raw -0.673 6.683 0.035 
Tenderness -1.630 8.663 0.013 
Stabbing 2.222 9.858 0.007 
Dull ache 2.732* 25.092 0.000* 
*indicates values outside recommended Bonferroni adjusted range (i.e. misfit) 
 
 
Table 6.9 presents the 11 pain items ordered by increasing chi-squared value.  Chi-
square values range from 0.622 (tingling) to 25.092 (dull ache).  Chi-Square values and 
how they change sequentially across items should be examined (298).  All pain items 
have similar-level chi-square values (gradual increase in chi-square values), but then 
there is a notable step increase in value for the last item (dull ache; Table 6.9).  Fit 
statistics indicate that one item (dull ache) has a significant chi-square probability; this 
item is not fitting the model at the Bonferroni adjusted significance level.  As chi-square 
statistics are sample size dependent, as the sample size and number of items 
increase, the more the likelihood that items will have significance, therefore values are 
Bonferroni adjusted to account for this.   
 
 Item characteristic curve (ICC) 
The third indicator of observed data-to-Rasch model fit is the ICC.  This graphical 
indicator of fit aids in the interpretation of the two fit statistics detailed above.  The ICC, 
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a graph (S-shaped curve), plots the expected individual item response (predicted from 
the Rasch model) at every level of the measurement continuum (85).  
 
Figure 6.8 illustrates the ICC for the item that „failed‟ the item-trait chi-square value 
tests of fit.  Item 2 is significantly under-discriminating, indicating that this item is not 
doing a good job at discriminating those persons with more pain.  The observed 
responses (black dots) are close to representing a horizontal line which indicates that 
the item does not discriminate difficulty. 
 
Item 2        
 
Figure 6.8 Item characteristic curves for pain items that „failed‟ item-trait 
chi-square value tests of fit 
 
 
Figure 6.9 presents the ICC for all pain items, apart from item 2.  ICCs indicate the 
expected score (y-axis) (observed responses can be 0, 1, 2 or 3 for pain bother but as 
responses are continuous, values can vary from 0 to 3) on each item for each possible 
location on the pain continuum (x-axis).  The four small vertical marks on the x-axis 
indicate the mean person locations for each of the four class intervals.  The four black 
dots indicate the observed mean score on each item for each of these four class 
intervals.   
 
The chi-squared values in Table 6.9 summarise the consistency between the observed 
responses (black dots) and expected responses (ICC) at the four points on the 
continuum; computed by summing the item chi-squared values for each class interval.  
Observed responses should closely match expected responses. 
 
Ten of 11 pain items pass all three fit criteria.  Item 2 has notable criterion failures: fit 
residual outside recommended range; high chi-squared value with significant p-value 
and adherence to the ICC (significantly under-discriminating).  No other items have 
departures from expectation.   
144  Preliminary psychometric evaluation 
 
 
Item 1      Item 3 
 
 
Item 4      Item 5 
 
 
Item 6      Item 7 
 
 
Item 8      Item 9 
 
 
Item 10     Item 11 
 
Figure 6.9 Item characteristic curves for „fitting‟ items including class intervals 
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6.6.5.6 Local dependency 
Does the response to one item directly influence the response to another?   
The local dependency of items was examined by looking at correlations between 
residuals.  The Rasch model requires that items in a scale are locally independent (i.e. 
response to one item is independent of the response to another item).  The assumption 
of local independence implies that once the Rasch factors have been extracted (the 
main scales), no leftover patterns in the residuals should be present; the residuals 
(observed – expected = residual value) should represent random error.  An absence of 
any meaningful pattern in the residuals (i.e. item residuals not correlated), is 
considered support for the assumption of local independence.  Correlated items imply 
that the answer to one item is dependent on another.  Thus, correlations among 
residuals should be low (the criterion of <0.30118 represents 10% shared variance but 
a value <0.4 is acceptable) (298). 
 
For the pain scale, in this sample, all residual correlations were below the threshold.  
This implies that the responses of the items are independent of each other and that the 
items are locally independent (Table 6.10). 
 
 
Table 6.10 Person-Item Residual correlation matrix 
 
 
6.6.5.7 Reliability 
Have the people in the sample been measured successfully? (Are the persons in the 
sample separated along the line defined by the items?).   
Figure 6.2 illustrates the distribution of person measurements (locations) relative to the 
item locations.  The sample is well spread with values ranging from around -4.0 to +3.2 
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logits.  The mean is -0.438 (SD 1.305), indicating the sample is off-centre of the items 
(mean of item locations is always 0).   
 
Figure 6.2 is a graphical indicator that the pain scale items have been successful in 
separating this sample of people with PUs.  A numerical indicator of the degree of 
separation is the PSI, computed from the person location estimates as the variation 
among person locations relative to the error of estimate for each person (316).  The 
PSI, comparable to Cronbach‟s alpha, is consistent with the traditional definition of 
reliability of a scale.  It provides information about how reliably a scale distinguishes 
between responders and how much of the variation of person estimates can be 
attributed to error variances (i.e. the extent to which scores are associated with random 
error); reliability indicators range from 0 (all error) to 1 (no error).  A low PSI indicates 
that the fit statistics obtained may not be reliable as there will be a certain amount of 
error surrounding them while a high PSI indicates more reliable fit statistics.   
 
For the pain scale, the PSI is 0.810 with extremes and 0.777 with no extremes, 
indicating good reliability (Table 6.6).  A low PSI is likely when there is large 
mistargeting or the construct is too big (see Section 6.5.3, Reliability).  In this instance, 
the construct is not very wide (specific pain issue) so targeting is within the expected 
range; the distribution curve indicates that the scale is within the range where most of 
the sample lie (Figure 6.3). 
 
6.6.6 Modification and reanalysis of Pain scale 
The sample was adequate for examining the scale but the scale was suboptimal for 
measuring the sample, suggesting that the scale might provide limited information 
about people at the extremes of the sample distribution.  The pain scale items mapped 
out a variable of increasing intensity, but not very wide, and the item locations indicated 
areas on the continuum where measurement could be improved. There was some 
bunching of thresholds at the centre of the scale, however if persons at the floor were 
removed then the targeting would be very good. 
 
The ordering of items along the variable was clinically sensible, except for the location 
of the „dull ache‟ and „itchiness‟ items; „dull ache‟ appeared to be more difficult than 
predicted while „itchiness‟ was considered not a property of pain but a separate 
symptom.  The four-category scoring function for the items did not work as intended for 
5/11 items.  For the other items, thresholds are very close to being disordered, 
suggesting that people had difficulty distinguishing between „a little bother‟ and „quite a 
bit of bother‟ categories.  The fit statistics highlighted that the „dull ache‟ item did not fit 
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the expectations of the measurement model.  No dependence among the pain scale 
items was observed in terms of residual correlations.   
 
Based on the Rasch findings, all response categories were rescored by combining 
response categories „a little bother‟ and „quite a bit of bother‟, resulting in a three-point 
response scale, and items „dull ache‟ and „itchiness‟ were removed from the scale and 
the Rasch analysis reran. 
 
6.6.7 Summary of findings from final Rasch analysis of the pain scale 
Rescoring the response categories and removing items „dull ache‟ and „itchiness‟ 
resulted in a good brief PU-specific pain scale.  The PSI was slightly lower (Table 6.11) 
but the three-category scoring function did not produce any disordered thresholds and 
the ordering of items along the variable was clinically sensible.  The fit statistics 
indicated no misfitting items and there was no dependence among the items in terms of 
residual correlations.  Item locations ranged from -1.0 to +1.0 and person locations 
range from -4.665 to 4.033, both ranges slightly wider than in the earlier analysis.  
However, similarly, the sample is reasonable for examining the scale but a suboptimal 
scale for measuring the sample, with no items representing people at the extremes of 
the sample distribution.  About 88 (45.8%) of people in the sample are located outside 
the best functioning of the scale.  Table 6.12 provides a summary of the Rasch 
statistics in item location order (indicating the line of increasing intensity for the pain 
scale) for the final PU-QOLI items. 
 
The analyses described in Section 6.5.2 were performed on all remaining PU-QOLI 
scales.  A summary of the Rasch results will be presented for each scale, followed by 
decisions made to any scale modifications, and finally presentation of the psychometric 
properties in summary tables.   
 
6.6.8 Summary of Rasch findings and recommendations for Exudate scale 
Item locations for the exudate scale range from -0.6 to +0.6 and person locations range 
from -3.2 to +3.2 logits.  There are no items representing people at the extremes of the 
sample distribution.  About 53.8% of people in the sample are located outside the best 
functioning of the scale (i.e. range -1 to +1 logits).  Item threshold locations spread 
from -1.6 to +1.2 logits but still do not cover the range of person locations in the 
sample.  The sample was adequate for examining the scale (item locations are covered 
by the people) but the scale was suboptimal for measuring the sample (person 
locations not covered by the items), suggesting that the scale might provide limited 
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information about people at the extremes of the sample distribution.  The exudate scale 
items mapped out a variable of increasing intensity, but not very wide, and the item 
locations indicated areas on the continuum where measurement could be improved 
(i.e. at the extreme ends of the scale).   
 
Item 1 („Weeping‟) was predicted to be the least bothersome while item 7 („Pus‟) was 
predicted to be the most bothersome.  The ordering of the 8 exudate items along the 
variable was clinically sensible.  4/8 exudate items had disordered thresholds; the point 
where the probability for scoring either 2 („quite a bit of bother‟) or 3 („a lot of bother‟) 
was lower than the point on the continuum where the probability of scoring either 1 („a 
little bother‟) or 2 („quite a bit of bother‟) occurred.  For the other items, the response 
categories were working as intended, however inspecting CPCs indicated thresholds 
( 1 and 2) were close to being disordered, suggesting that people had difficulty 
distinguishing between „a little bother‟ and „quite a bit of bother‟ categories. 
 
The exudate scale mean fit residual was -0.224, SD 1.440.  Item fit residuals ranged 
from -1.975 to 2.259.  Chi-square values ranged from 0.066 to 6.261.  All exudate 
items had similar-level chi-square values (gradual increase in chi-square values), no 
significant chi-square probabilities at the Bonferroni adjusted significance level, and no 
notable step increase in values.  The fit statistics indicate that all exudate items fit the 
expectations of the measurement model.  No dependence among the exudate scale 
items was observed in terms of residual correlations. In this sample, „weeping‟ (item 1) 
and „running‟ (item 2) had residual correlations exceeding 0.30 (0.320), however only 
slightly outside the recommended criterion.  No other residual correlations exceeded 
0.30; implying that the responses to items are independent of each other and items are 
locally independent.  No items had high negative residuals (all below -0.50), suggesting 
no redundant items. 
 
The sample is well spread with values ranging -3.2 to +3.2 logits.  The mean is -1.144 
(SD 1.579), indicating the sample is off-centre of the items (mean of item locations is 
always 0).  The PSI is 0.715 with extremes and 0.585 with no extremes, indicating 
reasonable reliability.  In this instance, the construct is not very wide (specific exudate 
issue) and not all people (only those with severe PUs) have problems with exudate; 
therefore the targeting is within the expected context.  Based on the Rasch findings, all 
response categories were rescored by combining response categories „a little bother‟ 
and „quite a bit of bother‟, resulting in a three-point response scale and the Rasch 
analysis reran. 
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6.6.9 Summary of findings from final Rasch analysis of the exudate scale 
Rescoring the response categories resulted in a good brief exudate scale.  The PSI 
was slightly lower (Table 6.11) but still reasonable reliability.  The three-category 
scoring function did not produce any disordered thresholds and the ordering of items 
along the variable was clinically sensible.  The fit statistics indicated no misfitting items 
and there was no dependence among the items in terms of residual correlations 
exceeding 0.3.  Item locations ranged from -0.709 to +0.697 and person locations 
range from -3.813 to 3.645, both ranges are slightly wider than in the earlier analysis.  
However, similarly, the sample is reasonable for examining the scale but a suboptimal 
scale for measuring the sample, with no items representing people at the extremes of 
the sample distribution.  About 61.4% of people in the sample are located outside the 
best functioning of the scale.  Table 6.12 provides a summary of the Rasch statistics in 
item location order (indicating the line of increasing intensity for the exudate scale). 
 
6.6.10 Summary of Rasch findings and recommendations for Odour scale 
Item locations for the odour scale range from -1.6 to +0.6 and person locations range 
from -5.6 to +3.6 logits.  There are no items representing people at the extremes of the 
sample distribution.  About 75% of people in the sample are located outside the best 
functioning of the scale (i.e. range -1 to +1 logits).  Item threshold locations spread 
from -4.6 to +2.0 logits but still do not cover the full range of person locations in the 
sample.  The sample was adequate for examining the scale but the scale was 
suboptimal for measuring the sample (the scale might provide limited information about 
people at the extremes of the sample distribution).  The odour scale items mapped out 
a variable of increasing intensity, but not very wide, and the item locations indicated 
areas on the continuum where measurement could be improved (i.e. at the extreme 
ends of the scale and between -4.2 and -1.2 logits).   
 
Item 1 („Unpleasant smell‟) was predicted to be the least bothersome while item 6 
(„putrid smell‟) was predicted to be the most bothersome.  The ordering of the 6 odour 
items along the variable was clinically sensible.  2/6 odour items had disordered 
thresholds; the remaining items were close to being disordered, suggesting that people 
had difficulty distinguishing between „a little bother‟ and „quite a bit of bother‟ 
categories. 
 
The odour scale mean fit residual was -0.141, SD 0.702.  Item fit residuals ranged from 
-0.962 to 0.897.  Chi-square values ranged from 0.812 to 3.286.  All odour items had 
similar-level chi-square values (gradual increase in chi-square values), no significant 
chi-square probabilities at the Bonferroni adjusted significance level, and no notable 
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step increase in values.  The fit statistics indicate that all odour items fit the 
expectations of the measurement model.  No dependence among the odour scale 
items was observed in terms of residual correlations exceeding 0.3, implying that the 
responses to items are independent of each other and items are locally independent.  
No items had high negative residuals (all below -0.55), suggesting no redundant items. 
 
The sample is well spread with values ranging -5.402 to +3.474 logits.  The mean is -
2.936 (SD 2.910), indicating the sample is off-centre of the items (mean of item 
locations is always 0).  The PSI is 0.550 with extremes and 0.622 with no extremes, 
indicating reasonable reliability.  In this instance, like the exudate scale, the construct is 
not very wide and not all people (only those with severe PUs) have problems with 
odour, therefore the targeting is within the expected context.  Based on the Rasch 
findings, all response categories were rescored by combining response categories „a 
little bother‟ and „quite a bit of bother‟, resulting in a three-point response scale and the 
Rasch analysis reran. 
 
6.6.11 Summary of findings from final Rasch analysis of the Odour scale 
Rescoring the response categories resulted in a good brief odour scale.  The PSI was 
slightly lower (Table 6.11) but still reasonable reliability.  The three-category scoring 
function did not produce any disordered thresholds and the ordering of items along the 
variable was clinically sensible.  The fit statistics indicated no misfitting items and there 
was no dependence among the items in terms of residual correlations exceeding +0.3 
or items with high negative residuals (all below -0.59), suggesting no redundant items.  
Item locations ranged from -2.063 to +0.801 and person locations range from -6.376 to 
3.925, both ranges are slightly wider than in the earlier analysis.  However, similarly, 
the sample is reasonable for examining the scale but a suboptimal scale for measuring 
the sample, with no items representing people at the extremes of the sample 
distribution, with a large proportion of the sample (about 83%) located outside the best 
functioning of the scale.  Table 6.12 provides a summary of the Rasch statistics in item 
location order (indicating the line of increasing intensity for the odour scale). 
 
6.6.12 Summary of Rasch findings and recommendations for Sleep scale 
Item locations for the sleep scale ranged from -0.5 to +0.3 and person locations range 
from -3.2 to +3.6 logits.  There are no items representing people at the extremes of the 
sample distribution.  About 49.7% of people in the sample are located outside the best 
functioning of the scale (i.e. range -1 to +1 logits).  Item threshold locations spread 
from -1.6 to +2.0 logits but still do not cover the full range of person locations in the 
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sample.  The sample was adequate for examining the scale but the scale was 
suboptimal for measuring the sample (the scale might provide limited information about 
people at the extremes of the sample distribution).  The sleep scale items mapped out 
a variable of increasing intensity, but not very wide, and the item locations indicated 
areas on the continuum where measurement could be improved (i.e. at the extreme 
ends of the scale).   
 
Item 6 („trouble finding comfortable position‟) was predicted to be the least bothersome 
while item 1 („trouble falling asleep‟) was predicted to be the most bothersome.  The 
ordering of the 6 sleep items along the variable was clinically sensible.  3/6 sleep items 
had disordered thresholds; the remaining items were close to being disordered, 
suggesting that people had difficulty distinguishing between „a little bother‟ and „quite a 
bit of bother‟ categories. 
 
The sleep scale mean fit residual was 0.148, SD 1.166.  Item fit residuals ranged from -
1.123 to 1.852.  Chi-square values ranged from 1.129 to 10.068.  All sleep items had 
similar-level chi-square values (gradual increase in chi-square values), with a notable 
step increase in values from 1.868 (item 6, „trouble finding comfortable position‟) to 
9.657 (item 4, „not getting amount of sleep needed‟) and no significant chi-square 
probabilities at the Bonferroni adjusted significance level.  Fit statistics indicated all 
sleep items fit the expectations of the measurement model.  No dependence among 
the sleep scale items was observed in terms of residual correlations exceeding 0.3, 
implying that the responses to items are independent of each other and items are 
locally independent.  No items had high negative residuals (all below -0.58), suggesting 
no redundant items. 
 
The sample is well spread with values ranging -3.031 to +3.574 logits.  The mean is -
0.466 (SD 1.766), indicating the sample is off-centre of the items (mean of item 
locations is always 0).  The PSI is 0.763 with extremes and 0.624 with no extremes, 
indicating reasonable reliability.  In this instance, the construct is not very wide and not 
all people have problems with sleep, hence targeting is within the expected context.  
Based on the Rasch findings, all response categories were rescored by combining 
response categories „a little bother‟ and „quite a bit of bother‟, resulting in a three-point 
response scale and the Rasch analysis reran. 
 
6.6.13 Summary of findings from final Rasch analysis of the Sleep scale 
Rescoring the response categories resulted in a good brief sleep scale.  The PSI was 
slightly lower (Table 6.11) but still reasonable reliability.  The three-category scoring 
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function did not produce any disordered thresholds and the ordering of items along the 
variable was clinically sensible.  The fit statistics indicated no misfitting items and there 
was no dependence among the items in terms of residual correlations exceeding +0.3 
or items with high negative residuals (all below -0.55), suggesting no redundant items.  
Item locations ranged from -0.751 to +0.349 and person locations range from -3.761 to 
3.729, both ranges are slightly wider than in the earlier analysis.  However, similarly, 
the sample is reasonable for examining the scale but a suboptimal scale for measuring 
the sample, with no items representing people at the extremes of the sample 
distribution, with a large proportion of the sample (about 69.6%) located outside the 
best functioning of the scale.  Table 6.12 provides a summary of the Rasch statistics in 
item location order (indicating the line of increasing intensity for the sleep scale). 
 
6.6.14 Summary of Rasch findings and recommendations for Mobility scale 
Item locations for the mobility scale range from -0.4 to +0.6 and person locations range 
from -3.8 to +3.8 logits.  There are no items representing people at the extremes of the 
sample distribution.  About 39.8% of people in the sample are located outside the best 
functioning of the scale (i.e. range -1 to +1 logits).  Item threshold locations spread 
from -1.8 to +1.8 logits but still do not cover the range of person locations in the 
sample.  The sample was adequate for examining the scale (item locations are covered 
by the people) but the scale was suboptimal for measuring the sample (person 
locations not covered by the items), suggesting that the scale might provide limited 
information about people at the extremes of the sample distribution.  The mobility scale 
items mapped out a variable of increasing intensity, but not very wide, and the item 
locations indicated areas on the continuum where measurement could be improved 
(i.e. at the extreme ends of the scale).   
 
Item 11 („walking slowed‟) was predicted to be the least bothersome while item 6 
(„difficulty transferring‟) was predicted to be the most bothersome.  The ordering of the 
8 exudate items along the variable was clinically sensible.  4/11 mobility items had 
disordered thresholds; the point where the probability for scoring either 2 („quite a bit of 
bother‟) or 3 („a lot of bother‟) was lower than the point on the continuum where the 
probability of scoring either 1 („a little bother‟) or 2 („quite a bit of bother‟) occurred.  For 
the other items, the response categories were working as intended, however inspecting 
CPCs indicated thresholds ( 1 and 2) were close to being disordered, suggesting that 
people had difficulty distinguishing between „a little bother‟ and „quite a bit of bother‟ 
categories. 
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The mobility scale mean fit residual was 0.114, SD 1.241.  Item fit residuals ranged 
from -1.694 to 2.332.  Chi-square values ranged from 0.313 to 4.887.  All mobility items 
had similar-level chi-square values (gradual increase in chi-square values), no 
significant chi-square probabilities at the Bonferroni adjusted significance level, and no 
notable step increase in values.  The fit statistics indicate that all mobility items fit the 
expectations of the measurement model.  Dependence among some mobility items 
was observed in terms of residual correlations. Positive correlations ranged from 0.03 
to 0.86 for item 9 („ability to walk‟) and item 10 („how far able to walk‟), suggesting local 
dependence.  Negative correlations ranged from -0.14 to -0.81 for item 3 („difficulty 
turning or moving in bed‟) and item 9 („ability to walk‟) suggesting one of the items was 
redundant.  
 
The sample is well spread with values ranging -3.701 to +3.738 logits.  The location 
mean is -0.067 (SD 1.582), indicating the sample is slightly off-centre of the items 
(mean of item locations is always 0).  The PSI is 0.753 with extremes and 0.582 with 
no extremes, indicating reasonable reliability at distinguishing between responders on 
mobility impairment.  Based on the Rasch findings, all response categories were 
rescored by combining response categories „a little bother‟ and „quite a bit of bother‟, 
resulting in a three-point response scale and the Rasch analysis reran. 
 
6.6.15 Summary of findings from final Rasch analysis of the mobility scale 
The three-category scoring function did not produce any disordered thresholds and the 
ordering of items along the variable was clinically sensible.  However, fit statistics 
indicated two items failed tests of fit; „pushing up to sitting‟ (item 4) and „sitting for long 
periods‟ (item 5) had fit residual values outside +/-2.5 logits but not exceeding +/-3.0, 
indicating a small departure from expectation).  Item 9 („ability to walk‟) and item 10 
(„how far able to walk‟) had 0.890 residual correlation value, suggesting local 
dependence and „sitting for long periods‟ (item 5) had high negative correlations (>0.7) 
with two items.  Based on these findings, items 5 and 10 were removed and Rasch 
reran. 
 
Removing these two items resulted in slightly improved item spread; all items met fit 
expectations of the measurement model; and residual correlations reduced (<0.52).  
However, the reliability of the scale to distinguish between responders on mobility 
impairment also reduced (PSI 0.663 with extremes and 0.323 without extremes).  Table 
6.12 provides a summary of the Rasch statistics in item location order (indicating the 
line of increasing intensity for the mobility scale). 
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6.6.16 Summary of Rasch findings and recommendations for Activity scale 
Item locations for the activity scale ranged from -0.6 to +0.6 and person locations range 
from -2.6 to +2.6 logits.  There are no items representing people at the extremes of the 
sample distribution.  About 41.3% of people in the sample are located outside the best 
functioning of the scale (i.e. range -1 to +1 logits).  Item threshold locations spread 
from -2.4 to +1.8 logits but still do not cover the full range of person locations in the 
sample.  The sample was adequate for examining the scale but the scale was 
suboptimal for measuring the sample (the scale might provide limited information about 
people at the extremes of the sample distribution).  The activity scale items mapped out 
a variable of increasing intensity, but not very wide, and the item locations indicated 
areas on the continuum where measurement could be improved (i.e. at the extreme 
ends of the scale and between -2.2 and -1.2 logits).   
 
Item 1 („washing‟) was predicted to be the least bothersome while item 8 („being 
emotionally close‟) was predicted to be the most bothersome.  The ordering of the 9 
activity items along the variable was clinically sensible.  8/9 activity items had 
disordered thresholds; people had difficulty distinguishing between „a little bother‟ and 
„quite a bit of bother‟ categories. 
 
The activity scale mean fit residual was -0.057, SD 0.733.  Item fit residuals ranged 
from -0.762 to 1.182.  Chi-square values ranged from 0.158 to 3.775.  All activity items 
had similar-level chi-square values (gradual increase in chi-square values), no 
significant chi-square probabilities at the Bonferroni adjusted significance level, and no 
notable step increase in values.  The fit statistics indicate that all activity items fit the 
expectations of the measurement model.  Dependence among some activity items was 
observed in terms of residual correlations.  Items 5 („gardening‟) and 6 („shopping‟) had 
0.62 residual correlations, suggesting local dependence.  No items had high negative 
residuals (all below -0.65), suggesting no redundant items. 
 
The sample is well spread with values ranging -2.580 to +2.520 logits.  The mean is -
0.461 (SD 1.125), indicating the sample is off-centre of the items (mean of item 
locations is always 0).  The PSI is 0.448 with extremes and 0.290 with no extremes, 
indicating poor reliability; the scale is not reliably distinguishing between responders on 
activity impairment.  Based on the Rasch findings, all response categories were 
rescored by combining response categories „a little bother‟ and „quite a bit of bother‟, 
resulting in a three-point response scale, item 5 („gardening‟) was removed as it was 
considered only relevant to a small proportion of people with PUs compared to item 6 
(„shopping‟), and the Rasch analysis reran. 
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6.6.17 Summary of findings from final Rasch analysis of the activities scale 
The three-category scoring function did not produce any disordered thresholds and the 
ordering of items along the variable was clinically sensible.  The fit statistics indicated 
no misfitting items and there was no dependence among the items in terms of residual 
correlations exceeding +0.3 or items with high negative residuals (all below -0.57), 
suggesting no redundant items.  However, the PSI was slightly lower (Table 6.11), 
indicating poor reliability of the scale to distinguish between responders on activity 
impairment.  Table 6.12 provides a summary of the Rasch statistics in item location 
order (indicating the line of increasing intensity for the activity scale). 
 
6.6.18 Summary of Rasch findings and recommendations for the vitality scale 
The decision was made to add items to the vitality scale as the three items did not 
produce a scale that met requirements for reliable and valid measurement.  Patient 
transcripts were revisited (Chapter 3) and an additional three items were added to the 
scale.  This new scale was empirically tested in the subsequent field test (Chapter 7). 
 
6.6.19 Summary of Rasch findings and recommendations for emotional well-
being scale 
The decision was made to combine mood, anxiety, autonomy and isolation scale items 
into an emotional well-being scale.  Apart from the mood scale, both the anxiety and 
isolation scale did not produce scales that met requirements for reliable and valid 
measurement.  Both traits were however considered properties important to people 
with PUs and therefore it was important to retain these in a PU-specific PRO 
instrument.  There was some uncertainty pertaining to whether the isolation items 
might fit better with the participation scale but as the isolation items were about feelings 
and not actually being physically isolated, conceptually they fitted better with emotional 
well-being; theoretically it made sense to combine all these items into an emotional 
well-being scale.  This would be tested empirically. 
 
Item locations for the emotional well-being scale ranged from -1.2 to +1.5 and person 
locations range from -4.4 to +4.0 logits.  There are no items representing people at the 
extremes of the sample distribution.  About 39.3% of people in the sample are located 
outside the best functioning of the scale (i.e. range -1 to +1 logits).  Item threshold 
locations spread from -2.4 to +2.2 logits, a much improved coverage of persons but still 
do not cover the full range of person locations in the sample.  The sample was 
adequate for examining the scale but the scale was suboptimal for measuring the 
sample (the scale might provide limited information about people at the extremes of the 
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sample distribution).  The emotional well-being scale items mapped out a variable of 
increasing intensity (> 4 logit spread) but the item locations indicated areas on the 
continuum where measurement could be improved (i.e. extreme ends of the scale).   
 
Item 2 („fed-up‟) was predicted to be the least bothersome while item 17 („people 
avoided or treated you differently‟) was predicted to be the most bothersome.  The 
ordering of the 17 emotional well-being items along the variable was clinically sensible.  
6/17 emotional well-being items had disordered thresholds; other items were close to 
being disordered, suggesting that people had difficulty distinguishing between „a little 
bother‟ and „quite a bit of bother‟ categories. 
 
The emotional well-being scale mean fit residual was -0.154, SD 1.379.  Item fit 
residuals ranged from -3.147 to 2.274.  Chi-square values ranged from 0.166 to 9.735.  
All emotional well-being items had similar-level chi-square values (gradual increase in 
chi-square values), no notable step increase in values and no significant chi-square 
probabilities at the Bonferroni adjusted significance level.  However, item 8 („feeling 
upset‟) had a fit residual statistic outside the recommended range (-3.147).  
Dependence was observed, in terms of high positive residual correlations (0.56), for 
items 6 („feeling down‟) and 7 („feeling depressed‟), suggesting local dependence.  No 
items had high negative residuals (all below -0.44), suggesting no redundant items. 
 
The sample is well spread with values ranging -3.980 to +3.629 logits.  The mean is -
0.488 (SD 1.535), indicating the sample is off-centre of the items (mean of item 
locations is always 0).  The PSI is 0.840 with extremes and 0.817 with no extremes, 
indicating good reliability.  Based on the Rasch findings, all response categories were 
rescored by combining response categories „a little bother‟ and „quite a bit of bother‟, 
resulting in a three-point response scale. Items feeling down‟ and „feeling upset‟ were 
removed and the Rasch analysis reran. 
 
6.6.20 Summary of findings from final Rasch analysis of the emotional well-being 
scale 
Rescoring the response categories resulted in a good emotional well-being scale.  The 
PSI was slightly lower (Table 6.11) but still good reliability.  The three-category scoring 
function did not produce any disordered thresholds and the ordering of items along the 
variable was clinically sensible.  The fit statistics indicated no misfitting items and there 
was no dependence among the items in terms of residual correlations exceeding +0.41 
or items with high negative residuals (all below -0.41), suggesting no redundant items.  
Item locations ranged from -1.539 to +2.081 and person locations range from -4.866 to 
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4.506, both ranges are slightly wider than in the earlier analysis.  However, similarly, 
the sample is reasonable for examining the scale but a suboptimal scale for measuring 
the sample, with no items representing people at the extremes of the sample 
distribution, with a large proportion of the sample (about 55.0%) located outside the 
best functioning of the scale.  Table 6.12 provides a summary of the Rasch statistics in 
item location order (indicating the line of increasing intensity for the emotional well-
being scale). 
 
6.6.21 Summary of Rasch findings and recommendations for Self-consciousness 
scale 
Item locations for the self-consciousness scale ranged from -1.0 to +0.8 and person 
locations range from -3.2 to +3.0 logits.  There are no items representing people at the 
extremes of the sample distribution.  About 54.3% of people in the sample are located 
outside the best functioning of the scale (i.e. range -1 to +1 logits).  Item threshold 
locations spread from -1.8 to +1.6 logits but still do not cover the full range of person 
locations in the sample.  The sample was adequate for examining the scale but the 
scale was suboptimal for measuring the sample (the scale might provide limited 
information about people at the extremes of the sample distribution).  The self-
consciousness scale items mapped out a variable of increasing intensity, but not very 
wide, and the item locations indicated areas on the continuum where measurement 
could be improved (i.e. at the extreme ends of the scale).   
 
Item 1 („feeling helpless‟) was predicted to be the least bothersome while item 7 
(„feeling lack of understanding‟) was predicted to be the most bothersome.  The 
ordering of the 7 self-consciousness items along the variable was clinically sensible.  
84/7 self-consciousness items had disordered thresholds; people had difficulty 
distinguishing between „a little bother‟ and „quite a bit of bother‟ categories. 
 
The self-consciousness scale mean fit residual was -0.356, SD 0.892.  Item fit 
residuals ranged from -1.650 to 0.981.  Chi-square values ranged from 1.050 to 3.849.  
All self-consciousness items had similar-level chi-square values (gradual increase in 
chi-square values), no significant chi-square probabilities at the Bonferroni adjusted 
significance level, and no notable step increase in values.  The fit statistics indicate that 
all self-consciousness items fit the expectations of the measurement model.  No 
dependence among the self-consciousness items was observed in terms of residual 
correlations exceeding 0.3, implying that the responses to items are independent of 
each other and items are locally independent.  No items had high negative residuals 
(all below -0.46), suggesting no redundant items. 
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The sample is well spread with values ranging -3.010 to +2.878 logits.  The mean is -
0.945 (SD 1.427), indicating the sample is off-centre of the items (mean of item 
locations is always 0).  The PSI is 0.658 with extremes and 0.562 with no extremes, 
indicating reasonable reliability.  Based on the Rasch findings, all response categories 
were rescored by combining response categories „a little bother‟ and „quite a bit of 
bother‟, resulting in a three-point response scale, and the Rasch analysis reran. 
 
6.6.22 Summary of findings from final Rasch analysis of the self-consciousness 
scale 
The three-category scoring function did not produce any disordered thresholds and the 
ordering of items along the variable was clinically sensible.  The fit statistics indicated 
no misfitting items and there was no dependence among the items in terms of residual 
correlations exceeding +0.3 or items with high negative residuals (all below -0.43), 
suggesting no redundant items.  The PSI improved slightly (Table 6.11), indicating 
reasonable reliability of the scale to distinguish between responders on self-
consciousness impairment.  Table 6.12 provides a summary of the Rasch statistics in 
item location order (indicating a line of increasing intensity for the self-consciousness 
scale). 
 
6.6.23 Summary of Rasch findings and recommendations for Participation scale 
Item locations for the participation scale ranged from -0.6 to +0.6 and person locations 
range from -3.2 to +3.6 logits.  There are no items representing people at the extremes 
of the sample distribution.  About 58.0% of people in the sample are located outside 
the best functioning of the scale (i.e. range -1 to +1 logits).  Item threshold locations 
spread from -2.2 to +1.8 logits but still do not cover the full range of person locations in 
the sample.  The sample was adequate for examining the scale but the scale was 
suboptimal for measuring the sample (the scale might provide limited information about 
people at the extremes of the sample distribution).  The participation scale items 
mapped out a variable of increasing intensity, but not very wide, and the item locations 
indicated areas on the continuum where measurement could be improved (i.e. at the 
extreme ends of the scale).   
 
Item 6 („restricted where go out‟) was predicted to be the least bothersome while item 2 
(„meeting/seeing family/friends‟) was predicted to be the most bothersome.  The 
ordering of the 9 participation items along the variable was clinically sensible.  3/9 
participation items had disordered thresholds; people had difficulty distinguishing 
between „a little bother‟ and „quite a bit of bother‟ categories. 
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The participation scale mean fit residual was 0.202, SD 1.002.  Item fit residuals 
ranged from -1.673 to 1.441.  Chi-square values ranged from 0.289 to 6.556.  All 
activity items had similar-level chi-square values (gradual increase in chi-square 
values), no significant chi-square probabilities at the Bonferroni adjusted significance 
level, and no notable step increase in values.  The fit statistics indicate that all 
participation items fit the expectations of the measurement model.  No dependence 
among the participation items was observed in terms of residual correlations exceeding 
0.3, implying that the responses to items are independent of each other and items are 
locally independent.  Items 2 („seeing/meeting family/friends‟) and 9 („time spent caring 
for PU‟) had high negative residuals (-0.62), suggesting one might be redundant items.  
However, at this stage, both items were retained as they were considered to measure 
important properties of participation impairment. 
 
The sample is well spread with values ranging -3.346 to +3.590 logits.  The mean is -
0.380 (SD 1.727), indicating the sample is off-centre of the items (mean of item 
locations is always 0).  The PSI is 0.705 with extremes and 0.647 with no extremes, 
indicating reasonable reliability.  Based on the Rasch findings, all response categories 
were rescored by combining response categories „a little bother‟ and „quite a bit of 
bother‟, resulting in a three-point response scale, and the Rasch analysis reran. 
 
6.6.24 Summary of findings from final Rasch analysis of the participation scale 
The three-category scoring function did not produce any disordered thresholds and the 
ordering of items along the variable was clinically sensible.  The fit statistics indicated 
no misfitting items and there was no dependence among the items in terms of residual 
correlations exceeding +0.3 or additional items with high negative residuals (all below -
0.63).  However, the PSI was slightly lower (Table 6.11), indicating reasonable 
reliability of the scale to distinguish between responders on participation impairment.  
Table 6.12 provides a summary of the Rasch statistics in item location order (indicating 
the line of increasing intensity for the participation scale). 
 
6.6.25 Summary of Rasch results and interpretations  
The targeting between the distribution of person measurements and the distribution of 
item locations indicated that the samples were adequate for examining the scales but 
the scales were suboptimal for measuring the sample.  There was a significant ceiling 
effect where item coverage was poorest above -2.0 logits for most scales, indicating 
that the scales might provide limited information about people at the extremes of the 
sample distribution (those with the least disability or impairment).  However, the 
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ordering of scale items along each variable was clinically sensible, providing evidence 
towards the construct validity of each scale variable. 
 
Some items had notable criterion failures: outside the +/-2.5 fit residual level; high chi-
squared values with significant p-value and adherence to the ICC (significantly under-
discriminating or over-discriminating).  Few items exceeded residual correlations of 
+0.3, implying that the responses to items are independent of each other and locally 
independent, and -0.3, suggesting no redundant items.  Departures from item fit 
expectation were relatively small but when considered in combination, resulted in some 
item removal.  PSI values indicated good to reasonable reliability for scales 
distinguishing between responders on each scale variable. 
 
Items considered clinically important but that did not fit into existing scales were 
retained as single items (e.g. itchiness).  Scales that did not meet requirements for 
reliable and valid measurement were either conceptually combined (e.g. items 
representing mood, anxiety, autonomy and isolation were combined into an emotional 
well-being scale) or items added (e.g. three items were added to the vitality and 
malaise scale to produce a six item scale). 
 
The Rasch analysis detected important limitations of the PU-QOLI scales.  It detected 
that the four-category item scoring function did not work as intended for multiple items 
within each PU-QOLI scale.  For the other items where the response categories were 
working as intended, inspecting CPCs indicated thresholds ( 1 and 2) were close to 
being disordered, suggesting that people had difficulty distinguishing between „a little 
bother‟ and „quite a bit of bother‟ categories.  This provided good evidence that all 
items would benefit from fewer response categories.  Consequently, all scale items 
were subjected to a post hoc rescoring by collapsing adjacent categories (so that all 
items had three response categories).  Re-analysis of the data demonstrated that all 
thresholds were now correctly ordered, producing scales with new categories („not b/c 
of PU‟ = treated as missing (descriptive); scale responses are: 0 = no bother, 1 = little 
bother, 2 = lot bother). 
 
6.6.26 Traditional psychometric evaluation of Rasch developed PU-QOLI scales 
All Rasch produced scales (Table 6.12) underwent a preliminary psychometric 
evaluation using traditional psychometric tests (see Table 6.1) to evaluate the newly 
formed scales for data completeness, targeting, scaling assumptions, reliability and 
validity.  The preliminary results of the traditional analysis supported the PU-QOLI 
scales as reliable and valid measures of PU-symptoms, physical and social functioning, 
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and psychological well-being.  The criteria were satisfied for most psychometric 
properties evaluated.  Briefly, data quality was high (scale scores were computable for 
93-99.6% of respondents; Table 6.13) and scaling assumptions were satisfied (mostly 
similar mean item scores, corrected item-total correlations range = 0.525 - 0.920; Table 
6.14).  Scale-to-sample targeting was good (scale scores spanned the scale range but 
were notably skewed for three scales (value outside +/-1.0), mean scores were near 
the scale mid-point for 6/9 scales, and ceiling effects were negligible, however floor 
effects exceeded the 15% criterion for 2 of 9 scales; Table 6.13).  Internal consistency 
reliability was high as demonstrated by Cronbach‟s alpha values (range 0.893 – 0.962; 
Table 6.14).  The item-total correlations, alpha coefficient and homogeneity coefficient 
(inter-item correlation mean and range; Table 6.14) provide evidence towards the 
internal construct validity of the PU-QOLI scales. 
 
6.7 Summary of Chapter 6 
The sub-study identified a large proportion of self-completed PU-QOLs returned with 
missing data, resulting with the continuation on only evaluating an administered 
version.  Although preliminary, DIF analysis indicated that administration mode did not 
impact on the way community patients responded to PU-QOLI items, supporting the 
equivalence of self-completed and interview-administered versions in community 
populations.  The first field test performed a psychometric evaluation of the preliminary 
PU-QOLI, producing a 10 scale instrument.   
 
Scale development and item reduction were primarily guided by Rasch measurement 
methods, which provided a vehicle for the detection of items deviating from model 
expectations with the intention of improving scale attributes.  Final decisions on item 
inclusion were made according to appraisals of the analyses of the observed data 
against measurement criteria and clinical relevance, as opposed to examinations 
carried out singularly or sequentially.  The use of mixed-methods was beneficial for 
providing evidence in selecting the optimal mode of administration for the PU-QOLI.  
The DIF analysis was an important methodological step for highlighting areas 
warranting further investigation if pursuing a self-completed version in the future.  A 
preliminary evaluation of the Rasch produced scales using traditional methods 
supported the PU-QOLI as reliable and valid.  The next stage required was quantitative 
confirmation and psychometric support for the modified final PU-QOLI scales 
(Appendix 6.1) which was undertaken in a second field test with patients with PUs. 
 
 
 
Table 6.11 Rasch summary statistics for the final PU-QOLI scales (following field test 1 analysis) 
Scale 
Person-Item threshold 
distribution (Scale-to-sample 
targeting) Item fit  Person fit 
Chi Square 
interaction PSI 
 
Sample 
location range 
Item location 
range Mean SD FitRes range Mean SD Value (df) p 
With 
ext No ext 
Pain -4.665 - 4.033 -1.054 - 1.087^ -0.267 1.213 -5.968* - 2.377 -0.707 1.517 (18) 18.414 0.429 0.734 0.605 
Exudate -3.813 - 3.645 -0.709 - 0.697^ -0.281 1.273 -8.722* - 2.168 -0.981 2.070 (8) 6.739 0.565 0.712 0.522 
Odour -6.376* - 3.925 -2.063 - 0.801^ -0.365 1.001 -5.625* - 1.813 -0.686 1.238 (6) 8.435 0.208 0.579 0.560 
Sleep -3.761 - 3.729 -0.751 - 0.349^ -0.431 1.239 -5.353* - 2.470 -1.072 1.858 (12) 17.056 0.148 0.709 0.482 
Mobility & Movement -4.049 - 4.031 -0.502 - 0.532^ -0.435 1.129 -6.362* - 2.315 -1.635 2.358 (18) 7.178 0.988 0.663 0.323 
Daily Activities  -3.342 – 3.312 -0.793 – 0.813 0.089 0.910 -13.339* - 1.636 -2.001 4.053 (8) 9.917 0.271 0.438 0.220 
Vitality & Malaise The 3 items did not produce a measurement scale; retain as 2 descriptive items or add items 
Mood Items combined to produce an emotional well-being scale 
Anxiety The 3 items did not produce a measurement scale; add items or combine with mood items into emotional well-being scale 
Autonomy The 3 items did not produce a measurement scale; add items or combine with mood items into emotional well-being scale 
Emotional well-being -4.866 – 4.506 -1.593 – 2.081^ -0.281 0.803 -7.591* - 2.373 -0.824 1.763 (30) 47.003 0.025 0.797 0.743 
Self-consciousness -3.741 – 3.740 -1.163 – 0.949^ -0.368 0.942 -10.506* - 2.011 -1.015 2.121 (14) 17.124 0.250 0.672 0.556 
Isolation The 4 items did not produce a measurement scale; add items or combine with emotional well-being scale 
Participation -4.018 – 3.979 -0.750 – 0.677^ -0.054 0.918 -4.889* - 2.089 -0.866 1.809 (9) 4.740 0.856 0.648 0.532 
*indicates values outside recommended range (i.e. misfit) 
^indicates suboptimal targeting (items do not spread across persons) 
SD standard deviation; FitRes fit residual; df degrees of freedom; p probability value; ext extremes cases; PSI person separation index 
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Table 6.12 Rasch summary statistics for final PU-QOLI scale items 
Item Location order Thresholds Location 
Standard 
error 
FitRes ChiSqu Prob 
Residual 
correlation 
   Pain Scale        
1 Uncomfortable Ordered -1.054 0.156 -0.617 2.701 0.259 <0.3 
5 Tenderness Ordered -1.044 0.151 -1.227 3.668 0.160 <0.3 
3 Annoying  Ordered -0.639 0.145 -1.104 2.515 0.284 <0.3 
10 Red raw  Ordered 0.002 0.146 -0.364 1.714 0.424 <0.3 
8 Stinging Ordered 0.240 0.150 -0.381 1.249 0.536 <0.3 
11 Burning  Ordered 0.278 0.143 -1.436 3.467 0.177 <0.3 
7 Throbbing Ordered 0.743 0.157 -0.817 0.926 0.629 <0.3 
9 Stabbing Ordered 0.698 0.162 1.904 1.159 0.560 <0.3 
6 Tingling Ordered 1.087 0.165 1.635 1.015 0.602 <0.3 
   Exudate scale        
1 Weeping Ordered -0.709 0.197 -1.484 0.521 0.470 <0.3 
5 Staining Ordered -0.436 0.178 -0.368 0.687 0.407 <0.3 
4 Messy  Ordered -0.321 0.197 -1.870 3.232 0.072 <0.3 
6 Dressing off  Ordered 0.043 0.204 1.963 0.316 0.574 <0.3 
2 Running Ordered 0.060 0.191 -1.248 0.652 0.419 <0.3 
3 Sticky  Ordered 0.195 0.199 0.055 0.013 0.910 <0.3 
8 Bleeding Ordered 0.472 0.206 -0.135 0.647 0.421 <0.3 
7 Pus Ordered 0.697 0.229 0.843 0.671 0.413 <0.3 
   Odour scale        
1 Unpleasant Ordered -2.063 0.380 -0.922 0.843 0.359 <0.3 
3 Stench or stink  Ordered -0.066 0.296 -1.673 0.763 0.382 <0.3 
4 Pungent Ordered 0.325 0.328 -0.735 3.861 0.049 <0.3 
2 Lingering Ordered 0.394 0.338 -0.345 1.774 0.183 <0.3 
5 Sickening Ordered 0.608 0.322 0.294 0.704 0.401 <0.3 
6 Putrid Ordered 0.801 0.335 1.190 0.490 0.484 <0.3 
   Sleep scale        
6 Trouble finding 
comfortable position 
Ordered -0.751 0.174 0.066 0.456 0.796 <0.3 
5 sleep in one position Ordered -0.218 0.169 1.096 0.374 0.829 <0.3 
4 Not getting amount of 
sleep needed 
Ordered 0.053 0.184 -1.454 5.435 0.066 <0.3 
2 Interrupted sleep  Ordered 0.283 0.184 -1.191 0.997 0.608 <0.3 
3 Being kept awake Ordered 0.284 0.185 -1.862 3.688 0.158 <0.3 
1 Trouble falling asleep Ordered 0.349 0.182 0.762 6.106 0.047 <0.3 
   Mobility scale        
9 walking slowed Ordered -0.502 0.244 -0.032 0.494 0.781 <0.38 
8 limited ability to walk Ordered -0.191 0.227 -0.600 0.975 0.614 <0.45 
2 adjusting in bed Ordered -0.127 0.191 -1.759 0.431 0.806 <0.31 
3Turning/moving in bed Ordered -0.115 0.185 -1.420 0.502 0.778 <0.30 
4 pushing up to a 
sitting position 
Ordered -0.055 0.174 -1.757 0.348 0.840 <0.30 
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Item Location order Thresholds Location 
Standard 
error 
FitRes ChiSqu Prob 
Residual 
correlation 
7 limited ability to go up 
and down stairs 
Ordered 0.063 0.275 0.754 1.718 0.424 <0.39 
6 standing long periods Ordered 0.086 0.195 0.488 0.686 0.710 <0.52 
1 sitting up in bed Ordered 0.308 0.190 -0.905 0.780 0.677 <0.32 
5 transferring Ordered 0.532 0.194 1.312 1.245 0.536 <0.39 
   Daily activities scale        
1 Washing Ordered -0.793 0.203 -0.415 0.250 0.617 <0.30 
5 Shopping Ordered -0.516 0.313 -0.645 0.185 0.668 <0.30 
8 Regular activities Ordered -0.334 0.257 0.041 1.211 0.271 <0.30 
3 Toileting Ordered -0.153 0.214 0.303 0.222 0.637 <0.30 
4 Jobs around house  Ordered -0.023 0.290 -0.718 3.274 0.070 <0.30 
2 Dressing Ordered 0.372 0.237 -0.725 2.395 0.122 <0.30 
6 Doing things enjoy Ordered 0.633 0.235 1.329 0.156 0.693 <0.30 
7 Emotionally close 
with loved ones 
Ordered 0.813 0.268 1.541 2.224 0.136 <0.30 
   Emotional well-being scale       
2 annoyed Ordered -1.593 0.149 -1.309 7.302 0.026 <0.30 
1 frustrated Ordered -1.196 0.148 -1.159 3.706 0.157 <0.31 
3 angry Ordered -0.792 0.142 -0.143 7.735 0.021 <0.33 
5 depressed Ordered -0.602 0.149 -1.806 1.854 0.396 <0.30 
11 physically 
dependent 
Ordered -0.432 0.171 0.553 2.912 0.233 <0.30 
7 concerned/worried Ordered -0.269 0.149 0.390 3.848 0.146 <0.30 
8 anxious Ordered -0.170 0.146 0.140 2.334 0.311 <0.36 
6 upset Ordered 0.004 0.150 -0.002 1.432 0.489 <0.30 
10 no control Ordered 0.030 0.163 -0.742 0.164 0.921 <0.30 
9 burden/nuisance Ordered 0.031 0.173 -0.792 0.751 0.687 <0.30 
4 miserable Ordered 0.262 0.148 -0.827 1.613 0.447 <0.30 
14 missing out Ordered 0.661 0.177 -0.077 3.614 0.164 <0.41 
13 lonely Ordered 0.838 0.187 1.107 3.881 0.144 <0.30 
12 cut off/isolated Ordered 1.147 0.184 0.536 3.691 0.158 <0.30 
15 others avoided/ 
treated you differently 
Ordered 2.081 0.251 -0.087 2.166 0.339 <0.30 
   Self-consciousness scale       
1 helpless Ordered -1.163 0.170 0.677 2.740 0.254 <0.30 
2 lacking confidence Ordered -0.519 0.171 -0.387 0.734 0.693 <0.30 
3 self-conscious Ordered -0.300 0.176 -0.108 3.646 0.162 <0.30 
4 embarrassed Ordered -0.125 0.178 -0.807 2.348 0.309 <0.30 
5 physically 
unattractive 
Ordered 0.425 0.200 -1.932 4.621 0.099 <0.30 
6 uneasy being close to 
others 
Ordered 0.734 0.216 -0.807 1.782 0.410 <0.30 
7 lack understanding 
from others 
Ordered 0.949 0.226 0.784 1.254 0.534 <0.30 
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Item Location order Thresholds Location 
Standard 
error 
FitRes ChiSqu Prob 
Residual 
correlation 
   Participation scale        
6 restricted where you 
could go out 
Ordered -0.750 0.242 -0.989 3.041 0.219 <0.30 
8 unable to get away 
for holiday or make a 
trip at the weekend 
Ordered -0.554 0.224 -0.726 5.303 0.071 <0.30 
5 give up on hobbies or 
leisure activities 
Ordered -0.343 0.243 -1.502 2.644 0.267 <0.30 
1 Difficulty going out Ordered -0.307 0.240 0.221 0.441 0.802 <0.30 
7 Being restricted to 
how long you could 
stay out 
Ordered 0.144 0.234 -0.011 0.919 0.632 <0.30 
4 Having to plan going 
out around pressure 
sore care 
Ordered 0.262 0.242 1.267 1.240 0.538 <0.30 
9 time involved in 
caring for PU 
Ordered 0.379 0.226 0.447 0.295 0.863 <0.30 
3 unable to participate 
in family gatherings 
Ordered 0.492 0.248 -0.240 0.846 0.655 <0.30 
2 meeting/seeing family 
and/or friends 
Ordered 0.677 0.237 1.046 4.757 0.093 <0.30 
*indicates values outside recommended range (i.e. misfit) 
^indicates suboptimal targeting (items do not spread across persons) 
+no DIF detected at Bonferroni adjusted level 
SD standard deviation; FitRes fit residual; ChiSqu chi square; df degrees of freedom; p probability value; ext 
extremes cases 
 
 
  
Table 6.13 PU-QOLI Scale level analyses – Data completeness and Targeting (n=227) 
  Targeting 
Scale Data completeness 
- Computable scale 
score (%) 
Possible 
score 
range  
Range 
mid-point 
Observed 
score range 
Mean 
score 
SD F/C effect (%) Skewness 
Pain 96.5 0 – 18 9 0 – 18 7.39 4.732 3.5/1.8 0.342 
Exudate 96.5 0 – 16 8 0 – 16 3.43 4.290 17.6/1.3 1.224 
Odour 99.1 0 – 12 6 0 – 12 2.27 3.760 26.9/2.6 1.560 
Sleep 99.6 0 – 12 6 0 – 12 4.68 3.816 9.7/4.4 0.409 
Malaise n/a n/a n/a n/a n/a n/a n/a n/a 
Mobility 96.9 0 – 18 9 0 – 18 8.39 5.659 1.3/1.8 0.265 
ADL 97.4 0 – 16 8 0 – 16 7.70 6.131 1.8/1.3 -0.032 
Emotional Well-being 93.0 0 - 30 15 0 - 30 11.57 8.007 2.6/0.9 0.450 
Mood n/a n/a n/a n/a n/a n/a n/a n/a 
Anxiety n/a n/a n/a n/a n/a n/a n/a n/a 
Appearance & self-consciousness 95.2 0 - 14 7 0 - 14 3.45 3.777 11.5/1.8 1.301 
Autonomy & independence n/a n/a n/a n/a n/a n/a n/a n/a 
Isolation n/a n/a n/a n/a n/a n/a n/a n/a 
Participation 96.0 0 - 18 9 0 - 18 8.93 6.341 2.6/3.1 0.018 
High scores indicate great bother/impact 
SD standard deviation; F/C floor/ceiling – floor effect =% scoring 100 (greatest bother/impact); ceiling effect = % scoring 0 (least bother/impact) 
 
 
 
 
 
  
Table 6.14 PU-QOLI Scale level analyses - Reliability and scaling assumptions: Validity within-scale analysis (n=227) 
Scale Internal consistency 
- 
Cronbach‟s alpha 
SEM 95% CI Mean IIC 
(n=227) 
Range IIC Scaling 
Assumptions - 
Corrected ITC 
Pain 0.893 0.453 6.50, 8.29 0.482 0.235 – 0.663 0.525 – 0.703^ 
Exudate 0.919 0.445 2.55, 4.31 0.582 0.397 – 0.857 0.563 – 0.836^ 
Odour 0.962 0.378 1.52, 3.02 0.808 0.735 – 0.908 0.825 – 0.920^ 
Sleep 0.920 0.361 3.96, 5.39 0.655 0.480 – 0.844 0.667 – 0.858^ 
Vitality n/a n/a n/a n/a n/a n/a 
Mobility 0.927 1.069 6.20, 10.59 0.586 0.226 – 0.912 0.666 – 0.799^ 
ADL 0.952 1.3741 4.83, 10.57 0.710 0.407 – 0.904 0.583 – 0.899^ 
Emotional Well-being 0.934 0.931 9.71, 13.42 0.486 0.242 – 0.789 0.537 – 0.761^ 
Mood n/a n/a n/a n/a n/a n/a 
Anxiety n/a n/a n/a n/a n/a n/a 
Appearance & self-
consciousness 
0.901 0.372 2.71, 4.18 0.569 0.409 – 0.750 0.598 – 0.792^ 
Autonomy & independence n/a n/a n/a n/a n/a n/a 
Isolation n/a n/a n/a n/a n/a n/a 
Participation 0.957 0.979 6.95, 10.90 0.710 0.526 – 0.887 0.733 – 0.900^ 
SEM standard error mean; CI confidence interval; IIC inter-item correlation 
^Range item-total correlation (ITC) 
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Chapter 7  
FIELD TEST 2 - 
PSYCHOMETRIC EVALUATION OF THE FINAL PU-QOLIV2 
 
7.1 Overview 
Chapter 7 presents the methods and results of the second of two quantitative field tests 
undertaken to evaluate the measurement properties of the final PU-QOLI scales 
developed in Chapter 6.  Consistent with methods undertaken in the previous Chapter, 
a Rasch analysis was performed first on all PU-QOLI scales, followed by traditional 
psychometrics. 
 
7.2 Objectives 
The purpose of the final stage of psychometric analysis was to carry out a 
comprehensive psychometric evaluation of the final (10 scale/83-item) PU-QOLIv2, 
using Rasch analysis and traditional psychometric methods, in a large independent 
sample of patients with PUs. 
 
7.3 Methods 
7.3.1 Participants 
Field test 1 sample 
A sample of 200-250 patients with PUs were purposively sampled following the 
methods described in section 6.4.2. 
 
7.3.2 Sample size 
To ensure an appropriate degree of precision, a sample of 200-250 patients was 
sought (see section 6.4.3).  A sample size of around 250 would provide sufficient 
subjects for analyses of test-retest reliability; correlations at the levels expected in test-
retest situations (e.g. r >= 0.80) can be estimated with reasonable precision (95% 
confidence intervals of ±0.1) with relatively few subjects (328, 329).  
 
7.3.3 Eligibility 
The eligibility criteria for field test 2 were consistent with the criteria detailed in section 
6.4.4. 
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7.3.4 Recruitment and Consent 
The recruitment and consent procedure was consistent with methods detailed in 
section 6.4.5. 
 
7.3.5 Registration 
Screened patients eligible for field test 2 participation were registered to the study via 
an automated telephone registration system.  Upon registration, a study number was 
issued.  Following registration, baseline data was collected and PU-QOLIs completed. 
 
7.3.6 Data collection/assessment  
Study data (e.g. registration, baseline clinical data, PU-QOLI) were recorded on CRFs 
by members of TVTs or CG.  A questionnaire pack was administered to all participants 
and training in administering the PU-QOLI was provided by CG.  A subsample of 
participants who completed a PU-QOLI at baseline also completed a second PU-QOLI 
2-7 days after the first adminstration to evaluate test-retest reliability.  The length of the 
test-retest interval had to be short enough to ensure that clinical change in the PU was 
unlikely to occur, but sufficiently long to ensure that respondents did not recall their 
responses during the first administration; a short test-retest interval is necessary to 
ensure that stability per se is evaluated, rather than clinical change in the PU.  
 
7.3.7 Monitoring and data cleaning 
The methods for data monitoring and data cleaning are consistent with the methods 
described in sections 6.4.8 and 6.4.9, respectively. 
 
7.4 Analysis Plan for Field Test 2 
7.4.1 Baseline characteristics of sample  
Baseline analysis took the form of methods described in section 6.5.1. 
 
7.4.2 Rasch analyses 
Methods for data analysis were consistent with those undertaken during the first field 
test.  However, in addition to Rasch statistics described in sections 6.5.3, additional 
questions were considered during the final psychometric evaluation, as follows: 
 
Person fit 
How valid is each person‟s measurement?  As with item fit residuals, person fit 
residuals summarise the extent to which individual responses are consistent with those 
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expected by the Rasch model, and can be used to identify misfitting individuals.  
Person residuals are produced by subtracting expected scores from observed scores; 
predicted scores are calculated from the Rasch model using the estimates of the 
person and item locations.  The residual is standardised by dividing it by the square 
root of the variance (computed from the expected value (EV) using the formula: 
variance = EV – EV2 (330)), producing a standardised fit residual for each person‟s 
response to each item.  These are then transformed and summarised to form the 
person fit residual which approximates a standard normal deviate.  Residuals between 
±2.5 indicate adequate person fit to the model (85).  
 
Person-fit was examined to identify any persons with high positive residuals.  Persons 
who deviate from model expectations may seriously affect fit at item level.  In terms of 
scale validation, this runs the risk of discarding the scale/item when it would be more 
appropriate to consider why those persons may have responded differently to everyone 
else (e.g. because of unrecorded comorbidity or cognitive impairment).  Removal of 
these persons from the analysis may make a significant difference to the scales 
internal construct validity, while at the same time raising questions about the external 
construct validity of the scale with the particular patient group.   
 
DIF 
Are the locations of the items stable across clinically important groups?  The extent to 
which item locations were stable across multiple groups was examined by a DIF 
analysis (see section 6.5.2, DIF) in relation to four clinical subgroupings: age (under 70 
years and 70 years over), gender (male and female), PU location (torso, limb, both), 
and healthcare setting (hospital and community).  Both uniform and non-uniform DIF 
were examined.  
 
Are PU-QOLI scale scores stable over a given period of time in which the respondent‟s 
condition is assumed to have remained unchanged?  A DIF analysis was undertaken to 
examine agreement between total scores at two time points (test-retest reproducibility). 
 
Validity 
Unlike traditional methods, a Rasch analysis does not examine correlations with other 
measures or hypothesis testing.  With a Rasch analysis, the clinical validating comes 
from conceptualisation of the instruments‟ scales.  Specifically, careful item 
construction and consideration of what each item is meant to measure, and then test 
them against model expectations.  Then, clinical questions are formulated as external 
validations (see Section 7.4.3, Differentiate known groups) and the empirical testing 
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comes from the Rasch model.  For example, people who have severe PUs might be 
expected to score higher on the symptom scales compared to those with superficial 
PUs.  The placements (responses) of individuals on each symptom scale continuum 
mapped out by symptom items should be largely consistent with expectation. 
 
7.4.3 Traditional psychometric analyses 
Consistent with methods undertaken during the first field test, final Rasch scales 
underwent a psychometric evaluation using the standard psychometric tests detailed in 
sections 6.5.4, as well as additional psychometric tests described below, for: 
acceptability (floor/ceiling effects and skew of scale scores), reliability (internal 
consistency and item-total correlations; test re-test) and validity (convergent, 
discriminant validity and known groups validity).  
 
Reliability 
In addition to reliability statistics described in section 6.5.4, test retest (TRT) 
reproducibility was determined.  A Pearson correlation was performed to investigate 
the strength of the relationship between scores at time 1 (baseline) and time 2 (retest 
2-7 days post baseline administration).  This type of test indicates whether scores at 
the two time point are statistically significantly correlated (criterion 0.7).  High 
correlations indicate a more reliable scale.  
 
Validity 
Validity testing for the final field test includes both within- and between-scales testing. 
 
 Construct 
Construct validity is assessed, instead of criterion-related validity, when no gold 
standard exists with which to compare a measure.  In the absence of such a validating 
measure, a within-scale construct validity analysis was undertaken to determine the 
extent to which PU-QOLI scales measure a single entity and whether items can be 
combined to form scale scores.  Other types of construct validity were evaluated by 
examining ITC (>0.3), alpha coefficient (>0.7), homogeneity coefficient (inter-item 
correlation mean and range; >0.3); indicators that a single construct is being 
measured, and that items can be combined into a scale, and correlations with external 
criteria (e.g. convergent validity), providing evidence towards the internal construct 
validity of the PU-QOLI scales. 
 
 Criterion  
172  Final psychometric evaluation 
 
 
Criterion validity is a special type of construct validity in which stronger hypotheses are 
made possible by the availability of a criterion or „gold standard‟ measure.  There are 
no true gold standard HRQL measures (245) and no PU-specific or chronic wound–
specific measures available (see Chapter 4). 
 
 Convergent validity 
Convergent validity - the degree to which constructs (or scores on a measure) 
expected to be related are, in fact, related (scores correlate with scores on other 
measures designed to assess the same construct) (331) - was examined by computing 
correlations between the SF12 (332) and PU-QOLI scales as well as overall QoL and 
pain questions.  The SF-12v2 Acute, English (UK) version was used (333) to minimise 
respondent burden.  It is a generic measure that asks respondents to rate their health 
and functioning during the past week on eight domains: physical functioning, role 
physical, bodily pain, general health, energy/fatigue, social functioning, role emotional 
and mental health.  Two summary scores can be produced: physical (PCS) and mental 
(MCS) component scores.  Most are composite scores consisting of two questions with 
the exception of four single item indicators for social function, energy/fatigue, pain and 
general health.  Higher scores indicate good HRQL.  
 
A Spearman rank-order correlation coefficient (used with linear or ordinal level data) 
was calculated between PU-QOLI scales and the Physical and Mental Health 
Composite Scale Scores of the SF-12 to determine how closely PU-QOLI scales were 
related to another instrument of similar constructs.  For exploratory purposes, the 
following hypotheses were proposed based on the proximity of the constructs; criteria 
were used as guides to the magnitude of correlations, as opposed to pass/fail 
benchmarks (high correlation r > 0.7; moderate correlation r = 0.3 - 0.7; low correlation < 
0.3) (193, 334):  
 The pain scale would positively correlate with the SF12 bodily pain item 
 The pain scale would positively correlate (r = > 0.7) with the PU-QOLI overall pain 
item 
 The vitality scale would correlate positively with the SF12 energy/fatigue item 
 The movement and mobility scale would correlate negatively with the SF12 
physical functioning scale 
 The emotional well-being scale would correlate negatively with the SF12 mental 
health scale 
 The participation scale would correlate negatively with the SF12 social function 
item 
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 All PU-QOLI scales would correlate positively with the PU-QOLI overall QoL 
question 
 
Moderate to high correlations (r= > 0.3) were predicted.  The direction of the relationship 
was also indicted as high SF12 scale scores indicate better outcome, whereas high PU-
QOLI scale scores indicate worse outcome.  The SF12 pain and fatigue items are 
negatively scored therefore scoring is consistent with PU-QOLI scores. 
 
 Discriminant validity 
Discriminant validity (or divergent validity) – the degree to which constructs expected to 
not be related (have no relationship) are, in fact, not related (or the ability to 
discriminate between known groups (331)) - was examined by computing Pearson 
correlation coefficients (used with interval level data) between PU-QOLI scales and age 
and gender to determine the extent to which responses were biased by these 
variables.  Low (<0.3) correlations were predicted for gender and age. 
 
 Differentiate known groups hypothesis testing 
Known-group comparisons are used to evaluate the clinical utility of PRO instruments.  
This method assesses the extent to which scales are able to discriminate between 
subgroups of patients known to differ in terms of clinical presentations (335).  The 
HRQL and PU literature is not well established and therefore limited for identifying 
clinical parameters to formulate known groups.  A one-way analysis of variance 
(AVOVA) (used where there are three or more groups) was used to test for statistically 
significant differences in mean scores between PU severity subgroups and PU-QOLI 
exudate and odour scales.  PU severity groups were classified as category 1, category 
2 and category 3 and 4 combined due to the small sample sizes of severe PUs.  A 
stepwise change in PU-QOLI scores across PU severity groups was predicted, and 
that mean scores would be significantly different (this is based on clinical expectation; 
people with superficial PUs do not have problems with exudate or odour).  For the 
remainder of scales, known-group difference was investigated on an exploratory basis, 
predicting a stepwise change in PU-QOLI scores across PU severity groups.   
 
7.5 Results 
7.5.1 Study sample 
A total 979 patients were screened for study participation of whom 391 were assessed 
as eligible and 231 eligible patients consented and were registered to the study (see 
Figure 7.1 for the flow of participants).  Respondents represented a wide range of age 
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groups.  There was a slightly higher proportion of men, and a small percentage of 
respondents from minority ethnic groups.  Approximately 60% of the sample were 
hospitalised patients and 45% at on-going long-term risk of PUs.  Over two third of the 
sample was married or cohabiting and just under half the sample had some 
educational qualification.  Table 7.1 shows patient characteristics for the final field test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.1 Assessment flow chart to field test 2 
 
7.5.2 Rasch analyses results 
The analyses described in section 6.5.3 were performed on all PU-QOLI scales 
independently.  A summary of the Rasch results will be presented for each scale, 
followed by decisions made to any scale modifications, and finally presentation of the 
final psychometric properties in summary tables.   
 
Not consented: 160 
 
45 Refused without reason 
48 Not wanting involvement in research 
36 Feels poorly/unwell 
17 Low grade PU 
10 Comorbidity 
  4 Other   
 
 
 
 
 
 
 
 
Unable to disturb 
C mmunication difficulties 
Other 
 
Main study analysis population (n=229) 
Screened (n=879) 
Assessed for eligibility 
(n=717) 
Consented (n=231) 
Enrolled to Main Study (n=231) 
 
Excluded from analysis (n=2, 0.9%) 
   Patient died (1) 
   Patient recruited twice (1) 
Not assessed: 162 
 
   29 Missed by TVS 
   20 Patient died 
   14 Patient transferred 
   50 Patient cognitively impaired 
   42 Patient on care pathway for the 
dying 
    7 Reason missing 
 
 
 
Unable to disturb 
Communication difficulties 
Other 
 
Eligible (n=391) 
Not eligible: 326 
 
    2 Patient under 18 years of age 
  47 Patient does not have a PU 
  22 Patient does not speak English 
  90 Patient unable give informed consent 
160 Patient is cognitively impaired 
    5 Missing 
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Table 7.1 Respondent Characteristics (n=229) 
Characteristics Range years (Mean, SD) 
Age 20 to 103 (71.3, 16.5) 
 Total n (%) 
Gender  
   Male 119 (52.0) 
   Female 110 (48.0) 
Ethnicity  
   White  227 (99.1) 
   Asian 2 (0.9) 
   Black/African 0 
   Chinese 0 
Setting  
   Hospital (surgery) 62 (27.1) 
   Hospital (medicine) 74 32.3) 
   Community 88 (38.4) 
PU severity  
   Category 1 76 (18.1%) 
   Category 2 170 (40.5%) 
   Category 3/4 170 (40.5%) 
   Missing 4 (0.9%) 
PU risk classification  
   Short-term 36 (15.7) 
   New medium to long-term 87 (38.0) 
   On-going long-term 103 (45.0) 
   Missing 3 (1.3) 
Marital status  
   Single (includes divorced, 
separated, widowed) 
71 (31.0) 
   Married 77 (33.6) 
   Cohabiting 75 (32.8) 
   Missing 6 (2.6) 
Living arrangements  
   Live alone 86 (37.6) 
   Cohabit with identified carer 51 (22.3) 
   Cohabit with other 48 (20.9) 
   Missing 44 (19.2) 
Education  
   No formal education 125 (54.6) 
   GCSE or equivalent 40 (17.5) 
   A-Level or equivalent 16 (6.9) 
   Degree or higher 21 (9.2) 
   Missing 27 (11.8) 
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7.5.3 Summary of Rasch findings for the pain scale 
The pain scale items mostly met Rasch measurement criteria.  The item „tingling‟ had a 
high chi square value (19.327) and a significant p value (0.000).  As the scale had good 
reliability (PSI =0.823), suggesting confidence in the accuracy of the fit statistics, the 
item „tingling‟ was removed post hoc.  Removing the item resulted in a good brief 
descriptive pain scale.  The PSI was slightly lower (Table 7.2) but still represented 
good reliability.  The ordering of items along the variable was clinically sensible; and 
the fit statistics indicated that all pain items fit the expectations of the measurement 
model.  There was no evidence to suggest that responses to pain items were biased by 
responses to another; and no evidence of significant DIF across clinically important 
groups. 
 
Item and person location ranges (Table 7.2) indicate that the sample is good for 
examining the psychometric properties of the 8-item pain scale but a suboptimal scale 
for measuring the sample, with no items representing people at the extremes of the 
sample distribution.  A total of 229 people were measured in the sample. Of these, 44 
scored at the floor (n = 35 lowest score) or ceiling (n = 9 high scores) and did not have 
person–item fit residual estimates.  Of the 185 people who had estimates of their 
person–item fit residuals, 9 people (4.9%) had values that were outside the range +/-
2.5.  These findings indicate that 95.1% of people gave responses that were consistent 
with expectation.   
 
7.5.4 Summary of Rasch findings for the exudate scale 
The sample for examining the psychometric properties of the 8-item exudate scale was 
small (n=95) due to many extreme persons (n=133); the largest frequency of patients 
was at the ceiling of the range, scoring the least bother with exudate.  In this instance, 
the construct is not very wide and people with only superficial PUs do not have 
problems with exudate (exudate is associated with skin breakdown which is consistent 
with severe PUs) therefore targeting is within the expected context.  Of the sample, 59 
people had person–item fit residual estimates and all values inside the range +/-2.5.   
 
Patients with only superficial PUs were removed from the analysis, the Rasch analysis 
reran, and findings compared with the findings from the complete sample.  Item and 
person location ranges (Table 7.2) indicated that the sample was good for examining 
the psychometric properties of the 8-item exudate scale but a suboptimal scale for 
measuring the sample, with no items representing people at the extremes of the 
sample distribution.  Removing superficial patients resulted in item „dressing coming 
off‟ (item 4) with reversed thresholds.  It would make clinical sense to dichotomise this 
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item (the dressing is either coming off or it is not).  However, due to the very small 
sample (n=59), additional empirical evidence is needed to be confident about any 
changes made to the exudate scale.  The final exudate scale had reasonable reliability 
(PSI =0.598); the ordering of items along the variable was clinically sensible; the fit 
statistics indicated that all exudate items fit expectations of the measurement model; 
there was no evidence to suggest that item responses were biased by responses to 
another; and no evidence of significant DIF across clinically important groups. 
 
7.5.5 Summary of Rasch findings for the odour scale 
Similar to the exudate scale, the sample for examining the psychometric properties of 
the 6-item odour scale was very small (n=28) due to many extreme persons (n=201); 
the largest frequency of patients was at the ceiling of the range, scoring the least 
bother with odour.  In this instance, the construct is not very wide and people with only 
superficial PUs do not have problems with odour (odour is associated with skin 
breakdown which is consistent with severe PUs); therefore the targeting is within the 
expected context.  Of the sample, 28 people had estimates of their person–item fit 
residuals; all people had values inside the range +/-2.5).   
 
Patients with only superficial PUs were removed from the analysis, the Rasch analyses 
reran, and findings compared with the findings from the complete sample.  Item and 
person location ranges (Table 7.2) indicated that the sample was good for examining 
the psychometric properties of the 6-item odour scale but a suboptimal scale for 
measuring the sample, with no items representing people at the extremes of the 
sample distribution.  Removing superficial patients resulted in a 21 patient sample, a 
sample considered too small to make reliable inferences about the statistics however, 
removing superficial people improved the PSI from 0.321 to 0.486. 
 
The final odour scale had reasonable reliability; the ordering of items along the variable 
was clinically sensible; the fit statistics indicated that all odour items fit the expectations 
of the measurement model; and there was no evidence of significant DIF across 
clinically important groups.  However, „stench‟ and „sickening‟ (items 2 and 5) had a 
high negative correlation (-0.65), indicating that one of the items might be redundant 
but further empirical evidence is needed due to the very small sample size. 
 
7.5.6 Summary of Rasch findings for the sleep scale 
The sleep scale items mostly met Rasch measurement criteria, therefore no changes 
were made to the items or response categories.  Two items failed on numerical tests of 
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fit; item „sleep in one position‟ (item 2) had a fit residual of 2.639, but this value is only 
marginally outside the recommended range, and item „not getting amount of sleep 
needed‟ (item 3) had a significant chi square value (0.0013) at the Bonferroni level (set 
at 0.001667), but again this is only marginally below the significant p value. 
 
The sleep scale had good reliability (PSI =0.719); the ordering of items along the 
variable was clinically sensible; there was no evidence to suggest that responses to 
any sleep items were biased by responses to another; and no evidence of significant 
DIF across clinically important groups.  Item and person location ranges (Table 7.2) 
indicate that the sample is good for examining the psychometric properties of the sleep 
scale but a suboptimal scale for measuring the sample, with no items representing 
people at the extremes of the sample distribution.  A total of 229 people were 
measured in the sample, of which 90 scored at the floor (lowest score) and did not 
have person–item fit residual estimates.  Of the 139 people who had person–item fit 
residual estimates, 7 people (5.0%) had values outside the range +/-2.5, indicating that 
95.0% of people gave responses that were consistent with expectation. 
 
7.5.7 Summary of Rasch findings for the movement and mobility scale 
Item and person location ranges (Table 7.2) indicate that the sample is good for 
examining the psychometric properties of the 9-item movement and mobility scale but a 
suboptimal scale for measuring the sample, with no items representing people at the 
extremes of the sample distribution.  The three-category item scoring function for the 
scale was inadequate for two items, however the frequency of category endorsements 
was <10 for both items.  The ordering of the nine items along the variable was clinically 
sensible and the items mapped out a variable of increasing intensity, but only covering 
a 2 logit spread.  The range of item thresholds and locations was narrow, and there 
were gaps in the continuum.   
 
The fit statistics indicated that all mobility items fit the expectations of the measurement 
model.  However, there was evidence to suggest that responses to some mobility items 
were biased by responses to another; and there was evidence of significant DIF for two 
items by healthcare setting (Table 7.3).  The PSI was low (Table 7.2) and the sample 
was small (n=130), with many persons with extreme scores; scoring at the floor or 
ceiling and did not have person–item fit residual estimates.  As such, there was little 
confidence in making significant changes to the mobility scale, without additional 
empirical evidence.  There may be some benefit in revisiting transcripts to possibly add 
items to cover the full measurement range. 
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7.5.8 Summary of Rasch findings for the activity scale 
Item and person location ranges (Table 7.2) indicate that the sample is good for 
examining the psychometric properties of the 8-item daily activities scale but a 
suboptimal scale for measuring the sample, with no items representing people at the 
extremes of the sample distribution.  The three-category item scoring function for the 
scale was inadequate for four items, however the frequency of category endorsements 
was <10 for these items.  The ordering of the eight items along the variable was 
clinically sensible but the range of item thresholds and locations was narrow, with items 
with similar locations and gaps in the continuum (Table 7.3).   
 
The fit statistics indicated that all daily activity items fit the expectations of the 
measurement model; there was no evidence to suggest that responses to any items 
were biased by responses to another; and there was no evidence of significant DIF 
across clinically important groups (Table 7.3).  However, the PSI was low (Table 7.2) 
and the sample small (n=117), with many persons scoring at the floor or ceiling and 
therefore did not have person–item fit residual estimates.  As such, there was little 
confidence in making significant changes to the daily activities scale, without additional 
empirical evidence.  There may be some benefit in revisiting transcripts to possibly add 
items to cover the full measurement range. 
 
7.5.9 Summary of Rasch findings for the vitality scale 
Item and person location ranges (Table 7.2) indicate that the sample is good for 
examining the psychometric properties of the 5-item vitality scale but a suboptimal 
scale for measuring the sample, with no items representing people at the extremes of 
the sample distribution.  The ordering of the five items along the variable was clinically 
sensible and the items mapped out a variable of increasing intensity, but only covering 
a 1.3 logit spread.  The range of item thresholds and locations was narrow, and there 
were gaps in the continuum.   
 
The fit statistics indicate that all vitality items fit the expectations of the measurement 
model and the three-category item scoring function was adequate for all items (Table 
7.3).  However, items „tired‟ and „fatigued‟ had similar locations and both correlated at 
0.49, suggesting responses to these items were biased by responses to each other, 
and there was evidence of significant DIF for item „feeling unwell‟ by age (Table 7.3). 
 
The PSI was low (Table 7.2) and the sample was small (n=98), with many persons with 
extreme scores; scoring at the floor or ceiling and did not have person–item fit residual 
estimates.  As such, there was little confidence in making significant changes to the 
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vitality scale, without additional empirical evidence.  There may be some benefit in 
revisiting transcripts to possibly add items to cover the full measurement range. 
 
7.5.10 Summary of Rasch findings for the emotional well-being scale 
The emotional well-being scale items mostly met Rasch measurement criteria however 
the three-category item scoring function for the scale was inadequate for two items.  
These two items were dichotomised and the Rasch analyses reran.  This resulted in a 
good emotional well-being scale, with good reliability (PSI =0.846) (Table 7.2).  The 
ordering of the emotional well-being items along the variable was clinically sensible; the 
fit statistics indicated that all items fit the expectations of the measurement model; and 
there was no evidence of significant DIF across clinically important groups.  However, 
there was some evidence to suggest that responses to some emotional well-being 
items might be biased by responses to another (Table 7.3). 
 
Item and person location ranges (Table 7.2) indicate that the sample is good for 
examining the psychometric properties of the 15-item emotional well-being scale but a 
suboptimal scale for measuring the sample, with no items representing people at the 
extremes of the sample distribution.  A total of 229 people were measured in the 
sample. Of these, 43 scored at the floor (lowest score) and did not have person–item fit 
residual estimates.  Of the 186 people who had person–item fit residual estimates, 64 
people (34.4%) had values outside the range +/-2.5, and 49 (26.3%) outside the range 
+/-3.0, indicating that 65.6% of people gave responses consistent with expectation. 
 
7.5.11 Summary of Rasch findings for the self-consciousness scale 
The ordering of the self-consciousness items along the variable was clinically sensible; 
the fit statistics indicated that all items fit the expectations of the measurement model; 
the three-category item scoring function was adequate for all items; and there was no 
evidence of significant DIF across clinically important groups.  However, there was 
some evidence to suggest that responses to items „self-conscious‟ and „embarrassed‟ 
were biased by each other (Table 7.3) and the PSI was low (Table 7.2).   
 
Item and person location ranges (Table 7.2) indicate that the sample is good for 
examining the psychometric properties of the 7-item self-consciousness scale but a 
suboptimal scale for measuring the sample, with no items representing people at the 
extremes of the sample distribution.  A total of 229 people were measured in the 
sample.  Of these, 89 scored at the floor (lowest score) and did not have person–item 
fit residual estimates.  Of the 140 people who had estimates of their person–item fit 
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residuals, 18 people (12.9%) had values that were outside the range +/-2.5, indicating 
that 87.1% of people gave responses that were consistent with expectation. 
 
7.5.12 Summary of Rasch findings for the participation scale 
Item and person location ranges (Table 7.2) indicate that the sample is good for 
examining the psychometric properties of the 9-item participation scale but a 
suboptimal scale for measuring the sample (no items representing people at the 
extremes of the sample distribution).  Item ordering along the variable was clinically 
sensible but item threshold and location ranges were narrow, with items at similar 
locations and gaps in the continuum (Table 7.3).  Fit statistics indicate all participation 
items fit expectations of the measurement model, and there was no evidence of 
significant DIF across groups.  However, some items had high residual correlations 
(Table 7.3); suggesting responses to the items were biased by responses to another.  
 
The three-category item scoring function for the scale was inadequate for seven items 
however the frequency of category endorsements was low for these items.  The PSI 
was low (Table 7.2) and the sample small (n=82), with many persons scored at the 
floor or ceiling and therefore did not have person–item fit residual estimates.  As such, 
there was little confidence in making significant changes to the participation scale, 
without additional empirical evidence.   
 
A total of 229 people were measured in the sample. Of these, 117 scored at the floor or 
ceiling and did not have person–item fit residual estimates.  Of the 112 people who had 
estimates of their person–item fit residuals, 36 people (32.1%) had values that were 
outside the range +/-2.5, indicating that 67.9% of people gave responses that were 
consistent with expectation.  There may be some benefit in revisiting transcripts to 
possibly add items to cover the full measurement range. 
 
Table 7.2 provides a summary of the Rasch statistics for the final PU-QOLI scales.  
Table 7.3 provides a summary of the Rasch statistics for all items in item location 
order, indicating the line of increasing intensity for the final PU-QOLI scales. 
 
7.5.13 Summary of Rasch findings  
The measurement properties of the PU-QOLIs‟ scales were largely supported as 
demonstrated through items that mapped out continua of increasing intensity and are 
located along those continua in a clinically sensible order.  Scale items work well 
together to define single variables, albeit, some item misfit, local dependence and 
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items exhibiting DIF detected.  For example, DIF was demonstrated in three items 
(Table 7.3), however the deviations from model expectations were marginal, 
suggesting item performance across the four clinical subgroups is stable and that these 
groups can be measured on a common ruler. 
 
The Rasch analysis detected important limitations of some PU-QOLI scales.  It 
detected that the three-category item scoring function did not work as intended for 
some scale items.  This would imply that these items had too many response options 
and required a post hoc rescoring of items by collapsing adjacent categories.  However 
the frequency of category endorsements was <10 for these items (336) therefore 
further empiric evidence might be required.  Some item locations indicated areas on 
the continuum within the scale range measured where the measurement could be 
improved (i.e. at extreme ends of the scale range).  As the sample sizes for these 
scales were quite small, major modifications to items and the scoring function were 
demeaned premature without additional empirical evidence.   
 
Another limitation pertains to the sample distribution.  For most scales, the sample was 
not normally distributed (normal distribution is neither expected nor wanted as sample 
distribution is an empirical finding rather than a requirement, but it does suggest that 
assumptions about the distribution of people and the variables measured in populations 
should not be made (85)).  The largest frequency of patients was often at the floor of 
scale ranges (least bother), suggesting suboptimal targeting of the PU-QOLI scales to 
the study sample.  Ideally there should be a good match between the scale range and 
sample range, with people falling within the range of the items.  For the symptom 
scales, the targeting can be justified as not all patients with PUs are expected to have 
problems with symptoms so it is clinically reasonable that these people would fall 
outside the scale range.  Importantly, where people have symptom bother, there needs 
to be items within the scales that will discriminate symptom bother, and in this instance, 
the symptom scales perform this function.  However, other scales were unable to 
separate the sample reliably, and people‟s patterns of responses were inconsistent 
with expectation as indicated by many misfitting persons in some instances.  
 
7.6 Traditional psychometric evaluation of final PU-QOLI scales 
The final PU-QOLI scales underwent a preliminary psychometric evaluation using 
traditional psychometric tests (see Table 6.1).  Results of the preliminary analysis for: 
data completeness, scaling assumptions, targeting, internal consistency reliability and 
construct validity are presented in Tables 7.4 to 7.6 and briefly described below.   
 
  
Table 7.2 Field Test 2 Rasch analysis summary statistics for final PU-QOLI scales 
Scale 
Person-Item threshold 
distribution (Scale-to-sample 
targeting) Item fit residual Person fit residual 
Chi Square 
interaction PSI 
 
Sample 
location range 
Item location 
range Mean SD FitRes range Mean SD Value (df) p 
With 
ext No ext 
Pain -4.017 - 3.232 -1.104 - 1.024^ -0.235 0.812 -2.722 - 2.339 -0.216 1.049 (24) 33.613 0.092 0.814 0.721 
Exudate -3.156 - 1.740 -0.751 - 0.843^ 0.020 0.908 -3.869 - 1.740 -0.156 1.100 (8)10.503 0.231 0.598 0.688 
Odour -5.070 - 2.869 -1.303 - 0.906^ -0.169 0.587  -1.742 - 1.809 -0.171 0.778 (6) 7.988 0.239 0.486 0.655 
Sleep -3.076 - 2.860 -0.907 - 0.451^ 0.071 1.805 -4.096 – 2.424 -0.317 1.277 (12) 39.710 0.000 0.719 0.616 
Movement & 
Mobility 
-3.011 - 2.686 -0.457 - 0.572^ 0.196 0.934 -16.062 – 1.970 -1.295 3.539 (18) 27.855 0.064 0.505 0.422 
Activities -2.418 - 2.150 -0.299 - 0.561^ 0.264 1.028 -8.209 – 1.790 -0.261 1.381 (8) 13.604 0.093 0.102 0.268 
Vitality -3.014 - 2.672 -0.500 - 0.804^ 0.072 1.479 -17.571 - 2.118 -1.263 3.900 (5) 11.381 0.044 0.557 0.375 
Emotional well-
being 
-4.005 - 3.896 -1.478 - 2.442^ -0.391 1.248 -10.177 - 2.128 -0.333 1.192 (45) 75.307 0.003 0.846 0.863 
Self-
consciousness 
-3.084 - 3.145 -1.268 - 1.022^ -0.090 0.693 -2.149 – 1.795 -0.241 0.864 (7) 11.340 0.125 0.529 0.579 
Participation -2.610 - 2.650 -0.912 - 0.995^ -0.107 0.517 -17.236 – 2.137 -1.128 3.847 (9) 6.998 0.637 0.435 0.571 
^ indicates suboptimal targeting (items do not spread across persons) 
SD standard deviation; FitRes fit residual; ChiSqu chi square; df degrees of freedom; p probability value; ext extremes cases 
 
 
 
 
 
  
Table 7.3 Field Test 2 Rasch analysis summary statistics for PU-QOLI scale items 
 Thresholds Location FitRes ChiSqu Prob 
Person-item 
correlations 
DIF age DIF gender DIF HC setting 
Uni Non Uni Non Uni Non 
Pain scale items (n=180; 4 CI)            
Uncomfortable Ordered -1.104 -0.771 6.527 0.089 <0.3 + + + + + + 
Tenderness Ordered -1.069 -0.192 3.708 0.295 <0.3 + + + + + + 
Annoying  Ordered -0.670 -1.817 7.508 0.057 <0.3 + + + + + + 
Red raw Ordered 0.219 -0.145 2.065 0.559 <0.3 + + + + + + 
Stinging Ordered 0.388 -0.496 2.817 0.421 <0.3 + + + + + + 
Burning Ordered 0.482 0.328 0.314 0.957 <0.3 + + + + + + 
Throbbing Ordered 0.729 0.692 4.205 0.240 <0.3 + + + + + + 
Stabbing Ordered 1.024 0.519 6.468 0.091 <0.3 + + + + + + 
Exudate scale items (n=59; 2 CI – people with only 
superficial PUs removed, if retained n=95) 
         
Dressing off Disordered 
Dichotomis
ed 
-0.751 0.804 0.020 0.887 <0.3 + + + + + + 
Staining Ordered -0.398 -0.758 0.367 0.544 <0.3 + + + + + + 
Weeping Ordered -0.356 -0.342 0.670 0.413 <0.3 + + + + + + 
Sticky Ordered -0.266 -0.129 0492 0.483 <0.3 + + + + + + 
Messy Ordered -0.006 -1.264 4.607 0.032 <0.3 + + + + + + 
Running Ordered 0.252 -0.269 0.255 0.613 <0.3 + + + + + + 
Bleeding Ordered 0.683 0.552 1.493 0.222 <0.3 + + + + + + 
Pus Ordered 0.843 1.566 2.599 0.107 <0.3 + + + + + + 
Odour scale items (n=21; 2 CI – people with only          
  
 Thresholds Location FitRes ChiSqu Prob 
Person-item 
correlations 
DIF age DIF gender DIF HC setting 
Uni Non Uni Non Uni Non 
superficial PUs removed, if retained n=27) 
Unpleasant Ordered -1.303 -0.039 1.340 0.247 <0.3 + + + + + + 
Lingering Ordered -0.207 -0.915 2.186 0.139 <0.3 + + + + + + 
Pungent Ordered -0.187 0.330 1.195 0.274 <0.3 + + + + + + 
Stench Ordered 0.047 -0.566 0.273 0.602 <0.3 + + + + + + 
Putrid Ordered 0.745 -0.465 0.404 0.525 <0.3 + + + + + + 
Sickening Ordered 0.906 0.640 2.591 0.108 <0.3 + + + + + + 
Sleep scale items (n=133; 3 
CI) 
           
Comfortable 
position 
Ordered -0.907 0.777 0.468 0.792 <0.3 + + + + + + 
Sleep in one 
position 
Ordered -0.058 2.639* 3.239 0.198 <0.3 + + + + + + 
Interrupted sleep Ordered 0.027 -1.144 9.530 0.009 <0.3 + + + + + + 
Not getting 
amount of sleep 
needed 
Ordered 0.065 -1.789 13.303 0.001*        
Kept awake Ordered 0.422 -1.485 6.333 0.042 <0.3 + + + + + + 
Trouble falling 
asleep 
Ordered 0.451 1.427 6.838 0.033 <0.3 + + + + + + 
Mobility & Movement scale items (n=130; 3CI)          
Pushing up to 
sitting 
Ordered -0.457 -0.123 3.303 0.192 <0.3 + + + + + + 
Adjusting in bed Ordered -0.349 -0.832 6.928 0.031 0.498 + + + + + + 
  
 Thresholds Location FitRes ChiSqu Prob 
Person-item 
correlations 
DIF age DIF gender DIF HC setting 
Uni Non Uni Non Uni Non 
Difficulty sitting Ordered -0.155 2.310 0.990 0.610 <0.3 + + + + + + 
Difficulty turning/ 
moving in bed 
Ordered -0.138 -0.454 3.079 0.214 0.498 + + + + + + 
Walking slowed Ordered -0.006 -0.501 6.426 0.040 0.701 + + + + 0.000 + 
Difficulty 
standing long 
periods 
Disordered 0.165 -0.060 1.008 0.604 <0.3 + + + + + + 
Limited in ability 
to walk 
Ordered 0.168 0.198 4.790 0.091 0.701 + + + + 0.001 + 
Difficulty 
transferring 
Ordered 0.201 0.747 0.378 0.828 <0.3 + + + + + + 
Limited in ability 
to go up/down 
stairs 
Disordered 0.572 0.475 0.954 0.621 <0.3 + + + + + + 
Activity scale items (n=95; 2 CI)           
Regular activities Disordered -0.299 0.956 0.652 0.419 <0.3       
Washing Ordered -0.298 1.564 0.097 0.756 <0.3 + + + + + + 
Shopping Disordered -0.230 -1.446 1.825 0.177 <0.3 + + + + + + 
Toileting Ordered -0.125 0.962 0.055 0.815 <0.3 + + + + + + 
Dressing Ordered -0.003 0.281 5.084 0.024 <0.3 + + + + + + 
Jobs around 
house 
Disordered 0.059 -0.814 2.247 0.134 <0.3 + + + + + + 
Doing things 
enjoy 
Ordered 0.334 0.872 2.002 0.157 <0.3 + + + + + + 
Being Disordered 0.561 -0.263 1.642 0.200 <0.3 + + + + + + 
  
 Thresholds Location FitRes ChiSqu Prob 
Person-item 
correlations 
DIF age DIF gender DIF HC setting 
Uni Non Uni Non Uni Non 
emotionally 
close 
Vitality scale items (n=98; 2 
CI) 
           
Tired Ordered -0.500 -0.327 0.992 0.319 0.49 + + + + + + 
Fatigued Ordered -0.493 -2.177 7.987 0.005 0.49 + + + + + + 
Energy reduced Ordered -0.148 0.104 0.824 0.364 <0.3 + + + + + + 
Unwell/poorly Ordered 0.338 1.624 0.415 0.521 <0.3 0.00 + + + + + 
Appetite reduced Ordered 0.804 1.133 1.164 0.281 <0.3 + + + + + + 
Emotional well-being scale items (n=181; 4 CI)          
Fed-up Ordered -1.478 1.109 2.428 0.489 <0.3 + + + + + + 
Frustrated Ordered -1.055 -1.298 9.373 0.025 <0.3 + + + + + + 
Annoyed/irritated Ordered -0.673 1.542 4.816 0.186 <0.3 + + + + + + 
Physically 
dependent 
Ordered -0.598 0.558 2.208 0.530 <0.3 + + + + + + 
Miserable Ordered -0.441 -1.073 7.850 0.049 <0.3 + + + + + + 
Anxious Ordered -0.298 1.223 7.749 0.052 0.560 + + + + + + 
No control Ordered -0.120 -2.261 7.078 0.069 <0.3 + + + + + + 
Burden/nuisance Ordered -0.113 -0.096 3.332 0.343 <0.3 + + + + + + 
Concerned/ 
worried 
Ordered -0.104 0.795 0.719 0.867 0.560 + + + + + + 
Angry Ordered - 
dichot 
0.164 -0.735 4.103 0.250 <0.3 + + + + + + 
Missing out Ordered 0.223 -1.209 5.481 0.140 <0.3 + + + + + + 
  
 Thresholds Location FitRes ChiSqu Prob 
Person-item 
correlations 
DIF age DIF gender DIF HC setting 
Uni Non Uni Non Uni Non 
Depressed Ordered 0.235 -2.361 9.588 0.022 <0.3 + + + + + + 
Lonely Ordered 0.891 -0.832 1.770 0.621 0.519 + + + + + + 
Cut off/isolated Ordered 0.926 -1.345 3.520 0.318 0.519 + + + + + + 
Others avoided Ordered - 
dichot 
2.442 0.117 5.294 0.152 <0.3 + + + + + + 
Self-consciousness scale items (n=100; 2 CI)          
Helpless Ordered -1.268 -0.517 0.784 0.376 <0.3 + + + + + + 
Lacking 
confidence 
Ordered -0.654 -0.025 0.143 0.705 <0.3 + + + + + + 
Self-conscious Ordered -0.465 0.114 1.388 0.239 0.415 + + + + + + 
Embarrassed Ordered -0.290 0.077 0.731 0.393 0.415 + + + + + + 
Feeling 
physically 
unattractive 
Ordered 0.727 -1.131 3.061 0.080 <0.3 + + + + + + 
Lack 
understanding 
from others 
Ordered 0.928 1.137 4.227 0.040 <0.3 + + + + + + 
Uneasy being 
close to others 
Ordered 1.022 -0.283 1.007 0.315 <0.3 + + + + + + 
Participation scale items (n=82; 2 CI           
Restricted where 
go out  
Disordered -0.912 -0.962 2.095 0.148 <0.3 + + + + + + 
Difficulty going 
out 
Ordered -0.877 -0.801 0.991 0.319 <0.3 + + + + + + 
Restricted how Disordered -0.664 -0.227 0.424 0.515 <0.3 + + + + + + 
  
 Thresholds Location FitRes ChiSqu Prob 
Person-item 
correlations 
DIF age DIF gender DIF HC setting 
Uni Non Uni Non Uni Non 
long stay out 
Holiday/weekend Disordered -0.016 0.403 0.690 0.406 <0.3 + + + + + + 
Give up hobbies/ 
leisure 
Disordered 0.188 -0.387 1.193 0.275 <0.3 + + + + + + 
Participate family 
gatherings 
Disordered 0.356 0.342 0.689 0.407 0.694 + + + + + + 
Meeting family/ 
friends 
Disordered 0.428 0.116 0.156 0.693 0.694 + + + + + + 
Plan going out 
around PU care 
Disordered 0.501 0.163 0.151 0.698 <0.3 + + + + + + 
Time involved 
caring for PU 
Ordered 0.995 0.387 0.608 0.436 <0.3 + + + + + + 
* indicates values outside recommended range (i.e. misfit) 
+ no DIF detected 
CI class interval; SD standard deviation; FitRes fit residual; ChiSqu chi square; DIF differential item functioning; df degrees of freedom; p probability value; ext 
extremes cases; HC healthcare; Uni Uniform; Non non-uniform 
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7.6.1 Data quality 
Total scores could be computed for most people for all scales (computable scale score 
range 95.6 – 99.6%; Table 7.4), implying good data quality. 
 
7.6.2 Scaling assumptions 
Scaling assumptions were mainly satisfied.  Mean scale scores and standard 
deviations were mostly similar to scale mid-points (Table 7.4).  All item–own-scale 
correlations were high (corrected item-total correlations range = 0.525 - 0.920; Table 
7.5), satisfying the recommended criteria (> 0.3), thus providing support that items 
within scales measured a common underlying construct.  Further, corrected item-total 
correlation > 0.3 indicate that items within each scale contain a similar proportion of 
information. 
 
7.6.3 Targeting 
Scale-to-sample targeting was reasonable.  Scale scores spanned the scale range but 
were notably skewed for four scales (value outside +/-1.0); mean scores were near the 
scale mid-point for only 3/10 scales, however, due to many people responding at the 
floor (lowest score), this finding is expected; and ceiling effects were negligible, 
however floor effects exceeded the 15% criterion for 4/10 scales (Table 7.4).   
 
7.6.4 Reliability 
Internal consistency reliability was high as demonstrated by Cronbach‟s alpha values 
for all PU-QOLI scales exceeding the standard criterion of 0.7 (range 0.893 – 0.969; 
Table 7.5).  Item–total correlations ranged from 0.525 - 0.920, fulfilling the 
recommended criteria of >0.3.  Finally, test-retest correlations for 8/10 scales exceeded 
0.7 and 6/10 scale correlated over 0.8; two scales had correlations below the 
recommended criteria, but marginally (Table 7.4), thus mostly fulfilling the 
recommended minimum criteria and indicating good scale stability.   
 
7.6.5 Validity 
Within-Scale Analyses 
Evidence towards the internal construct validity of the PU-QOLI scales is supported by 
moderate to high item-total correlations; high Cronbach‟s coefficient alphas; and 
moderate to high inter-item correlations (means > 0.48 and ranges between 0.226 – 
0.934 indicate that PU-QOLI scale items were mostly correlated with scale scores; 
Table 7.5), indicating that each scale measures a single construct.   
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Convergent validity 
Correlations between PU-QOLI scales and hypothesised related scales of the SF-12 and 
the PU-QOLI overall QoL and pain items were consistent with most predictions (Table 
7.6), providing support that PU-QOLI scales measure what they intend to measure; 
moderate to high correlations (r >0.30) were predicted. 
 
Discriminant validity 
Correlations between PU-QOLI scales and sociodemographic variables (age, gender) 
were consistent with predictions (r <0.30; Table 7.6), thus suggesting that responses to 
PU-QOLI scales are not biased by age or gender. 
 
Known Groups validity 
The PU-QOLI exudate and odour scales confirm hypothesised group differences as 
predicted; there was a significant step increase in mean scores by PU severity groups 
(Table 7.6).  Tests of group difference also found a significant step increase in scores 
for scales vitality, daily activities, emotional well-being, and self-consciousness by PU 
severity.  In contrast, no step increase in scores was observed for scales pain, sleep, 
mobility and movement, and participation.  These tests were considered exploratory as 
samples sizes used for scale analysis ranged between 4 and 82 patients.  For all 
scales apart from the sleep scale, the mean score on HRQL outcomes for category 1 
PU severity was lower than category 3/4 PU severity, suggesting that HRQL outcomes 
are worse for people with severe PUs compared to those with superficial category 1 
PUs.  It is important to note that category 1 PUs had small samples (range 4-14 
patients) therefore the known groups validity results are preliminary and require further 
empirical evidence to provide confidence in whether PU-QOLI scales can detect small 
differences in the constructs being measured. 
 
7.6.6 Summary of traditional psychometric analyses  
The traditional analysis supported the PU-QOLI scales as reliable and valid measures 
of PU-symptoms, physical and social functioning, and psychological well-being.  The 
criteria were satisfied for most psychometric properties evaluated.  Briefly, data quality 
was high (scale scores were computable for 95.2-99.6% of respondents) and scaling 
assumptions were satisfied (mostly similar mean item scores, corrected item-total 
correlations range = 0.511 - 0.940).  Scale-to-sample targeting was good, apart from 
those scales where skew was clinically reasonable (scale scores spanned the scale 
range but were notably skewed for four scales (value outside +/-1.0), mean scores 
were near the scale mid-point for 6/10 scales, and ceiling effects were negligible, 
however floor effects exceeded the 15% criterion for 4/10 scales).   
  
 
 
Table 7.4 PU-QOLI scale level analyses – Data completeness and Targeting (n=229) 
Scale Data completeness 
- Computable scale 
score (%) 
Targeting 
Possible 
score 
range  
Range 
mid-point 
Observed 
score range 
Mean 
score 
SD F/C effect (%) Skewness 
Pain 95.6 0 – 16 8 0 – 16 6.14 4.586 15.2/3.9 0.396 
Exudate 98.3 0 – 15 7.5 0 – 15 2.09 3.494 57.0/0.9 1.898 
Odour 99.6 0 – 12 6 0 – 12 0.97 2.850 83.0/4.3 3.144 
Sleep 99.6 0 – 12 6 0 – 12 4.66 4.302 10.7/4.1 0.434 
Vitality 98.3 0 - 10 5 0 - 10 2.72 3.217 27.0/2.2 0.896 
Mobility 97.8 0 – 18 9 0 – 17 7.077 5.377 1.5/0.4 0.362 
ADL 95.6 0 – 16 8 0 – 14 3.67 4.389 3.9/0.4 1.058 
Emotional Well-being 95.2 0 - 30 15 0 - 28 10.15 9.190 8.3/1.3 0.673 
Appearance & self-consciousness 96.5 0 - 14 7 0 - 14 2.53 3.632 38.7/2.2 1.566 
Participation 95.6 0 - 18 9 0 - 18 5.658 6.264 6.2/0.4 0.587 
High scores indicate great bother/impact 
SD standard deviation; F/C floor/ceiling – floor effect =% scoring 100 (greatest bother/impact); ceiling effect = % scoring 0 (least bother/impact) 
 
  
 
 
Table 7.5 PU-QOLI scale level analyses - Reliability and scaling assumptions: Validity within-scale analysis (n=227) 
Scale Internal 
consistency 
Cronbach‟s 
alpha 
SEM 95% CI Mean 
IIC  
IIC Scaling 
Assumptions 
-Corrected ITC 
Test Retest Reproducibility 
ICC 
consistency 
ICC 
absolute 
Correlation 
Pain 0.893 0.453 6.50, 8.29 0.482 0.235 – 
0.663^ 
0.525 – 0.703^ 0.803 0.805 0.804 
Exudate 0.907 0.233 1.63, 2.55 0.544 0.316 – 
0.715^ 
0.511 – 0.752^ 0.622 0.625 0.622 
Odour 0.969 0.187 0.60, 1.35 0.841 0.716 – 
0.934^ 
0.794 – 0.940^ 0.681 0.680 0.700 
Sleep 0.920 0.327 4.01, 5.30 0.657 0.491 – 
0.805^ 
0.681 – 0.846^ 0.822 0.816 0.824 
Vitality 0.900 0.275 2.18, 3.27 0.638 0.488 – 
0.902^ 
0.628 – 0.898 0.735 0.738 0.736 
Mobility 0.927 1.069 6.20, 10.59 0.586 0.226 – 
0.912^ 
0.666 – 0.799^ 0.873 0.864 0.879 
ADL 0.952 1.3741 4.83, 10.57 0.710 0.407 – 
0.904^ 
0.583 – 0.899^ 0.866 0.872 0.870 
Emotional Well-being 0.934 0.931 9.71, 13.42 0.486 0.242 – 
0.789^ 
0.537 – 0.761^ 0.829 0.820 0.832 
Appearance & self-
consciousness 
0.894 0.271 1.99, 3.07 0.557 0.371 – 
0.789^ 
0.617 – 0.755^ 0.812 0.814 0.814 
Participation 0.932 0.719 4.23, 7.09 0.601 0.359 – 
0.877^ 
0.599 – 0.861^ 0.627 0.639 0.634 
SEM standard error mean; CI confidence interval; IIC inter-item correlation 
^Range item-total correlation (ITC) 
 
  
 
 
Table 7.6 PU-QOLI scale level analyses – Validity (n=229) 
Scale 
Convergent Validity Discriminant Validity Known Groups 
SF12 
Physical 
Function 
Scale  r
1
  
SF12 
Social 
Function 
Scale  r
1
  
SF12 Role 
Physical 
Scale  r
1
  
SF12 
Mental 
Health 
Scale r
1
  
SF12 
Pain item 
r
1
  
SF12 
Fatigue 
item r
1
  
PU-QOL 
pain item 
r
1
  
PU-QOL 
QOL item 
r
1
 (n) 
Gender 
R
2
 (n) 
Age r
2
 (n) PU 
severity^   
R
3
  
Mean 
score (n) 
P value (CI) 
Pain 
   Category 1 
   Category 2 
   Category 3/4 
- - - - 0.48
 b
 - 0.79
b
 0.38
 b
  (206) 0.13
b
 (214) 0.11
b
 (214) 0.895  
5.36 (14) 
5.81 (77) 
5.51 (68) 
0.895 
(2.85, 7.86) 
(4.78, 6.83) 
(4.49, 6.54) 
Exudate 
   Category 1 
   Category 2 
   Category 3/4 
- - - - - - - 0.25
a
 (216) 0.08
b
 (225) -0.14
b
 (224) 0.000*  
0.64 (14) 
1.07 (81) 
3.26 (72) 
0.000* 
(-0.43, 1.72) 
(0.55, 1.60) 
(2.31, 4.21) 
Odour 
   Category 1 
   Category 2 
   Category 3/4 
- - - - - - - 0.20
a
 (217) 0.05
b
 (228) -0.14
b
 (227) 0.004*  
0.07 (14) 
0.28 (82) 
1.60 (72) 
0.004* 
(-0.08, 0.23) 
(-0.05, 0.61) 
(0.77, 2.43) 
Sleep 
   Category 1 
   Category 2 
   Category 3/4 
- - - - - - - 0.32
 b
  (171) 0.21
b
 (178) 0.10
b
 (178) 0.774  
4.89 (9) 
4.49 (65) 
4.02 (54) 
0.774 
(1.36, 8.42) 
(3.41, 5.57) 
(2.84, 5.20) 
Vitality 
   Category 1 
   Category 2 
   Category 3/4 
- - - - - 0.36
 b
 - 0.52
 b
  (135) 0.03
b
 (137) -0.16
b
 (137) 0.036*  
1.22 (9) 
1.82 (50) 
3.25 (48) 
0.036* 
(-0.40, 2.84) 
(1.02, 2.62) 
(2.26, 4.24) 
  
 
 
1 Spearman correlation 
2 Pearson correlation 
3 ANOVA 
^PU severity categorised into 3 PU groups: category 1, category 2, and category 3 and 4 combined 
*Correlation significant at p=0.05 
aCorrelations falling outside of the predicted range; bCorrelations consistent with predictions 
CI confidence interval
Mobility 
   Category 1 
   Category 2 
   Category 3/4 
-0.50
b
 - - - - - - 0.39
 b
  (37) 0.04
b
 (39) 0.22
b
 (39) 0.137  
5.00 (4) 
4.36 (11) 
8.31 (13) 
0.137 
(-1.62, 11.62) 
(1.94, 6.79) 
(4.82, 11.80) 
ADL 
   Category 1 
   Category 2 
   Category 3/4 
- - -0.389
b
 - - - - 0.35
 b
  (48) -0.05
b
 (49) -0.19
b
 (49) 0.094  
1.60 (5) 
1.73 (11) 
4.63 (24) 
0.094 
(-0.66, 3.86) 
(-1.06, 4.51) 
(2.81, 6.44) 
Emotional Well-
being 
   Category 1 
   Category 2 
   Category 3/4 
- - - -0.44
b
 - - - 0.58
 b
  (133) 0.16
b
 (135) -0.15
b
 (135) 0.001*  
 
4.13 (8) 
7.41 (46) 
13.28 (47) 
0.001* 
 
(1.39, 6.86) 
(4.98, 9.84) 
(10.39,16.16) 
Appearance 
and self-
consciousness 
   Category 1 
   Category 2 
   Category 3/4 
- - - -0.40
b
 - - - 0.50
 b
  (176) 0.23
b
 (179) -0.03
b
 (178) 0.014*  
 
 
0.92 (12) 
1.85 (62) 
2.52 (58) 
0.014* 
 
 
(-0.42, 2.26) 
(1.02, 2.68) 
(2.43, 4.71) 
Participation 
   Category 1 
   Category 2 
   Category 3/4 
- -0.523
b
 - - - - - 0.51
 b
  (75) 0.01
b
 (76) -0.29
b
 (76) 0.018*  
3.67 (6) 
2.55 (22) 
7.35 (31) 
0.018* 
(-1.55, 8.88) 
(0.43, 4.66) 
(4.84, 9.87) 
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Findings from the reliability analyses supported PU-QOLI scales as reliable measures, 
with acceptable internal consistency (i.e. supporting the scales are measuring single 
constructs), and the ability to produce highly reproducible scores on repeated 
applications.  The high item-total correlations and alpha coefficients provide evidence 
towards the internal construct validity of the PU-QOLI scales.  There was good 
evidence for convergent and discriminant construct validity; moderate to strong 
correlations were demonstrated between PU-QOLI scales with related constructs and 
low correlations between PU-QOLI scale scores and external unrelated variables.  
Scales exudate and odour were able to differentiate known groups as predicted.  All 
other tests of known group difference tests were considered exploratory. 
 
7.7 Discussion 
The final psychometric evaluation demonstrated that PU-QOLI scales mostly satisfy 
criteria for rigorous measurement, confirming the acceptability, reliability and validity of 
PU-QOLI scales.  Some problems were detected that suggest improvements could be 
made (i.e. revisit qualitative work to add items to extend the measurement at the 
floor/ceiling scale range) and some scales would benefit from additional empirical 
evidence to support any changes or modifications required to improve the scales. 
 
The final version of the PU-QOLI is a 10 scale PRO instrument for measuring 
symptoms, physical functioning, psychological well-being and social participation 
specific to PUs (Appendix 7.1).  There are three symptom scales measuring: pain (8 
items), exudate (8 items), and odour (6 items); four physical functioning scales 
measuring: sleep (6 items), movement and mobility (9 items), daily activities (8 items) 
and vitality (5 items); two psychological well-being scales measuring: emotional well-
being (15 items) and self-consciousness and appearance (7 items); and one social 
participation scale (8 items).  Scale scores are generated by summing items and then 
transforming to a 0-100 scale.  High scores indicate greater patient bother.   
 
7.8 Summary of Chapter 7 
The psychometric evaluation of the PU-QOLI was undertaken in two field tests, 
applying both Rasch measurement and tradition psychometric methods.  The final 
psychometric evaluation confirmed the acceptability, reliability and validity of the PU-QOLI 
scales but also demonstrated important limitations in some of the scales that require 
further testing.  The next Chapter presents a discussion of the findings of the whole thesis, 
and considers study limitations and future directions. 
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CHAPTER 8  
GENERAL DISCUSSION 
 
8.1 Overview 
This thesis aimed to establish the impact of PUs on HRQL and determine the need for 
a PU-specific PRO instrument.  The research methods undertaken, important findings 
and the methodological developments woven into the research have been discussed 
thoroughly in their respective chapters.  Thus, this chapter aims to summarise the main 
findings from the thesis, discuss study limitations, and explore the implications for PU 
management and future research. 
 
8.2 Summary of findings from phase one 
Phase one of this research consisted of two systematic reviews of the literature, a 
qualitative study, and development of a conceptual framework.  The existing research 
in PUs was reviewed to establish the impact of PUs on HRQL and the potential need 
for a PU-specific PRO instrument (Chapter 2).  Despite a sparse PU and HRQL 
literature, some important findings emerged.  PUs and PU interventions cause patients 
significant burden, specifically severe pain and increased discomfort due to treatment.  
PU symptoms, use of various PU treatments and interventions, and the healthcare 
environment have detrimental effects on patients, contributing to physical, social and 
psychological impairment.  People with PUs have mixed beliefs about PU causes; the 
most common being a direct result of the healthcare received, and unless a patient had 
a history of PUs or belonged to groups at high-risk of PU development, there was lack 
of knowledge about PUs, suggesting the need for patient information and education 
about PU risks and treatments.  Other important issues identified related to patients‟ 
views and concerns being ignored by healthcare professionals, early warning signs 
(e.g. pain) did not always prompt action, and the physical, social and psychological 
aspects of patient need were not routinely met.   
 
The HRQL literature in the PU field is mainly qualitative, with emphasis on pain and 
physical functioning impairment rather than a comprehensive exploration of issues 
important to patients that may be broader than the commonly investigated HRQL 
domains.  Potential sources of bias in the qualitative work are due to low sample sizes 
(n=≤10) and underrepresentation of people with superficial PUs, the elderly (>70 
years), and those acutely ill or with various comorbidity.  PUs are common in patients 
with serious acute and chronic illness and the current evidence does not include the 
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views of all types of people with PUs.  Further, there is a lack of clear definitions and 
consistency in conceptualisation of HRQL outcomes, making it difficult to formulate 
precise operational constructs to guide the development of new specific PRO 
instruments. 
 
The review highlighted HRQL outcomes that are unique to PUs although there is a lack 
of quantitative work and these outcomes are currently not systematically included as 
outcomes in clinical trials.  Therefore the PU literature is unconvincing in terms of 
robust evaluation of the impact of PUs treatments on HRQL.  The few quantitative 
studies designed to explore HRQL in PUs had used measures not developed or 
validated for use with patients with PUs.  For RCTs, some included ad hoc questions 
(i.e. a questionnaire designed for a specific study, but not psychometrically evaluated) 
to measure sleep, comfort and pain rather than utilising existing validated instruments 
to assess HRQL outcomes.  Consequently, the limitations associated with the conduct 
and reporting of quantitative studies limited the furthering of our understanding of the 
impact of PUs and PU interventions on HRQL.  
 
The intention of the review was to identify all possible research on PU-specific HRQL.  
Interventional studies are intended to evaluate an intervention and not necessarily to 
illuminate the nature of HRQL, however interventional studies were reviewed as PROs 
associated with the impact of PU interventions (e.g. asking patients about their 
preference, comfort or pain) or HRQL outcomes using existing PRO instruments may 
have been assessed.  Quality assessment was applied, based on standards set by 
others (39, 337), for inclusion of RCTs.  Reasoning for applying the criteria was for 
consideration of study quality and consequently confidence in study results.  The loss 
to follow-up criteria was imposed on the study primary outcome rather than PRO data 
as failure to complete questionnaires or return them is likely in research.  Compliance 
with PU treatment was a problem for all RCTs, with many patients lost through the 
course of the study, resulting in RCTs being excluded.  If this had been a review of 
intervention effectiveness then a strict quality criteria would have been required.  
However, as the intention was to generate content (e.g. qualitative elements from 
quantitative research), such a strict criteria was not needed.  Although all RCTs were 
excluded at this stage, those that included PROs were considered for content and 
relevance to people with PUs in subsequent work (Chapter 4). 
 
Despite limited evidence, phase one of this research produced a working conceptual 
framework of HRQL domains specific to PUs and highlighted the potential need for 
outcome measures that can accurately depict the impact of PUs on HRQL.  The next 
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stage of the first phase was to confirm the relative importance of findings and formulate 
a final conceptual framework.  
 
New instrument construction needs to be underpinned with a strong conceptual base to 
ensure valid measurement; one that adequately defines the variables and relationships 
conceptually and gives operational meaning that guides the development (or selection) 
of PRO instruments (or scales) (86).  Development of a PU-specific conceptual 
framework was hampered by poor quality and quantity of literature, and as a result the 
framework development relied heavily on qualitative interviews with patients, endorsed 
by expert opinion.   
 
A PU-specific conceptual framework of HRQL was developed (Chapter 3) that includes 
four constructs: PU-specific symptoms, physical functioning, psychological well-being 
and social functioning.  These constructs are similar to those in generic HRQL models 
(78, 89, 96) however, this framework also incorporates components specific to PUs.  
There is no universally accepted definition of HRQL; however, central to most 
definitions is that HRQL is reflected by an individual‟s subjective perceptions, 
suggesting that the patients‟ unique perspective is vital and necessary when 
developing new PRO instruments.  On the basis of the Food and Drug Administration 
recommendations (86), the perspective of people with PUs was kept central at all 
stages of the development and validation of the PU-QOLI. 
 
The researcher, having reviewed the literature, may be criticised during data collection 
and/or analysis as being constrained by preconceived ideas of the relationships 
between some HRQL constructs and their properties.  However, as this research was 
applied in nature, some focus as to the constructs to be measured (i.e. HRQL) was 
considered acceptable.  The intention was to provide support for the work that had 
been done before and formulate a final conceptual framework based on previous 
research and new patient-reported data.  To minimise the risk of bias, an interview 
guide was developed to probe patient responses and ensure comprehensiveness 
rather than force comments or use leading questions.  Other precautions were used to 
ensure that data was analysed in a systematic manner, and that data interpretations 
were grounded in actual patient data to avoid bias that could be introduced with 
familiarisation with previous literature. 
 
Informal discussions with tissue viability nurse specialists/consultants allowed greater 
understanding of the experience of PUs and opinions regarding patient needs.  
However, the clinical experts consulted were part of the wider project team and 
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therefore, the opinions expressed may not have been generalisable to all tissue 
viability professionals at other clinical sites.  Consultation with clinical experts at this 
stage of the research was intended to help contextualise the impact of PUs, identify 
any important missed information, and provide clinical support for the findings 
(outcomes of interest) derived qualitatively. 
 
The framework includes conceptual domains for:  symptoms, including pain, exudate 
and odour; sleep impairment; difficulty with range of movement and mobility; limitations 
in daily activities, including aspects of self-care, home life, and doing things one enjoys; 
psychological functioning, including emotional well-being (i.e. mood, anxiety, isolation, 
dependence) and self-consciousness about ones physical appearance; and ability to 
participate socially.  Importantly, in the PU literature, the studies that developed and 
used ad hoc measures, despite seldom assessing symptoms, sleep, comfort and 
physical functioning outcomes, suggested that these outcomes are important in wound 
care.  The reason for them not being systematically included in PU research may 
therefore be due to a lack of appropriate (reliable and valid) measures to assess these 
outcomes.   
 
This research was the first to conceptually map the range and nature of the impact of 
PUs on HRQL and investigate patterns of association unique to specific patient factors 
in patients across all adult age-groups and gender, PU severity and skin site, clinical 
specialities and healthcare settings.  This was to ensure that the PU-specific HRQL 
conceptual model captured the views of all types of people with PUs and allowed a 
between case analysis comparison, where arising themes were coded and analysed so 
that commonalities between patients were identified.  Inclusion of patients with varying 
comorbidities assisted in separating out the effect of existing conditions from the effect 
of PUs to ensure that the conceptual framework was representative of PU-specific 
impact on HRQL and relevant to all types of patients with PUs.  However, the sample 
was limited to those who are English-speaking British nationals without cognitive 
impairment.  Differences in outcomes were explored by age, gender, PU severity and 
location.  PU symptoms were problematic for all patients, however older patients were 
less likely to report pain and for those with impaired sensitivity it was assumed pain 
was not a problem.  This suggests that special attention to PU management 
procedures that could inflict pain, particularly in older patients who may be less likely to 
report pain, is needed.  It also warrants further PU pain assessment and pain 
management research.  Further cross-case analysis, investigating patterns of 
association by other PU subgroups and investigation of mediating factors that affect 
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HRQL in PUs will add to the growing body of evidence about the impact of PUs on 
HRQL. 
 
The review of the PU and HRQL literature (Chapter 2) failed to identify PRO 
instruments specific for PUs.  The few studies that measured HRQL outcomes related 
to PU and PU treatment impact assessed outcomes with generic or chronic-wound 
specific PRO instruments.  This suggested that measures for other similar chronic 
wounds were available but suitability for use in PUs had to be determined.  Therefore, 
before developing a new instrument, existing instruments were examined.  The final 
conceptual framework provided a structured and formal method to assess the content 
of any available measures against and potentially provided the basis for the 
development of a new PU-specific measure of HRQL if required.  
 
The review of HRQL measures used in PU and other chronic wound research (Chapter 
4) revealed that HRQL outcomes important in PUs are inadequately covered by 
generic and chronic wound-specific instruments.  Despite similarities between 
conceptual models, the content differed at sub-domain and item level.  For example, 
the VLU measure had 75% of relevant HRQL domains, but items contained in relevant 
domains were not PU-specific.  The VLU physical functioning scale contains the item 
“difficult to move” but misses important PU-specific issues such as difficulty with 
transferring, sitting for long periods, and moving around on pressure-relieving 
mattresses.  Due to issues of content validity and specificity, the appropriateness of 
using existing PRO measures in PU research was questioned.  The 75% cut-off 
(included 10 of 13 PU-specific domains) was selected to determine whether existing 
PROs represented PU-specific issues (domains).  If a lower threshold had been used 
then additional PROs would have been considered.  The items from existing PROs 
used in chronic wounds research were inspected to include in the item pool but items 
were found to not be PU-specific. 
 
Underlying the limitations of using these instruments in PUs is a lack of understanding 
of what patients perceive to be important in terms of HRQL outcome.  Consequently 
none of the existing PRO instruments used can be considered valid measures of PU 
patient perceptions of outcome, as there has been no research to comprehensively 
uncover these perceptions.  In addition, measurement of general health status and 
HRQL in relation to outcome of PU treatment has been largely ignored to date (i.e. lack 
of data concerning benefits, cost effectiveness and long term outcomes of many 
common PU interventions).  When selecting a PRO instrument, careful consideration of 
the conceptualisation of PRO instruments content as well as determining fit-for-purpose 
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is needed, prior to evidence for validity, reliability and responsiveness of outcome 
measures.  As no PU-specific PRO instruments exist, and to address some of the 
limitations of using available instruments in PU research, patient-assessed HRQL 
measures specific for patients with PUs are needed for use in clinical practice and 
future research. 
 
It was considered that a new measure, using stringent international criteria from the 
health measurement literature, would provide a vehicle by which data on PUs could be 
collected.  Measures to address issues concerning outcomes of PUs and the impact of 
treatment was pertinent as to date there was no easy, standardised method for 
assessing outcomes important to people with PUs due to a lack of a suitable 
instrument  (i.e. need precise (required for individual clinical decision making) and less 
burdensome PRO measures).  The empirically derived PU-specific conceptual 
framework informed the development of a new HRQL instrument for PUs.   
 
8.3 Summary of findings from phase two 
Thorough and systematic steps were taken to develop and pretest (Chaoter 5) the PU-
specific PRO instrument of HRQL (the PU-QOLI). 
 
8.3.1 Development and Pre-Testing the PU-QOLI scales 
The objective of this phase of the research was to develop a PRO instrument for PUs 
that assessed the conceptual domains generated from the review of the literature, 
patient interviews and expert opinion.  Properties of the conceptual model formed the 
content (items) of the new instruments scales.  The patient experience needed to be 
captured and therefore patient statements were included as items to ensure that the 
PU-QOLI was from the perspective of those with PUs using their words.  However, 
some words included may not be meaningful to all people in the UK (e.g. “foisty”).  At 
this stage the inclusive approach was used to ensure that all issues important to 
patients with PUs were captured and then tested and refined in subsequent work (i.e. 
pre-test and first field test).  In order to encourage optimal instrument completion (the 
best responses and completion with no missing data), the way the PU-QOLI was 
designed was tailored to the characteristics of patients with PUs (i.e. understood by 
and relevant to the intended population).  Careful consideration of the layout and 
instructions, framing of questions, response format and recall period was taken to 
reduce potential biases and cognitive and respondent burden.   
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Criteria designed to guide questionnaire design and item construction where followed 
(132, 211, 244).  Wherever possible, the exact wording used by patients during the 
qualitative work was retained for items.  Jargon (words not part of everyday 
vocabulary), ambiguity (vague terms) and double-barrelled questions (a questions asks 
about more than one issue) were avoided to reduce confusion.  The appearance of a 
PRO instrument needs to be designed so that variability between interviewers is 
reduced, response rates enhanced and non-response bias and bias arising from 
respondent error (e.g. ticking wrong box) reduced.  Instructions contained only 
essential information needed for PU-QOLI completion.  Important instructions were 
highlighted and each section (question) defined in order to ensure that meaning was 
consistent across respondents.   
 
Deciding on the number of response options to include is a balance between 
maximising precision and minimising bias and respondent burden (85, 132).  The 
response categories were chosen so as not to have more than five responses in order 
to maximise the extent to which patients were distributed across response categories 
(132).  Wording used was clear and appropriate to the question stem and intended 
population and a clear distinction was made between choices; discrete response option 
category scored with successive integer scores that imply a continuum of increasing 
impact, from less to more. 
 
Important disease changes/progression and memory error (recall bias) need to be 
considered when choosing a time-frame.  A recall period of the past-week was chosen 
on clinical grounds, as changes in PU severity and symptomology often occur over 
days and thus a longer recall period would risk not capturing relevant changes to 
HRQL outcomes.  Events that occurred over a month ago may no longer be relevant or 
have since been resolved or treated. 
 
Obtaining the best possible health outcomes data requires the use of appropriate 
methods to ensure high quality data with limited bias.  A potential problem for data 
quality is interviewer bias; bias introduced due to the social interaction between the 
respondent and interviewer (e.g. social acquiescence or characteristics of the 
interviewer may affect both response rates and the nature of responses given).  It was 
envisaged that the PU-QOLI would be used in future PU treatment effectiveness 
research; therefore the mode of administration selected for the new instrument was 
self-completed.  In research, self-completed versions are often preferred as they are 
associated with lower costs, can cover largely dispersed populations (if postal), require 
less time to collect data, and avoid potential interviewer bias (244).  However, 
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importantly, as many patients had difficulty with self-completion during pretesting, the 
mode of administration was changed to interview-administered (expanded in section 
7.4).  If mode was not changed then a large proportion of eligible patients would be 
excluded in future research as they would be unable to self-complete the PU-QOLI 
scales.  The equivalence of self-completed and interview-administered versions of the 
PU-QOLI was investigated during preliminary field testing (expanded in section 7.3.2).  
In hindsight, the advantages of administration (response rates are typically higher, 
reducing non-response bias) make this method preferable for elderly or chronically ill 
populations, and accordingly suitable for people with PUs.  
 
Pre-testing was carried out in order to ensure that the steps taken to reduce sources of 
potential bias had been effective and that the preliminary PU-QOLI was clear, 
understood and relevant to the intended population.  This process was effective for 
identifying problems with PU-QOLI items and design early in the development process, 
and for guiding changes to layout, content and mode of administration.  Using mixed 
methods provided useful information needed for item selection and deletion, 
particularly for ensuring clinical meaningfulness, importance to patients and good 
measurement properties (expanded in section 8.5).   
 
Pretesting was particularly important in this population as patients with PUs often have 
underlying comorbidities.  Therefore, to ensure that reported issues were PU-specific, 
outcomes associated with other comorbidities were isolated from PU-specific 
outcomes.  Interview probes were carefully developed to ensure unbiased phrasing 
(i.e. ensure probes were not leading respondents) and further clarifying questions were 
asked (e.g. Do you think [that] is only because of your PU or resulting from a 
combination of things?), to ensure that the PU-QOLI detected PU-impact rather than 
impact on HRQL due to other medical conditions.  
 
Caution should be used when making significant changes to newly developed 
instruments on the basis of small samples.  Modifications made should improve the 
content and quality of data collected.  For the PU-QOLI, a crude estimate (>40%) was 
used to provide a systematic approach based on standard psychometric criteria (37, 
38) for the removal or merging of items.  During development, an inclusive approach 
was taken, where all patient verbatim were retained as items, including verbatim/items 
with very similar wording.  During cognitive interviews, patients were specifically asked 
to comment on similarities with the intention of retaining those items most 
representative of the patient perspective.  Decisions to remove or merge items were 
made after extensive discussion with both clinical and health outcome methodology 
205   General discussion 
 
 
experts to ensure that specific components of each construct/scale were not removed 
but rather only items pertaining to the same component but that were worded slightly 
different.  Expert consultation also resulted in the addition of items representing PU-
symptoms.  Counting frequency or assessing intensity of symptoms may not be an 
adequate measure of HRQL (39), but the impact of these symptoms and the meaning 
for individuals is an important aspect of HRQL assessment and therefore considered 
important outcomes for inclusion in a PU-specific PRO instrument.   
 
Minor changes made following pre-testing resulted in a 13 scale instrument intended 
for interview-administration.  The modified PU-QOLI was tested to ensure that no 
subsequent problems were introduced after modification, and confirmed acceptability of 
the final preliminary version, which took around 30 minutes to complete.  The 
completion time may be considered a burden to patients, however, part of the rationale 
for the next stage of research (item-reduction) was to reduce patient burden through 
the generation of scales that included items with the best measurement properties.   
 
Pretesting was useful for identifying problems with PU-QOLI items and design.  The 
methods guided changes to layout, content, administration mode, and item selection to 
reduce respondent burden, decrease data errors and non-response, and provide 
further validity and clinical utility of each PU-QOLI scale as reflected by clinically 
meaningful hierarchical scales, prior to formal psychometric evaluation.  Patient input 
proved to be the most important element of the development process.  The Rasch 
analysis was not used to make changes to the PU-QOLI scales.  However, it was a 
useful demonstration of how Rasch measurement methods can provide a 
complementary method alongside standard qualitative pretesting, for evaluating the 
strengths and weaknesses of PROs during early testing and illustrated the changes 
that could have been made if both methods were used simultaneously.  This was a 
novel methodological development, as Rasch measurement methods have not been 
previously used during early PRO development therefore the ideas presented here are 
new.  Historically, the Rasch paradigm has not been widely adopted in health 
measurement research, but more recently the benefits of using Rasch methods are 
demonstrated (87, 262, 284, 305).  This work highlights that iterative, small tests, were 
PRO development is based on qualitative and empirical data is beneficial, with the 
Rasch evidence collected to highlight anomalies in the data and interpreted 
interactively, rather than used as strict cut-off criteria to throw out items.   
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8.4 Summary of findings from phase three 
Phase three of this research involved psychometrically evaluating the PU-QOLI in two 
field tests (Chapters 6 and 7) and determining optimal mode of administration in a sub-
study. 
 
8.4.1 Preliminary psychometric evaluation of PU-QOLI scales 
The preliminary PU-QOLI was field tested in 236 patients with PUs.  The feasibility and 
acceptability was established as demonstrated by acceptable data quality, indicating the 
suitability of interview administration.  The sample included mostly white British 
nationals.  It could be argued that there were a disproportionate number of people from 
different ethnicities represented in this sample.  However, this sample reflected the 
patients with PUs under the care of tissue viability teams in the 34 hospitals and 
community services around the UK participating in this research, and therefore, as one 
of the goals of the instrument was to be used in PU research, it was important for the 
PU-QOLI to be based upon representative samples of patients. 
 
This research took an approach to scale development that is strongly recommended 
(87, 284) but differs somewhat from approaches adopted by others.  Specifically, PU-
QOLI was developed on the basis of a conceptual model that defined the areas for 
scale development and then used an explicit mathematical model (Rasch) to guide the 
development of each PU-QOLI scale.  More typically health rating scale development 
uses statistical techniques, such as factor analysis of an item pool, to define the 
content of the constructs (scales) to be measured, and then traditional psychometric 
methods to test the reliability and validity of produced scales and for further refinement 
(item reduce) of scales based on whether individual items meet certain psychometric 
criteria.  With this approach, the content (items) of a scale, rather than the construct 
intended for measurement, define what the scale measures (87).  Grouping items 
statistically or thematically can be misleading, as it assumes, based on correlations 
between items, that they measure the same thing, however this does not ensure that 
items in a group measure the same construct.  
 
Most outcome measures used in healthcare are ordinal in nature, making them valid for 
group-level-based research.  Ordinal measurements describe order but not the relative 
size or degree of the difference between measurements, which means that equal 
meaning of change scores for an underlying latent trait cannot be assumed.  Put 
another way, a change from „no bother‟ to „a little bother‟ for say „difficulty transferring 
from a bed to chair‟ may not have the same significance as change from „a little bother‟ 
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to „lot of bother‟ on the same item.  Rasch methods offer the ability to construct linear, 
interval-level measurements from ordinal-level rating scale data (291, 338), thereby 
addressing a major concern of using rating scales as outcome measures (339).  Linear 
transformation produces a hierarchical ordering of items along the underlying 
measurement (construct) continuum, thus examination of changes in scores are 
comparable as the distance between items has meaning (290, 340).   
 
The Rasch model also provides a powerful framework to guide scale construction, 
enable sophisticated checks of internal validity and consistency of scores, and a means 
for determining whether fundamental measurement properties are achieved, properties 
required for valid transformation to interval scaling.  These properties include: 
numerical order (one mark on the ruler (the measurement continuum or item set) 
represents more or less of the construct than another); addition (points on rulers may 
be added); and specific objectivity (the calibration of the ruler is independent of the 
sample used to calibrate it and vice versa) (273, 290).  To determine whether these 
properties are confirmed, testing: the scale for unidimensionality, a requirement for 
construct validity (132); the invariance of items (the ratio of difficulty between any pair 
of items remains constant across the ability levels of respondents), required for 
interval-level scaling; appropriate category ordering (whether the items response 
categories are working as expected); and DIF (whether responses to items are biased 
by subgroups in the sample) (85, 262, 308), is undertaken.  When these tests are 
confirmed, or when data fit the Rasch model, the PRO instruments developed with 
Rasch methods are useful clinical measurement tools for individual patients, making 
them well-suited for use in both research and routine clinical practice (90, 341).  
However, for some clinicians and researchers, Rasch methods may appear 
complicated, requiring both specialist knowledge and training in undertaking the 
analyses, use of the software, and interpretation of the results.  The clinically 
meaningful scientific advantages of using Rasch potentially outweigh these concerns.   
 
Despite Rasch methods providing a unified approach to evaluating PRO instruments, 
there are no strict criteria for guiding item reduction; rather, decisions for the 
inclusion/exclusion of items were made according to appraisals of multiple analyses of 
the observed data against measurement criteria, as opposed to examinations carried 
out singularly or sequentially, with consideration of clinical meaningfulness.  As such, 
some decisions about item reductions were based on conservative estimates.  Therefore, 
it must be considered that if more stringent criteria were used for item selection then 
this would have resulted in different items being retained for the final scales.  For 
example, some scale items had residual correlations above 0.30, suggesting local 
208   General discussion 
 
 
dependency.  However, these items were not necessarily removed based on this 
criteria alone; consideration of multiple criterions allowed for a fairer assessment of 
content, in which different item properties were assessed in combination and 
considered for clinical meaningfulness were retained.  This is a problem faced by all 
developers of new rating scales.  In order to justify these decisions, importantly, the 
items retained were needed for the breadth, range and measurement precision of each 
construct they measure.  This was considered particularly important for clinical care and 
research where precise estimates of people‟s locations on a measurement continuum are 
needed for detecting clinically significant change; items are needed to cover the full 
measurement range of each construct measured.  Thus, at this stage of PU-QOLI 
development, although issues relating to psychometric cut-off points are pertinent, there 
was reluctance to reduce the number of items any further so as not to compromise 
content and clinical validity or risk reducing the measurement range but still ensuring 
that only the best indicators of outcome were retained.   
 
In an attempt to create scales that captured the entirety of the patient experience as 
represented by the a priori conceptual model, for each conceptual domain, items were 
selected to produce a scale representing that domain.  The psychometric evaluation 
revealed that not all scales met requirements for reliable and valid measurement.  
Therefore some exploratory post hoc analyses were undertaken, where items were 
added to the vitality scale and conceptually related constructs were combined, and the 
psychometric properties of the new scales explored.  A criticism of this method might 
be that the content of the new scales was thematically driven rather than by the explicit 
definitions of the constructs (domains) contained in the conceptual model.  Patient 
transcripts were revisited to identify additional items for the vitality scale.  The vitality 
scale was selected in the first instance as a means of testing the methodology in one 
scale, with the potential for using the same methods to improve the other scales (i.e. 
revisit transcripts and/or targeted qualitative work to improve the scales‟ measurement 
range).  The measurement properties of the modified vitality scale were tested during 
the first field test.  Only psychological constructs mood, anxiety, autonomy and isolation 
were combined into a higher order construct - emotional well-being, as items for these 
constructs all pertained to feelings (not items covering a wide range of constructs).  
The rationale for retaining these items was so that content capturing important data 
related to the PU-experience of individuals was not excluded.  The process of 
modifying a newly developed instrument is part of an evolving measurement process 
intended to strengthen the hypothesised conceptual relationships with empiric evidence 
(82).  Importantly, the new emotional well-being scale demonstrated good reliability and 
within scale validity.  Finally, the item „itchiness‟ was considered a separate 
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consequence of PUs that‟s has clinical value, especially in terms of patient bother and 
symptom management, and therefore retained as a single descriptive item.   
 
The first field test was carried out in order to retain scale items with the best 
psychometric measurement properties (items that perform best against established 
psychometric criteria) and investigate the item response format selected for the PU-
QOLI against a strict paradigm, the Rasch measurement model (276).  The empirical 
evidence suggested that in an attempt to get good precision (greater number of 
response categories), people were unable to discriminate between the 4-point 
response options as demonstrated by disordered thresholds.  Disordered thresholds 
threaten validity.  A post hoc reduction of response options from 4 to 3-points indicated 
that the modification was justified as demonstrated by no subsequent disordering of 
thresholds.   
 
In addition, an empirical investigation of optimal mode of administration for the PU-
QOLI scales revealed that self-completion was not suitable for patients with PUs.  
Consequently, mode was changed to interview-administered to ensure that the PU-
QOLI would be applicable for a wider range of people with PUs and potentially yield 
higher quality data.  Administering a PRO instrument to a patient rather than them self-
completing it on their own may potentially affect the responses given.  The suitability of 
self-completion was investigated in this patient group and found not to be acceptable 
(pre-test and sub-study results, Chapter 5 and 6).  A patient-self-completed PU-QOLI 
was preferred but practical constraints meant that this method was not appropriate.  A 
user manual has been developed to guide PU-QOLI administration to ensure that the 
interviewer acts only as an intermediary for recording patients own responses on the 
instrument and to minimise the interviewer‟s potential for interpreting responses. 
 
Due to the requirement for equivalent groups for a DIF analysis, only those able to self-
complete the PUQOLI were included in the sub-study.  The sub-study findings do not 
tell us anything about those people unable to self-complete.  The intention was to 
provide preliminary empirical evidence for whether two mode versions could be 
developed.  In the process, it set the ground work for hypotheses that can be tested in 
subsequent research (e.g. determine whether both mode versions are suitable for 
community patients). 
 
A preliminary psychometric evaluation of the Rasch produced PU-QOLI scales 
supported the acceptability (demonstrated through a high percentage of computable 
scale scores) and reliability (demonstrated through internal consistency and item-total 
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correlations exceeding psychometric criteria).  Construct validity was limited to within 
scales analysis.  The final PU-QOLI scales underwent a full psychometric evaluation in 
a large independent sample of patients with PUs. 
 
8.4.2 Final psychometric evaluation of PU-QOLI scales 
The purpose of the final field test was to assess data quality, scaling assumptions, 
targeting, reliability and validity to ensure that the final PU-QOLI performed 
appropriately in an independent sample.  Final field testing was carried in 231 patients 
with PUs.  The empirical evidence supported the underlying conceptual model; 
producing 10 factors, including scales for PU symptoms, limitations of physical 
functioning, psychological functioning, and social participation.  The final PU-QOLI 
contains 81 items which might be considered too long for routine clinical use or research.  
Importantly, the instrument consists of 10 independently evaluated scales.  Each scale is 
a stand-alone measurement instrument that contains items needed for measurement 
precision of each construct they measure.  However, where evaluation of PROs is often 
undertaken in busy multidisciplinary healthcare services, development of a short-form 
version of the PU-QOLI, where the most clinically appropriate items from each scale are 
selected (342), may be beneficial (expanded Section 8.8.3, Clinical application). 
 
Overall support was established for the psychometric properties of the PU-QOLI scales 
demonstrated by adequate fit to the Rasch model, marginal DIF bias, good internal 
consistency and support for unidimensionality of the scales.  Two items presented with 
item fit statistics below the recommended criteria, however the discrepancies were small 
and therefore unlikely to impact on measurement.  However, important issues emerged in 
relation to the item response categories and sample-to-scale targeting.  Inspection of 
the item response format revealed issues regarding the ordering of response 
categories for items in 5/10 scales.  A reduction in the number of response categories, 
from three to two, might resolve any disordering; however no rescoring was undertaken 
at this stage.  The problem with the response format may be influenced by the 
relatively small sample used in this study.  As such, verification of findings is needed in 
a larger sample before specific recommendations are made.  It does however suggest 
that dichotomizing items may be warranted in future studies to reduce potential 
confusion for respondents as the findings suggest that respondents are unable to 
reliably distinguish between what is meant by 'a little' and 'a lot'.  It might be that for 
people with PUs, they either have the problem or they do not, in which case, a yes/no 
response option would be justified.  
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Another important finding was suboptimal scale-to-sample targeting.  It is expected that in 
a sample of people with mixed severity PUs, people would have a range of difficulty or 
impairment due to PUs that would consequently affect aspects of their HRQL.  However, 
94% of PU-QOLI items had „no bother‟ as the highest category frequency, with almost half 
(48.8%) of the items having a substantial percentage of people (>50%) scoring 0 (no 
bother).  This finding implies that these patients had no bother with PUs impacting on 
HRQL outcomes, which is inconsistent with expectation.  In practice, there is likely to be 
more clinical heterogeneity in patients with PUs than is implied by this finding, which 
indicates a targeting problem (possible mismatch between item difficulties and patients‟ 
abilities in this sample).  As discussed by others (343), this is important because the 
limited item level targeting will impact on the overall ability of the PU-QOLI scales to 
detect HRQL differences between people and groups and potentially be less sensitive to 
the effects of interventions.  Ideally, the range of outcome measured by the PU-QOLI 
scales should be well-matched to the range of outcome present in the study sample so 
that the scales have the ability to detect variability among and within individuals.  Poorly 
targeted scales are likely to underestimate changes over time and differences between 
groups (274), which is relevant for future PU clinical trials that tend to recruit people with 
superficial PUs (123). 
 
The issue of targeting could be improved with the addition of items to cover the construct 
measurement range at the extreme ends.  Further work is required to determine whether 
some items would benefit from different response categories (i.e. dichotomising 
responses) or additional items, to make the scales psychometrically stronger, yet retaining 
their clinical meaningfulness. 
 
The final PU-QOLI scales were also analysed using traditional methods to provide 
traditional psychometric evidence for the final scales, in line with current FDA guidelines 
(86).  The methods and criteria used were the same as those used in the preliminary 
psychometric evaluation (i.e. post Rasch analysis and item reduction).  The PU-QOLI 
was acceptable to patients, as the proportion of missing data was low.  Tests of scaling 
assumptions mostly confirmed that items were grouped correctly.  For example, 
corrected item-total correlations exceeded recommended criteria for all scales, 
however, item mean scores and variances were not especially similar.  Whilst this 
implies that some criteria for scaling assumptions were not satisfied, it is important to 
note that the samples were not evenly distributed, with many people scoring at the 
lowest range of the scale, which may be the reason for this finding; notably, all item 
mean scores are below the mid-point range for each scale, supporting this explanation. 
Scale scores spanned the entire range of the scales however there were significant 
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floor effects for four scales and four were notably skewed.  These findings indicate 
adequate scale-to-sample targeting but potentially poor item-to-sample targeting; the 
range mapped out by items in these scales was poorly matched to the range of 
variable in this sample.  Standard criteria were effectively satisfied for internal 
consistency reliability as demonstrated with high alpha coefficients and item-total 
correlations.  Test-retest ICCs were high for 8/10 scales.  Two scales were below the 
recommended minimum (>0.70), however, only marginally (>0.60). 
 
In addition, comparison with external measures were employed for assessing construct 
validity including the SF12 (333) and PU-QOLI overal QoL and overal pain items.  The 
order of the battery of instruments administered to patients was the PU-QOLI 
adminsitered first, followed by the SF12, consistently throughout.  No alternative order 
of administrations were tested, as this was beyond the remit of this thesis.  It could be 
argued that presenting the questionnaire battery in this fashion may have resulted in 
order effects.  Mixed findings have been reported when the effects of changing 
questionnaire order have been investigated; some have found significant order effects 
(344) while others found no differences in scores on any measure (345).  Hence, the 
potential order effects on the PU-QOLI would need investigation.  
 
Construct validity revealed satisfactory levels regarding within scales analysis and 
against external measures; the generated hypotheses were supported, thus providing 
evidence for convergent and discriminant validity.  Ideally for the results of correlations 
between PU-QOLI scales and other scales to be fully interpretable the external 
measures should be reliable and valid.  The psychometric properties of the SF12 have 
not previously been examined in PUs.  Reasoning for selecting the SF12 was on the 
basis of its wide-spread use in chronic wounds and other dermatological conditions.  
However, it should be noted that conflicting results have been found when changes in 
HRQL due to PUs have been assessed using the SF36 and other generic instruments 
(109, 112).  Generic instruments are intended for population comparisons on broad 
domain level, for a wide range of health conditions, and therefore may not be sensitive 
enough to detect the true impact of PUs on HRQL and provide information about the 
real changes within patients with PUs or differences among them.  As such, additional 
evidence for convergent validity would provide further support for the PU-QOLI scales.   
 
In general, the Classical psychometric evaluation provided the first evidence towards 
support for the acceptability, reliability and validity of PU-QOLI scales.  The PU-QOLI 
scales meet FDA criteria for use in clinical trials (86) with patients with PUs at group 
level.  However, the Rasch analysis demonstrated that some of the scales would benefit 
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from further work to improve their content and measurement properties and suitability 
for individual patient assessment.  Consequently, further work is proposed (see Section 
8.8) and any future use of the PU-QOLI scales should include further psychometric 
evaluation. 
 
8.5 Further methodological outcomes of this research 
8.5.1 Optimal retrieval methods for HRQL qualitative data 
Part of this research included an evaluation of the effectiveness of qualitative 
methodology search strategies with subject-specific (HRQL) search strategies in the 
retrieval of qualitative PRO data of the impact of PUs on HRQL (Appendix 2.2).  The 
subject-specific (HRQL) search strategy developed for this research identified all 
studies reporting qualitative HRQL data, whereas, research methodology-based 
(qualitative) strategies did not identify qualitative data reported in mixed method 
studies.  Thus use of the HRQL search strategy maximised yield of relevant studies, 
making subject-based strategies more effective in retrieving the data of interest and the 
preferred method for comprehensive literature searching.  However, for time efficiency, 
a broad-based qualitative-methodology search strategy is suitable for identifying most 
qualitative patient-reported HRQL research.  Importantly it was found that in the HRQL 
field, qualitative data are reported in both qualitative and mixed methodology research 
and searching for this type of data involves trade-offs between yield, sensitivity and 
specificity.  Accurate indexing of subject-specific outcomes and methodology used in 
electronic databases and publications is needed.  
 
8.5.2 Mixed methods 
This research was the first study to use Rasch measurement methods during the early 
stage of PRO instrument development.  Rasch analyses provided useful information for 
scale development, specifically support for item -fit, ordering and validity by supporting 
patients' views that items made contextual sense and were relevant to them.  This was 
further demonstrated by determining that items work together to define single variables 
and map out a discernable line of increasing intensity.  This important contribution 
ensures that scale construction is underpinned with a strong conceptual base, a 
process central to valid measurement (3, 25).  This work adopted an experimental 
approach that suits the Rasch paradigm, providing cross validation, for example, where 
patients reported problems with the PU-QOLI, the quantitative preliminary analysis 
verified qualitative comments made.  One of the unique features of the Rasch model 
includes parameter separatability; where relatively robust estimates are possible with 
small sample sizes (13, 14, 15, 16), justifying inclusion of Rasch methods for pretesting 
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where small samples are often used.  The ultimate goal was to provide an early 
quantitative view of the extent of potential problems/issues with PU-QOLI scales, 
however all findings needed to be verified and empirically strengthened in a larger 
sample as small sample sizes have implications for the interpretation of results.   
 
Mixed methods, with the inclusion of a DIF analysis, were also used in a sub-study 
intended to determine optimal mode-of-administration for the PU-QOLI, providing both 
qualitative and empirical evidence for the selection of the most appropriate 
administration mode for the target population.  This methodology allowed for 
consideration of characteristics response rate, data quality and potential for bias from 
sources other than non-response such as measurement equivalence between self-
completed and interview-administered modes.  Qualitative findings highlighted difficulty 
with patient self-completion.  Investigation of response rate and data quality indicated 
no difference in response rate between mode groups but a difference was observed in 
data quality; a large proportion of PU-QOLIs were returned with missing data in the 
self-completed group, supporting the qualitative findings.  Sub-group analysis indicated 
that the missing data was mainly observed in acute hospital patients who self-
completed, suggesting a self-completed version might be inappropriate for acute 
patients but potentially feasible for community patients; there was no difference in 
response rate and data quality by mode for the community setting group.   
 
The DIF observed was marginal thus providing preliminary evidence of stable item 
performance across mode groups.  However, given the small sample size; DIF is a 
product of the sample and not the scale (85), the sample size was amended (inflated) 
and DIF re-examined.  Increasing the sample size identified additional items with DIF, 
highlighting items to be cognisant of if pursuing a self-completed version in the future.  
Additional empirical evidence is needed for support of measurement equivalence 
between mode groups.  As a significant proportion of missing data was found in the 
self-completed group, it was considered that a self-completed PU-QOLI would limit the 
people that could be assessed.  In longitudinal research, this can be problematic as the 
progress of PUs and the impact they have on patients may not be accurately assessed 
due to high levels of missing responses on repeated measurement, hence the need for 
interview-administered methods.  The Rasch/DIF analyses provided a complementary 
method alongside standard testing for examining optimal administration methods, with 
the intention of flagging issues with DIF for future examination.   
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8.5.3 Comparison of psychometric methods modern and classical 
It is important to highlight that the traditional psychometric methods implied that the 
PU-QOLI scales are reliable and valid indicators of PU-impact and patient bother.  
However, the more sophisticated techniques employed in the Rasch analysis 
uncovered a number of inherent problems with some of the final PU-QOLI scales, 
specifically with the scoring function (e.g. participation scale) and scale-to-sample 
targeting that indicated limited measurement range at the extreme ends of scales (e.g. 
movement and mobility scale).  Classical and Rasch methods are related in that they 
are both based on mathematical principles and used to evaluate rating scale‟s 
psychometric properties (e.g. the equation 0=T+E).  There are equivalences such as 
the PSI and Cronbach‟s alpha for reliability estimates.  However, Rasch extends on 
Classical methods by providing sophisticated tests intended for disclosing anomalies 
that may threaten valid measurement.  Traditional methods are limited in the 
information they provide at item level, particularly about the adequacy of the response 
options and fail to provide specific guidance on how items might be improved.  Rasch 
methods overcome these limitations as they are able to better diagnose specific issues 
surrounding the performance of rating scales (284, 346).   
 
Statistical tests of fit provide stringent checks of the extent to which observed data 
satisfy measurement model requirements.  Some misfit is to be expected, however the 
key focus of the analysis is not to only identify misfit but seek to explain why items 
initially hypothesised to belong to a common variable do not support that prediction 
(291).  As was demonstrated here, reversed response categories and item misfit were 
detected, despite meeting traditional criteria for reliable and valid measurement.  
Reversed response categories indicate that the scoring function does not work as 
intended which is problematic as ordered thresholds are a fundamental necessity for 
establishing scale validity (85, 276, 305).  Reversed thresholds can also contribute to 
item misfit.  Some of the scales had small sample sizes and low frequency of response 
category endorsement, indicating further testing is required in a larger sample.   
 
PRO instruments developed from a traditional perspective often include an item 
reduction stage, where items that do not meet psychometric criteria are removed from 
the scale (182, 294, 318, 330, 347).  As already discussed, evidence from a Rasch 
analysis is used to understand why scale items might not be working, rather than used 
as a method to remove items from a scale.  The evidence helps to establish which 
items are working/not working, and pin points where improvements could be made.  
For example, if the ordering of polytomous response options is not working as 
expected, categories with disordered thresholds could be collapsed.  In practice it 
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might be preferred to have instruments with fewer items however, item reduction using 
classical methods is often detrimental to the measurement range and construct validity, 
as items at the floor and/or ceiling are often removed due to infrequent endorsement 
(85).   
 
8.6 Methodological issues and study limitations 
In the qualitative phase of PU-QOLI development, in-depth interviews were used to 
develop and refine the content of scales.  Additional qualitative methods such as focus 
groups and interviews with the carers of people with PUs may have provided a further 
opportunity to marry findings.  However, the qualitative interviews were continued to 
the point at which no new information emerged, ensuring that the conceptual 
framework adequately covered outcomes important to patients with PUs.  Subsequent 
pretesting with patients confirmed the framework that emerged from the qualitative 
work, providing support for the adequacy of the qualitative method used in this thesis. 
 
Traditionally, clinical intuition and experience have often been regarded as sufficient 
prerequisites for the construction of PRO instruments.  Yet, PRO measurement in 
patients with PUs is complex, and there are number of measurement issues in studying 
this patient group.  For example, the validity evidence for the PU-QOLI scales must be 
interpreted with some caution.  This is because of the inherent difficulty in 
differentiating the impact of PUs on HRQL from patient comorbidity.  Efforts were made 
during the qualitative work to elicit outcomes specific to PUs, but it may be difficult for 
some patients to think only of PU impact when they have a multitude of medical 
problems.  Clarifying questions were used to try and extrapolate PU specific issues 
from patients‟ reports.   
 
The qualitative work focused on PU bother and impact.  Questioning was intended to 
elicit the worst aspect of having a PU and consequently assumptions were made about 
how PUs can impact all people with PUs.  This line of questioning may have also 
missed valuable information about the patient‟s experience of when PU symptoms and 
other aspects are managed well.  Better use of qualitative questioning would have 
included patients with healed PUs or severe PUs close to healed.  These patients 
could have been asked about the entirety of their experience, with more thought given 
to covering the full spectrum of the PU experience.  For example, questions pertaining 
to the patients‟ experience of when treatment was effective or the PU impact was 
milder/not at its worst, and words to describe the benefit/PU improvement.  This may 
have helped with improving the measurement range by inclusion of items that 
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represented milder PU impact/bother.  The patient transcripts could be revisited with 
this in mind or new qualitative work undertaken for further conceptualisation. 
 
Each item within a scale is a component of the construct being measured and each 
construct (scale) is operationalised by the items (content) within it.  To enable 
measurement of clinical variables, each scale requires a set of items that map out the 
construct they purport to measure.  The aim of items is to mark out a measurement 
continuum for each construct on which people can be located or measured (87).  
However, consideration is needed of whether quantification of PU symptoms into 
multiple item scales is necessary.  For scales where a measurement hierarchy is 
required to capture less of or more of a construct (e.g. difficulty with mobility), multiple 
descriptors are needed, but for exudate and odour, where a patient either has smell or 
leaking and is bothered by it, one item rather than multiple descriptors may be 
appropriate.  For PU pain, the impact of pain is not necessarily related to the intensity 
therefore multiple descriptors may be required to differentiate between the types of 
pain a patient is experiencing (e.g. inflammatory pain versus neuropathic pain).  Each 
PU-QOLI scale is intended to measure one construct and therefore multiple items 
represent a measurement continuum upon which patients can be located and 
monitored for changes.  The legitimacy of including particular items in a scale was 
investigated using Rasch methods; principles that are based on measurement theory.  
Using Rasch methods allowed the assessment of whether each item within a scale 
contributed towards defining the construct measured.  The analyses supported the 
items contained within the three symptom scales; however subsequent work could 
consider the selection of the most clinically appropriate items from each scale (see 
Section 8.8.3).   
 
Key indicators of the quality of a PRO instrument are the reliability and validity of the 
measurement.  A limitation of this study was that the psychometric properties of the 
final version of the PU-QOLI were estimated using data from a single study, where, due 
to many people scoring at the floor of the measurement range, small samples were 
often used for scale analysis (expanded Section 8.8.3, Reanalysis).  Since the 
psychometric estimates are subject to sampling variation, it is possible that different 
items might have been selected if more data had been available.  The samples were 
small for some scale test-retest which can influence the generalisability of the results.  
Evidence indicates that useful reliability estimates can be obtained from small samples 
(348, 349) but the scales would benefit from further examination of the measurement 
properties to ensure reliability.  Further, as due to small sample sizes, the severe 
category 3 and 4 PUs were combined for the known groups tests, reanalysis is 
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required in larger samples to allow a true picture of how well PU-QOLI scales are able 
to discriminate between subgroups of patients known to differ in terms of clinical 
presentation.  In addition, responsiveness - the ability of an instrument to accurately 
detect true change in the trait measured when true change has occurred - is of interest 
in healthcare applications where improvement in outcomes as a result of treatment is 
often a primary goal of research (350).  Examination of responsiveness was not 
undertaken as it requires longitudinal research for testing (e.g. RCTs).   
 
The validity testing of PU-QOLI scales was limited, in part, by a lack of appropriate 
validating measures and the ability to formulate hypothesises to enable known group 
difference testing.  The literature is limited about the role PU severity, duration and 
location play in affecting HRQL outcomes.  Such gaps in knowledge limit the ability to 
develop strong hypotheses to evaluate known group validity.  Scale development is an 
on-going process.  As the PU-QOLI scales are implemented and used in different 
samples, the estimates of validity, reliability and responsiveness may change as 
subsequent data is collected, and consequently various modifications to the scales 
may be needed.  The usefulness of new measures is therefore demonstrated by 
multiple applications in different studies (accumulative body of evidence to support the 
measurement properties of new scales). 
 
The PU-QOLI scales have the potential to be scientifically strong measurement tools 
however they are currently limited in their ability to detect differences in HRQL 
outcomes between people with different PU severity.  Thus, in order for the scales to 
be valuable measurement tools for individual patients, these limitations need to be 
addressed.  The targeting issues already discussed and the findings from the known 
group analysis suggest that some PU-QOLI scales may be limited in their ability to 
detect clinical change when it occurs and some items may underestimate differences in 
PU impact in people with superficial PUs.  This has important implications for the 
inferences of future research using the PU-QOLI.  Further evaluations are warranted to 
maximise the PU-QOLI as a measure of PU impact on HRQL in people with PUs. 
 
Another consideration is that during field testing, as is standard practice, many patients 
would have received some form of treatment for their PU.  This information was not 
collected (e.g. amount of analgesia).  As such, the true impact of PUs may not have 
been captured (lower severity represented in the sample due to treatment effect) and 
be the reason for, at least in part, mistargeting and misrepresentation of known groups 
testing.  In actual fact, PUs appear to cause patients more bother than was 
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represented in the sample (as indicated from the qualitative work) but because of good 
care received, lower PU impact was demonstrated in the sample.   
 
Given the heterogeneity of the population with PUs, further work is required to ensure 
that the PU-QOLI scales fit the needs of all people with PUs including patients with 
superficial PUs.  One tool is intended for effectiveness intervention research where 
patients with all PU severity might be included in research (e.g. a mattress trial where 
both improvement and deterioration in HRQL needs to be assessed) and differences in 
HRQL are explored by severity.  In research and clinical practice, information 
pertaining to treatments received can be collected and accounted for when analysing 
PU-QOLI data for changes within patients.  The intention is to flag issues, promote 
patient-clinician communication, and help guide decisions on patient treatment and PU 
management.  The next step of this research will investigate the sensitivity of the PU-
QOLI scales to change, accounting for any treatment received. 
 
The PU-QOLI was developed in adult patients with PUs of any location, duration or 
severity, receiving any PU-specific intervention from primary and secondary care.  Until 
further validation, PU-QOLI scales are not considered valid for patients that were not 
represented in the development process.  Despite being a multi-centre study including 
34 centres around the UK from various settings and specialities, there were a 
disproportionate number of different ethnicities represented in this sample.  
Convenience sampling resulted in recruitment of predominantly British-white nationals.  
Therefore the results of this study may not be generalisable to all patients with PUs in 
the UK.  More research is needed to determine suitability for use of PU-QOLI scales 
with non-white ethnic groups.  Further, it was not possible to include patients with 
cognitive impairment due to the unavoidable difficulty of obtaining informed consent 
from these patients.   
 
Another limitation of this study was that items with DIF were not accounted for.  A post-
hoc qualitative evaluation of the possible reasons for DIF are recommended (303, 351), 
however were beyond the scope of this research.  At this stage the intention was to 
develop good scales (item level statistics) and examine some key clinically reasonable 
variables with the intention of flagging any potential issues with DIF for generating 
hypotheses/experimental tests for future investigation.  DIF was marginal in this study 
and therefore not worrying at this stage (scale formation stage of the research).  
However, as DIF is a product of the sample and not the scale, the potential issues with 
DIF might need to be accounted for psychometrically in subsequent evaluations.   
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On a similar note, misfitting persons were not accounted for.  To ensure good quality 
data is collected when obtained using PU-QOLI scales, person fit and item responses 
should be considered.  As the intention was to develop good scales, only item level 
statistics were considered at this stage.  Once scales demonstrate valid and reliable 
measurement, then problematic person data can be considered and interpreted.  The 
Rasch model can be used to identify person misfit by identifying individual persons‟ 
response patterns across scale items (i.e. responses to each item for misfitting persons 
are reviewed in an attempt to highlight any unexpected responses), and determining 
whether responses are inconsistent with expectation, hence misfitting.  The pattern of 
responses invokes enquiry as to why such an unlikely pattern of responses occurred.  
The cause of the misfit requires further qualitative exploration of the individuals (85).   
 
Mixed methods were used throughout this work but as new ideas were explored in this 
thesis, the work was often undertaken with little guidance.  Consequently, a range of 
exploratory work was carried out including use of mixed methods during pretesting and 
investigation of optimal administration methods.  Mixed methods research was 
challenging in that each has established methods that often constrained the work in 
this thesis.  For example, current guidance recommends a three step process to 
instrument development including early qualitative work to generate constructs and 
content, pretesting and psychometric evaluation.  This model was followed but proved 
suboptimal for PU-QOLI development.  An interactive, iterative approach, with better 
use of qualitative methods would have been beneficial.  Both qualitative and empirical 
findings should be used to inform subsequent work and to make improvements to new 
scales.  The findings suggest that current scale development guidelines may need to 
be revised.   
 
8.7 Implications of findings 
This research stemmed from a need for precise and comprehensive PRO measures for 
research and clinical practice to assess important outcomes for patients with PUs.  The 
use of ad hoc measures without a theoretical basis or psychometric testing in much PU 
research motivated the work in this thesis.  In the first instance, appropriate 
assessment of outcomes in healthcare requires inclusion of PRO assessment.  In 
developing the PU-QOLI, HRQL conceptual domains important to patients with PUs 
were identified.  Elucidation of conceptual domains important in PUs provides a useful 
framework for designing future research, and consequently improving the quality of 
research in the PU field by inclusion of PU-specific PROs.  Implications for clinical 
practice and future PU research are considered below. 
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8.7.1 Clinical practice 
There are many potential benefits for using PRO measures in clinical practice, 
including: facilitation of clinician-patient communication and shared decision making; 
identifying and prioritising patient problems; screening for hidden problems; identifying 
patient preferences; monitoring changes or outcomes of treatment; training new staff; 
measurement of the performance of healthcare providers; and clinical audit (113, 352, 
353, 354, 355, 356).  The PU-QOLI potentially provides a means for comprehensive 
assessment of the impact of PUs, and a way of quantifying the benefits of PU 
interventions from the patient‟s perspective; a recognised essential part of healthcare 
evaluation (357, 358).  Thus, subject to further work, PU-QOLI data could provide an 
important source of information for supporting patient-focused decision making, provide 
a PRO measure for intervention and evaluation research, increase understanding of 
the impact of PUs on individuals, and ultimately result in adjustments in care delivery to 
meet patient requirements.  This is particularly important for changing practice through 
mandated NICE guidance, where the perceived value of PU interventions and 
evaluating PROs associated with treatment and relative PU burden must have a robust 
evidence base (86, 120, 359) and can help inform decisions about the most 
appropriate management of PUs. 
 
Importantly, trials of PU intervention clinical effectiveness have not used the highest 
quality PROs (122, 123, 360).  The selection of appropriate outcome measures 
underpins the meaningful interpretation of study results (i.e. data can only be 
meaningful if the instruments used to collect the data are valid and reliable and 
appropriate to address the research question) (87, 361).  Further, the assessment of 
treatment benefits as perceived by patients is particularly important as they may differ 
from clinically important outcomes.  Hence, a range of carefully selected and 
complementary outcomes may be needed for clinical practice for the measurement of 
benefits from health expenditure and in the assessment of the management and 
delivery of healthcare in the PU field. 
 
It may be premature to expect that the PU-QOLI will rapidly gain acceptance for clinical 
practice.  In practice, the focus is on PU prevention or treatment that ultimately results 
in healing, rather than assessment of PROs.  PU management should involve 
multidisciplinary care plans with consideration of all factors contributing to and affecting 
the wound as well outcomes important to patient.  However, concerns about PU-QOLIs 
relevance to patients with superficial PUs and its ability to accurately detect differences 
in people known to differ on clinical presentation, suggests that PU-QOLI scales are 
currently not suitable for clinical use.  Further work is needed to improve the 
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measurement precision and psychometric properties before it is used for the 
assessment and management of individual patients in clinical practice. 
 
8.7.2 Research 
Quality outcome instruments are the cornerstone of clinical research.  The findings 
support the PU-QOLI as valid and reliable according to FDA criteria for use in clinical 
trials (86),  however the Rasch analysis findings highlighted that further work is 
required before the PU-QOLI scales can be used as the main PRO measure in future 
clinical trials or other research.  PU-QOLI scales could be included as one outcome 
measure amongst others in future PU research (e.g. clinical trials, observational or 
epidemiological studies, audit and service evaluation) on the proviso that studies have 
built in a parallel psychometric analysis to indicate the performance (psychometric 
evaluation) of the scales in future samples.  Currently, the PUQOLI scales are most 
appropriate for patients with severe PUs, as demonstrated by a lack of items to 
represent people with little or no bother due to PUs.  The exudate and odour scales are 
not intended for people with superficial PUs (<category 2 PU).  Electronically defined 
skip questions would assist in the selection of scales and items that are relevant to 
each patient‟s circumstance.  Appropriateness for PU-QOLIs use in individual decision-
making requires further investigation.   
 
The PU-QOLI and practical information necessary for administration and scoring in a 
user‟s manual will be made freely available via the University of Leeds, CTRU website.  
The PU-QOLI should be administered using the manual.  Due to limitations to PU-
QOLIs measurement properties, the manual will also include information to potential 
users about the purposes for which the PU-QOLI should and should not be used. 
 
Individual scales can be selected depending on the nature of the research and the 
research question of interest (individual scale scores rather than an overall HRQL 
score)Imputation of missing data, based on methods undertaken for scoring the SF36 
(95), can be undertaken provided at least 50% of items are complete for an individual.  
For these cases missing data can be imputed using the person mean substitution (the 
mean scale score divided by the completed items) (100, 362).  Cases with less than 
50% data complete are excluded.  There are some limitations to imputation (i.e. making 
assumptions about unknown item values, bias in estimating values (363)) but these 
can be overcome by providing a scoring algorithm for all PU-QOLI scales; this method 
would not require imputation of missing data (expanded in Section 8.8.3, Clinical 
application).  Questions 3 (overall pain), 4 (itchiness) and 13 (overall QoL) (Appendix 
6.1) are not included in scale scores but provide descriptive information for clinical 
223   General discussion 
 
 
decision making.  All scale items are scored 0 (no bother) to 2 (a lot of bother).  Scale 
items are summed to produce a total scale score.  A lower score indicates better 
outcome. 
 
It is increasingly important to demonstrate the value of healthcare interventions within 
the cost effectiveness framework used by NICE.  To date, PU interventions have 
struggled to demonstrate their value within this framework due to the lack of 
appropriate health outcome measures.  NICE guidelines (54, 55, 364) highlight that in 
the PU field resource availability is not based upon health economic evaluation and 
there is no systematic way of considering patients priorities for interventions.  So whilst 
efforts have been made to develop evidence-based practice, a major limitation of 
national guidelines is that they are largely based upon consensus and not an evidence-
base.  In addition, PUs usually develop as a secondary medical problem in a wide 
case-mix of patients.  Due to the multitude of medical problems these patients often 
face, issues surrounding resource allocation and priority setting arise.  Data from the 
PU-QOLI could be used to improve knowledge of different PU treatments (i.e. 
comparison of different wound management approaches and „end results‟ such as 
patients‟ perceived benefit of treatment) and of the health problems faced by patients 
with PUs.  This information could then be used (in part) as a basis for determining 
efficient allocation of resources for healthcare.  Further, a mapping of PU-specific 
constructs to a utility measure would allow cost-effectiveness analysis (expanded 
Section 8.8.1, Use in economic evaluation).  The use of rigorous outcome measures 
will provide evidence-based information to allow health authorities to select the most 
effective healthcare for patients and to audit and monitor the quality of care given.   
 
During the last decade, the NHS has become more interested in audit, and have 
started the routine collection of PRO data for all patients before and after receiving 
NHS-funded care via its PRO measures initiative (365).  Routine audit in PUs using the 
PU-QOLI could assist clinicians in monitoring the outcomes of care.  This data could be 
part of a dataset collected in addition to other clinical data, as has already proven 
possible by the NHS PRO measures initiative.  Such data can enhance evidence-
based policy and help to inform treatment guidelines in the PU field, which are of 
interest to government bodies such as NICE.  The use of such data in conjunction with 
other treatment outcome and cost information will help determine the cost effectiveness 
of different methods of PU care and help prioritise patient care according to the impact 
on patient‟s HRQL.  This is pertinent as it is increasingly necessary to carry out multi-
centre clinical trials to demonstrate benefits gained from various treatments and 
interventions. 
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Finally, using a PU-specific instrument may provide a more appropriate comprehensive 
assessment of important outcomes that compliment the information generated by 
generic measures.  Importantly, generic measures do not include, for example, the 
assessment of PU symptoms or limitations of movement such as transferring that are 
specific consequences of PUs; thus useful clinical indicators for tissue viability 
specialists.  In addition, the methods used to develop and evaluate the PU-QOLI could 
be applied to other PRO instruments.  Uniformity of research approaches used to 
develop PRO measures could lead to consistency in health measurement and the 
inclusion of Rasch measurement methods in accepted international guidelines.   
 
8.8 Future research 
8.8.1 Further development and evaluation of PU-QOLI  
The PU-QOLI was found to be acceptable, reliable and valid in line with FDA criteria 
(86), supporting the applicability for use with patients with PUs in future research.  
However, issues with item response categories and sample-to-scale targeting emerged 
which suggest that some of the scales require further work to improve the top end of the 
measurement range and subsequent empirical demonstrations in well targeted 
samples.  Inspection of threshold distributions demonstrated sub-optimal targeting for 
most scales (items did not span the full range of the patient sample).  However, scale 
scores for >65% of the samples were within the best performing part of the scales.  For 
example, the pain scale items spread 2-logits compared to a person spread of 7 logits, 
indicating suboptimal targeting.  But for the vast majority of people in the sample, the 
pain scale performed well as the measurement range distribution was within the range 
where most people lay.  This work has been the first step to producing PU-specific 
scales.  The final Rasch analyses provide an initial evidence-base for future testing to 
improve the PU-QOLI scales and to establish the extent that psychometrically sound 
scales have been developed.  Small samples are considered adequate for a Rasch 
analysis if there is good targeting (261), however future studies utilising larger samples 
should be undertaken using Rasch analysis to confirm this study‟s findings.  Despite 
attempts to sample the broad PU population, including a wide variety of patients with 
PUs drawn from different settings, a problem with targeting emerged.   
 
The problem of targeting could be improved by developing PU-QOLI scale items that 
span a wider range of measurement.  Although item-level floor and ceiling effects are 
likely to exist to some extent, attempts should be made to minimise them in order to 
maximise the potential of the PU-QOLI to detect change.  Three scales had large floor 
effects, implying that it may be beneficial to extend their measurement range in the 
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future.  This can be achieved without affecting the scales as they stand, because the 
item locations are calibrated relative to each other.  This work was the first step 
towards establishing item estimates for each PU-QOLI scale.  Future scale 
developments can be empirically driven as the distribution of item locations highlight 
where „gaps‟ in the measurement continuum are (notable distances in item locations 
could be filled with items, particularly those representing superficial PU impact), and 
the distribution of person measurements indicate that it may be valuable to extend the 
measurement range at the extreme ends of the continuum.  Subsequent work would 
extend this work and move towards establishing better precision and construct definition 
(cumulative data will allow for establishing better precision of item estimates or finding 
empirical support for the ones established in this study).  Qualitative work would be 
needed to explore the addition of items to extend the measurement range or more PU-
QOLI data for item calibration to confirm the fixed item estimates.   
 
Another consideration is that the scales produced are hypotheses of how each variable 
could be measured in PUs.  So despite the finding of narrow measurement ranges for 
some scales, in reality this may be true in PUs.  Put another way, the true 
measurement range for each variable is actually captured and represented by each 
PU-QOLI scale but in this instance the sample was mistargeted.  The finding is that the 
targeting was not optimal, not necessarily the item estimates; in this sample this might 
be the reality.  Noteworthy, during development, scale construction was carefully 
thought-out (content of each scale) and underpinned by sound qualitative work that 
included patients at every stage of the development process, which led to the produced 
hypothesised scales.  Finally, further evaluation of the response format of the scales 
should be undertaken as some items indicated problems with the scoring function.  The 
scoring function in this study was assessed in small samples, therefore requires further 
examination to guide decisions about whether rescoring is appropriate. 
 
In the short-term, to begin exploring some of the measurement issues outlined, it is 
proposed that data from both field tests will be merged and the psychometric properties 
reanalysed.  Data from both field tests will increase the sample size and provide 
accumulating evidence for the appropriateness of PU-QOLI scales and items.  Further 
psychometric evaluation and replication is a basic requirement for any new instrument, 
and although all the results require replication, test-retest reliability in particular should 
be evaluated in a larger sample, and further consideration should be given to the 
targeting and response option categories.   
 
Evaluation of responsiveness 
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Responsiveness of the PU-QOLI needs to be evaluated in future research.  
Determining PU-QOLIs ability to accurately detect true change is essential if it is to be 
used to evaluate PU interventions.  PRO instruments need to be able to detect the 
effects of treatment on outcomes and changes in outcome over time.  Further, the 
effect of PU interventions on HRQL is largely unknown.  It is intended that 
responsiveness will be evaluated in a future PU mattress clinical trial (PRESSURE II). 
 
Proxy and cross-cultural PU-QOLI 
PU-QOLI scales are not considered valid for patients that were not represented in the 
development process.  To address this limitation, development of condition-specific 
modules (e.g. SCI-specific) and proxy measures (to enable patients with cognitive 
impairment to be included in research) are recommended.  The PU-QOLI is not for use 
with children (under 18 years) or those with cognitive impairment.  People with 
cognitive impairment are often excluded from PU research studies, despite the 
considerable number of people with cognitive impairment that develop PUs.  This 
presents a major challenge to health and social services.  During field testing, 
approximately 40% of patients screened for study participation were assessed as 
cognitively impaired.  Given the high percentage of patients with cognitive impairment, 
outcome measures are needed to enable inclusion of these patients in future research 
as well as for evaluations of PU interventions to widen the potential use of the PU-
QOLI.  Such work would require the development of a proxy measure intended for 
patients who are cognitively impaired or who lack capacity.  The FDA guidance 
identifies that some patients over the course of a clinical trial may become too ill to 
complete a questionnaire or respond to an interview, suggesting that proxy reporting 
may help to prevent missing data.  Qualitative work with carers of people with PUs is 
needed to determine whether the perspectives of carers are consistent with the 
perspective of people with PUs.  If so, the current PU-specific conceptual framework 
provides a useful basis for the development of PU-QOLI-proxy.  Work is needed to 
assess the relationship between patient and proxy reports.  An alternative to a proxy 
measure may be validating the PU-QOLI for carer-assisted mode of administration 
 
The PU-QOLI was developed in a UK population.  Relatively few participants in this 
study were from minority ethnic groups.  Given the cultural diversity in the UK there is a 
need to be able to judge the effectiveness of interventions in people with PUs from 
minority ethnic groups.  Moreover, there is need for PRO instruments that can be used 
in cross-national studies such as multi-country and multi-centre RCTs.  This requires 
linguistic validation studies on language translations and cross-cultural adaptation of 
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the PU-QOLI for use in other groups and cultures, particularly as patient perceptions 
are not independent of their cultural environment.   
 
Use in economic evaluation 
There is need for a PRO instrument for use in economic evaluations of interventions for 
people with PUs.  Work is planned, as part of the larger NIHR PU Programme of 
Research, to use the PU-QOLI to generate health scenarios for the development of a 
preference-based measure specific to PUs for use in economic evaluation. 
 
8.8.2 Methodological research 
Feasibility of self-completed PU-QOLI for community patients 
The mixed methods work undertaken in this thesis provided evidence for the feasibility 
of a self-completed version for community patients.  However, as the study was not 
powered accordingly (n=33 community patients), more work is needed to confirm 
appropriateness.  Nonetheless, the results provide positive preliminary evidence for a 
community self-completed version and items where DIF is reaching significance were 
identified.  Parallel use of qualitative methods to determine reasons for DIF may allow 
these issues to be accounted for (i.e. adapt/improve items) if pursuing a self-completed 
version in the future. 
 
Prognostic modelling 
The PU-QOLI can be included in clinical research evaluating PU interventions, wound 
care management and healthcare services; subject to further replication and 
demonstration of responsiveness.  In addition, there has been little study of mediating 
factors associated with HRQL in PUs.  The PU-QOLI will allow for the investigation of 
how HRQL is affected by other factors related to the person with PUs (e.g. severity, 
location and duration of PUs, motivation and other psychosocial factors), their family 
and/or carer (e.g. nature and quality of relationship), and factors associated with 
experience of care (e.g. satisfaction with treatment, perceived professional 
competence).  There is also a lack of prospective studies measuring changes in HRQL 
over time.  Such studies would allow for the identification of factors predicting higher 
and lower HRQL.  At group level, longitudinal studies are needed to enable the 
interpretation of scores, in particular the meaning of change scores.  Further work may 
be needed to elaborate on particular aspects of wound care management and skincare 
following healing in order to provide a richer picture of the impact of PUs on HRQL.  
Finally, unlike other chronic wounds that may be the principal health problem (i.e. leg 
ulcers), PUs are usually a consequence of other comorbidity associated with mobility 
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impairment (e.g. stroke, multiple sclerosis, dementia).  Little work has been done to 
evaluate HRQL in these sub-groups. 
 
Computer adaptive testing 
There is growing interest in, and use of, computer technology in the collection of PRO 
data.  Computer adaptive testing (CAT) can help minimise routine errors and omissions 
that can occur when asking questions, recording responses and following complex skip 
instructions (253).  The concept of CAT is based on presenting the respondent with 
only the most relevant items to his/her ability or disability level (item presentation is 
guided by the respondent‟s response to previous items) (366), thus minimising the 
number of items required to obtain a reliable measure on a particular trait or variable 
(367).  Despite benefits of using CAT in healthcare (e.g. reducing respondent burden), 
set-up costs associated with purchasing hardware and programming computers may 
be prohibitive for use by many researchers and application in clinical settings. 
 
8.8.3 Next steps 
Reanalysis 
For strengthening the psychometrics and decisions made to PU-QOLI items and 
scales, reanalysis of PU-QOLI scales from data combined from field tests one and two 
is proposed.  In a Rasch analysis, people at the extremes of the scale range (those at 
the floor/ceiling) are excluded from the estimation of item statistics as they offer no 
comparison across the items to facilitate the examination of relative item difficulty (85).  
This is because people at the extremes of the scale range achieve the same score on 
all the items of the scale.  In the PU-QOLI analysis, people at the extremes were 
excluded thus the sample for evaluating item statistics were computed from only n = 27 
to 184 range.  Combining the samples would increase the sample size.   
 
The presence of many extreme scores can influence the variability across the range of 
the scale and influence the targeting.  For example, for exudate and odour symptoms, 
patients with superficial PUs are not expected to have problems with these symptoms; 
only severe PUs where skin breakdown occurs is attributed with exudate and odour.  
As the sample consisted of patients with both superficial and severe PUs, 
approximately half the sample would not be expected to have problems with these 
symptoms.  As these patients were included in the analysis, the samples produced 
poor targeting with many patients considered extremes.  For the next PU-QOLI version, 
consideration of the addition of screening questions such as “have you had any 
problems with smell or odour because of your PU in the past week?” (If yes, complete 
the questions below; if no, move onto the next question) will be made. 
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Clinical application 
A pertinent question for tissue viability specialists is the appropriateness of using the 
PU-QOLI for individual clinical decision-making.  The intention is to develop the PU-
QOLI as a clinical intervention tool intended for targeted treatment.  This may require 
the development of a short-form version of the PU-QOLI, where the most clinically 
appropriate items from each scale are selected (342).  Like in other clinical areas (113, 
368), it would be used to facilitate patient-clinician communication and assist with 
priority setting.  Importantly, completion of PU-QOLI prior to meeting with a tissue 
viability specialist would allow for issues most important (or bothersome) to patients to 
be discussed during the consultation and direct treatment decisions that consequently 
improve HRQL outcomes for patients.  It is advised that the development work would 
include the construction and testing of a scoring algorithm programme to enable wide 
use of the PU-QOLI to inform clinical management of individual patients across 
different clinical settings and ease the interpretation of scale scores (368). 
 
Translation and validation 
Interest has been expressed from members of the EPUAP regarding PU-QOLI 
translation into various European languages however uncertainty about which methods 
to use to undertake this work were stressed.  It is proposed that as part of the PU-QOLI 
user manual, guidelines for language translation will be included based on 
internationally accepted methods (86, 102, 369).   
 
8.9 Summary and Conclusions 
The thesis aimed to assess the applicability of developing a new PRO instrument for 
people with PUs.  A review of the literature revealed that few studies measured HRQL 
outcomes related to PUs and treatment.  If assessed, generic or chronic-wound 
specific PROs were used but the outcomes important in PUs were inadequately 
covered despite similarities between conceptual models.  This suggested the need for 
an easy, standardised method for assessing health outcomes important to patients with 
PUs.  Given the limitations of the PU research literature, this work was the first to 
conceptualise the impact of PUs on HRQL from the patients perspective, and develop 
a PRO instrument that captures issues important to patients using development and 
evaluation methods accepted and applied in the wider health measurement field.  In 
addition, various methodological developments were woven into the research.  They 
highlighted that the traditional three stage approach may not be appropriate for 
producing scientifically sound scales in all clinical areas.  What was demonstrated was 
that small iterative steps, using mixed methods in an interactive way, particularly at 
early content and scale format/design development, is needed.   
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A PRO instrument for people with PUs (the PU-QOLI) was developed and validated.  It 
includes 10 outcomes of PU symptoms, limitations of physical functioning, 
psychological functioning, and social participation.  This thesis demonstrates that PUs 
impact on HRQL and the PU-QOLI provides a method for evaluating HRQL in PUs.  
The PU-QOLI is intended for interview-administration, following a user manual, and is 
currently appropriate for use in adults with severe PUs of any location or duration, and 
suitable for use in all UK healthcare settings.  Individual scales can be selected for use, 
depending on the nature of the research and scale items can be summed to produce 
scores, without weighting or standardisation.   
 
Longitudinal studies should be undertaken to assess the responsiveness of the PU-
QOLI over time, as clinical studies evaluating the efficacy of various PU treatments and 
interventions require accurate detection of true change.  Further research is also 
needed to: confirm the study findings in an independent sample and the generalisability 
of the findings from this study; investigate the feasibility of use in specific subgroups, 
economic evaluation; and the development of proxy measures and language 
translations given the prevalence of cognitively impaired patients with PUs and the high 
PU prevalence worldwide.  Long-term goals include developing the PU-QOLI as a 
clinical tool intended for individual-patient decision making and applying the 
methodology used in this thesis to other medical areas.  This could lead to the 
development of guidelines that include mixed methods as well as the more 
sophisticated psychometric methods, such as Rasch measurement.  This work was the 
first step towards establishing measurement precision but additional research is 
needed to improve some of the measurement properties of PU-QOLI scales. 
 
This study makes important contributions to the PU and wider health measurement 
fields.  The findings demonstrate that mixed methods, including Rasch measurement 
methods were a suitable approach to developing a new PRO instrument specific for 
PUs (the PU-QOLI); a methodology that can be applied for further development of the 
PU-QOLI as well as PROs in other health areas.  The PU-QOLI provides a means for 
the comprehensive assessment of PU impact and for quantifying the benefits of PU 
interventions from the patient‟s perspective, thus far lacking in the area.  And finally, 
PRO measurement needs to become more common place in the PU field so that the 
goal of PU management can be to enhance and maintain the HRQL of people with 
PUs.  Subject to further development as detailed above, PU-QOLI is a tool with which 
to evaluate whether PU treatments and the healthcare given achieve this; outcomes 
that are ultimately best judged by patients themselves. 
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Appendices 
 
Appendix 2.1 Search strategies  
Pressure Ulcer filter 
1. decubitus.sh 
2. skin ulcer.sh 
3. exp decubitus ulcer 
4. decubitus ulcer$.tw 
5. pressure ulcer$.tw. 
6. pressure damage$.tw 
7. pressure sore$.tw 
8. bed sore$.tw  
9. skin ulcer$.tw 
10. or/1-9 
 
PU Symptom terms 
11. exp pain 
12. pain.tw 
13. comfort$.tw 
14. acceptab$.tw 
15. discomfort.tw 
16. exp quality of sleep 
17. sleep.tw 
18. exp smell 
19. smell$.tw 
20. odo?r$.tw 
21. exudat$.tw 
22. or/11-21 
 
QoL terms 
23. (sf36 or sf 36).ti,ab,tw,sh,kw 
24. (eq5d or eq 5d or 
euroqol).ti,ab,tw,sh,kw 
25. (short form 36 or shortform 36 or sf 
thirtysix or sf thirty six or shortform 
thirtysix or shortform thirty six or 
short form thirtysix or short form 
thirty six).ti,ab,tw,sh,kw 
26. (hrql or hrqol or qol or hql or 
hqol).ti,ab,tw,sh,kw 
27. (hye or hyes or health$ year$ 
equivalent$ or health 
utilit$).ti,ab,tw,sh,kw 
28. rosser.ti,ab,tw,sh,kw 
29. (quality of wellbeing or quality of 
well being or quality of wellbeing 
index or qwb).ti,ab,tw,sh,kw 
30. (wellbeing or well 
being).ti,ab,tw,sh,kw 
31. (health utilities index or 
hui).ti,ab,tw,sh,kw 
32. (medical outcomes survey or 
mos).ti,ab,tw,sh,kw 
33. (qaly$ or qualy$ or quality adjusted 
life or quality adjusted life year or 
quality of life or life 
quality).ti,ab,tw,sh,kw 
34. exp quality of life 
35. quality of living.tw 
36. (health status or health 
state$).ti,ab,tw,sh,kw 
37. health status indicators.mp 
38. sickness impact 
profile.ti,ab,tw,sh,kw 
39. health measurement$.ti,ab,tw,sh,kw 
40. (health survey questionnaire$ or 
health survey$ or health care 
survey$).ti,ab,tw,sh,kw 
41. (general health questionnaire$ or 
ghq).ti,ab,tw,sh,kw 
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42. or/23-41 
 
Patient issue terms 
43. patient.tw,mp  
44. view$.tw 
45. satisfaction$.tw 
46. preference$.tw 
47. opinion$.tw 
48. perspective$.tw 
49. concern$.tw 
50. issue$.tw 
51. experience$.tw,mp 
52. journey$.tw,mp 
53. (worry or worries).tw,mp 
54. (attitude$ or emotion$ or 
feeling$).tw 
55. ((psycho$ or social) adj (adjust$ or 
adap$)).tw 
56. (cope$ or coping).tw 
57. or/44-56 
58. 43 and 57 
59. exp emotion 
60. depression.tw,mp 
61. exp stress 
62. exp stress, psychological 
63. exp adaptation, psychological 
64. exp acceptance, psychological 
65. or/59-64 
66. 58 or 65 
67. 22 or 42 or 66 
68. 10 and 67 
 
RCT filter 
1. randomi?ed-controlled-trial.pt 
2. meta-analysis.pt 
3. controlled-clinical-trial.pt 
4. clinical-trial.pt 
5. (clin$ trial$).tw 
6. control$ and (trial$ or stud$).tw 
7. random$.tw 
8. (meta-analys?s or metaanalys?s or 
meta analys?s).tw 
9. (singl$ or doubl$ or tripl$ or trebl$) 
and (blind$ or mask$).tw 
10. exp clinical trial.sh 
11. research-design.sh 
12. comparative study.sh 
13. placebo$.tw 
14. crossover.ti,ab,sh 
15. or/1-14 
16. 15 and pressure ulcer filter above 
 
Comprehensive search strategies 
including (a) Thesaurus terms, (b) 
Free text terms, and (c) Broad-based 
terms for Qualitative studies 
 
(A) Thesaurus Terms 
1. qualitative research 
2. nursing methodology research 
3. questionnaires 
4. exp attitude 
5. focus groups 
6. discourse analysis.mp 
7. content analysis.mp 
8. ethnographic research.mp 
9. ethnological research.mp 
10. ethnonursing research.mp 
11. constant comparative method.mp 
12. qualitative validity.mp 
13. purposive sample.mp 
14. observational method$.mp 
15. field stud$.mp 
16. theoretical sampl$.mp 
17. phenomenology 
18. phenomenological research.mp 
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19. life experience$.mp 
20. cluster sampl$.mp 
21. or/1-20 
22. 21 and pressure ulcer filter above 
 
(B) Free Text Terms 
1. ethnonursing.af 
2. ethnograph$.mp 
3. phenomenol$.af 
4. grounded theory.mp 
5. (grounded adj (theor$ or stud$ or 
research or analys?s)).af 
6. ((life stor$) or women$ stor$)).af 
7. (emic or etic or hermeneutic$ or 
heuristic$ or semiotic$).af or (data 
adj1 saturat$).tw or (participant 
observ$).tw 
8. ((social construct$ or (postmodern$ 
or post-structural$) or post 
structural$ or poststructural$) or 
post  modern$) or post-modern$ or 
feminis$ or interpret$).mp 
9. (action research or cooperative 
inquir$ or (co operative inquir$) or 
(co-operative inquir$)).mp 
10. (humanistic or existential or 
experiential or paradigm$).mp 
11. (field adj (study or studies or 
research).tw 
12. (human science).tw 
13. (biographical method).tw 
14. (qualitative validity).af 
15. (purposive sampl$).af 
16. (theoretical sampl$).af 
17. ((purpose$ adj4 sampl$) or (focus 
adj group$)).af 
18. (account or accounts or 
unstructured or open-ended or 
(open ended) or text$ or 
narrative$).mp 
19. ((life world) or life-world or 
conversation analys?s or personal 
experience$ or theoretical 
saturation).mp 
20. (lived experience$).mp 
21. (life experience$).mp 
22. (cluster sampl$).mp 
23. (theme$ or thematic).mp 
24. category$.mp 
25. observational method$.mp 
26. field stud$.mp 
27. focus group$.af 
28. questionnaire$.mp 
29. (content analysis).af 
30. (thematic analysis).af 
31. (constant comparative).af 
32. (discourse analys?s).af 
33. ((discourse$ or discurs$ adj3 
analys?s).tw 
34. (constant adj (comparative or 
comparison)).af 
35. (narrative analys?s).af 
36. Heidegger$.tw 
37. colaizzi$.tw 
38. speigelberg$.tw 
39. (van adj manen$).tw 
40. (van adj kaam$).tw 
41. merleau adj ponty$).tw 
42. Husserl$.tw 
43. giorgi$.tw 
44. Foucault$.tw 
45. (corbin$ adj2 strauss$).tw 
46. (strauss$ adj2 corbin$).tw 
47. (glaser$ adj2 strauss$).tw 
48. glaser$.tw 
49. or/1-48 
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50. 49 and pressure ulcer filter above 
 
 (C) Simple broad-based terms 
1. findings.af 
2. interview$.af or Interviews 
3. qualitative.af 
4. or/1-3 
5. 4 and pressure ulcer filter above 
 
The following refinement filter was 
added to all the searches listed above: 
 
Refinement filter 
1. historical article.pt. 
2. review.pt. 
3. (systematic adj review$).ti,ab,pt 
4. (meta adj analysis).ti,ab 
5. audit.ti,ab,pt 
6. case report.tw,sh,mp 
7. (case adj stud$).ti,ab,pt 
8. exp guidelines 
9. letter.pt. 
10. comment.pt. 
11. editorial.pt. 
12. or/1-11 
13. (all final searches above) not 12 
14. limit 13 to humans 
15. leg ulcer.mp 
16. varicose ulcer.mp 
17. pilonidal.tw 
18. surgical flap$.mp 
19. skin transplantation$.mp 
20. burn$.mp 
21. gunshot.mp 
22. corneal ulcer.mp 
23. exp dentistry 
24. peptic ulcer.mp 
25. duodenal ulcer.mp 
26. stomach ulcer.mp 
27. fistula$.mp 
28. bite.tw 
29. or/15-28 
30. (all final searches above) not 29 
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Appendix 2.2 Additional Searches 
Theses and dissertations 
The following databases were searched for theses and dissertations: 
 Proquest 
 Networked Digital Library of Theses and Dissertations (NDLTD) 
 International Theses in Progress 
 Theses Canada Portal 
 Australian Digital Theses Program (ADT) 
 Russian Academy of Sciences Bibliographies 
 Index to Theses 
 
Hand searching 
 Journals 
The following specialist journals were hand searched: 
 Journal of Tissue Viability, 1990-present 
 Journal of Wound Care, 1991-present 
 Wounds Repair and Regeneration, 2000-present 
 Review European Pressure Ulcer Advisory Panel, 1999-present 
 International Wound Journal, 2004-present 
 European Wound Management Association Journal, 2001-May 2007 
 Journal of Health and Quality of Life Outcomes, 1999-present 
 Journal of the American Medical Association archive collection of „Quality of 
Life‟, 1998-present 
http://pubs.amaassn.org/cgi/collection/quality_of_life?page=1) 
 
 Conference proceedings 
The following conference proceedings were hand searched: 
 European Conference on Advances in Wound Management, 1991 - 2000 
 Conference of the European Wound Management Association, 2001 - 2006 
 Proceedings of the European Wound Management Association and Journal of 
Wound Care, 1997 - 1998 
 2nd World Union of Wound Healing Societies‟ Meeting, 2004 
 Journal of Wound Healing 2nd Conference, 2005 
 Wounds UK Conference, 2004 
 The European Pressure Ulcer Advisory Panel Open Meeting, 1997 - 2007 
 European Tissue Repair Society, Focus Meeting, 2000 - 2005 
 Conference of the International Society Of Quality Of Life Research, 1997 - 2007 
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Experts 
The following experts in the field were contacted to enquire about ongoing and recently 
published research: P Price; D Mendoca; S Bale; M Fox; A Hopkins; D Langemo; D 
Rastinehad; S Wellard; C Moffatt; J Krause; P Franks; C Dealey  
 
Additional searches 
 UK National Research Register 
http://www.dh.gov.uk/en/Aboutus/Researchanddevelopment/AtoZ/DH_4002357 
 Internet search of web content relating to PU self-help and focus group:  
- http://www.ukselfhelp.info/ 
-  http://www.patient.co.uk/selfhelp.asp  
- http://www.dipex.org/DesktopDefault.aspx (website offering personal patient 
experiences of various health and illnesses)  
 Patient-Reported Outcome and Quality of Life Database (PROQOLID, 
http://www.qolid.org/)  
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Appendix 3.1Topic Guide: Example questions 
I. Intro/Background and General Questions 
 Tell me a little about your experience- 
 When was the skin problem first noticed? What were you told about the PU?  
 Did you tell anyone? What did you do when you first realised you had a PU? 
II. Experience and impact 
 What is it like to live with a PU? 
 How has your life changed since your ulcer developed?-anything else? 
 What kinds of things are more difficult for you to do?  Any other tasks? 
III. Treatment and HC/wound management questions 
 Have you received any treatment on that area? 
 Can you tell me about your experience of the wound care treatments that you 
received (i.e. symptoms; acceptability; satisfaction)? 
 How has your PU been attended to, what sorts of things have been done?  
IV. Patient involvement 
 Have the different types of wound treatments been discussed with you? 
 Have you sought ways to help yourself rather than tell someone/ask for help?  
 Have you considered alternative treatment and actually sought it? 
V. Visualisation and PU improvements 
 Have you seen it? (If yes, what did you think about it? How did it make you 
feel? If no, has anyone else seen it, how have they described it to you?  
 Would you have liked to have seen it? (pictures, mirror, during dressings) 
VI. General health and symptoms 
 How would you describe your general health?  
 Has developing a PU changed how you perceive your health status? 
 What kind of symptoms have you experienced? 
VII. Pain & pain assessment  
 Can you try and describe the pain you feel? Do you feel pain at other times? 
 Tell me how it feels when you move/sit/stand/reposition? 
VIII. Final questions 
 If someone came to you and said “I‟m going to develop a PU what should I 
expect”, what would you tell them? How would you prepare them? 
 Have you experienced anything else that we have not covered today?  
 Is there anything else that you want to add about your experience? 
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Appendix 4.1. Search Strategy for review of existing PROs used in pressure 
ulcers and similar chronic wounds 
 
Pressure Ulcer terms  
1. decubitus.sh 
2. skin ulcer.sh 
3. exp decubitus ulcer 
4. decubitus ulcer$.tw 
5. pressure ulcer$.tw. 
6. pressure damage$.tw 
7. pressure sore$.tw 
8. bed sore$.tw  
9. skin ulcer$.tw 
10. or/1-9 
 
Chronic wound terms 
11. chronic wound$.tw 
12. leg ulcer$.tw 
13. foot ulcer$.tw 
14. venous ulcer$.tw 
15. necrotic wound$.tw 
16. ischaemic ulcer$.tw 
17. arterial ulcer$.tw 
18. fungating wound$.tw 
19. diabetic ulcer$.tw 
20. varicose vein$.tw 
21. dehisced wound$.tw 
22. pilonidal.tw 
23. or/11-22 
24. 10 or 23 
 
QOL terms (Symptoms, social 
functioning, mood, life satisfaction) 
25.  (wellbeing or well 
being).ti,ab,tw,sh,kw 
26. (hrql or hrqol or qol or hql or 
hqol).ti,ab,tw,sh,kw 
27. exp quality of life 
28. quality of living.tw 
29. (health status or health 
state$).ti,ab,tw,sh,kw 
30. (satisfaction or life satisfaction or 
satisfaction with life).tw 
31. (attitude$ or emotion$ or feeling$ or 
mood$).tw 
32. ((psycho$ or social) adj (adjust$ or 
adap$ or function$)).tw 
33. (cope$ or coping).tw 
34. exp emotion 
35. exp psychological 
36. exp adaptation, psychological 
37. exp acceptance, psychological 
38. symptom$.tw,ab,sh,kw 
39. exp pain 
40. pain.tw 
41. exp smell 
42. smell$.tw 
43. odo?r$.tw 
44. exudat$.tw 
45. or/25-44 
 
Measures terms 
46. (instrument$ or questionnaire$ or 
survey$ or measure$).kw,ab,ti  
47. (patient outcome$ or patient 
reported outcome$ or 
PRO$).ti,ab,tw,sh,kw 
48. (sf36 or sf 36).ti,ab,tw,sh,kw 
49. (eq5d or eq 5d or 
euroqol).ti,ab,tw,sh,kw 
50. (short form 36 or shortform 36 or sf 
thirtysix or sf thirty six or shortform 
thirtysix or shortform thirty six or 
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short form thirtysix or short form 
thirty six).ti,ab,tw,sh,kw 
51. sickness impact 
profile.ti,ab,tw,sh,kw 
52. (medical outcomes survey or 
mos).ti,ab,tw,sh,kw 
53.  (quality of wellbeing or quality of 
well being or quality of wellbeing 
index or qwb).ti,ab,tw,sh,kw 
54.  (hye or health$ year$ equivalent$ 
or health utilit$ or health utilities 
index or utilit$ approach$ or health 
gain or hui or hui2 or hui 2 or hui3 
or hui 3).ti,ab,tw,sh,kw  
55.  (qaly$ or qualy$ or quality adjusted 
life or quality adjusted life year or 
quality of life or life 
quality).ti,ab,tw,sh,kw 
56. health measurement$.ti,ab,tw,sh,kw 
57. (health survey questionnaire$ or 
health survey$ or health care 
survey$).ti,ab,tw,sh,kw 
58. (general health questionnaire$ or 
ghq).ti,ab,tw,sh,kw 
59. health status indicators.mp 
60. (disutilities or disutility or daly or 
disability adjusted life).ti,ab. 
61. preference based.ti,ab. 
62. (state adj2 valu$).ti,ab. 
63. (categor$ scal$ or linear scal$ or 
linear analog$ scal$ or visual scal$ 
or magnitude estimat$).ti,ab. 
64. (multiattribute$ health or multi 
attribute$ health).ti,ab. 
65. (multiattribute$ theor$ or multi 
attribute$ theor$ or multiattribute$ 
analys$ or multi attribute$ 
analys$).ti,ab. 
66. (multiattribute$ utilit$ or multi 
attribute$ utilit$).ti,ab. 
67. or/46-66 
68. 24 and 45 
69. 24 and 67 
70. 68 or 69 
 
Refinement 
71. historical article.pt. 
72. review.pt. 
73. (systematic adj review$).ti,ab,pt 
74. (meta adj analysis).ti,ab 
75. audit.ti,ab,pt 
76. case report.tw,sh,mp,pt 
77. (case adj stud$).ti,ab,pt 
78. exp guidelines 
79. letter.pt. 
80. comment.pt. 
81. editorial.pt. 
82. or/71-81 
83. 70 not 82 
84. limit 83 to humans, English, adult 
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Appendix 4.2 Additional searches  
Hand Searched Journals 
 Journal of Tissue Viability, 1990-present 
 Journal of Wound Care, 1991-present 
 Wounds Repair and Regeneration, 2000-present 
 International Wound Journal, 2004-present 
 European Wound Management Association Journal, 2001-May 2007 
 Journal of Health and Quality of Life Outcomes, 1999-present 
 Journal of the American Medical Association archive collection of „Quality of 
Life‟,1998-present http://pubs.amaassn.org/cgi/collection/quality_of_life?page=1) 
Hand search Conference Proceedings 
 European Conference on Advances in Wound Management, 1991 - 2000 
 Conference of the European Wound Management Association, 1997 - 2006 
 2nd World Union of Wound Healing Societies‟ Meeting, 2004 
 Journal of Wound Healing 2nd Conference, 2005 
 Wounds UK Conference, 2004 
 The European Pressure Ulcer Advisory Panel Open Meeting, 1997 - 2008 
 European Tissue Repair Society, Focus Meeting, 2000 - 2005 
 Conference of the International Society Of Quality Of Life Research, 1997 - 2008 
Searched Theses and dissertation databases 
 Proquest 
 Networked Digital Library of Theses and Dissertations  
 International Theses in Progress 
 Theses Canada Portal 
 Australian Digital Theses Program  
 Index to Theses 
Experts 
The following experts in the field were contacted to enquire about ongoing and recently 
published research: P Price; D Mendoca; S Bale; M Fox; A Hopkins; D Langemo; D 
Rastinehad; S Wellard; C Moffatt; J Krause; P Franks; C Dealey  
Additional searches 
 UK National Research Register 
http://www.dh.gov.uk/en/Aboutus/Researchanddevelopment/AtoZ/DH_4002357 
 Patient-Reported Outcome and Quality of Life Database http://www.qolid.org/)   
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Appendix  5.1 Final PU-QOLI item map  
Domain 
(Sub-domain) 
 Reduced Item List (87) –  
post pretest 
Original Item list (118) 
Symptoms Feeling uncomfortable Feeling uncomfortable 
(Pain & Discomfort) Annoying pain or discomfort Annoying pain or discomfort 
Itchiness Itchiness 
 Tenderness Tenderness 
  Niggling 
  Soreness 
 A dull ache Aching 
  Pins and needles 
 Tingling Tingling 
 Throbbing Throbbing 
  Nagging 
  Shooting 
 Stinging Stinging 
 Stabbing pains Stabbing 
  Electric shocks 
 Red raw Red raw 
 Burning Burning 
(Exudate) Weeping Weeping 
  Oozing 
 Running Running 
 Sticky Sticky 
  Slimy 
  Wet 
 Messy Messy 
 Staining Staining 
 Causing dressing to come off Causing dressing to come off 
  Gungy 
 Pus Pus 
 Bleeding Bleeding 
(Odour) Unpleasant smell Unpleasant smell 
 Lingering smell Lingering smell 
  Dirty smell 
  Foisty smell 
 Stench or stink Stench 
  Stink 
  Stale smell 
 Pungent smell Pungent smell 
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Domain 
(Sub-domain) 
 Reduced Item List (87) –  
post pretest 
Original Item list (118) 
 Sickening smell Sickening smell 
 Putrid smell Putrid smell 
Physical functioning Difficulty sitting up in bed Difficulty sitting up in bed 
(Mobility/movement) Difficulty adjusting yourself in bed Difficulty adjusting yourself in bed 
 Difficulty turning or moving in bed Difficulty turning in bed 
 Difficulty pushing up to a sitting 
position 
Difficulty pushing up to a sitting 
position 
 Difficulty sitting in one position for 
long periods 
Difficulty sitting in one position for 
long periods 
 Difficulty standing for long periods Difficulty standing for long periods 
 Difficulty transferring (e.g. from 
bed to a chair or to a car) 
Difficulty transferring from bed to 
a chair 
 Feeling limited in your ability to 
walk 
Feeling limited in ability to walk 
 Feeling limited in your ability to go 
up and down stairs 
Feeling limited in ability to go up 
and down stairs 
 Feeling limited in how far you 
were able to walk 
Feeling limited in how far you 
were able to walk 
 Feeling that your walking was 
slowed down 
Feeling that your walking was 
slowed down 
(ADL) Being able to wash yourself in 
your usual way (e.g. hand wash, 
bath, shower) 
Washing yourself in the bath or 
shower 
 Getting dressed or undressed Getting dressed or undressed 
 Doing jobs around the house (e.g. 
cooking, housework, DIY) 
Doing housework 
 Doing gardening Doing gardening 
 Doing shopping Doing shopping 
 Being able to go to the toilet Going to the toilet 
  Being able to travel or drive a car 
 Doing things that you enjoy (e.g. 
reading a book, watching a 
movie, using a computer) 
Doing things that you enjoy 
  Getting up and about to do things 
that you enjoy 
 Being emotionally close or 
affectionate with loved ones 
Being intimate with loved ones 
 Doing your regular daily activities 
(e.g. work, volunteering, religious 
service, clubs, university) 
Doing usual work 
(General vitality) Feeling that your appetite has 
reduced 
Feeling that your appetite has 
reduced 
 Feeling unwell or poorly Feeling unwell or poorly 
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Domain 
(Sub-domain) 
 Reduced Item List (87) –  
post pretest 
Original Item list (118) 
 Feeling that your energy levels 
have been reduced (e.g. feeling 
tired, fatigued) 
Feeling that your energy levels 
have been reduced 
(Sleep) Trouble falling asleep Trouble falling asleep 
 Interrupted sleep (e.g. restless 
sleep or being woken up during 
your sleep) 
Restless sleep 
 Being kept awake Being kept awake 
  Being woken up during the night 
 Not getting the amount of sleep 
that you needed 
Not getting the amount of sleep 
that you needed 
 Having to sleep in one position 
(e.g. your back or side) 
Having to sleep in one position 
 Trouble finding a comfortable 
position 
Trouble finding a comfortable 
position 
Psychological  
well-being  
(Mood) 
Feeling frustrated Feeling frustrated 
Feeling fed-up Feeling fed-up 
Feeling annoyed or irritated Feeling annoyed 
 Feeling irritated 
  Feeling bad tempered 
 Feeling angry Feeling angry 
 Feeling miserable Feeling miserable 
 Feeling down Feeling down 
 Feeling depressed Feeling depressed 
(anxiety & worry)  Feeling fearful 
  Feeling afraid 
 Feeling upset Feeling upset 
 Feeling concerned or worried Feeling concerned 
  Feeling worried 
 Feeling anxious Feeling anxious 
  Feeling surprised 
  Feeling shocked 
(Self-efficacy & 
dependence) 
Feeling like a burden or nuisance 
on others 
Feeling like a burden or nuisance 
on others 
 Feeling like you have no control 
over your life because of your 
sore 
Feeling like you have no control 
over your life 
 Feeling physically dependent on 
others 
Feeling physically dependent on 
others 
(Appearance/self-
consciousness) 
Feeling helpless Feeling helpless 
 Feeling a lack of self-esteem 
Feeling self-conscious Feeling self-conscious 
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Domain 
(Sub-domain) 
 Reduced Item List (87) –  
post pretest 
Original Item list (118) 
 Lacking in confidence Feeling a lack of self-confidence 
 Feeling embarrassed Feeling embarrassed 
 Feeling physically unattractive Feeling physically unattractive 
  Feeling disinterested in 
socialising 
 Feeling uneasy being close to or 
around other people 
Feeling uneasy being close to 
people 
  Feeling worried about how others 
will react to your ulcer 
 Feeling a lack of understanding 
from those close to you 
Feeling a lack of understanding 
from those close to you 
Social functioning 
(Isolation) 
 Feeling left out 
 Feeling isolated 
Feeling cut off or isolated from 
others 
Feeling cut off 
 Feeling lonely Feeling lonely 
 Feeling like you were missing out Feeling like you were missing out 
 Feeling like people avoided you 
or treated you differently now 
Feeling like people avoided you 
or treated you differently now 
(Participation) Difficulty going out Difficulty going out 
  Being unable to meet up with 
others 
 Difficulty meeting up or seeing 
family and/or friends 
Difficulty seeing family and/or 
friends 
 Being unable to participate in 
family gatherings or activities 
Being unable to participate in 
family gatherings or activities 
 Having to plan going out around 
ulcer care 
Having to plan going out around 
ulcer care 
  Being unable to do things 
spontaneously 
 Having to give up on hobbies or 
leisure activities 
Giving up on hobbies or leisure 
activities 
 Being restricted to where you 
could go out 
Being restricted to where you 
could go out 
 Being restricted to how long you 
could stay out 
Being restricted to how long you 
could stay out 
 Being unable to get away for a 
holiday or make a trip at the 
weekend 
Being unable to get away for a 
holiday or make a trip at the 
weekend 
 The amount of time involved in 
caring for your ulcer 
The amount of time involved in 
caring for your ulcer 
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Appendix 5.2 - Preliminary PU-QOL version 
 
Pressure Ulcer Quality of Life Questionnaire (PU-QOL v1)  
 
 
This questionnaire asks your views about the impact that your pressure ulcer(s) has 
had on your everyday life during the past week.  
 
To start, please tick the box(es) below to indicate the part(s) of your body where you 
currently have a pressure ulcer(s).  
 
I currently have a pressure ulcer on my: (tick all that apply) 
 
       Sacrum (the area at the bottom 
       of your spine area) 
          Ankle/foot 
       Buttocks           Heel 
       Back of leg and/or thigh           Elbow 
       Hip           Head and/or face 
       Other, please specify: 
 
 
This questionnaire asks about your physical and social functioning, mood, and any 
symptoms that you may have experienced as a result of having a pressure ulcer(s). All 
of the information you provide is completely confidential.  
 
Please read all the questions that follow, and for each one choose the answer that best 
describes your experience by ticking  in the box. Only tick one box for each 
question.  
 
There are no right or wrong answers. If you are not sure how to answer a question, the 
first response you think of is often the best one. If you have more than one pressure 
ulcer, please try to think about the overall impact of your pressure ulcers when 
answering the questions. 
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People with pressure ulcers may experience some type of pain or discomfort. 
 
1. During the past week, how much were you 
bothered by these types of pain or discomfort 
from your pressure ulcer(s)? Not at all A little 
Quite a 
bit A lot 
a) Feeling uncomfortable     
b) Annoying pain or discomfort     
c) Itchiness     
d) Tenderness     
e) Niggling     
f) Soreness     
g) Aching      
h) Pins and needles     
i) Tingling     
j) Throbbing     
k) Nagging     
l) Shooting     
m) Stinging     
n) Stabbing     
o) Electric shocks     
p) Red raw     
q) Burning     
 
 
2. During the past week, how would you rate the overall pain or discomfort you 
experienced from your pressure ulcer(s)? 
 None 
 Very mild 
 Mild 
 Moderate 
 Severe 
 Very severe (excruciating) 
 
 
3. If you have experienced any pain or discomfort from your pressure ulcer(s) during 
the past week, how would you describe it? 
 I did not experience any pain/discomfort during the past week 
 Occasional 
 Intermittent 
 Only when I move 
 Only when the ulcer is touched 
 Only when the ulcer dressing is changed 
 Frequent 
 Constant 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
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People with pressure ulcers may experience leaking from their ulcer(s). 
 
4. During the past week, how much were you 
bothered by these types of leaking from your 
pressure ulcer(s)? Not at all A little 
Quite a 
bit A lot 
a) Weeping     
b) Oozing     
c) Running     
d) Sticky     
e) Slimy     
f) Wet     
g) Messy     
h) Staining     
i) Causing dressing to come off     
j) Gungy     
k) Pus     
l) Bleeding     
 
 
 
People with pressure ulcers may experience a smell or odour from their ulcer. 
 
5. During the past week, how much were you 
bothered by these types of smell or odour from 
your pressure ulcer(s)? Not at all A little 
Quite a 
bit A lot 
a) An unpleasant smell     
b) A lingering smell     
c) A dirty smell     
d) A foisty smell     
e) A stench     
f) A stink     
g) A stale smell     
h) A pungent smell     
i) A sickening smell     
j) A putrid smell     
 
 
 
 
 
 
 
 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
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Pressure ulcers may interfere with a person’s quality of sleep. 
 
6. During the past week, how much were you 
bothered by these sleep problems because of 
your pressure ulcer(s)? Not at all A little 
Quite a 
bit A lot 
a) Trouble falling asleep     
b) A restless sleep     
c) Being kept awake     
d) Being woken up during your sleep     
e) Not getting the amount of sleep that you 
needed 
    
f) Having to sleep in one position (e.g. your back 
or side) 
    
g) Trouble finding a comfortable position     
 
 
 
 
Now some questions about everyday movements.  
 
7. During the past week, how much were you 
bothered by these everyday movements 
because of your pressure ulcer(s)? Not at all A little 
Quite a 
bit A lot 
a) Difficulty sitting up in bed     
b) Difficulty adjusting yourself in bed     
c) Difficulty turning in bed     
d) Difficulty pushing up to a sitting position     
e) Difficulty sitting up in one position for long 
periods 
    
f) Difficulty standing for long periods     
g) Difficulty transferring from a bed to a chair     
h) Feeling limited in your ability to walk     
i) Feeling limited in your ability to go up and down 
stairs 
    
j) Feeling limited in how far you were able to walk     
k) Feeling that your walking was slowed down     
 
 
 
 
 
 
 
 
 
 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
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Now some questions about how you might be feeling within yourself. 
 
8. During the past week, how much were you 
bothered by these health aspects because of 
your pressure ulcer(s)? Not at all A little 
Quite a 
bit A lot 
a) Feeling that your appetite has reduced     
b) Feeling unwell or poorly     
c) Feeling that your energy levels have been 
reduced (i.e. feeling tired or fatigued) 
    
 
 
 
 
The following questions are about everyday activities.  
 
9. During the past week, how much were you 
bothered by difficulty doing these everyday 
activities because of your pressure ulcer(s)? 
None at 
all A little 
Quite a 
bit A lot 
a) Washing yourself in the bath or shower     
b) Getting dressed or undressed     
c) Doing housework (e.g. cooking or cleaning)     
d) Doing gardening     
e) Doing shopping     
f) Going to the toilet     
g) Being able to travel in or drive a car     
h) Doing things that you enjoy (e.g. reading a 
book, watching a movie) 
    
i) Getting up and about to do things that you 
enjoy 
    
j) Being intimate with loved ones     
k) Doing usual work (e.g. employment, 
volunteering, university, clubs) 
    
 
  
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
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Next are some questions about your feelings. 
 
10. During the past week, how much were you 
bothered by these feelings because of your 
pressure ulcer(s)? Not at all A little 
Quite a 
bit A lot 
a) Feeling frustrated     
b) Feeling fed-up     
c) Feeling annoyed     
d) Feeling irritated     
e) Feeling bad tempered     
f) Feeling angry     
g) Feeling miserable     
h) Feeling down     
i) Feeling depressed     
j) Feeling fearful     
k) Feeling afraid     
l) Feeling upset     
m) Feeling concerned     
n) Feeling worried     
o) Feeling anxious     
p) Feeling surprised     
q) Feeling shocked     
r) Feeling helpless     
s) Feeling a lack of self-confidence     
t) Feeling a lack of self-esteem     
u) Feeling self-conscious     
v) Feeling embarrassed     
w) Feeling physically unattractive     
x) Feeling disinterested in socialising     
y) Feeling uneasy being close to people     
z) Feeling worried about how others will react to 
your ulcer 
    
 
 
 
 
 
 
 
 
 
 
 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
284   Appendices 
 
 
 
Some more questions about your feelings. 
 
11. During the past week, how much were you 
bothered by these feelings because of your 
pressure ulcer(s)? Not at all A little 
Quite a 
bit A lot 
a) Feeling physically dependent on others     
b) Feeling left out     
c) Feeling isolated     
d) Feeling cut off     
e) Feeling lonely     
f) Feeling like you were missing out     
g) Feeling that people avoided you or treated you 
differently now 
    
h) Feeling a lack of understanding from those 
close to you 
    
i) Feeling like a burden or nuisance on others     
j) Feeling like you have no control over your life?     
 
 
 
Next are some questions about your usual social activities with family, friends, 
neighbours and groups. 
 
12. During the past week, how much were you 
bothered by these limitations in your social 
activities because of your pressure ulcer(s)? Not at all A little 
Quite a 
bit A lot 
a) Difficulty going out     
b) Being unable to meet up with others     
c) Difficulty seeing family and/or friends     
d) Being unable to participate in family gatherings 
or activities 
    
e) Having to plan going out around ulcer care     
f) Being able to do things spontaneously     
g) Giving up on hobbies or leisure activities     
h) Being restricted to where you could go out     
i) Being restricted to how long you could stay out     
j) Being unable to get away for a holiday or make 
a trip at the weekend 
    
k) The amount of time involved in caring for your 
ulcer 
    
 
 
 
 
 
 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
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13. We have asked about the impact of your pressure ulcer(s) on many aspects of 
your everyday life. Thinking about all of these aspects of your everyday life, how 
would you rate your overall quality of life? 
 
        Very Good             Good          Fair         Poor         Very Poor 
 
 
 
Thank you for completing the questions above. To end, some questions about 
you 
 
Your initials? _________________________________ 
 
Your date of birth? ________________________________(day/month/year)_ 
 
Your gender? (please tick)     Male   Female 
 
How long you have had your pressure ulcer(s)? _______________(months)_ 
 
Today‟s date: ___/___/_____ (day/month/year) 
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Appendix 5.3 Final pretested PU-QOLI for field testing 
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Appendix 6.1 Final PU-QOLv2 
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